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ABSTRACT 
 
Hydroxyapatite, (HAp), Ca10(PO4)6(OH)2, is a naturally occurring mineral found in the 
inorganic component of human bone and enamel. The constituent elements of HAp are 
primarily calcium and phosphorous, with a stoichiometric calcium to phosphorous ratio of 
1.667 capable of promoting intimate bone growth onto femoral implants. HAp is rendered a 
bioactive material since it has the ability to promote such growth with rapid fixation in what 
is also considered an osteoconductive process. The performance, lifespan and quality of the 
resultant biological coating in vivo is largely dependent on the coating morphology, phase 
composition, particle size and crystallinity of the powders pre-coating application.  
The present study aims to synthesise phase pure HAp powders via the wet chemical 
precipitation technique, in order to evaluate the critical process parameters and their effect 
(main and interaction) on controlling the final HAp powder characteristics, such as, phase 
composition, purity, crystallinity, crystallite size, lattice parameters, particle size and particle 
size distribution. These powders were synthesised with a view to satisfying regulatory 
requirements. These effects were quantified using Design of Experiments (Design Expert) to 
develop mathematical models, in terms of the chemical precipitation process parameters. 
HAp possessing optimum powder characteristics for orthopaedic application via the 
thermal plasma spray technique can therefore be prepared using the following chemical 
precipitation process parameters: reaction temperature 60ºC, ripening time 48h and stirring 
speed 1500rpm using high reagent concentrations. In the case of HAp synthesis at a lower 
reaction temperature, synthesis under a controlled environment (inert atmosphere) is desirable 
in order to achieve a high level of crystallinity: with an increase from 86.32% synthesised at 
20ºC to 95.19% synthesised at 60ºC. The presence of an inert atmosphere appears less critical 
at synthesis under increased levels of reaction temperature. Ripening time and stirring speed 
significantly affect the final phase purity. An increase in both the ripening time (0.5 - 48h) 
and stirring speed (600 - 1500rpm) can result in an increase of purity by 77.74% (21.15 – 
98.89%). Crystallite size, lattice parameters and mean particle size were also optimised within 
the research to find desired settings to achieve results suitable for FDA regulations. 
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1 INTRODUCTION 
 
HAp, Ca10(PO4)6(OH)2, is composed primarily of calcium and phosphorous with 
hydroxide ions that are eliminated at elevated temperatures. HAp and other related 
calcium phosphate minerals have been utilised extensively as implant materials for 
many years due to its excellent biocompatibility and bone bonding ability and also 
due to its structural and compositional similarity to that of the mineral phase of hard 
tissue in human bones. HAp coatings have good potential as they can exploit the 
biocompatible and bone bonding properties of the ceramic, while utilising the 
mechanical properties of substrates such as Ti6-Al4-V and other biocompatible 
alloys. While the metallic materials have the required mechanical properties, they 
benefit from the HAp which provides an osteoconductive surface for new bone 
growth, anchoring the implant and transferring load to the skeleton, helping to combat 
bone atrophy. 
 
Their Ca/P ratio of 1.52±2.0 makes them an excellent choice for most dental and 
orthopaedic application in the form of bioceramic coatings. The quality of a coating is 
closely dependent on the overall attributes and characteristics of the synthesised 
powders. Such attributes include phase composition, purity, crytsallinity, particle size, 
particle-size distribution, specific surface area, density and particle morphology. 
These important factors determine the resulting success of the HAp coating deposited 
onto orthopaedic implants through plasma thermal spraying. The chemical nature of 
HAp, however, lends itself to substitution, meaning that it is not uncommon for non-
stoichiometric HAp to exist. The most common substitutions involve carbonate, 
fluoride and chloride substitutions for hydroxyl groups, while defects can also exist 
resulting in deficient HAp. 
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1.1 AIMS OF THIS STUDY 
The aim of this research is to synthesise phase pure HAp powders via the wet 
chemical precipitation technique in order to evaluate the critical process parameters 
and their effect (main and interaction) on controlling the final HAp powder 
characteristics, such as, phase composition, purity, crystallinity, crystallite size, lattice 
parameters, particle size and particle size distribution. These powders will be 
synthesised with a view to satisfying regulatory requirements.  
 
It is the goal of this work to apply Design of Experiments (DoE) to develop 
mathematical models, in terms of the chemical precipitation process parameters. 
These models will assist researchers, engineers and industry to achieve desirable HAp 
powder characteristics. This approach assures the highest reliability, lowers process 
start-up costs and improves powder quality. Furthermore, DoE reduces the numbers 
of experiments without any significance loss in the accuracy of the models developed. 
In addition, the developed models are useful in predicting the effect of each response 
(that is, powder characteristic). It will also aid in the selection of the optimum process 
parameters to maximise or minimise the various response.  
 
The aim in developing these mathematical models using Fractional Factorial and Box-
Behnken designs, with the aid of Design-Expert (V7) statistical software, is to predict 
the following responses:  
 Phase purity. 
 Crystallinity  
 Crystallite sizes in the 002 and 300 plane. 
 Lattice parameter ratio 
 Particle size.  
 
The developed models will be presented in various plots (such as, 3D plots and 
contour graphs). These plots and graphs will explain the effect of the chemical 
precipitation parameters and their interactions on the above-mentioned responses. 
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Another aim is to demonstrate the individual effect of a certain parameter on a given 
response at such values of the remaining parameters and hence to determine the 
optimal combination of the process input variables, based on the developed models 
and numerical optimisation, to achieve the desired criterion. 
 
1.2 THESIS OUTLINE  
The thesis is divided into a number of sections. Chapter two discusses human bone 
composition and its mechanical properties. The various methods for synthesising HAp 
are considered. The end product of synthetic bone produced, that is, HAp, is then 
analysed on account of the physical and mechanical properties attainable and 
compared against those desired to simulate biological apatite. This chapter also 
discusses the great effect of the process parameters using the chemical precipitation 
technique for the synthesis of high HAp purity and crystallinity and examines the 
effect of varying these parameters on other HAp powder characteristics, such as, 
crystallite size, lattice parameters, particle size, morphology and its biocompatible and 
rheological properties. The chapter finishes with an outline of the standards pertaining 
to the requirements in fully satisfying the regulations (such as, FDA). 
 
Chapter three describes the process adopted to synthesise the HAp in this study via 
the chemical precipitation technique. An overview of the apparatus designed to allow 
for optimum control over the numerous precipitation parameters (such as, synthesis 
temperature, stirring speed, acid addition rate) is also outlined. The experimental 
equipment involved in the production of the HAp powders is presented along with its 
associated procedures. A description of the experimental designs and optimisation 
approach used in the current research is outlined in this chapter. The materials 
characterisation equipment used in the current investigation in order to characterise 
the HAp powder characteristics under the various experimental conditions are 
described with respect to HAp powder phase purity, crystallinity, crystallite size, 
lattice parameters, particle size and powder morphology. The equipment and methods 
for observing the rheological properties of the HAp in a slurry and powder form are 
also presented. An investigation to evaluate the in vitro behaviour of the synthesised 
powders is presented with a description of the cell studies and procedures outlined. 
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In chapter four, the experimental results and discussions are presented for the various 
HAp powders analysed in the comparative analysis of commercial HAp and for 
powders prepared under the various conditions based on the experimental designs 
(fractional factorial and box-behnken). The results show the phase composition 
(purity) and crystallographic properties (such as, crystallinity, crystallite size and 
lattice parameters) for HAp, as obtained through x-ray diffraction data. The particle 
size and particle size distribution results are determined using laser diffraction and 
discussed in contrast to their respective specific surface areas using the BET 
(Brunnaeur Emmett Teller) method. A morphological evaluation is presented for each 
HAp produced. The rheological properties (in slurry and powder) of the HAp are also 
discussed. The results investigating the biological responses of the prepared powders 
is also presented in this chapter. 
 
Finally, chapter five summarises conclusions from the results found within the present 
research, and presents recommendations for future research. The future research 
includes expanding the current study to investigate the effect of all the chemical 
precipitation process parameters on the final HAp powder characteristics using 
response surface methodology and also investigating the HAp precipitation 
mechanisms of which the transformation process could be investigated under different 
conditions, including the optimal ones.  
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_________________________________________ 
2 LITERATURE REVIEW 
 
2.1 INTRODUCTION 
Ceramic materials for orthopaedic applications were introduced in the 1970s, where 
failures of the biomaterials in use then, such as steel, cobalt alloys and poly (methyl 
methacrylate), began to be detected. Hence, attention was directed to ceramic 
materials in an attempt to find good bone integration features. 
 
Ceramic materials used in surgery can either be bioinert or bioactive. A bioinert 
material, is one which does not illicit a reaction with the surrounding physiological 
tissue upon implantation. A bioactive material, however, is one that allows a specific 
biological response at its interface, thus enabling the formation of links between the 
tissues and said material. [1] 
 
Hydroxyapatite, (HAp), and other related calcium phosphate minerals are used 
extensively to improve the integration of femoral implants into the hip joint. HAp 
appears the most promising due to its outstanding biological properties such us 
atoxicity, lack of inflammatory response and absence of fibrous or immunological 
reactions [1]. HAp possesses identical chemical composition and high 
biocompatibility with natural bone [2].  
 
The bioactive nature of HAp gives rise to a favorable reaction product, through a 
chemical transformation of its starting material to the desired final product. 
Subsequently, when HAp comes in contact with physiological fluids, a chemical 
reaction towards the production of newly formed bone takes place, in what is also 
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termed an osteoconductive process [1].  Bioactivity is related to a modification of the 
surface of the material with formation of naturally induced; biologically equivalent 
HAp as a result of dissolution, precipitation and ion exchange reactions with the 
physiological environment. This ability to bond to bone tissue without the formation 
of a fibrous tissue layer at the bone - implant interface is extremely important since it 
guarantees the fixation and stabilisation of implants and prostheses. The bone - 
implant interface mimics the type of interface that is formed when natural tissues 
repair themselves; it is dynamic in its nature, changes with time and requires a 
controlled degree of chemical reactivity of the ceramic [1]. Hence, the clinical 
advantage of HAp is due to its bioactive characteristics, which is dependent upon its 
synthetic structure such as chemical stoichiometry, crystallinity and surface 
morphology [1]. HAp has many crystallographic features that are similar to those of 
natural bone tissue; although they show insufficient mechanical reliability for medical 
applications where high loads are required [1]. 
 
Thermal spray processes have frequently been used to deposit functionally biomedical 
active coatings, such as HAp, onto prosthetic implants [3]. Kweh et al. [2] confirm 
from their investigation, that the quality of a HAp coating onto substrate is closely 
dependent on the overall attributes and characteristics of the synthesised powders. 
These attributes include particle size, particle-size distribution and particle 
morphology. These attributes help to determine the flow characteristics of the HAp 
particles in the powder-feeding systems and their subsequent melting behaviour in the 
plasma jet. Consequently, the use of powder particles with spherical geometry and 
narrow size distributions so as to induce excellent heat transfer and consistent melting 
capabilities, increase the deposition efficiency and decrease coating porosity [2]. 
Spherical powders in general have better rheological properties than irregular powders 
and, thus, produce better coatings for femoral implants [4]. 
 
Several attempts to determine the exact composition of HAp via chemical analysis 
were undertaken in the first half of the 18
th
 century. About a century later, the current 
concepts of synthesising materials comprising of the various calcium phosphate 
crystal phases was introduced [5]. Most calcium phosphates are classified as 
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resorbable biomaterials. This means that under physiological conditions they will 
dissolve. The benefit of calcium phosphate biomaterials is that the dissolution 
products can be readily assimilated by the human body. 
 
The following section will discuss human bone composition and its mechanical 
properties. The various methods of synthesising HAp will also be considered, 
highlighting the advantages and disadvantages associated to each technique for 
industrial application. The end product of synthetic bone produced, that is, HAp, will 
then be analysed on account of the physical and mechanical properties attainable and 
compared against those desired of natural bone. 
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2.2 BIOLOGICAL APATITE 
2.2.1 Natural Human Bone Mineral 
Precise knowledge of the physical, chemical, and mechanical properties of natural 
human bone is critical for the development of bone-like materials. The study of 
biological apatite (that is, human bone mineral) has been widely investigated. As a 
result, their chemical composition and structure is well understood. Natural human 
bone has a varied arrangement of material structures at many length scales which 
work in harmony to perform diverse mechanical, biological and chemical functions; 
such as structural support, protection and storage of healing cells, and mineral ion 
homeostasis. Scale is of importance in discussing bone architecture as the structure is 
hierarchical and complex. In order to understand the mechanical properties of bone 
material, it is important to understand the structural relationship between them at the 
various levels of hierarchical structural organisation This section therefore, outlines 
the various levels associated with the hierarchical structure of human bone, the 
chemical composition for the biological apatite mineral (carbonated apatite), the 
physiology of bone, bone remodelling, and biological responses. 
 
2.2.2 Hierarchical Structure Of Bone 
 
Despite the variety of external forms, the internal structure of bone is relatively 
consistent. Bone structure is hierarchically organized, which means that bone displays 
different structural entities at different length scales [6, 7]. Four structural levels of 
hierarchy can be distinguished in adult human bone. These levels will be denoted as 
the continuum level (or level 0), tissue level (level 1), cellular level (level 2) and 
molecular level (level 3). The structural entities at each level will be denoted as the 
macrostructure, mesostructure, microstructure and nanostructure, respectively. The 
hierarchical structural organisation in human bone is summarised in Figure 2-1 below. 
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Figure 2-1: Hierarchical structural organisation of bone: Level 1: cortical and 
cancellous bone; Level 2: osteons with haversian systems and lamellae; Level 3: collagen 
fiber assemblies of collagen fibrils and Level 4: bone mineral crystals, collagen 
molecules, and non-collagenous proteins. Adapted from [6, 8, 9] 
 
2.2.3 Macrostructure 
At the continuum level, the scale of 5 mm and higher, the bone structure is classified 
according to its porosity. The two classifications are cortical (or compact) bone and 
trabecular (or cancellous) bone. Cortical bone has a porosity ranging between 5% and 
10%, and it is usually found along the exterior shaft section of long bones. Cortical 
bone forms the outer shell around the trabecular bone in joints and in vertebrae [10]. 
Trabecular bone has a porosity ranging from 75% to 95%. It is usually found in 
cubicoidal bones (such as, vertebrae), flat bones (such as, the pelvis) and the end of 
long bones (such as, the femur). The non-mineralized spaces within trabecular bone 
contain bone marrow, which is a tissue composed of blood vessels, nerves and various 
types of cells. Cortical bone accounts for about 80% of the total skeletal mass while 
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trabecular bone constitutes some 70% of the skeletal volume. The anisotropic 
structure of bone leads to mechanical properties that exhibit directionality. This 
directionality results from the fact that bone has evolved to be both tough and stiff, 
two competing properties which are optimised in bone but with an inherent loss in 
isotropy. Nevertheless, bone exhibits extraordinary mechanical properties, displaying 
both viscoelastic and semi-brittle behaviour. The microstructure produced by the 
compaction of cancellous bone is composed of irregular, sinuous convolutions of 
lamellae. In contrast, the microstructure of cortical bone is composed of regular, 
cylindrically shaped lamellae. Therefore, reliable differentiation can only be achieved 
by microscopy methods. 
 
2.2.4 Mesotructure 
At the tissue level, the scale of 100 μm to 1 mm, major differences can be identified 
within the cortical and trabecular structures. Cortical bone is composed of osteons or 
Haversian systems. The osteons (150 to 300 μm in diameter and up to 3 to 5 mm in 
length) are embedded in a matrix of lamellar bone known as interstitial lamellae (see 
Section 2.2.) [8]. The central cavity inside an osteon is known as the Haversian canal. 
Haversian canals are typically 40 to 50 μm in diameter and run along the long axis of 
a bone. Normally a blood vessel (15 μm in diameter) as well as nerve terminations are 
found inside Haversian canals. Volkmann‘s canals are short transverse channels 
connecting the Haversian canals. These canals also contain blood vessels and 
probably nerves [10]. The mesostructure of trabecular bone is composed of plates and 
struts called trabeculae. Sometimes trabeculae appear organized into orthogonal 
arrays, but they are often more randomly arranged. Each trabecula is about 200 μm 
thick. Rarely, it is possible to find trabeculae thick enough to contain a blood vessel 
and some osteon-like structure. Within a trabecula, one can find trabecular packets, 
which are the product of new tissue formed after remodelling. A typical trabecular 
packet is about 50 μm thick and 1 mm long. 
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2.2.5 Microstructure 
At the cellular level, the scale of 5 to 50 μm, two types of bone can be found: woven 
bone and lamellar bone. Woven bone is a poorly organised tissue and may usually be 
found in adults post fracture injury. With maturation, the woven bone is converted 
into lamellar bone. Lamellar bone, adversely, is a slowly formed, highly organised 
bone tissue consisting of lamellae. The lamellae are bands or layers, 3 to 7 μm thick, 
forming an anisotropic matrix of mineral crystals and collagen fibers. Woven bone 
may become more highly mineralized than lamellar bone, which may help to 
compensate for its lack of organisation [10]. Trabecular packets and osteons are 
formed of lamellae and attached to the bone matrix by cement lines. The cement lines 
are found where bone resorption ends and bone formation begins. They are about 1 to 
5 μm in thickness. The ―porosities‖ at this level are identified as lacunae (ellipsoidal 
holes) and canaliculi (micro-channels) (refer to Figure 2-1). Canaliculi are about 0.2 
μm in diameter [11]. 
 
2.2.6 Nanostructure 
At the molecular level, the scale of 100 nm and smaller, there exists three main 
materials of importance, such as biologic apatite crystals, collagens, and non-
collagenous organic proteins. The mature crystals are not needle-shaped, but plate-
shaped [6, 8]. Plate-like biological apatite crystals of bone occur within the discrete 
spaces within the collagen fibrils, thereby limiting the possible primary growth of the 
mineral crystals, and forcing the crystals to be discrete and discontinuous. The 
mineral crystals grow with a specific crystalline orientation—the c axes of the crystals 
are roughly parallel to the long axes of the collagen fibrils [6, 8]. The average lengths 
and widths of the plates are 50 x 25 nm. Crystal thickness is 2–3 nm [6, 8]. The 
nanocrystalline bone apatite has small but significant amounts of impurities such as 
HPO4, Na, Mg, citrate, carbonate and K [8]. The carbonate apatite crystal, not only 
exhibit a hexagonal crystal structure but is shown to produce x-ray diffraction 
patterns, analogous to that of HAp [6]. An explanation for their plate-like structure is 
proposed by Weiner et al. [6] in that they grow via an octacalcium phosphate 
transition phase. Octacalcium phosphate crystals (explained in greater depth in 
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Section 2.5.4) are plate-shaped and have a structure very similar to apatite, except for 
the presence of a hydrated layer. 
 
2.2.7 Chemical Composition Of Human Bone Mineral 
Natural bone can be considered to comprise of both organic and inorganic material. 
Moreover, 90 – 95% of the organic component consists of collagen whilst the 
inorganic component consists primarily of calcium and phosphate [12, 13].  
 
A typical wet cortical bone is composed of 25 wt. % organic phase (that is, the 
matrix), 62 wt. % inorganic phase (that is, carbonated apatite; HAp), 10 wt. % water 
and 3wt. % residual (See Figure 2-2).  The organic phase consisting mainly of 
collagen laid down in the form of fibres aid in the provision of flexibility to bone. As 
discussed previously, the inorganic phase consists of submicroscopic crystals of an 
apatite of calcium and phosphate, whose crystal structure resembles that of carbonate 
HAp and other mineralised phases, such as, chlorapatite (ClAp), fluorapatite (FAp), 
sodium-containing apatite and magnesium-containing apatite. The mineral phase is 
made of a continuous cellular structure, which gives good mechanical strength. HAp 
is the main mineral constituent for bone, dentin and teeth. [12, 13] 
 
Figure 2-2: Chemical compositional analysis of human bone 
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As an estimate per weight, bone tissue is composed of 25% water, 43% mineral, 29% 
collagen and 3% of non-collagenous organic molecules (refer to Figure 2-3)  [10]. 
Bone stores 99% of the total body calcium while the remaining 1% circulates in the 
blood [8].  
 
 
Figure 2-3: Comportments of human bone tissue 
 
The inorganic component of human bone consists of calcium compound, as identical 
to synthetic carbonated  HAp, made up of calcium ions, phosphate ions and hydroxyl 
ions in the ratio of the chemical formula,  Ca10(PO4)6(OH)2. The constituent elements 
within bone mineral are given in Table 2-1. Mg, Na, K and carbonate ions are also 
present in bone salts, although they are not organised into specific crystals. Fluid Ca-P 
compounds in the matrix are transformed to HAp. 
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Table 2-1: Composition of the mineral phase in human bone. Adapted from [12 - 14] 
Mineral Component Chemical Formula 
 
Enamel Bone 
Constituents (wt. %)    
Calcium Ca2+ 36.0 24.5 
Phosphorous P 17.7 11.5 
Ca/P molar ratio 
 
 1.62 1.65 
Carbonate 
 
CO3
2- 3.2 5.8 
Sodium  
 
Na+ 0.5 0.7 
Magnesium 
 
Mg2+ 0.44 0.55 
Potassium K+ 
 
 0.08  0.03 
Chloride Cl- 
 
0.30 0.10 
Fluoride 
 
F- 0.01 0.02 
Total Inorganic 
(mineral) 
 97.0 65.0 
Total Organic  1.0 25.0 
Absorbed H2O  1.5 9.7 
Trace elements Sr2+, Pb2+, Zn2+, Cu2+, Fe3+   
 
While the main mineral components forming human bone are calcium (36.7 wt. %) 
and phosphorous (16.0 wt. %) with trace amounts of other minerals [15]; a significant 
amount of carbonate (7.4 wt. %), also appears to be present within the biological 
apatite, bone. Slosarczyk et al. [15] confirm that biological apatites present in; bone; 
dentin and enamel contain different amounts of carbonate 7.4: 5.6: 3.5 wt% 
respectively. The presence of CO3
2-
 in their structure is of paramount importance; as it 
is the main source of lattice distortion, creating microstresses and crystalline defects 
in its vicinity which, in turn, play a fundamental role in its solubility. As a 
consequence, synthetic apatites aimed at emulating the biological scenario should 
exhibit small particle sizes and the presence of CO3
2-
[1]. The apatite crystals which 
form natural bone are smaller than 500 Å (nm) in size. This is a critical factor in 
understanding the solubility of biological apatites and the continuous bone 
regeneration due to constant dissolution–crystallisation cycles. [1] 
 
On the other hand, the organic component of bone matrix comprises mainly of type I 
collagen; a fibrillar protein formed from three protein chains, wound together in a 
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triple helix. Collagen type I is laid down by bone forming cells (osteoblasts) in 
organised parallel sheets (lamellae) and subsequently the collagen chains become 
cross-linked by specialised covalent bonds (pyridinium cross-links) which help to 
give bone its tensile strength [12, 16]. When bone is formed rapidly, the lamellae are 
laid down in a disorderly fashion giving rise to "woven bone", which is mechanically 
weak and easily fractured. Bone matrix also contains small amounts of other 
collagens and several non-collagenous proteins and glycoproteins. Some of these, 
such as osteocalcin, are specific to bone, whereas others, such as osteopontin and 
fibronectin and various peptide growth factors are also found in other connective 
tissues. The function of non-collagenous bone proteins is unclear, but it is thought that 
they are involved in mediating the attachment of bone cells to bone matrix, and in 
regulating bone cell activity during the process of bone remodelling. The organic 
component of bone forms a framework upon which mineralisation occurs. During 
bone formation, osteoblasts lay down uncalcified bone matrix (osteoid) which 
contains the components described above and small amounts of other proteins, which 
are adsorbed from extracellular fluid. After a lag phase (~ 10 days), the matrix 
becomes mineralised, as HAp crystals are deposited in the spaces between collagen 
fibrils. Mineralisation confers upon bone the property of mechanical rigidity, which 
complements the tensile strength, and elasticity derived from bone collagen [16]. 
 
2.2.8 Human Bone Physiology 
In any specimen of bone, three functionally distinct cell types are present; osteocytes, 
osteoblasts, and osteoclasts (refer to Figure 2-4). An overview for each cell type is 
described as follows [12, 17, 18]: 
 
A. Osteocytes 
Osteocytes are small, inactive cells, seemingly isolated from one another in individual 
lacunae.  Inconspicuous cell processes extend out through tiny canaliculi and provide 
gap-junctional contact among neighbouring osteocytes as a means of communication 
and nutrient supply.   
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Figure: 2-4: Bone physiology. Osteoclasts are cells 20-100 μm in diameter that resorb 
old bone. Osteblasts are 10 μm in diameter and form new bone. Osteocytes are encased 
osteblasts that sense mechanical stimulus. Adapted from [18] 
 
B. Osteoblasts 
Osteoblasts (bone-forming cells) are small cuboidal cells, up to 10 μm in diameter, 
usually found lying adjacent to one another upon lamellae they have just secreted. 
Osteoblasts synthesise and deposit uncalcified new bone matrix (or osteoid). They are 
active in bone development and also in bone remodelling. During remodelling, these 
cells radially refill the gap open by the osteoclasts at a rate of about 1 μm per day 
(formation rate). Populations of osteocytes and osteoblasts may be interchangeable, 
reflecting different stages in the activity of individual cells.  That is, active osteoblasts 
that become enclosed in bone may adopt the resting osteocyte form, while osteocytes 
which are released from their bony matrix (by osteoclast activity) may become active 
osteoblasts. 
 
 
C. Osteoclasts 
Osteoclasts (bone-removing cells) are large cells with multiple nuclei, typically 20 to 
100 μm in diameter, each one typically sitting alone within a small hollow (Howship's 
lacuna) that it has just made by "eating" away the adjacent bone matrix. These cells 
secrete acids and enzymes to break down the mineralized bone matrix. Osteoclasts 
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remove pre-existing bone.  They erode bone structure as they make their way through 
the bone matrix at a rate of about 40 μm per day (resorption rate) [18]. They are active 
in bone development and also in bone remodelling. Osteoclasts are more closely 
related to macrophages than to osteocytes or osteoblasts.  They form a distinct cell 
population derived from the same precursor cells as macrophages.  
 
2.2.9 Bone Remodelling By Human Bone Cells 
Bone, as a living tissue, is continually adapting to changes in the physical 
environment. Throughout an individual‘s lifetime, old bone is removed (resorption) 
and new bone is added (formation). In human adults, 5% of cortical bone and 25% of 
trabecular bone is replaced every year by remodelling [10].  
 
From a physiological standpoint, bone modelling can be defined as the reshaping of 
bone by independent action of osteoblasts and osteoclasts. The modeling and 
remodeling processes of human bone are not indifferent at cellular level. They are 
based on the separate actions of bone resorbing cells, called osteoclasts, and bone 
forming cells, called osteoblasts [17, 19]. The remodeling process begins at a 
quiescent bone surface with the appearance of osteoclasts. These are large 
multinucleated cells that form by fusion of mononuclear precursors of haemotopoetic 
origin. They attach to the bone tissue matrix and form a ruffled border at the 
bone/osteoclast interface that is completely surrounded by a ―sealing‖ zone. Thus the 
osteoclast creates an isolated microenvironment. Subsequently the osteoclast acidifies 
the microenvironment and dissolves the organic and inorganic matrices of the bone. 
For a brief period after this resorptive process stops, osteoblasts appear at the same 
surface site. The osteoblasts derive from mesenchymal stem cells found in the bone 
marrow, periosteum and soft tissues. They deposit osteoid and mineralise it, so 
actually forming new bone. Some of the osteoblasts are encapsulated in the osteoid 
matrix and differentiate to osteocytes. Remaining osteoblasts continue to synthesize 
bone until they eventually stop and transform to quiescent lining cells that completely 
cover the newly formed bone surface. These lining cells are highly interconnected 
with the osteocytes in the bone matrix through a network of canaliculi. It appears that 
osteoclasts and osteoblasts closely collaborate in the remodeling process in what is 
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called a Basic Multicellular Unit (BMU) [17]. This indicates that a coupling 
mechanism must exist between formation and resorption. The nature of this coupling 
mechanism, however, is not known. The organisation of the BMU‘s in cortical and 
trabecular bone differs, but these differences are mainly morphological rather than 
biological. In cortical bone, the BMU forms a cylindrical canal of about 2000 mm 
long and 150-200 mm wide [17]. It gradually burrows through the bone with a speed 
of 20-40 mm/day [17]. In the tip, on the order of ten osteoclasts dig a circular tunnel 
(cutting cone) in the dominant loading direction. They are followed by several 
thousands of osteoblasts that fill the tunnel (closing cone) to produce a (secondary) 
osteon of renewed bone. In this way, between 2% and 5% of cortical bone is 
remodelled each year [17]. The remodeling process in trabecular bone is mainly a 
surface event. Due to the much larger surface to volume ratio, it is more actively 
remodelled than cortical bone, with remodeling rates that can be up to 10 times 
higher. Again osteoclasts come first in the process. They travel across the trabecular 
surface with a speed of approximately 25 mm/day, digging a trench rather than a 
tunnel, with a depth of 40-60 mm [17]. Like in cortical bone they are followed by 
osteoblast bone formation. Active remodeling sites cover areas of varying sizes from 
as small as 50×20 mm up to 1000×1000 mm [17] (refer to Figure 2-5). The trabecular 
BMU can be regarded as half a cortical BMU. The resulting structure that is formed is 
called a trabecular osteon or hemi-osteon. The cellular activities of osteoclasts and 
osteoblasts in modeling are basically similar to those in remodeling. However, in this 
case formation and resorption are not balanced, which causes changes in the micro-
architecture. It can even occur that the activities of osteoclasts and osteoblasts are 
entirely uncoupled. Indeed, complete unloading may cause resorption not to be 
followed by formation. That bone formation is not necessarily preceded by resorption 
can be concluded from the observation that lining cells at the bone surface can 
transform back to bone forming osteoblasts. 
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Figure 2-5: The bone remodeling cycle 
 
2.2.10 Mechanical Properties Of Human Bone 
The mechanical properties of the macrostructural form human bone (that is, trabecular 
and cortical) have been studied greatly; in terms of compressive strength, tensile 
strength, Young‘s modulus, hardness and fracture toughness. Overall, the differences 
between the mechanical properties in cancellous bone are much broader than those in 
cortical bone and indeed may vary by a factor of 2–5 from bone to bone [8]. To a 
great extent, differences between whole bones may be explained by the variance in 
their structure and mechanical function. 
 
In cortical bone the mechanical properties are influenced greatly by the porosity, the 
mineralisation level and the organization of the solid matrix. The mechanical 
properties of human cortical bone from the tibia, femur, and humerus have been found 
to vary between subjects, although the density remains the same. In human cancellous 
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bone, by contrast, there is no difference in the mechanical properties of the humerus, 
the proximal tibia, and the lumbar spine. [8] 
 
The mechanical properties are largely affected in vivo, with the orientation of bone 
specimen, which may be defined as longitudinal (running parallel to the predominant 
osteon ligaments), or transverse (through the osteon section) [12, 13]. An osteon 
defines a central long axis about which mineral-containing fibrils are arranged into 
lamellar sheets running helically with respect to the osteon. The mineral-containing 
fibrils are indeed the apatite-phase, forming needle-like crystals, which are orientated 
to the collagen fibre matrix [13]. 
 
Other factors, such as, humidity, mode of applied load, direction of the applied load 
and location of bone within the body also has an impact upon the mechanical 
properties of bone. Moreover, strength and other mechanical properties of bone 
depend upon bone density, porosity, and the molecular structure and arrangement of 
its constituent apatite crystals within their collagen matrix [13]. Typical mechanical 
properties of human bone are provided in Table 2-2. 
 
Table 2-2: Mechanical properties of human femoral (cortical) bone tissue [12, 13] 
Mechanical Properties 
Test direction related to bone axis 
Parallel Normal 
Tensile Strength (MPa) 
 
124 - 174 49 
Compressive Strength (MPa) 
 
170 - 193 133 
Young‘s Modulus (GPa) 
 
17 – 18.9 
 
11.5 
Micro Hardness (VPN) 
 
30-60 - 
Fracture Toughness (MPa m1/2) 
 
2-12 8 
Bending Strength (MPa) 160 
 
 
Shear Strength (MPa) 54 
 
 
Ultimate Tensile Strain (UTS) 0.014 – 0.031 
 
0.007 
Ultimate Compressive Strain 0.0185 – 0.026 
 
0.028 
Yield Tensile Strain 0.007 
 
0.004 
Yield Compressive Strain 0.010 
 
0.011 
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2.3 SYNTHETIC APATITE 
2.3.1 Hydroxyapatite (HAp) Calcium Phosphate 
Calcium phosphate in the form of crystallized HAp and/or amorphous calcium 
phosphate (ACP) provides stiffness to the bone [20]. The mechanical properties of 
natural human bone depend largely on the humidity of its surrounding environment 
[20]. HAp ceramics do not exhibit any cytotoxic (cell-killing) effects; rather it shows 
excellent biocompatibility with hard tissues and also with skin and muscle tissues. 
Moreover, HAp can bond directly to bone [2, 12, 13, 20]. The benefits of HAp 
materials in coated implants have been widely acknowledged, but the occurrence of 
several poor performances such as improper melting of the feedstock after spraying, 
reproducibility and satisfying biomedical requirements has generated concerns over 
the consistency and reliability of thermally sprayed HAp coatings [21]. Recent 
investigations using HAp coatings have shown that process related variability has a 
significant influence on coating characteristics such as phase composition, structure 
and chemical composition, and performance such as bioresorption, degradation and 
bone apposition [2]. Variation in process parameters such as powder morphology can 
induce microstructural and mechanical inconsistencies that have an effect on the 
service performance of the coating [21, 22]. 
 
Ca/P ratios from 1.5 - 2.0, of HAp, are commonly used for orthopaedic applications in 
the form of bioceramic coatings [1]. The ideal Ca/P ratio for stoichiometric (that is, 
pure, single phase) HAp is 1.667 and the theoretical density is 3.156g cm
-3
 [12, 13, 
23]. However, Suchanek et al. [24] reports that the Ca/P ratio does not significantly 
influence the grain growth of the HAp ceramics. Many studies conducted around the 
synthesis of HAp, show that a pH > 9.0 provides an appropriate environment for the 
formation of stoichiometric pure HAp powders [2]. HAp is the most stable calcium 
phosphate salt at physiological temperatures.  
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2.4 TECHNIQUES FOR PREPARING SYNTHETIC HAp 
The various methodologies employed to produce synthetic HAp are discussed in this 
section to provide the necessary background information with respect to HAp powder 
production techniques, used to date. It is important to note that each method is greatly 
dependent on their synthetic starter / raw materials [23]. Bernard et al. [25] 
investigated the effect of purity of raw materials on the end HAp product. . It was 
established that the stoichiometry (that is, optimum concentration) of the HAp 
precipitate and its purity post thermal treatment, depends on the quality of the raw 
materials used. The production of synthetic ceramic HAp powders may be classified 
under four main headings: 
 
i. Wet Chemical Synthesis (such as, Precipitation, Hydrothermal, Hydrolysis  and 
Sol-Gel Techniques) 
ii. Dry Chemical Synthesis (such as, solid-state reactions, mechanochemical 
synthesis) 
iii. Vapour Phase Reactions (such as, spray and freeze-drying) 
iv. Novel Techniques 
 
Since the present research utilises the wet chemical precipitation method to synthesise 
phase pure HAp, this method is discussed in detail, with an overview of other possible 
synthetic routes for its synthesis. A comprehensive discussion of all of these 
techniques and the kinetics of precipitation are explained in Kehoe [26]. In this work, 
the advantages and disadvantages of each technique are considered, and compared 
against that of the wet chemical precipitation method. 
 
The main advantage associated to the wet process, is that its by-product consists 
primarily of water and the probability of contamination during processing is very low. 
Low processing costs has also been reported. Its disadvantage is that the resulting 
product can be greatly affected by even a slight difference in the reaction conditions. 
The dry process, on the other hand shows high reproducibility in spite of the high risk 
of contamination during stages of milling and long heat treatment times [2, 13, 27].  
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2.4.1 Chemical Precipitation Route 
In the precipitation route, HAp powders are obtained from a chemical reaction of 
inorganic oxide solutions [23]. The two most popular ways in precipitating HAp are 
described in the two reactions below [2, 23, 28]: 
A. Reaction 1 
The precipitation method for the reaction of orthophosphoric acid with calcium 
hydroxide: 
        
OHOHPOCaPOHOHCa 226410432 18)()(6)(10             Equation (2-1)
 
B. Reaction 2 
The precipitation method for the reaction of diammonium hydrogen phosphate with 
calcium nitrate: 
OHNONHOHPOCaOHNHHPONHNOCa 23426410442423 620)()(8)(6)(10
                Equation (2-2)
 
 
Reaction 1 is simple, cheap, suitable for large scale industrial production and non-
polluting by nature, but often leads to the production of non-stoichiometric HAp, 
which creates subsequent problems during sintering (thermal decomposition of non-
stoichiometric HAp leads to TCP when the Ca/P molar ratio < 1.67), or to CaO when 
the Ca/P molar ratio > 1.67. In contrast, Reaction 2 is expensive to produce and 
polluting by nature, in that it‘s by products must be removed. The quality of the initial 
reagents also play an important role in obtained high quality phase pure HAp. 
Synthesis, based on Reaction 1 has demonstrated that the purity and the properties of 
the chemicals and process parameters, such as, reagent addition flow rate, stirring 
rate, pH and reaction temperature all have a significant influence on the final quality 
of the HAp in relation to its crystallinity, crystallite size, morphology, particle size 
distribution, density and surface area. Another study has shown the effect of ripening 
time on crystallinity and sinterability and mechanical properties for dense HAp can be 
related to the initial reagent properties. 
 
HAp synthesised by work conducted by Kweh et al. [2] using Reaction 2, have found 
that the reaction temperature, the reactant concentrations, rate of mixing the reactants 
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and the residence time can affect the overall characteristics of the HAp produced. The 
research also found that other phases can be produced with different reaction pH 
values. 
 
HAp with a Ca/P molar ratio, ranging from 1.5 to 1.667 (0 ≤ x ≤ 1) using the 
conventional aqueous precipitation method from the addition of a diammonium 
phosphate solution ((NH4)2HPO4) into a reactor containing a calcium nitrate solution 
was prepared by Raynaud et al. [22]. The device implemented was fully automated 
with the reactor placed in an argon atmosphere under dynamic flow in order to 
prevent any presence of CO2, which could result in carbonate apatite formation. In 
this study, pH and temperature of synthesis were the preponderant parameters for the 
control of the precipitate composition. 
 
Overall, precipitation techniques can produce small particle size and high-purity HAp 
powders, when the precipitation system and conditions are well controlled to obtain a 
reproducible precipitate. The important precipitation process variables include 
solution concentration (Ca/P ratio), pH, acid addition rate, stirrer speed, temperature, 
reaction time and atmospheric condition. [2] 
 
The overall production routes for both precipitation reactions are outlined in Figure 2-
6, while production routes concerning the hydrothermal [23, 28, 29], hydrolysis [30], 
sol-gel [31], solid-state [32 - 34], spray-drying [35] and freeze-drying [36, 37] 
techniques, as well as other various novel synthesis routes [38 – 42] for preparing 
HAp using novel precursor material [43], are outlined in Kehoe [26].  
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Figure 2-6: A flow chart for the synthesis of HAp powders via the precipitation route for 
Reaction 1 (left hand side) and Reaction 2 (right hand side) 
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2.5 PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES OF HAp 
The present section will review the physical and mechanical properties of synthetic 
HAp powders yielded from the implementation of the various HAp powder 
production techniques (as discussed in the previous section). This section will aim to 
highlight the main differences between the HAp synthesised to-date against that of 
biological HAp (section 2.2).  
 
2.5.1 Mechanical Properties Of HAp 
To produce implant materials capable of withstanding mechanical loads, it is 
necessary to use densely sintered HAp, which surpasses porous HAp in strength. 
Ceramics should consist of fine grains because, according to the well-known Hall - 
Petch formula [12]: 
 
                                                    bd0
-1/2                                                 
Equation (2-3) 
 
where δ0 and b are constants and d is the grain size, mechanical strength increases 
with decreasing grain size. The density of the HAp thus fabricated approaches 
theoretical density (3.156 g/cm
3
) [13]. 
 
Tables 2-3 and 2-4 presents the values published for physical properties pertaining to 
HAp and the mechanical and physical properties of synthetic HAp, respectively. The 
key characteristics for highly dense HAp are its bending strength, tensile strength, and 
fracture toughness. The bending, compressive, and tensile strength values of HAp lie 
in the ranges 38–250, 120–150, and 38–300 MPa, respectively [12, 13, 45]. The large 
scatter is due to many factors, such as, the random strength distribution and the effects 
of residual microporosity, grain size and ion impurities. With increasing Ca/P ratio, 
the strength increases, reaches a peak at Ca/P of 1.67, and sharply decreases for Ca/P 
> 1.67 [24]. 
 
Weibull‘s modulus of dense HAp lies in the range 5–18, characteristic of brittle 
materials. The decelerated crack propagation coefficient ranges from 26 to 80 in a dry 
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atmosphere and from 12 to 49 in a humid atmosphere, indicating a high sensitivity to 
decelerated crack propagation [24, 46]. 
 
Young‘s modulus of dense HAp varies from 35 to 120 GPa [24], depending on the 
residual porosity and impurities. Young‘s modulus in bending is 44 to 88 GPa. The 
Vickers hardness of dense ceramics is 3 to 7 GPa. Dense HAp ceramics exhibit 
superplasticity at temperatures between 1000 and 1100°C due to grain boundary slip. 
The wear resistance and friction coefficient of dense HAp ceramics are comparable to 
those of enamel.  
 
Table 2-3: Physical properties of synthetic HAp [12 - 15] 
Physical Property Metric Units 
Density 3.00 - 3.219 g/cc 
Porosity 0.1 - 3 % 
Lattice Parameters ( 003.0 nm)  
a lattice constant 9.432 – 0.9418 nm 
b lattice constant 6.881 – 0.6884 nm 
Crystallinity Index 33 - 37 
Crystallite Size 0.0250 x 0.0030 (nm) 
Ignition Products HAp + CaO 
 
Table 2-4: Mechanical properties of synthetic HAp [12, 13] 
Mechanical Properties Metric Units 
Ultimate Tensile Strength (UTS) 38 - 48 MPa 
Modulus of Elasticity 7 - 13 GPa 
Flexural Strength 100 - 120 MPa 
Compressive Strength 350 - 450 MPa  
Fracture Toughness, KIC <1.0 MPa.m
1/2
 
Poisson's Ratio 0.27 
 
It is evident that calcium phosphate in the form of crystallised HAp and/or amorphous 
calcium phosphate (ACP) provides stiffness to the bone [20]. The mechanical 
properties of bone, however, depend largely upon the humidity, mode of the applied 
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load, direction of the applied load and the location of the bone within the human 
body. Although HAp exhibits valuable properties as a biomaterial (regards 
biocompatibility, bioactivity, osteoconductivity, direct bonding with bones), its 
mechanical properties are poor, as indicated by its poor fracture toughness (KIC is 0.8 
to 1.2 MPa m
1/2
), which is found to decrease almost linearly with increasing porosity.  
As a consequence, this severely restricts its field of application in orthopaedics. 
However, it still remains an excellent candidate for coating metallic prostheses or 
filling small bone defects. In the former application it would result in a combination 
of the good mechanical properties of metals and alloys with the excellent 
biocompatibility and bioactivity of HAp in guiding the bone growth to bond firmly 
from a mechanical point of view [1]. 
 
Mechanical integrity of natural bone is optimised with respect to weight minimisation 
and the ability to rapidly deliver calcium to support histological processes. The latter 
two factors require porosity. The mechanical disadvantages of the presence of pores 
in bone, which are regarded as flaws from the standpoint of fracture mechanics, are 
overcome by the incorporation of a large proportion of collagen reinforcement. The 
conflicting requirements of mechanical integrity and porosity, supports the 
unlikeliness that a single material would be capable of closely approximating the 
mechanical functional requirements of bone.  
 
As natural bone consists of an inorganic/organic composite structure with grain size 
of 20 nm in diameter and 50 nm in length, from a bionics viewpoint, therefore HAp 
grains with a similar size would be more desirable for the application of implants 
[42]. Therefore, it is possible to consider a composite which can exhibit adequate 
mechanical properties. Kalita et al. [47] improved the densification, hardness and 
compression strength of synthetic HAp ceramics by introducing small quantities of 
MgO-CaO-P2O5-Na2O-based sintering additives. Some compositions showed more 
than a 40% increase in Vickers microhardness compared to pure HAp processed 
under the same conditions. Adding HAp to a polymer matrix was also found to 
strengthen the material as a whole, often raising the tensile strength to within the 
range of cortical bone [48]. 
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2.5.2 Crystal Structure Of HAp 
It is generally accepted that slightly nonstoichiometric HAp has the hexagonal space 
group P63/m structure, with a = 9.422 and c = 6.880 nm, while in the case of 
stoichiometric HAp the structure becomes monoclinic P21/b [49]. This is 
characterised by ordering within OH  ion columns to form a sequence OH OH OH
OH , with an ordered arrangement of these columns, so that the b-axis is doubled 
giving lattice parameters a = 9.421(8), b = 2a, c = 6.8814(7) nm, γ = 1203 [32]. 
However, stoichiometric HAp may also be hexagonal, if OH  are disordered. 
Normally, only those preparations that have a final high-temperature stage have the 
possibility of yielding monoclinic HAp. Other preparations are normally hexagonal, 
presumably because sufficient OH  ions are missing, replaced by H2O or impurity 
ions, so that the ordering is disturbed. Work carried out by the National Institute of 
Standards Technology (NIST) propose that the hexagonal form of HAp is formed by 
precipitation from supersaturated solutions at 25ºC to 100ºC, while the monoclinic 
form of HAp is primarily formed by heating the hexagonal form at 850ºC in air and 
then cooling to room temperature [50].  
 
Recent theoretical studies by Calderin et al. [51] however, find the hexagonal and 
monoclinic structures both energetically acceptable for HAp, but Haverty et al. [52] 
finds that the P63/m or the P63 hexagonal structural models are energetically 
unfavorable in comparison with a model based on the P21/b symmetry or the newly 
proposed monoclinic P21 structural model (see Figure 2-10). They also conclude from 
Rietveld analysis of X-ray diffraction patterns from a NIST standard reference 
specimen that HAp (SRM-2910) crystallizes in a mixture of 23% P21/b and 77% P21 
monoclinic phases [50].  The overall XRD patterns of hexagonal and monoclinic HAp 
are almost identical; however the pattern of monoclinic HAp has additional weak 
lines whose intensities are less than 1% of the strongest hexagonal HAp line [50]. 
 
Figure 2-11 illustrates a half unit cell of a hexagonal HAp structure projected onto the 
‗a‘ and ‗b‘ axes. The hydroxyl ions are located on the projection at the corners of the 
rhombic base of the unit cell forming columns of hydroxyls at the ‗c‘ axis of ¼ and ¾ 
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(or with a spacing of half the unit-cell height). There are two kinds of calcium-ion 
position contained in the lattice cell; hexagonal and columnar calcium.  
 
Figure 2-7: Various proposed HAp structures: Experimental HAp (Top: P63/m), 
Theoretical HAp (Middle: P63) and Monclinic (Bottom: P21/b). Adapted from [53] 
 
Hexagonal calcium ions (or six-calcium ions) are associated with these hydroxyls, 
forming equilateral triangles centred on and perpendicular to the hydroxyl columns. 
Six of the PO4
2-
-tetrahedra are also on these planes. Columnar calcium ions being the 
net total of 4-calcium ions, are placed at the lattice points of [1/3, 2/3, 0] and [1/3, 2/3, 
0] [13, 54].  Table 2-5 outlines the lattice coordinates for its unit cell. 
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Figure 2-8: Illustration of (A) crystal structure and (B) ac or bc face of Calcium HAp. 
The area enclosed by dotted lines was 0.943 nm (a or b) x 0.688 nm (c) = 0.649 nm
2
 [55] 
 
 
Table 2-5: Unit-cell positions of the HAp lattice [13] where; α = 90o, β=90o, γ =120o 
 
Atom  
 
 
x/a  
 
y/b  
 
z/c  
Ca(I)  1/3 2/3 0.0010 
Ca(II)  0.2464 0.9938 1/4 
P  0.3999 0.3698 1/4 
O(I)  0.3272 0.4837 1/4 
O(II)  0.5899 0.4666 1/4 
O(III)  0.3457 0.2595 0.0736 
Hydroxyl 0.0000 0.0000 0.1930 
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2.5.3 Substitutions In HAp 
An important consideration in the production and processing of HAp has been the 
control and the reduction in impurity levels (Table 2-6). These impurities may be 
classified as either substitutional or additional phases. Foreign elements obtained in 
HAp in the range of parts per million have not altered the overall biocompatibility 
response of the material [56].  
 
Table 2-6: Impurity contents in HAp [13] 
Trace element HAp powder 
(ppm) Laboratory (ppm) Commercial (ppm) 
Al - 100 - 1000 
Cu 8 1 - 10 
Fe 30 - 40 100 - 1000 
Ge - 10 - 100 
Mg 50 1000 - 2000 
Mn 3 - 8 100 - 1000 
Na 400 1000 - 3000 
Pb 7 1 - 10 
Si 200 100 - 1000 
Ti - 30 - 1000 
Zn 20 10 - 100 
 
 
HAp is capable of accommodating several substituents, while still maintaining its 
basic apatetic structure. Ca
2+
 can be substituted by various cations, such as, 
monovalent (Na
+
, K
+
) [57], divalent (Mg
2+
, Sr
2+
, Ba
2+
, Pb
2+
) [58] and trivalent (Y
3+
) 
cations [58]. Significant anionic substitutions, include the replacement of OH by 
CO3
2-
, F
-
 , Cl
-
, and PO4
3- 
by CO3
2-
 [59, 60], AsO4
3-
 and VO4
3-
 [61]. Some substitutions 
are coupled with others to maintain the charge balance in the apatite, such as, CO3
2-
 
for PO4
3-
 coupled with Na
+
 for Ca
2+
. The trivalent anionic phosphate sites cannot 
accept vacancies, as the trivalent anions are quite large and vacancies are believed to 
destabilise the lattice [62]. Adversely, the cationic sites can accept vacancies, up to a 
maximum of 2 sites out of the 10 existing in stoichiometric apatites [63]. The possible 
substitutions for each sublattice are indicated in Table 2.7. 
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Table 2-7: Summary of possible apatite structures 
26410 )( XZOM  
M = Ca, Sr, Ba, Cd, Pb, Mg, Na, K, H, D, …   
Z = P, CO3, V, … 
X =  OH, OD, CO3, O, BO2, F, Cl, Br, vacancies 
 
Fluoride substituted apatites are less soluble than fluoride free synthetic and 
biological apatites [64]. Carbonate, CO3, can substitute either as a type A or B 
substitution, dependent on its mode of carbonate substitution: CO3
2-
for OH  (type A) 
or CO3
2- 
for PO4
3-
 (type B). Biological apatites are principally type B [59]. In 
synthetic powders prepared by wet methods, some fractions of PO4
3-
 as well as OH  
groups are replaced by CO3
2- 
groups (type AB). Among the variety of HAp-based 
bioceramics, CHAp seems to be a more promising material for bioresorbable bone 
substitution rather than bioactive coatings in orthopaedic application. Sintering time, 
temperature and the atmosphere are important parameters to control the level and type 
of carbonate substitution. The presence of CO3
2- 
in HAp structure influences the 
decomposition, sinterability, solubility and biological reactivity of CHAp 
implantation materials [59]. The presence of CO3
2- 
in the HAp structure influences 
decomposition, sinterability, solubility and biological reactivity of implantation 
material. Slosarczyk et al. [15] observed that the decomposition of HAp synthesised 
without any CO3
2- 
additive did not occur. CO3
2- 
ions, hence, are found to lower the 
thermal stability of HAp powders and produces CaO as a secondary phase, whose 
amount grows as treatment temperatures are increased to 1250ºC. CO3
2- 
replacing 
PO4
3-
 increase the Ca/P molar ratio of 1.667, resulting in non-stoichiometric solutions 
which are thermally less stable that those containing no substitutions. These results 
indicate that although carbonate can be found in natural bone, it is an undesirable 
impurity within synthetic HAp. 
 
LeGeros et al. [59] have also demonstrated that the coupled CO3 – for PO4 and Na – 
for Ca substitution can alter the size and shape of the apatite crystal: from acicular to 
rods to equi-axed crystals with increasing carbonate content and in dissolution 
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properties, with the CO3 substituted apatite being more soluble than CO3-free 
synthetic apatites. 
 
The magnesium content in raw materials used as precipitation precursors has also 
been found to have an adverse effect on the final HAp powder properties achieved 
[24, 65]. The presence of magnesium can alter the conditions of calcium phosphate 
precipitation and more precisely of HAp precipitation: it delays nucleation, growth 
and HAp maturation. It was also found to lead to the production of non-stoichiometric 
HAp decomposing upon subsequent calcinations [65]. Mg or Sr substitutions for Ca 
can cause an increase in the extent of dissolution of the apatite [64]. 
 
Differences in lattice parameters between substituted and unsubstituted HAp reflects 
the size and the amount of the substituting ions (see Table 2-8 and Table 2-9). Various 
substitutions in the apatite besides those of F
-
 or Cl
-
 for –OH or CO3 for PO4 
mentioned above, also effect the crystallinity, thermal stability, and dissolution 
properties or solubility of the apatite crystal. When two or more substitutions are 
present, the substituents can have a synergistic or antagonistic effect on the properties 
of the apatite, such that Mg and CO3 have synergistic effects on the crystallinity and 
dissolution properties of synthetic apatites: Mg and F or CO3 and F have antagonistic, 
with F being the more dominant.  
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Table 2-8: Lattice parameters of aqueous and non-aqueous synthetic apatites. Adapted 
from [64] 
Apatite Major         
Substituent 
Lattice Parameter,          
a , +0/-.003nm   
Lattice Parameter,          
c , +/-0.003nm 
Synthetic (non-aqueous)
a
    
OH-apatite - 9.441 6.882 
F-apatite F 9.375 6.880 
Cl-apatite Cl 9.646 6.771 
CO3 apatite CO3 9.544 6.859 
    
Synthetic (aqueous)
b
    
OH-apatite (Ca-deficient) HPO4
**
 9.438 6.882 
F-apatite F 9.382 6.880 
(Cl, OH)-apatite Cl
**
 9.515 6.858 
CO3-OH apatite CO3
**
 9.298 6.924 
CO3-F apatite CO3
**
 , F 9.268 6.924 
Sr-apatite Sr 9.739 6.913 
Pb-apatite Pb 9.894 7.422 
Ba-apatite Ba 10.162 7.722 
a 
Prepared at high temperatures (1000ºC) by solid state reaction route 
b Prepared at 100ºC either by precipitation or by hydrolysis methods 
** Maximum incorporation in case of Cl is less than one mole; in the case of CO3 is 3 moles; in cases of H3PO4 is unknown. 
In these cases the substitutions are: F or Cl for OH; CO3 for OH (Type A); CO3 for PO4 coupled with Na for Ca (Type B); 
HPO4 for PO4; Sr, Pb or Ba for Ca 
 
 
Table 2-9: Qualitative effects of some substituents for Ca
2+
, PO4
3-
, or OH in HAp on the 
lattice parameters and crystallinity of apatites. Adapted from [64] 
Substituent Ionic Rad (nm) Lattice Parameter, 
a , +/-0.003nm 
Lattice Parameter, 
c , +/-0.003nm 
Crystallinity 
for Calcium, Ca2+ 0.99 9.438 6.882  
Strontium, Sr2+ 1.12 (+) (+) (nc) 
Barium, Ba2+ 1.34 (+) (+) (-) 
Lead, Pb2+ 1.20 (+) (+) (-) 
Potassium, K+ 1.33 (nc) (nc) (nc) 
Sodium, Na+ 0.97 (nc) (nc) (nc) 
Lithium, Li+ 0.68 (nc) (nc) (nc) 
Magnesium, Mg2+ 0.66 (-)** (-)** (-)** 
Cadmium, Cd2+ 0.97 (-) (-) (-) 
Manganese, Mn2+ 0.80 (-) (-) (-) 
Zinc, Zn2+ 0.74 (+)** (+)** (-)** 
Aluminium, Al3+ 0.51 (+) (+) (-) 
     
for OH     
Fluoride, F- 1.36 (-) (nc) (+) 
Chloride, Cl- 1.81 (+) (-) (nc) 
     
for PO4
3-     
Carbonate, Co3
2-  (-) (+) (-) 
HPO4
2-  (+) (nc) (nc) 
(+) increase, (-) decrease, (nc) no change, **TCP formed in addition. 
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2.5.4 Solubility Of HAp In Relation To Other Calcium Phosphates 
Various calcium phosphate compounds have been used in the field of biomedical 
engineering owing to the range of properties that they offer, from Tricalcium 
Phosphate (TCP) being resorbable to HAp being bioactive [66], while microscale 
HAp is typical highly phase stable and thus less bioresorbable [67]. 
 
Calcium phosphates (CaPs) contain the phosphate group PO4
3-
. Two different 
categories of CaP can be categorised as follows: (i) CaP obtained by precipitation 
from an aqueous solution at or around room temperature (low-temperature CaP) and 
(ii) CaP obtained by thermal reaction (high-temperature CaP). The most important 
property of CaP is its solubility in water, since the in vivo behaviour of CaPs can be 
predicted to a large extent by their solubility [68]. If the solubility of a CaP, (such as, 
HAp) is less than the mineral part of bone, it degrades extremely slowly if at all. 
 
 
Figure 2-9: Solubility isotherms of CaP phases in the system Ca(OH)2-H3PO4-H2O at  
37°C. The solubility is expressed in the total amount of calcium ions in solution [69] 
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If the solubility of a CaP is greater than that of the mineral part of bone, it is degraded. 
Therefore, using the different solubility isotherms of CaP, the in vivo degradation rate 
of CaP can be predicted to be in the order of (at pH 7.0):  
 
MCPM > TTCP ≈ α-TCP > DCPD > DCPA > OCP > β-TCP > Ca-dHAp > HAp  
 
However, the surface of a highly-soluble CaP can be reactive and may become 
covered with a poorly soluble CaP, hence reducing its degradation rate (refer to 
Figure 2-12). 
 
In aqueous solutions and at ambient temperature (21ºC), the most important calcium 
phosphate salts may be identified. Factors affecting the solubility of HAp include the 
method of preparation, the resultant crystallinity, density and the extent of ionic 
substitutions into the apatite lattice [70]. While the forming method and exact 
stoichiometry will have an effect on solubility, the generally accepted order of 
solubility is as shown in Table 2-10. 
 
Under normal physiological conditions (pH 7.2), HAp is the stable calcium phosphate 
compound [71]. This can drop to as low as a pH of 5.5 in the region of tissue damage, 
although this eventually returns back to a pH of 7.2 over a period of time. Even under 
these conditions HAp still remains a stable phase [71]. 
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Table 2-10: Calcium phosphate compounds: chemical formulae, Ca/P molar ratios, 
dissolution rates and their acronyms 
Ca/P molar 
ratio 
Calcium Phosphate Mineral Phase Chemical Formula Acronym 
2.0 Tetracalcium phosphate Hilgenstockite 
 
Ca4O(PO4)2 
 
TTCP 
1.67 Hydroxyapatite Hydroxyapatite Ca10(PO4)6(OH)2 
 
HAp 
1.67 Oxyapatite  Ca10(PO4)6O 
 
OXA 
1.33 – 1.67 Calcium deficient hydroxyapatite  Ca10-xHx(PO4)6(OH)2-x 
 
Ca-dHAp 
1.5 β – Tricalcium phosphate  β – Ca3(PO4)2 
 
β – TCP 
1.5 α - Tricalcium phosphate  α - Ca3(PO4)2 
 
α - TCP 
1.5 γ – Tricalcium phosphate  γ - Ca3(PO4)2 
 
γ – TCP 
1.33 Octacalcium phosphate  Ca4H(PO4)3 3H2O 
 
OCP 
1.00 Dicalcium phosphate anyhdrous Monetite CaHPO4 
 
DCPA 
1.00 Dicalcium phosphate dihydrate Brushite CaHPO4.2H2O 
 
DCPD 
1.00 Calcium pyrophosphate (α, β, γ)  α - Ca2P2O7 
β - Ca2P2O7 
γ - Ca2P2O7 
 
CPP 
1.00 Calcium pyrophosphate dihydrate  Ca2P2O7.2H2O 
 
CPPD 
0.7 Heptacalcium phosphate  Ca7(P5O16)2 
 
HCP 
0.65 Tetracalcium dihydrogen phosphate  Ca4H2P6O20 TDHP 
0.5 Monocalcium hydrate monohydrate  Ca(H2PO4)2.H2O 
 
MCPM 
0.5 Calcium metaphophate (α, β, γ)  Ca(PO3)2 
 
CMP 
 Amorphous calcium phosphate  Ca3(PO4)2⋅3H2O
a 
 
ACP 
a = an approximation [72] 
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2.5.5 Osseointegration Of HAp With Bone In Vivo 
Since the clinical success of orthopaedic and dental implants depend on the 
osseointegration at the bone-implant interface; surfaces of bone-contacting devices 
would be desirable to be compositional, structural and functional analogous to that of 
human bone. Surface composition containing Ca and P; display good 
cytocompatibility in vitro and enhanced bone contact and greater new bone 
apposition, particularly Ca [16]. 
 
HAp coated implants have been shown to favour cell adhesion, differentiation and 
mineralization, and bone integration of the implant compared to uncoated titanium 
due to the osteoconductive properties of synthetic HAp [16].  The favourable effect of 
calcium phosphate coatings on bone response may be explained through the 
hypothesis that dissolution and reprecipitation of calcium ions from the coating 
stimulates osteogenic cells to differentiate and deposit a mineralised matrix. It is 
therefore expected that the new bone will form directly on the surface of the HAp 
coating. HAp coatings with high degrees of crystallinity show low-dissolution rates in 
vitro and less resorption and more direct bone contact in vivo. However, HAp 
coatings with a high amorphous content result in rapid weakening and disintegration 
of the coating and often promote inflammatory responses in the surrounding tissue. 
Okamoto et al. [73] reported that a significantly higher number of cells adhered to 
HAp than to uncoated titanium. 
 
The crystallinity, composition, morphology and particle size of calcium phosphate 
effect its dissolution [16]. Synthetic HAp exhibits strong affinity to host hard tissue, 
promotes osseointegration and expedites the healing period required for titanium 
implants. It is known that human bone consists of roughly 70% HAp mineral and an 
organic matrix consisting largely of collagen type I, which is the principle collagen of 
skin and bone. Previous research has studied the coating of titanium alloy with 
collagen type I to investigate its beneficial effect in osseointegration [19]. It is 
demonstrated that the initial adhesion and spreading of osteoblasts have been 
accelerated. However, although collagen supports the adhesion of cells; enhanced 
bone mineral deposition still requires HAp. 
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The success or failure of HAp coated orthopaedic implants; depends on the control 
and consequences of cell behaviour post implantation [74]. Thus, the first and 
essential step for bone tissue-implant interface studies are in vivo tests using 
osteoblast cells due to the important role in which they play in the osteointegration of 
the implant. They have the ability to synthesise and produce extracellular matrix and 
to control its mineralization and thus regulate the ingrowth of bone to the implant. 
 
Cell lines and primary human cells are commonly used for in vitro tests. But, primary 
human cell culture system does not exhibit reproducible results on account of 
differences between donors. An immortalised cell line is relatively easier to maintain 
over a long period of time with many passages without any loss of phenotypic 
expression. MG-63 cell line may be used to study the interactions between cells and 
biomaterial and to study the biocompatibility of the biomaterial [74]. 
 
2.5.6 Effect Of Surface Topography On Biological Response 
The response of cells and tissues at implant interfaces can be affected by surface 
topography on a macroscopic as well as microscopic level. On the cell level, surface 
topgography plays a fundamental role in regulating cell behaviour, that is, the 
morphology, orientation and adhesion, proliferation and differentiation of mammalian 
cells [16]. The reaction of cells to topography of the substrate to which they are 
attached is one of the first phenomena observed in tissue culture and therefore plays a 
major role in the evolution and the properties of the implant-tissue interface 
(osseointegration). 
 
A. Surface Roughness 
Using MG63 (human osteoblast-like) culture cells, Martin et al. [75] demonstrated 
that cells cultured on rougher titanium surfaces exhibited decreased cellular 
proliferation and expressed more differentiated phenotype, which is a more 
osteoblastic phenotype. Also, cells on the rougher surfaces were found to release 
higher levels of prostaglandin E2 (PGE2) and latent transforming growth factor β 
(LTGF - β), both factors involved in regulation of bone formation. Thomas et al. [76] 
found that the surface texture (that is, a combination of topography and roughness) 
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significantly effect the interface response to the implant. An implant possessing a 
rough surface was found to yield both greater shear strength and direct bone 
apposition, whereas the implant with a smoother surface exhibited various degrees of 
fibrous encapsulation. Therefore, rough surfaces are assumed to produce better bone 
fixation than smooth surfaces. On the other hand, an in vivo study suggested that very 
different levels of rough surfaces of titanium exhibited a similar bony reaction and no 
significant difference in the interface length percentage covered by bone. Thus, the 
organisation of surface features also takes effect on bone formation at the implant-
implant interface. 
 
 
B. Surface Structures 
Cells not only discriminate between various surface roughness levels, but also with 
surfaces of comparable roughness levels and different topologies. Micron and nano-
topography present strong cues for cell behaviour and thus, the interactions of cells 
with topographic features of the substrate they attach to will affect a variety of cellular 
processes such as, cell adhesion, cytoskeletal organisation, cell motility, migration 
patterns and cell differentiation [16]. The reaction of cells to the topography of their 
substrate are assumed contact guidance, the phenomenon has been demonstrated by 
the organisation of surface roughness. The tendency of surface topography to 
influence cell spreading is otherwise termed ‗contact cue guidance‘ [16]. 
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2.6 PROCESS VARIABLES AFFECTING THE CHEMICAL 
PRECIPITATION METHOD 
In this section, the process variable associated with the wet chemical precipitation 
method (reaction (1), Equation 2-1) will be discussed; in relation to the effect they 
impose upon the final physicochemical HAp powder particles obtained. Control over 
these process variables, in order to develop HAp powders of optimum quality; for 
plasma spray coating application onto femoral implants, will is also considered. This 
will ensure that reproducibility of the final HAp powder physicochemical 
characteristics is repeatedly obtainable. Table 2-11 highlights the variance between 
the precipitation process variables and the HAp powder properties achieved, through 
prior research investigations conducted in the fields of HAp synthesis. An explanation 
of the effects in varying these parameters on the final HAp powder properties (such 
as, stoichiometry, particle size, morphology, purity and crystallinity) will also be 
outlined.  
 
2.6.1  Initial Reactant Concentration 
Direct HAp formation has been reported, for low reactant concentrations (in the 10
-3
 
M range and at pH 7.4), where the solution was undersaturated or slightly 
supersaturated with respect to the precursor phase [77, 78]. All the variance in results 
obtained for final HAp powder characteristics, define the complex role of chemical 
media in HAp formation; whose influence is evident not only through the super-
saturation effect, but also through the nature and concentrations of ionic species. 
Difficulties encountered in preparing stoichiometric HAp from aqueous solution are 
caused by a high apatite affinity towards various impurities as well as the complex 
nature of the calcium phosphate system and the predominant role of kinetic 
parameters over thermodynamic ones during phase transformations [79]. 
 
Due to the low cost and simplicity of the wet chemical precipitation procedure, there 
is considerable interest in the HAp synthesis from aqueous solutions. However, most 
of the apatites obtained from this method are reported as non-stoichiometric [79]. 
During heating, non-stoichiometric apatites decompose and appear as either TCP or 
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CaO. Sintering of pure stoichiometric HAp powder, however, yields pure dense HAp 
powders with superior mechanical properties, while sintering of nonstoichiometric 
HAp, lead to the presence of other phases, such as: CaO if the Ca/P molar ratio 
exceeds 1.67 and TCP if Ca/P is below 1.67. Decomposition of calcium deficient 
apatites (Ca/P<1.67) in the temperature range 22–900°C takes place according to the 
following chemical reaction [71]: 
 
Ca10−x(HPO4)x(PO4)6−x(OH)2−x→xCa9(PO4)6(β)+(1−x)Ca10(PO4)6(OH)2     Equation (2-4) 
 
 
while in the reactant concentrations containing an excess of Ca(OH)2 during thermal 
treatment; CaO is formed. A change in composition of HAp can decrease the strength 
of the final material, increase its dissolution rate, and consequently affect the rate and 
extent of biodegradation.  
 
The substitution of phosphate ions PO4
3−
 by hydrogen phosphate HPO4
2−
 allows a 
continuous variation of the Ca/P atomic ratio between 9/6 and 10/6. This leads to 
calcium-deficient HAp (Ca-dHAp). Ca-dHAp powders can be precipitated from 
conventional wet chemical methods and decomposed into a mixture of HAP and 
tricalcium phosphate, Ca3(PO4)2 (TCP) by thermal treatment above 700 °C, dependent 
upon the initial reactant (that is, Ca
2+
) concentration. The resulting Ca/P molar ratio of 
the HAP powder is one of the most crucial parameters in determining its thermal 
stability. In general, HAp prepared at low pH is highly Ca-deficient (Ca/P = 1.58), 
while the wet mechanochemical route is also known to produces powders with Ca/P 
ratio of 1.65 [80].  
 
Since precipitated anions (PO4
3−
) are generated slowly in solutions containing the 
metal ion (Ca
2+
) during chemical precipitation; this process entails adding the 
phosphate solution drops to the calcium ion-containing solution. The hydroxyl ions 
originally present in the calcium hydroxide suspension are readily exhausted by the 
phosphoric acid under a very high addition rate, lowering pH in the bulk apart from 
the calcium hydroxide particles. It is important that the reactants have the correct 
molar ratio of calcium and phosphorous and if the pH level falls below 9 or 7, it leads 
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to the production of calcium monophosphate and calcium dehydrates. They are more 
soluble in aqueous media and will resorb upon implantation.  
 
Koutsopoulos [5] reported on the capacity for potassium ions of substituting calcium 
ions into the HAp crystal lattice and forming locally nonstoichiometric HAP islands 
within the bulk crystal. This finding is ambiguous and doubts arise from the different 
charges and the significant difference in the radii of the two ions (rCa
2+
 = 99 pm, rK
+
 = 
133 pm). 
 
The control of pH is vital to the successful control of the chemical precipitation 
process. HAp, with a high crystallinity and with its primary particles in the submicron 
range and of finely divided precipitate was formed at a high pH in excess of 10 [5, 
78]. Conn et al. [81] also confirm that the precipitation must be carried out at a pH 
above 10 in order to precipitate HAp powders with low bulk density and a high 
surface area. This research achieved this through implementing a two-stage reactor to 
produce HAp on a continuous basis with both stages under vigorous agitation. The 
phosphoric acid is added in the first stage in a manner suitable to disperse the acid so 
that high local concentrations of acid are avoided. It is important to hold the pH in 
stage one between about 9.5 to about 11. A pH of 9.5-10 indicates that the reaction in 
stage one is approaching 100% and the viscosity of the reaction mass approaches a 
maximum where agitation becomes less efficient. A pH above about 11 indicates that 
the extent of reaction is too low in stage one. Deviation from a pH of from about 9.5 
to about 11, preferably from about 10 to about 11 and, more preferably, at about 10.5 
indicates that either acid or lime flow is not correct and must be adjusted. Phosphoric 
acid delivery to the second stage is controlled in such a manner as to hold the pH at 
about 7.0 to about 7.4, preferably from about 7.2 to about 7.3.
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Table 2-11: Comparative analysis of previous chemical precipitation process parameters investigated, where - denotes data unpublished 
Source Chemical Precipitation  
Reaction Method 
PROCESS VARIABLES POWDER CHARACTERISTICS 
Ca/P molar 
ratio 
Acid Addition 
Rate  
Stirring 
Speed 
(rpm) 
Temperature 
(°C) 
pH Density 
(g/cm3) 
Specific 
Surface Area 
(m2/g) 
Crystallite Size Particle 
Size 
Morphology 
[82] Reaction Method 1 1.67 - - - 10 3.219g/cm3 - 20 - 55nm 
 
1 - 8μm Spherical 
[67] Reaction Method 1 
 
 
1.665 2mL/min 2000 40 - 65 10 - 11 - - - - - 
[22] Reaction Method 1 1.5 - 1.71 - - 30 - 95 6.5 - 9 - 
58 1.5 
- - - 
 [2] Reaction Method 2 1.67 - - - 9 - - - 20 - 125μm - 
[21] Reaction Method 2 - - - - - - - - 53 - 75μm 
(Sintered 
HAp) 
Spherical 
geometry 
(Sintered HAp) 
[41] Reaction Method 2 - 1.5L/h - 40 8 -  
- 
20nm - Scherrer formula                               
250 nm - TEM image 
- - 
[83] Reaction Method 2 
 
 
1.667 1 – 2 drops/s 500-2400 
40 2 
7.5 - 9 -  - - - 
[84] Reaction Method 2 1.667 1 – 2 drops/s 2400 
40 2 
7.5 - 54.5 - 50nm Angular 
[81] Reaction Method 2 1.667 70.8kg/h High 20 - 50 9.5 – 11; 
7.0 – 7.4 
- - - - - 
[85] Reaction Method 2 1.55 – 1.71 1 – 10mL/min 100 - 300 25 - 95 7.0 - - - - - 
 [71] Reaction Method 2 1.667 - - 22 - 95 9.5 - 12 - - - - - 
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Solids concentration also increases the collision frequency (since two particles are 
involved in each collision). pH has a very strong effect on the surface potential, for 
every compound there is a pH where the particle surface is electrically neutral (the 
isoelectric point). At this pH, particle-particle repulsion vanishes and agglomeration is 
highest [86]. A high ionic strength depresses the double layer, thus stimulating 
agglomeration. A high supersaturation decreases the time needed for binding particles 
together, thereby facilitating agglomeration [86]. 
 
2.6.2 Reaction Temperature 
Temperature is found to affect predominantly the crystalline phase fraction, crystallite 
size and, as a consequence, specific surface area [71]. Controlling the reaction 
temperature during precipitation, Tampieri et al. [87] varied the degree of crystallinity 
(representing the fraction of completely crystallised phase) approximately from 20 to 
80%. The resulting morphology of the two powders is shown in Figures 2-13(a) (80% 
crystalline) and 2-13(b) (20% crystalline). It is clear from these figures that increasing 
the precipitation temperature not only increases the crystallinity of the HAp powders 
but also induces an enhanced spherical morphology [41, 71, 79, 87]. A pure-phase 
HAp with the desired morphology could therefore be prepared by adjusting the 
reaction temperature and time [88]. 
 
 
Figure 2-10: SEM micrographs showing morphologies of untreated HAp (a) 80% 
crystalline; (b) 20% crystalline [87] 
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The morphology of HAp crystals are strongly dependant on the temperature of the 
reaction [87, 88, 89]. Increasing the precipitation temperature from 20-100ºC induces 
a change in morphology from need-like precipitate to highly spheroidal precipitate 
respectively, for chemical precipitation reaction (2), Equation 2-2 [87]. However, the 
morphological change with temperature follows the reverse order when HAp is 
precipitated via the chemical precipitation reaction (1), Equation 2-1. Instead, it was 
reported that the morphology of the HAp particles changed from spheroidal to needle-
like with increasing temperature [87]. In general, a needle-like morphology can be 
expected when the growth rate is faster and the aspect ratio decreases as the growth 
rate decreases. Thus, the growth rate of HAp should be expected to increase with 
increasing temperature when it is precipitated via chemical reaction (1), Equation 2-1 
while decreasing with increasing temperature when precipitated via chemical reaction 
(2), Equation 2-2. An enhanced spherical morphology with larger particle size has 
elsewhere been reported with an increase in precipitation temperature. Kumar et al. 
[88] reinforces this evidence with Transmission Electron Microscopy (TEM) graphs 
of HAp powders (synthesised via the wet chemical using Ca(OH)2 and H3PO4 
revealed needle-shaped particles with a high aspect ratio at 40°C, which changed to 
spheroidal when the precipitation temperature was increased to 100°C. The changes 
in the morphology with temperature were analysed taking into account the driving 
force for the HAp precipitation and the supersaturation level of Ca
2+ 
and PO4
3-
 ions 
with respect to HAp [90]. The analysis indicated that the supersaturation level of the 
reactants, especially the concentration of Ca
2+
 ions, played a predominant role on the 
precipitate morphology for this classical acid-base reaction. Lazic et al. [71] also 
prove the stoichiometry of the non-matured HAp varied significantly with reaction 
synthesis temperature, such that samples precipitated at 95°C demonstrated properties 
of thermally stable stoichiometric HAp. The crystals precipitated at 22°C had the 
form of tiny needles with an average length of 110 nm and width of 11 nm. 
Maturation (that is, ripening time) under conditions of precipitation does not 
significantly affect crystal size. The crystals however become thicker and aggregation 
more pronounced. Crystals precipitated at high temperature are well-rounded. For 
studies conducted by Lazic et al. [71] at reaction synthesis temperatures of 15°C, the 
particle size of HAp was less than 10 nm, and at 60°C it became an acicular crystal 
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with a length of 100 nm. Figure 2-14 illustrates the aging / maturation time required at 
a particular precipitation temperature in order to obtain stoichiometric HAp [91]. 
 
 
Figure 2-11: Time dependency of precipitation temperature to obtain phase pure HAp 
[91] 
 
XRD analyses were carried out by Pang and Bao [90] with respect to HAp prepared 
by chemical precipitation through aqueous solutions of calcium chloride and 
ammonium hydrogenphosphate. Broad diffraction peaks were observed for the HAp 
powders synthesised at low temperature (15ºC). When the synthetic temperature was 
increased these diffraction peaks became sharper, indicating an increase in final HAp 
crystallinity. The crystallinity increased from 0.03% to 0.53% for the HAp powders 
prepared from 15 - 99ºC (refluxing) respectively, which indicated a strong synthetic 
temperature dependence of the crystallinity of prepared HAp. It was also noticed that 
the increase of the crystallinity with temperature was not linear. There was no 
significant change in crystallinity when the synthetic temperature was lower than 
70ºC, however, a sharp increase in the crystallinity were observed at synthetic 
temperatures over 70ºC, as the crystalline activation energy of the HAp was overcome 
at that temperature.  Kothappalli et al. [89] also indicate that when the reaction 
temperature is increased at a constant concentration, the diffraction peaks became 
more intense, indicating an increase in the crystallinity of the HAp powders. 
Smiciklas et al. [85] also find that increasing the reaction temperature, the crystallite 
size and the fraction of crystalline phase increases, while the specific surface area 
decreases [85]. The calculated crystallite size (Xs) for the HAp powders synthesised at 
different temperatures is listed in Table 2-12. 
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Table 2-12: The eﬀect of synthetic temperature on the fraction crystallinity and 
crystallite size of HAp nanocrystals before and after calcination at 650ºC for 6 h [90] 
Temperature (ºC) Crystallinity, Xc Crystallite Size, Xs, (nm) 
Before calcination After 
calcination 
Before 
calcination 
After 
calcination 
15 
50 
70 
80 
90 
99 
0.03 
0.06 
0.10 
0.32 
0.48 
0.53 
0.39 
0.58 
0.63 
0.65 
0.71 
0.72 
20.8 
27.8 
34.9 
45.9 
50.0 
52.7 
35.1 
37.3 
42.7 
44.0 
46.5 
47.4 
 
Synthetic HAp occurs in two structural forms, hexagonal and monoclinic, which have 
minor structural differences. The hexagonal HAp form is usually formed by 
precipitation from supersaturated solutions at 25°C to 100°C and the monoclinic form 
of HAp is primarily formed by heating the hexagonal form at 850°C in air and then 
cooling to room temperature [92]. The overall XRD patterns of hexagonal and 
monoclinic HAp are almost identical; however the pattern of monoclinic HAp has 
additional weak lines whose intensities are less than 1 % of the strongest hexagonal 
HAp line. The main phase formed at room temperature was ACP, with minor amounts 
of HAp, whereas at 90°C HAP crystallized. This behavior cannot be explained from 
the supersaturations in these experiments, since the solubility of HAp is higher at low 
temperatures [78]. 
 
At a constant reactant concentration, as the reaction temperature is increased, the 
particle size and aspect ratio is also reported to increase [89]. However, with this 
increase of reactant temperature, the HAp agglomerate size decreased and it was 
observed that larger agglomerates were formed for relatively smaller particles, such as 
those synthesised at 25°C. Their sintering density also improved in spite of the 
decrease of the surface area with agglomerate size. Kothapalli et al. [89] also found 
that the density of the pre-sintered HAp increased with synthesis temperature in spite 
of the concentration of the reactants.  The reactant temperature had more impact on 
the strength than the actual concentration. At a constant concentration, as the 
temperature increased, the flexural strength increased proportionally. 
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In the case of low temperature precipitation, stirring in the maturation stage has 
shown to play an essential role in obtaining required stoichiometry [71]. Also, raising 
the reaction temperature can also greatly shorten the reaction time for the formation of 
pure-phase HAp. Afshar et al. report a chemical precipitation reaction temperature of 
40 °C is required to achieve a pure HAp product [83]. 
 
An investigation conducted by Conn et al. [81] reported that the temperature at which 
the chemical precipitation reaction is carried out has little effect on the product quality 
or on the efficiency of the process. Accordingly, temperatures from 35 to 90°C were 
stated as satisfactory in this study. Lower temperatures and aging time can extensively 
improve the yield and reduce the cost of the reaction. On the other hand, however, 
these parameters can also lead to heterogeneous compositions and morphology, and a 
calcium deficiency in the final product [85]. 
 
2.6.3 Reactant Addition Rate 
A slow and controlled addition of phosphoric acid in an alkaline environment is 
necessary (as it controls the pH level) in order to fabricate pure stoichiometric HAp 
[2, 5, 83, 85]. A slow reactant addition rate is found to yield pure, well-crystallised 
HAp, due to low supersaturation and an avoidance of local inhomogeneity [96]. A 
high addition rate of phosphoric acid or in excess, leads to the formation of calcium 
deficient precipitate [2]. Afshar et al. [83] used extra acid solution to remove any 
extra calcium in the HA precipitate.  
 
The rate of reactant addition effects the rate of HAp nucleation [5]. A slow addition 
rate ensures the absence of continuous nucleation. Addition times of 60 min or longer 
are found to result in a well crystallized HAp powder while an addition time of 30 
min resulted in a biphasic mixture of HAp and ACP. For the latter case it is likely that 
the rate of addition of reactants was higher than the rate of their consumption due to 
HAp crystallization [78]. Therefore, the concentrations of calcium and phosphate ions 
in the solution built up during the addition period and eventually the solution became 
supersaturated with respect to ACP, which then formed preferentially. When the 
addition time was the longest (240 min), the crystallinity index was also the highest. 
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Although this result cannot be attributed exclusively to the addition time, it suggests 
ways to further improve the crystallinity.  
 
Large HAp powder particle sizes are obtained when the addition rate of acid is 
lowered [84]. The order in which the reactants are added also play an important role 
in producing phase pure HAp. When the Ca solution is added to the P solution, a Ca-
dHAp is produced at the beginning of the reaction and the final product can also be 
Ca- deficient, which is a common problem when employing wet methods of synthesis 
[93]. When P solution is added to a Ca solution, there exists a Ca-rich precipitate at 
the beginning, which progressively evolves into stoichiometric HAp towards the end 
of the reaction [93]. 
 
When the addition rate of the phosphoric acid is very high (2400 ml/min.), the 
synthesis reaction conversion decreases and there is some Ca(OH)2 appears in the 
final product. When the acid addition rate is below 100 ml/min, the conversion rate of 
the reaction is 100% [94]. The addition rate of reactant, during the reaction synthesis 
therefore has a strong influence on the resulting composition. A higher addition rate 
of acid systematically results in an undesired increase of the Ca(OH)2 content. This 
can be explained in terms of pH of the reaction media. When the acid is introduced at 
a very high addition rate, the pH of the reaction media decreases drastically (pH 7). 
Orthophosphoric acid is a weak triacid, in which the acidity potentials are as follows 
[94]: 
   
    2.21apK                   Equation (2-5)
 
HHPOPOH 2442   2.72apK                                    Equation (2-6)
 
HPOHPO 344   3.123apK    
      
Equation (2-7) 
 
 
If pH  pKa then the dissociation of H3PO4 will occur according to the Le Chatelier 
principle [94]. In the other case the recombination will occur. Therefore when the acid 
is introduced in the reaction media at a high addition rate (2400ml/min) the pH 
decreases leading to an incomplete dissociation of orthophosphoric acid. In the 
absence of PO4
3-
, the formation of the HAp structure is compromised. This explains 
the presence of residual or unreacted Ca(OH)2 which will further transform in lime 
HPOHPOH 4243
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during heat treatment. In this condition, the synthesised HAp can contain a fraction of 
dihydrogenophosphate (H2PO4
-
) or hydrogenophosphate ions (HPO4
2-
)  substituted for 
phosphate ions (PO4
3-
) which can explain the residual Ca(OH)2. Although 
hydrogenophosphated phases are quite difficult to detect by XRD, their presence 
induces small distortions in the unit cell. Those phases can be written by the following 
chemical expression [94]:  
 
Ca10-x(HPO4)x(PO4)6-x(OH)2-x,            Equation (2-8)
 
with 0 x 2        
                                     
2.6.4 Stirring Speed 
The chemical precipitation reaction requires mixing on a molecular level before actual 
precipitation of the crystallised product can proceed. The mixing procedure 
determines the final stoichiometry of HAp precipitate [93]. Since many precipitation 
processes are conducted at very high supersaturations, the characteristic reaction time 
can be of the same order of magnitude or even smaller than the mixing time [86]. 
When this situation prevails, the course of the mixing process helps to determine the 
course of supersaturation. Guilletti et al. [86] described these mixing conditions to 
affect crystal shape, purity, crystallinity, and even the phases that are formed. When 
large crystals of high crystallinity and purity are desired, precipitation should be 
conducted at low supersaturation. Therefore, reactants should be added near areas of 
high mixing intensity, and as far as possible from each other, (that is, a good 
dispersion of the concentrated reactant with the reactor contents should be 
stimulated). If fine particles with a narrow size distribution are desired, intense mixing 
should provide rapid contact between concentrated reactants [86]. Mixing effects have 
to be considered in order to extrapolate correctly a pilot reactor to the industrial scale 
[82]. The hydrodynamic factors which govern mixing and the initial contact between 
the reagents play an essential role on morphology and on crystal size distribution [78]. 
 
The stirring speed should be high enough to prepare a good homogenous media for 
precipitation of HAp. Both Monetite and Brushite formation occurs by insufficient 
mixing of calcium solution as the orthophosphoric solution is added [85]. The PO4
3−
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ion concentration builds up when it is not distributed homogeneously and a localised 
low pH is established. This part of the reaction vessel can be richer in PO4
3−
 and 
provides conditions for the formation of soluble precipitates. A powerful and high-
speed stirring device can be used to overcome this possibility [84]. Excellent agitation 
can be required to form a quality product [85], as poor agitation in the suspension 
contains entrapped unreacted Ca(OH)2.  High local concentrations of phosphoric acid 
must be avoided in order to prevent the formation of dicalcium phosphate which is 
impossible to convert to the desired HAp [81].  
 
Lazic et al. [71] report that in the case of low temperature precipitation, stirring in the 
maturation stage is an essential role in obtaining the required stoichiometric Hap. 
Efficient agitation is very important to obtain equilibrium so that the pH of the final 
HAp slurry will not drift. Insufficient agitation will result in a rapid, wide change in 
pH as unmixed portions of different pH are carried through the chemical precipitation 
process. 
 
Agglomeration is present in almost all precipitation processes and in some 
crystallisation systems, particularly during start-up, where higher supersaturations 
prevail [86]. When solid-liquid separation is critical, agglomeration is desired since it 
leads to larger, easy-to-filter particles. When products of high purity are required, 
agglomeration should be avoided since agglomerates trap impurities within their 
interstices [86]. The process of agglomeration starts with the transport of particles 
towards one another. When the particles have enough kinetic energy to overcome the 
repulsion due to their surface potential, they collide. If they remain in contact long 
enough for growth to take place and thereby bind the particles together; an 
agglomerate is formed [86]. Thus, the variables can affect agglomeration during 
industrial precipitation. Mixing intensity improves the particle collision frequency and 
thus agglomeration. However, a mixing intensity that is too high promotes particle 
disruption [86]. 
 
  
CHAPTER 2: Literature Review 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-54- 
2.6.5 Ripening Time 
During aging, the HAp crystals are subject to a process that includes dissolution and 
recrystallisation. During this stage the smallest crystals disappear in favour of the 
larger ones, which grow further. As a consequence the total number of crystals is 
reduced and the surface roughness of the crystals is reduced. Both phenomena result 
in a decrease of the specific surface area [5]. 
 
HAp crystallinity can be largely dependent upon ripening or maturation time allowed 
after the precipitation reaction [87]. Both the crystallinity and crystallite size of the 
HAp powders are found to increase very rapidly at the early ripening stages and 
gradually levelled off as ripening continues. Tampieri et al. found similar results were 
obtained when the synthetic temperature was raised to 99ºC [87]. The degree of 
crystallinity of HAp powders increased from 20 - 70% by increasing the maturation 
time to 24 h. Pang et al. [90] investigated the increase of crystallinity with the 
increase of the ripening time to observe a clear sharpening of the diffraction peaks 
(XRD) of the HAp powders. Both the crystallinity and crystallite size of the HAp 
powders increased very rapidly at the early ripening stages and gradually levelled off 
as ripening lasted.  This profile of crystallinity increase with ripening time was also 
confirmed by FTIR analysis. The characteristic bands for HAp are exhibited in all the 
three patterns (1h, 96h and after calcination): 900–1200 cm−1 for phosphate 
stretching, 602 cm
−1
 for phosphate bending, 632 and 3571 cm
−1
 for hydroxyl 
vibrations [90]. The intensities of these two hydroxyl absorption bands and the band 
at 940 cm
−1
 for phosphate can be used as an indication of the HAp crystallinity. It is 
seen that the intensities of these three bands increase with the ripening time. In 
addition, the broad band at 2500–3700 cm−1, which is a reflection of the combined 
water in HAp powders, also decreases with increasing the ripening time. The lower 
combined water content results from the higher crystallinity of HAp powder, implying 
the crystalline HAp powder is less hydrophilic than its amorphous counterpart. 
 
Further evidence for the change of combined water with ripening time was provided 
by thermal gravimetric – dilatometry analysis (TG–DTA) measurements. The weight 
loss of HAp powders heated up to 750 °C is about 7.6 and 6% for 1- and 96-h 
ripening samples, respectively. The area of endothermic peak on DTA curve shows 
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the same result, too. The weight loss starts at about 100 °C and ends at about 500 °C 
based on the DTA curves. This weight loss comes from the elimination of combined 
water [90].  
 
This crystalline behaviour as a function of ripening time can be explained by the 
mechanism of crystal growth in solution. It is well known that precipitation of 
particles involves nucleation and growth from a supersaturated solution. Chemical 
precipitation often experiences high reaction-induced supersaturation, leading to high 
nucleation rates [86]. In this case, a crystal nucleus usually has a rough surface due to 
the rapid production of insoluble materials. This rough surface provides energetically 
favourable conditions for crystal growth because the molecules adding on it has 
greater sticking probability. So the rough surface results in high growth rate. 
However, as the crystal continues to grow, its surface becomes smoother and as a 
result, the rate of crystal growth slows down. This is because the addition of 
molecules on the smooth surface has lower sticking probability.   
 
TEM observations on the morphology changes of the HAp as a function of ripening 
time provide further evidence that this mechanism is controlling the rate of 
crystallisation. These TEM micrographs clearly show that the particles become 
increasingly regular and smooth with increasing ripening time [90]. 
 
Aging the suspension leads to the growth of the precipitate and changes the 
morphology to a more equiaxed status [84]. Leaving the suspension to settle after 
adding the acid solution causes completion of precipitation and more suitable 
properties as well as the process efficiency [84]. The thermodynamic stability of a 
solid compound arises from the ordered arrangement of its molecules in a crystal 
lattice in an infinite medium. For particles of finite size, the average particle stability 
is an average of its volume and surface contributions [86]. Since surfaces have a low 
stability, the smaller the particle, the lower its stability, (that is, the higher its 
solubility). This effect can be important for particles of 1 mm or less. In late stages of 
batch precipitation, when supersaturation is low, smaller particles tend to re-dissolve 
[86]. The residual supersaturation can slowly be consumed by larger particles. Aging 
can take days or even months, and in general, it helps to improve product quality as it 
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results in larger crystal sizes and improved product crystallinity. Further XRD 
analyses have also confirmed that performing calcinations after HA precipitation can 
significantly increase the resultant crystallinity of the HAp precipitate [89]. 
 
The formation of synthetic HAP crystals from a highly supersaturated solutions 
proceeds via intermediate precursor phases, which have a transitory existence, such as 
TCP and OCP. Traces of precursors can be detected even after prolonged ripening 
times, therefore affecting the quality of the final HAp product. [5] 
 
2.6.6 Atmospheric Environment 
During the chemical precipitation route, adsorption of atmospheric CO2 may occur, 
which in the form of CO3
2-
 anion can be incorporated into the HAp crystal lattice, 
resulting in micro-stresses and distortion of the stoichiometric HAp lattice [59]. 
However, within Nitrogen (N2) controlled environments, small percentages of CO3
2-
 
contamination was also found to arise as a consequence of subsequent sample 
handling steps [85].  
 
Filtered inert gas should be continuously injected to both the reactor and the acid 
solution container during the precipitation process [83]. The filter should contain a 
sufficient amount of carbon dioxide absorber (such as, KOH or N2). The HAp powder 
can be very hospitable in the substitution of carbon dioxide in its crystal structure. 
CO3
2-
ions can substitute hydroxyls or phosphates sites and based on this substitution, 
type A and type B of carbonated HAp are, respectively, formed. So, in order to reach 
a pure HAp precipitate without any carbon dioxide contamination, it is effective to 
use controlled atmosphere during precipitation process. Filtered inert gas shall be 
continuously injected to the reactor and the acid solution container during the 
precipitation process. The filter should contain a sufficient amount of carbon dioxide 
absorber.  
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2.7 HAp POWDER CHARACTERISTICS 
The physicochemical properties for HAp powders prepared from the chemical 
precipitation technique vary considerably due to the process variable conditions and 
raw materials used. These properties are discussed with respect the optimum values 
required for HAp powder properties for plasma spray application as a coating onto 
orthopaedic implants. An overview of HAp powder properties, such as, its 
crystallinity, phase purity, crystallite size, lattice parameters, particle size and particle 
morphology are discussed in this section. 
 
2.7.1 Crystallinity 
Crystallinity depends on crystallite size and crystal strain and is the amount of 
crystalline phase present compared to its amorphous phase content. HAp 
crystallisation obeys the Ostwald rule of stages, so it is usually formed upon 
recrystallisation of precursor phases such as OCP, DCPD and ACP [78].  There are 
two different crystallisation processes involved in the crystallisation of HAp particles 
during synthesis and calcination. The crystallisation of HAp during synthesis follows 
a mechanism of solution crystallisation. Since the crystal growth proceeds through the 
packing of HAp molecules from the solution on the formed nuclei during the ripening 
process, the crystallites can freely grow on the surfaces of the precipitates in all 
directions. It is expected that the larger crystallites will be formed with longer 
ripening time until the crystallisation reaches to its equilibrium. During calcination, 
crystallisation of HAp experiences both the nucleation and crystal growth by the 
rearrangement of HAp molecules in amorphous phase. The nucleation and growth 
take place throughout the precipitates rather than on the surfaces only [78, 86, 90]. As 
more HAp molecules are available inside the precipitates for the nucleation and the 
crystal growth is in a confined environment, as well as the diffusion of the molecules 
in solid state is very slow, relatively smaller but more crystallites are expected to be 
produced in present calcination conditions. The dramatic increase in crystallinity after 
calcination indicates that the number of crystallites formed during calcination is large 
than that formed during synthesis, particularly for the "as prepared" HAp powders 
with lower crystallinity. As a result, the apparent crystallinity post sintering (Xc) is 
reduced after calcination for the "as prepared" samples with high crystallinity and 
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larger crystallites because a large amount of relatively smaller new crystallites are 
formed during calcination. On the other hand, the increased Xc for the "as prepared" 
samples with lower crystallinity and smaller crystallites comes from the growth of 
these smaller crystallites and new crystallites formed during calcination, which are 
relatively larger than "as prepared" smaller crystallites [90].  
 
2.7.2 Phase Composition (Purity) 
Deviation from the stoichiometry of HAp is due to the presence in the crystal lattice 
of vacancies and ion substitutes such as carbonates, hydrogen phosphates, potassium, 
sodium, nitrates, and chloride which are usually introduced into the precipitating 
system with the reactants [5]. Contamination of HAp with these ions or formation of 
deficient Hap‘s suffer from significant changes in their crystallographic 
characteristics and have different crystal morphology as compared to stoichiometric 
HAp. 
 
The substitution of phosphate ions PO4
3−
 by hydrogen phosphate HPO4
2−
 allows a 
continuous variation of the Ca/P atomic ratio between 9/6 and 10/6. This leads to Ca-
dHAp [80]. Ca-dHAp powders can be precipitated from conventional wet chemical 
methods and decomposed into a mixture of HAp and TCP by thermal treatment above 
700 °C. This allows a direct processing of biphasic calcium phosphate ceramics 
HAp/TCP without the step of powder blending. Raynaud et al. [22] proved the 
reliability of the Ca/P atomic ratio of the initial HAp powder calculated by 
determining the phase proportions in calcined biphasic calcium phosphates. Thus, the 
percent of β-TCP and HAp in the sintered bodies can be determined from the Ca/P 
ratio of the precursor HAp powder. Considering the Ca-dHAp change with thermal 
treatment to stoichiometric HAp and β-TCP according to the following equation [80]: 
 
Ca10−x(HPO4)x(PO4)6−x(OH)2−x → (1 − x)Ca10(PO4)6(OH)2 + 3xβ-Ca3(PO4)2 + xH2O 
       Equation (2-9) 
 
where x is the calcium deficiency, and thus, Ca/P = (10 − x)/6. The mole fraction of β-
TCP to the mole fraction of HAp in the sintered bodies is given by: 
XTCP/XHAp = 3x/(1 − x). Since; 
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XHAp = 1 − XTCP, and XTCP/(1 − XTCP) = 3x/(1 − x)                                  Equation (2-10)  
 
the percent of β-TCP can be calculated by knowing calcium deficiency (x) from the 
chemical analysis. During the precipitation of the crystalline material, a precursor 
phase is formed which is amorphous to XRD. This phase has been shown to be 
structurally and chemically distinct from HAp. Calculations assuming the amorphous 
phase consisted of individual or groups of individual HAp unit cells were incapable of 
explaining the observed diffraction pattern. Chemical analysis of the precursor phase 
indicated that this noncrystalline phase is a hydrated calcium phosphate of calcium to 
phosphorus ratio 3/2 as compared to the 5/3 ratio found in HAp [71]. This distinct 
amorphous phase converts, in the presence of water, to microcrystalline HAp. The 
lifetime of the metastable amorphous precursor in aqueous solution was reported to be 
a function of the presence of certain macromolecules and interfering ions, pH, 
viscosity, ionic strength, and temperature. A preliminary study of the kinetics of 
conversion of metastable ACP to HAp indicated that at high pH the rate of conversion 
was proportional to the amount of HAp already formed, suggesting that the 
conversion was proceeding autocatalytically [71]. 
 
Thermal heat treatment (T= 600ºC) of HAp synthesised at low temperature leads to 
the decomposition (dehydroxylation) of the calcium hydroxide (Ca(OH)2) to form 
lime (CaO) with water.  The addition rate of reactant during the reaction synthesis has 
also a strong influence on the resultant composition. A higher addition rate of acid 
systematically results in an increase of the Ca(OH)2 content [94]. 
 
2.7.3 Crystallite Size 
Very small crystallites in contrast to crystallinity may still be very crystalline. 
Stoichiometric HAp has the smallest crystallite size (as low as 57 nm) and Ca-dHAp 
have the largest ones [78]. These results agree well with the after-mentioned surface 
area measurements. Ca-dHAp has the largest crystallites, since it was prepared under 
acidic conditions. Many authors found that the crystallite size increases with 
increasing the acidity of the precipitation medium [78]. 
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2.7.4 Lattice Parameters 
Aizawa et al. [95] measured the lattice parameters of the a-axis and the c-axis. With 
increase of the Ca/P molar ratio of the resulting apatite, the lattice parameter of the a-
axis slightly decreased, while that of the c-axis increased. In addition, the a/c ratio 
decreased with increasing Ca/P molar ratio of the resulting apatite. According to 
Elliott [69] the lattice parameters of crystalline Ca-dHAp increase in the a-axis 
direction with decreasing Ca/P molar ratio, but decrease in the c-axis direction. Thus, 
the a/c ratio increases with a decrease in the Ca/P ratio. The increase in the a-axis 
parameter with decreasing Ca/P ratio may be due to more incorporation of HPO4
2-
 ion 
into Ca-dHAp structure. 
 
2.7.5 Particle Size 
The synthesis of small HAp powder particles (comprised of either smaller primary 
crystallites mentioned earlier or a mixture of primary crystallites with powder 
particles) are found to be attributed to the high supersaturations derived from the high 
pH and short reactant addition time. An increased carbonate concentration may also 
contribute to the formation of small particles [78]. 
 
HAp precipitated by Knowles et al. [96] at 60°C had a particle size of 61.06 nm and at 
80°C, a particle size of 82.24 nm, measured by line broadening effects. Whilst the 
mean particle size for the HAp precipitated at 80°C is larger, there appears in the 
TEM to be some fine particulate, which would stay in suspension more easily. 
 
2.7.6 Particle Morphology 
Spherical powders, in general, have better rheological properties than irregular 
powders and, thus, produce better coatings for hip implants and chromatographic 
separation [82]. The powders morphology will depend on whether the powder particle 
or crystallite size is being assessed. The temperature synthesis effect on the HAp 
morphpology indicates that at low synthesis temperature the crystals carry a needle-
shape [94]. Increasing the reaction temperature changes the crystal from as-needle 
shape to a more regular shape, close to circular. A shape factor can be defined by the 
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ratio length/width of the Hap crystals: Fs =L/1 (Fs: shape factor; L: particle length 
[m] and l: particle width [m]. The shape factor, Fs, of the HAp crystals decreases with 
an increase of the synthesis temperature. After heating at high temperature T= 850ºC/ 
4 h and then at T=1250ºC/ 4 h, the particle shape are with a more regular shape. After 
heat treatment at 1250ºC all the particles become thicker with a shape factor close to 
1, this is due to the sintering of all the particles. Transmission electronic diffraction 
provides information at a one particle scale. The main axis of the HAp particle with 
the needle shape corresponds to the c-axis of the HAp structure. This is true for 
nanocrystals synthesised at low temperature (T 45ºC). Moreover the crystal looks 
like a monocrystal. At higher synthesis temperature, nanocrystals are shown to lose 
their tendency to grow as a monocrystal following the c-axis of the apatitic structure. 
The crystallite size reaches a maximum value which corresponds to a temperature 
around 60ºC. This phenomenon can be explained by two temperature dependent 
effects which are concurrent. First of all, a temperature rise increases HAp 
crystallinity which is thermally activated. Secondly, the temperature increase limits 
the tendency to the monocrystalline HAp nanocrystals growth following the HAp c-
axis, because from this critical temperature, particles become more regular and 
circular. Above this temperature, the tendency to grow stops. This explains the 
maximum size for the HAp crystallites at this temperature. HAp precipitated in work 
carried out by Knowles et al. [96] also confirms that the reaction temperature 
significantly affects the precipitate morphology.  
 
2.7.7 HAp Rheology 
The rheology of HAp was studied by Knowles et al. [96] where they found that the 
viscosity increased with the increase of the particle size with the behaviour ranging 
from newtonian to dilatant.  No thixotropic properties were noticeable in any of the 
suspensions, due to the low solids content that was used in the experiments. In 
rheological tests conducted by Tian et al. [97], it was found that a second calcination 
at a higher temperature for a longer time produced a larger size which in turn reduced 
the viscosity of the suspensions over a wide range of shear rates. 
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2.8 THERMAL TREATMENT OF HAp 
It is generally accepted that the heating of HAp leads to three concurrent processes 
which involve (i) the evaporation of water, (ii) dehydroxylation, and (iii) 
decomposition. Although there is agreement between researchers about the processes 
which occur during the thermal decomposition of HAp, it is difficult to predict the 
exact temperatures at which these reactions occur. This is because the reactions do not 
occur instantly but over a wide temperature range, which depends on a number of 
factors relating to both the environment and the composition of the HAp. 
 
Upon heating to 700–800 °C, it is accepted that Ca-deficient apatite transforms to the 
low temperature polymorph of β-TCP with a loss of water as described in the 
following reaction [98]: 
OHPOCaOHPOHPOCa 22435449 )(3)())((                                  Equation (2-11)
 
 
Sintering beyond 1180 °C induces the phase transformation of β-TCP to the high-
temperature polymorph, α-TCP [98]. Therefore, β-TCP is stable below 1180 °C, 
while α-TCP is stable in the temperature range 1180 – 1400 ° C and super α-TCP is 
observed above 1470 °C. This phase transformation is accompanied by density 
changes in the calcium phosphate material. The density decreases with phase 
transformation in the following sequence when heat-treated to higher temperatures, 
such that [98]: 
 
HAp (3.156 g/cm
3
) > β-TCP (3.07 g/cm3) > α-TCP (2.77 g/cm3)                                                                                                                         
                                                                                                                Equation (2-12)  
 
As previously discussed, the dissolution rate of β-TCP is indeed 3 – 12 times faster 
than that of stoichiometric HAp with in vitro studies conducted revealing that α-TCP 
exhibits a higher dissolution rate than β-TCP. Thus, the order of relative solubility 
follows the order: α-TCP > β-TCP >> HAp 
 
The decomposition of phase pure HAp has been reported by Sridhar et al. [99] to 
occur from 1050°C onwards. Tampieri et al. [87] found that decomposition began to 
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occur from 1200°C. Liao et al. [100] found that HAp was stable 1000°C -1350°C. 
The highest thermal stability which has been found in the literature is that reported by 
Deram et al. [101]. They found that HAp powder samples didn‘t show any phase 
transformation up to a temperature of 1450°C.  
 
The decomposition of HAp into, β-TCP, TTCP and α-TCP has been reported to begin 
at 1050°C by Sridhar et al. [99], 1200°C by Tampieri et al. [87] and 1400°C by Liao 
et al. [100]. A melting temperature of 1550°C was reported by Fazan [102] for phase 
pure HAp; 1630°C for TTCP and 1730°C for TCP. The temperature ranges in which 
reactions occur as HAp is heated from ambient temperature to 1730°C are 
summarised in Table 2-13. 
 
Table 2-13: Thermal effects on HAp [103] 
Temperature  Reaction(s)  
25-200°C Evaporation of absorbed water 
200-600°C Evaporation of lattice water 
600-800°C Decarbonation 
800-900°C 
Dehydroxylation of HAp  forming partially or completely dehydroxylated 
oxyhydroxyapatite (OHAp)     
1050-1400°C HA decomposes to form β-TCP and TTCP    
< 1120°C β-TCP is stable 
1120-1470°C β-TCP is converted to α-TCP 
1550°C Melting temperature of HAp 
1630°C Melting temperature of TTCP, leaving behind CaO 
1730°C Melting of TCP 
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2.8.1 Calcination (Drying) 
 
A. Oven Drying 
The oven drying stage of HAp powder processing, otherwise known as a calcination 
processes; may be defined as endothermic reactions in which an oxysalt, such as a 
carbonate or hydroxide, decomposes leaving an oxide as a solid product and liberating 
a gas [104]. Finely divided and sinterable ceramic powders are produced via this 
process. The surface area and particle size are a strong function of the calcination 
temperature and therefore are carefully controlled throughout the process. Heating 
just above the decomposition temperature, produces very fine, high surface area 
powders. Heating at temperatures well above the decomposition temperatures reduces 
the surface area (by forming hard agglomerates and increasing the particle size) to any 
degree desired. Decomposition of coarse salt particles to small, high surface area 
oxide particles occurs during calcination [104]. Subdivision occurs as a result of the 
nucleation of many oxide particles within each salt particle, or by fracture associated 
with strains between the shrinking parent salt and growing product oxide particles. 
These strains arise, since the oxide always maintains an orientation relationship within 
the salt. The oxide lattice always attempts to maintain coherence with the salt along 
preferred orientations. However, the large difference between volume and lattice 
spacing of the salts and oxides leads to strains and fracture.  
 
Calcined powders are invariably agglomerated often with several levels of porosity. 
These pores arise from the large shrinkage associated with transformation from high 
volume salt to low volume oxide. The largest agglomerates are usually porous relicts 
that are pseudomorphs (that is, possessing the same shape) of the salt particles. Finer 
agglomerates within the pseudomorph can arise from clusters of nucleated oxide 
particles within the salt resulting in a coral like structure.  
 
The majority of the research employing the oven-drying step for the calcination of 
HAp powders generally implement a drying temperature; ranging between 65 – 105ºC 
[56, 71, 79, 83 - 85, 90, 94, 105]. 
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B. Spray Drying 
Spray drying is a process whereby the HAp slurry (produced via the wet chemical 
precipitation method) is sprayed into a warm drying medium to ideally produce 
spherical powder agglomerates of relative homogeneity. It is considered a relatively 
efficient process since the HAp is well dispersed in the drying medium, the diffusion 
path is shorter, and the high specific surface area contributes to a higher rate of 
evaporation per unit mass of HAp product. The large surface area-to-volume ratio of 
the droplets allows rapid water evaporation and the resulting dry powder once 
separated from the air can be stored for later use [106, 107]. 
 
Spray drying is a popular method for HAp powder production due to its control over 
the final HAp powder properties obtained, particularly with regards to its powder 
morphology [108, 109].  Its most important aspect is the first stage of the process; 
atomisation.  The basic principles underlying spray drying have traditionally been 
used in the following sequence; (i) a liquid ceramic feed material is initially filtered, 
(ii) tray dried, (iii) rewet and (iv) crushed into a workable particle size.  The spray 
dryer apparatus combines these steps into a single step process.  The spray drying 
process sprays a liquid, (with the material content, such as, the HAp in its slurry 
form), into a heated chamber; the liquid then becomes evaporated and the powder can 
then be collected at its designated collection point. Batch mixing in slurry form (at the 
precipitation stage) along with atomising facilitate mixing and the achievement of 
mixedness [107]. Atomisation of the solution in a hot furnace can be implemented to 
combine drying and calcination all in the one step [106 - 111]. The main objective of 
atomisation is to produce a large number of small droplets from a liquid stream so that 
the droplets can be dried into particles. 
 
2.8.2 Sintering 
Sintering of the HAp powder post drying occurs within a controlled atmospheric 
environment raising the powder to a temperature below the melting point but 
sufficient to allow solid-state diffusion and to permit bonding of the particles. The 
first stage involves the combustion of air and volatisation of any thermal labile 
compounds that may interfere with good bonding [106]. The second stage (or high 
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temperature stage) involves solid-state diffusion and bonding between the powder 
particles to occur. Finally, a cooling period will be required to lower the temperature 
of the HAp product. The cooling period maintains the product in a controlled 
environment, serving to prevent oxidation that would occur upon direct discharge into 
air and possible thermal shock from rapid cooling [106]. 
 
The control of sintering behaviour in the production of HAp powders is very 
important [112 - 117]. Highly dense HAp is desirable to prevent the preparation of 
human fluid into the interfacial area between the HAp coating (described later) and 
Ti-alloys in hip joint replacements, while porous HAp are required for the 
replacement of fractured bone to allow ingrowth of the natural and artificial bones to 
occur and a strong bond between them to be readily attained [116]. HAp powders 
sintered by Sung et al. [114] at 1000ºC for 1h showed highly dense and almost pore-
free morphology. The sintered density value for the sintered HAp was determined as 
99.9% of the theoretical value for HAp, owing to the fine particle size produced 
during HAp synthesis. HAp powders, consisting of very fine particles have a much 
higher surface area, which is the driving force for solid-state sintering and the amount 
of surface energy decrease is proportional to the free energy decrease for the sintering 
reaction [114]. Therefore, sintering behaviour of HAp powders can be controlled by 
characterising powder particle size. Kim et al. [115] sintered HAp powders with a 
specific surface area of 68m
2
/g at 1200ºC for 2h to improve the crystallinity of the 
final HAp product. It was also noted that prior calcinations at 900ºC for 4h in air with 
subsequent ball milling were effective in eliminating agglomerates in the HAp 
powder. Results from Juang et al. [116] showed that sintering treatments increased the 
average particle size and distribution. The sintering behaviours were investigated by 
dilatometry and density measurement. The fluidity of the HAp powders and the 
driving force for sintering were found to dominate the properties. Sintering at 1250ºC 
was found to result in a higher bending strength (about 55MPa) with a finer grain size. 
Work carried out by Ramesh et al. [117] supported this evidence, as scanning electron 
microscope (SEM) analyses of the sintered microstructure revealed an exponential 
increase in grain size with increasing sintering temperature. 
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Ramesh et al. [117] states that the HAp phase was stable when sintered below 1400ºC 
for 2h. However, sintering at temperatures ≥1400ºC resulted in the decomposition of 
HAp to form TCP, TTCP and CaO products. It was believed that the high humidity 
content present in the sintering atmosphere slowed down the decomposition rates by 
preventing dehydration of the OH
-
 groups from the HAp matrix [117]. 
 
Kim et al. [115] observed that substitutions into the HAp lattice (such as, carbonate, 
magnesium, silicon) inhibited apatite crystallisation in solution and destabilised the 
structure of HAp and favoured its thermal conversion into α- or β-TCP. An adverse 
affect on the sinterability of the HAp was identified. HAp decomposes to form other 
calcium phosphates at elevated temperatures. Two mechanisms have been proposed 
for the decomposition as follows [118]: 
 
                Equation (2-13) 
OHCaOPOCaOHPOCa 224326410 )(3)()(                       Equation (2-14) 
 
Of these, the former is the more accepted mechanism. Further heating results in the 
transformation of -tricalcium phosphate ( -Ca3(PO4)2), forming -tricalcium 
phosphate. This usually requires exposure to temperatures in excess of 1350°C for 
this phase transformation to take place. It is believed that phase pure HAp can be 
sintered without decomposition at temperatures of up to ~1300°C [12]. Regardless of 
which mechanism takes place, both result in the formation of soluble or resorbable 
calcium phosphates, which dissolve when exposed to physiological environments 
[118]. 
  
OHOPCaPOCaOHPOCa 292424326410 )(2)()(
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2.8.3 Factors Affecting Thermal Decomposition Of HAp 
The factors affecting the thermal decomposition of HAp are as follows [118]: 
 
A. Sintering Temperature and Atmosphere 
The highest possible sintering temperature depends on the sintering atmosphere 
(partial pressure of water vapour) [12]: increasing the ambient humidity stabilizes 
HAp to higher temperatures. As discussed previously (section 2.8), increasing the 
temperature to 1500°C leads to rapid HAp decomposition, while, under ambient 
sintering conditions, decomposition is reported to begin in the range 1050-1100°C. 
Some researchers, however, have observed synthetic HAp to resist decomposition 
until 1200°C. Since a gaseous species exists on the products side of the 
decomposition reactions, sintering atmosphere is expected to influence the 
decomposition kinetics of HAp [118]. Consequently, sintering under vacuum 
conditions can induce decomposition at lower temperatures, favouring the formation 
of water vapour. On the other hand sintering in a moist atmosphere is found to 
counteract this effect and delay decomposition to some degree [94, 95, 118]. 
 
B. Ca/P Molar Ratio 
HAp has a theoretical stoichiometric Ca/P molar ratio of 1.67, however this has been 
known to vary due to the HAp structure‘s willingness to undergo substitutions. 
Materials with Ca/P molar ratios different from 1.67 are known to be less thermally 
stable compared to stoichiometric HAp [98 - 103]. There is experimental evidence 
that HAp with a Ca/P molar ratio of 1.68 does not decompose at temperatures of up to 
1450°C over a period of 3 h [12]. 
 
C. Initial Particle Size 
Sintering of fine-particle HAp powder at 1300°C for 3 h ensures a nearly theoretical 
density. Sintering at higher temperatures is accompanied by secondary 
recrystallisation: as the sintering temperature is raised from 1300 to 1450°C, the grain 
size increases from 4 to 14 µm. The grain size as a function of heat-treatment 
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temperature exhibits Arrhenius behaviour with an apparent activation energy of 196 
kJ/mol.  
 
Clearly, the optimal sintering temperature and duration depend on the prior history 
and particle size of the powder, which influence its sintering behaviour and the phase 
composition of the resulting material. Increasing the particle size of the HAp powder 
from 1 to 4.2 mm markedly raises the shrinkage onset temperature [12]. In spite of the 
higher green density of coarse-particle compacts, the sintered density increases with 
decreasing particle size. 
 
D. Initial HAp Synthesis Reaction 
It is believed that the method used to synthesise the HAp powder can influence its 
thermal stability [114-116, 118, 119]. The belief is that HAp powders synthesised 
using hydrothermal methods are more stable compared to precipitated powders. This 
may be attributed to the presence of adsorbed HPO4
2-
 ions. 
 
E. Secondary Phases 
Several researchers [118] have tried reinforcing HAp with secondary phases to 
improve its mechanical properties, which are not generally accepted to be suitable for 
load-bearing biomedical applications. In almost all cases, the presence of these phases 
reduced the temperature at which decomposition began. The same conclusion was 
applied to impurities in HAp powders.  
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2.9 POST-SINTERING PROCESSING OF HAp 
2.9.1 Grinding 
The next stage in the HAp powder processing is often the size reduction of the HAp 
powder particle agglomerates that have been produced upon sintering. Grinding and 
milling are extensively applied in the field of ceramics for size reduction [3]. The 
general phenomena during a solid state size reduction are based on fracture 
mechanics: the nucleation of cracks, followed by crack propagation and fracture, by 
which new surfaces are formed. A further decrease of mean particle size will only 
take place when these processes occur. The kinetic energy within the milling 
aggregate is partially transformed into mechanical stresses within the powder material 
to be disintegrated. The forces acting in these processes cause mainly compression 
and shear stresses, applied as impact. In ceramic materials, plastic deformation does 
not take place in coarse particles, but becomes significant for mean particle sizes in 
the micron range. The main process phenomenon for all grinding and milling 
processes, however, is crack propagation and fracture, which is accompanied by local, 
not well defined, temperature increase [3]. These are often defined as thermal ‗spikes‘ 
and can result in anomalous structures [3]. The limit of the minimum obtainable 
particle size depends on the conditions of the mechanical process as well as on the 
material itself.   
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2.9.2 Sieving 
Post sintering and grinding, the HAp powders are sieved through the desired mesh 
size (see Table 2-14) in order to ensure that the correct particle size distribution 
(>90% of the HAp powder particles are <100μm) can be achieved prior to plasma 
spraying the HAp powder as a coating onto orthopaedic implants.  
 
Table 2-14: ASTM mesh sizes. According to ASTM B 214 – 07 [120] 
Mesh Size Microns Inches 
4 4760 0.185 
6 3360 0.131 
8 2380 0.093 
12 1680 0.065 
16 1190 0.046 
20 840 0.0328 
30 590 0.0232 
40 420 0.0164 
50 297 0.0116 
60 250 0.0097 
70 210 0.0082 
80 177 0.0069 
100 149 0.0058 
140 105 0.0041 
200 74 0.0029 
230 62 0.0023 
270 53 0.0021 
325 44 0.0017 
400 37 0.0015 
625 20 0.0008 
1250 10 0.0004 
2500 5 0.0002 
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2.10 RHEOLOGICAL PROPERTIES OF HAp 
Rheology is the most sensitive method for material characterisation because flow 
behaviour is responsive to properties such as molecular weight and molecular weight 
distribution. Rheology measurements are also useful in following the course of a 
chemical reaction [121]. Such measurements can be employed as a quality check 
during production or to monitor and/or control a process. Rheological measurements 
allow the study of chemical, mechanical, and thermal treatments, the effects of 
additives, or the course of a curing reaction. 
 
2.10.1 HAp Precipitating Slurry 
Tian et al. [97] made a comparative investigation on particle size, zeta potential and 
rheology behavior of suspensions of HAp powders produced by a wet-chemical 
synthesis method. Results showed that temperature and soaking time of the 
calcinations process significantly affected the HAp particle size and resulted in a 
reduction of the zeta potential and suspension viscosity. On this basis, it was 
concluded that the reduction in the viscosity was attributed to a higher repulsion 
barrier in interparticle potential. 
 
According to Padilla et al. [122] HAp suspensions with high solids content were 
obtained through the wet chemical precipitation technique using Ca(OH)2 and H3PO4 . 
Powder calcinations temperatures were found to have an effect on phase composition, 
surface area, porosity and rheological behaviour [116]. HAp powders calcined at 
1200ºC were capable of achieving 60% vol. of concentrated slurry.  
 
2.10.2 HAp Powder Particles 
A simple definition of powder flowability is the ability of a powder to flow [123]. 
Flow behaviour is multidimensional and depends on many powder characteristics and 
variables (See Table 2-15) [123]. Flowability is the result of a number of the 
combination of material physical properties that affect material flow and the 
equipment used to handle it. Equal consideration needs to be given to both the 
material and the equipment [123]. Powders are sometimes considered to be relatively 
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stable entities like the individual solid particles that make up their mass. This is not 
the case since the rheological properties of the mass are greatly influenced by the 
presence or absence of air [124]. 
 
The inherent changeability of powders means that processing and handling are not 
straightforward and predictable procedures [124 - 128]. Powder flowability is 
inherently complex due to the many physical and environmental variables that 
determine how it responds to being moved. Investigating flowability requires the use 
of a technique with exceptional sensitivity and repeatability of measurement.  
 
Table 2-15: Variables affecting powder flowability [124] 
Powder or Particle variables External Factors influencing 
Powder Behaviour 
 
Particle size 
Size distribution 
Shape 
Surface texture 
Cohesivity 
Surface coating 
Particle interaction 
Wear or attrition characteristic 
Propensity to electro-static charge 
Ability to recover from compaction 
 
Flow rate 
Compaction condition 
Vibration 
Temperature 
Humidity 
Electro-static charge 
Aeration 
Transportation experience 
Container surface effects 
 
 
 
There are no reliable quantitative relationships between primary properties like 
particle size and distribution, particle shape and secondary properties such as failure 
properties or bulk density [129]. Therefore, in order to reliably predict flow 
performance, an understanding of the impact and the interaction of all the above 
variables needs to be realised. 
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2.11 THERMAL SPRAY APPLICATION OF HAp POWDER FOR 
ORTHOAPEDIC COATING APPLICATION 
 
2.11.1 Thermal Spray Method 
Thermal spraying represents a group of processes which employ heat and velocity to 
coat the surface of one material with another, using powder or wire as feedstock. 
Thermal spray methods can be divided into two principal energy sources, chemical 
energy of the combustion gases that power the flame spray torch and electric currents 
providing energy for the plasma generators. Figure 2-15 highlights the principal 
thermal spray methods associated to both energy sources. 
 
 
Figure 2-12: Thermal spray techniques divided by their principal energy sources 
 
Many orthopaedic implant systems utilise osteoconductive surfaces, such as, HAp 
coatings to promote implant fixation to bone by direct bonding or osteointegration [2, 
21, 131]. Of the many techniques used for depositing HAp onto orthopaedic implants, 
plasma spraying is the most commercially accepted and only FDA approved method 
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for producing HAp coatings [2, 21, 103, 131].  Plasma spraying has the ability to 
produce specialised coatings with functional properties such as, biocompatibility, 
fixation, corrosion and wear resistance that is beneficial to the field of biomedical 
engineering [132]. The principle of plasma spray operation is illustrated in Figure 2-
16. 
  
 
Figure 2-13: Schematic diagram of the thermal spray process [103] 
 
2.11.2 Plasma Spray Operation 
The plasma spray process is basically the spraying of molten or heat softened material 
onto a surface to provide a coating. Material in the form of powder is injected into a 
very high temperature plasma flame (caused by a mixture of high current arc and 
combustion gases), where it is rapidly heated and accelerated to a high velocity. The 
hot material impacts the substrate surface and rapidly cools forming a coating [103, 
106, 109, 132-136].  
 
The plasma spray gun comprises of a copper anode and tungsten cathode, both of 
which are water cooled. Plasma gas (inert gases; argon or nitrogen and combustion 
gases; hydrogen or helium) flow around the cathode and through the anode which are 
shaped in a nozzle shaped assembly. The combustion gas is not used for HAp 
production as this has chemical effects on resultant deposit. The plasma is initiated by 
a high voltage discharge which causes localised ionisation and a conductive path for a 
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DC arc to form between the cathode and anode [103, 132]. The resistance heating 
from the arc causes the (inert and combustion) gas to reach extreme temperatures as 
high as 30,000ºC, dissociate and ionise to form plasma [132, 136]. The plasma exits 
the anode nozzle as a free or neutral plasma flame (plasma which does not carry 
electric current) where the arc extends to the surface to be coated. When the plasma is 
stabilised (ready for spraying), the electric arc extends down the nozzle rather than 
shorting out to the nearest edge of the anode nozzle (arc instabilities are governed by 
the electrode design, gas injection mode, spraying parameters and the condition of the 
anode wall) [132]. This stretching of the arc is due to a thermal pinch effect [136]. 
The HAp powder is fed from a hopper unit using an inert gas (such as, Argon) into the 
plasma flame via an external powder port mounted near the anode nozzle exit [136]. 
The powder is rapidly heated and accelerated (velocity of 200-300 m.sec
-1
) over spray 
distances of 25 to 150 mm [132]. Thermally sprayed coatings have a characteristic 
layered structure made of individual powder splats oriented parallel to the substrate 
surface producing high levels of anisotropy [102, 103, 132, 133, 136]. 
 
The plasma spray process is most commonly used in normal atmospheric conditions 
and referred to as Atmospheric Plasma Spraying (APS). A problem pertinent to the 
plasma-sprayed HA coating is the generation of an amorphous phase, along with other 
non-bioactive calcium phosphate phases following plasma spraying [132]. Calcium 
oxide is usually formed when HAp deposition is performed in air [132]. Coatings 
sprayed with large starting powders are found to undergo dramatic degradation after 
immersion in vitro [132]. The integrity of the coating produced in this environment 
ultimately depends on the amount of calcium oxide formed. Some plasma spraying 
have been conducted in protective environments using vacuum chambers normally 
back filled with a protective gas at low pressure; this is referred as Vacuum Plasma 
Spraying (VPS) or Low Pressure Plasma Spraying (LPPS) [132]. The different 
techniques distinguished by the surrounding atmosphere for plasma spraying are 
illustrated in Figure 2-17. 
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Figure 2-14: Plasma spray techniques divided by their surrounding atmospheres 
 
Ideally, only a thin layer of each powder particle ends up in a molten plastic state, 
which undergoes phase transitions [132]. This plastic state, however, is necessary to 
ensure dense, adhesive and cohesive coatings. Subsequently, the properties of plasma 
sprayed coatings depend on the optimal relation between the particle size, particle 
chemistry, the gas used, the speed of the plasma, the distance between the plasma 
nozzle and the substrate (consisting of a Ti-alloy implant) and the cooling process for 
the desired composition and crystallinity [132]. Many of the parameters chosen in the 
control of the thermal spray techniques will have a dramatic influence on the final 
structure of the ceramic coating and must therefore be carefully controlled in order to 
optimise the performance of the HAp coating in vivo. In the plasma spray process, the 
main parameters include power, current, distance between nozzle and substrate 
(orthopaedic, Ti-alloy implant), plasma work gas rate, carrier gas rate and powder 
feed rate. The heat content of the plasma flame and thus the ability to increase the 
temperature of the powder particle depends on the type of gas used. Argon mixed 
with hydrogen gives a higher degree of crystallinity [132]. The combustion of the 
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inert and combustion gases has an effect on coating thickness and crystallinity [132]. 
The use of nitrogen gas as the carrier gas, as opposed to argon results in thicker 
coatings [132]. The plasma spray parameters commonly used to deposit the HAp 
powders onto orthopaedic implants are shown in Table 2-16. 
 
Table 2-16: Optimum plasma spray parameters used for depositing dense HAp coatings 
onto orthopaedic implants. Adapted from [130] 
Coating Current 
(A) 
Spray 
distance 
(mm) 
Gas flow rate 
(scfh) 
Carrier gas flow 
rate (scfh) 
Powder feed 
rate (g/min) 
HAp 750 70 114.59 10 20 
 
Where scfh is standard cubic feet per hour 
 
Plasma spraying has the advantage that it can spray very high melting point materials. 
Plasma sprayed coatings are generally much denser, stronger and cleaner than the 
other thermal spray processes with the exception of High Velocity Oxy-Fuel (HVOF) 
and detonation processes [133]. Plasma spray coatings account for the widest range of 
thermal spray coatings and applications, making this process the most versatile. Its 
main disadvantages owes to its relative high cost and complexity [96]. 
 
The deposition of HAp coatings on medical devices range between 50 to 100μm thick 
[102, 103, 134, 135]. Coatings with thicknesses greater than 80μm become brittle, 
whereas very thin coatings often resorb too fast [102]. Significant porosity of the HAp 
material lowers the mechanical strength and increases the resorption rate [102]. 
Optimum coatings consist of completely dense and pure HAp powders, with a Ca/P 
molar ratio close to that of natural bone (1.667) [2]. The optimum HAp powder 
particle size for plasma spraying generally does not exceed 160μm (Table 2-17). 
Hence the production and characterisation of HAp powder before thermal spraying 
will enhance the deposits performance in vivo. 
 
Table 2-17: Properties of HAp applied onto Ti-Alloy substrates. [64]  
Surface Average Roughness (μm) Initial Powder Size (μm) 
HAp coating on Ti Substrate 4.96 0.43 45 - 160 
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2.11.3 Thermal Stability Of HAp Coating 
The ability to adapt to the harsh physiological environment depends very much on the 
degradation strength and thermal stability of a resultant HAp coating. Kweh et al. [2] 
noted that a pH of about 9 would produce the correct stoichiometric condition 
whereby only pure, single-phase HAp is formed. No other undesirable phases such 
TCP or CaO were found in the above research. 
 
The use of precipitated HAp powder, subsequently spray dried has proven the ability 
to produce porous coating microstructures to aid in enhanced bone ingrowth. Flame-
spheroidized powder however possesses the capability to produce dense, coherent 
HAp coatings with highly lamella structures, aiding in osteoconduction [1]. 
Spheroidized HAp (SHAp) powder provide better flowability and stability, which 
eventually affects the deposition and phase formation in the resultant coating [1]. This 
is achieved through an intermediate stage of flame spraying.  
 
The level of crystallinity of the heat-treated SHAp powder was found to be much 
higher than that of the untreated powder. No undesirable phases of TCP and CaO 
were detected for both the SDHAp and SHAp powders [2]. This was identified by the 
increase in peak height and the narrow peak width. SHAp powder appears to inherit 
better particle characteristics than the former including, a spherical geometry, dense 
internal structure and a smooth glassy surface as mentioned earlier in this section. 
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2.12 STANDARDS AND REGULATORY REQUIREMENTS IN HAp 
POWDER PRODUCTION FOR ORTHOPAEDIC COATING 
APPLICATION 
 
HAp coated titanium implants have been identified as Class III medical devices in 
accordance with the Food and Drug Authority (FDA) regulations [137]. The chemical 
and physical parameters for HAp as stated in the ―Draft Guidance for Calcium 
Phosphate (Ca-P) Coatings for Preparation of FDA Submissions for Orthopaedic and 
Dental Endosseous Implants‖ [137] are in parallel to the American Standard for 
Testing of Materials, ASTM, F1609-08; ―Standard specification for calcium 
phosphate coatings for implantable materials‖ [138]. These drafts outline the methods, 
regulations and standards (Table 2-18) associated to attaining optimum HAp powder 
properties with respect to elemental analysis, Ca/P ratio, density and solubility of 
HAp powders (Table 2-19).  
 
Technical specifications for HAp, in its particulate form (that is, HAp powder) is 
outlined in ISO 13779-1, Implants for Surgery – Hydroxyapatite, Part 1 and  ASTM 
F1185-03 [139, 140] is another specification, which covers the chemical and 
crystallographic requirements for HAp intended for surgical implants. In order for a 
material to be referenced as HAp, it must conform to this specification. The biological 
response to HAp in soft tissue and bone has been characterised by a history of clinical 
use and by laboratory studies. This specification includes powder, particulate, and 
forms intended for use as surgical implants, components of surgical implants, or as 
raw materials for manufacturing processes such as thermal spray coating, 
electrophoretic deposition, physical vapour deposition, while excluding HAp 
coatings, ACP, ceramic-glasses, tribasic calcium phosphate, whitlockite, and α- and β-
TCP, which are alternatively covered under the standard specification for composition 
of Beta - Tricalcium phosphate for surgical implants, ASTM F1088-03 [141]. 
 
 
A highly pure, homogeneous, and highly crystalline HAp, produced and certified by 
the National Institute of Standards and Technology (NIST) is the standard reference 
material, SRM 2910 [50]. The contents of Ca
2+
, PO4
3-
, OH
-
, HPO4
2-
, H2O, CO3
2-
 and 
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trace constituents, the Ca/P molar ratio, crystal size and morphology, surface area, 
unit-cell parameters, crystallinity, and solubility of this HAp are also presented for 
this reference material. 
 
2.12.1 Chemical And Crystallographic Analysis Of The Ca-P Powder 
The FDA requires the following test data to be reported when using or proposing HAp 
products: 
 
A. Elemental Analysis 
An elemental analysis for the powder noting any impurities including, but not limited 
to, 50-ppm heavy metals, as identified in ASTM F1185 [140] is required. 
Characterisation of the protein present in the powder should also be included [138]. 
 
B. Calcium To Phosphorous (Ca/P) Ratio 
The Ca/P ratios in atomic percent for the powder should be reported. In order to 
account for the deviation that may occur from the ideal stoichiometric ratio (Ca/P = 
1.667); a sufficient number of samples are required for analysis in order to produce a 
statistically meaningful mean and variance (95% confidence interval) [138]. 
 
However, Table 2-19 indicates ranges for Ca/P ratio that have been found acceptable 
[120]. Therefore, the content of calcium and phosphorous ratio, Ca/P, shall have a 
value of 1.65  Ca/P  1.82 for the atomic ratio in accordance to ISO 13779-1[139]. 
This must be determined using the specifications described in ISO 13779-3 [142]. 
 
C. X-Ray Diffraction (XRD) 
Individually superimposed patterns of the formed HAp powder over the standard 
given for the relevant calcium phosphate compound (such as, HAp, JCPDS 9-342 
[143]) in the powder diffraction files of the JCPDS (Joint Committee on Powder 
Diffraction Standards) must be determined.  
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Table 2-18: Relevant standards, methods and publications. Adapted from [137] 
Guidance Standard(s) Method(s) Publication(s) Comments 
 
Elemental 
Analysis 
ASTM F1185 
ASTM F1088 
 
Atomic Absorption   
X-Ray 
Diffraction 
JCPDS 9-342 
 
 
 
ASTM 
F4.2.3.8 
Hanawalt Method 
for Powder 
 
 
Calculation of total 
area under curve 
(% amorphous 
material) 
Cullinity [126] Methods dependent 
upon starting 
material 
Solubility   Ducheyne et al.[54] 
 
 
Density  Helium 
Pycnometer 
  
 
 
Table 2-19: Calcium Phosphate Powder Characteristics of Legally Marketed Devices. 
Adapted from [137] 
Guidance Maximum or 
Minimum Cleared 
Range Comments 
 
 
Elemental 
Analysis 
50 ppm heavy metals 
(MAX) 
 
  
Ca/P ratio  - Powder: 
1.66 – 1.67 
-Coating: 
1.67 – 1.76 
 
 
Crystallinity 95% Crystallinity 
(MIN) 
 
  
Purity 95% Purity (MIN)  If the purity of the HAp powder is less 
than 95% or if the coating is less than 
90%, the labelling of the implant 
should identify all major compounds 
present. 
 
Density - Powder: 
>3.00 g/cm
3
 
-Coating: 
>2.98 g/cm
3 
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D. Infrared Spectrometry (IR) 
The IR spectra of the HAp powder must also be indicated. Spectra must be plotted as 
percent transmittance versus wavenumber [137]. The characteristic absorption bands 
for HAp are as follows [137]: 
 
PO4
3-
: 570cm
-1
, 962cm
-1
, 1050cm
-1
 
OH-: 630cm
-1
, 3540cm
-1 
 
 
E. Solubility Of Ca/P Compound 
A complete report regarding the solubility testing is required and should be conducted 
in a physiologically similar solution to tris-HCL buffered solution at 37 C, tested at a 
pH of 3.0 and 7.3 [137]. Room temperature and 100 C measurements are optional. 
Alteration in pH must also be recorder with the solubility product of HAp being based 
upon the normal stoichiometric formula Ca10(PO4)6(OH)2.  
 
Xue et al. [135] examined the dissolution behaviour of HAp coatings in tris-buffer 
solutions. The results obtained indicated that the coating having the high crystallinity 
showed the lower dissolution as compared to the low crystallinity coating. Their 
crystallinity‘s were about 55% and 98%, respectively; indicating the significance in 
complying with FDA requirements of a 95% minimum with regards crystallinity 
obtained.  
 
The HAp coated orthopaedic implant is required to satisfy the requirements for ISO 
13779-2, ISO 13779-3 and ISO 13779-4, Implants for Surgery – Hydroxyapatite, 
Parts 2, 3 and 4 [142, 146, 147]. The chemical composition of the HAp coated 
orthopaedic implant is required to meet the specifications as outlined in ISO 13779-3, 
―Implants for surgery – hydroxyapatite: chemical analysis and characterization of 
crystallinity and phase purity‖. The practice ASTM F2024-00 [148] is for the 
determination, by the Reference Intensity Ratio (RIR) external standard method, of 
the percent by weight of the crystalline phases, HAp, β-TCP, and CaO in coatings 
deposited upon metallic substrates by plasma-spraying HAp. A major component in 
plasma-sprayed HAp coatings other than HAp is expected to be ACP. Crystalline 
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components other than HAp that may be present include α- and β-TCP, TTCP, CaO, 
and calcium pyrophosphates. Quantification of the minor crystalline components has 
proven to be very unreliable due to extreme overlap and confounding of XRD peaks. 
Therefore, this practice addresses the quantification of only HAp, B -TCP, and CaO. 
This practice was developed for plasma-sprayed HAp coatings with HAp contents of 
at least 50 % of the total coating.  
 
Biocompatibility requirements are outlined in the ISO standard 10993, ―Biological 
Evaluation of Medical Devices‖ [149] where part 1 of the standard aids in outlining 
the selection of tests required in order to assess its biological response in vivo. Part 5 
outlines the tests for cytotoxicity through various in vitro methods [150] while parts 6, 
9, 11 and 12 relate to tests for local effects after implantation, the degradation of the 
materials related to biological testing, tests for systemic toxicity, and sample 
preparation and reference materials, respectively [151 – 154]. 
 
 
2.13 SUMMARY 
This literature survey highlights the great effect of the process parameters using the 
chemical precipitation technique for the synthesis of high HAp purity and 
crystallinity, which are in effect the deciding factors for its thermal stability and hence 
dissolution in a physiological environment. It also highlights the effect of varying 
these parameters on other HAp powder characteristics, such as, crystallite size, lattice 
parameters, particle size, morphology and its rheological properties. Therefore, in 
order to produce HAp powder with predictable powder characteristics, these 
parameters are required to be effectively designed. To evaluate the influence of these 
conditions on the final powder properties, various equipment and procedures were 
used and are described in the following chapter. 
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3 EXPERIMENTAL EQUIPMENT, 
PROCEDURES AND MATERIALS 
CHARACTERISATION 
 
3.1 INTRODUCTION 
This chapter outlines the experimental procedures, equipment, and material 
characterisation techniques used in the current research, in the preparation of high phase 
purity and crystalline HAp powders (both ≥95%), for application via plasma spraying 
onto orthopaedic implants in order to investigate the effect of the synthesis parameters on 
the final HAp powder properties obtained. The HAp was characterised at various stages 
of the production process ((i) post precipitation in slurry form and (ii) post sintering in 
powder form) to evaluate the various HAp properties, such as, phase purity, crystallinity, 
crystallite size, lattice parameters, particle size, density, specific surface area, porosity, 
morphology and rheological/viscous properties. The route used to prepare HAp powder 
in the initial stage of this investigation, was based on the process currently used in Irish 
industry (company name cannot be disclosed due to intellectual property rights) and 
reproduced in-house on a laboratory scaled version. The properties obtained for the 
powders produced in Irish industry and the current research were evaluated and compared 
against that of other marketed HAp powder producers (such as, CAMCERAM®, 
Tomito®, Plasma Biotal® and a sister company of the Irish based industrial company) to 
screen the powders of optimum quality for plasma spraying and identify the factors 
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affecting the final properties yielded. The observations aided in the selection of the 
process parameters for screening at the experimental design stages.  
 
Two experimental designs were constructed: (i) screening experiments using a fractional 
factorial design to screen the factors which have a significant effect on the powder 
properties obtained and (ii) optimisation experiments using a box - behnken design to 
optimise the critical parameters controlling the powder properties obtained. A description 
of both the experimental designs used in the research is outlined in Section 3.6. The 
optimisation approach is outlined in Section 3.7. 
 
The materials characterisation equipment used in the current investigation in order to 
characterise the HAp powders are described in Section 3.8, with respect to HAp powder 
phase purity, crystallinity, crystallite size, lattice parameters, particle size, specific 
surface area, powder density and powder morphology. The equipment and methods for 
observing the rheological properties of the HAp in a slurry and powder form are also 
presented. 
 
An investigation to evaluate the in vitro behaviour of the powders produced was also 
conducted, through cell studies, such as, cell proliferation, cell viability and cell 
morphology. A description of these procedures is outlined in Section 3.9. 
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3.2 PREPARATION OF HAp POWDER  
In order to replicate the HAp powder production process used by the Irish industry in-
house on a laboratory scale, the following procedure was implemented (based on 
literature, industrial placement and practice), whereby the HAp was synthesised via the 
chemical precipitation method, using the precursor materials, calcium hydroxide, 
Ca(OH)2 (produced in-house) and phosphoric acid, H3PO4 (JT Baker, Analyzed, 85% 
Pure)  in the chemical reaction based on Equation 2-1. The initial stage of the process, 
involves the preparation of a Ca(OH)2 slurry via the addition of 79.55g of CaO (JT 
Baker, Analyzed, 100% Pure) powders to 500mL of distilled water in a 1000mL-enclosed 
beaker, under vigorous agitation conditions with a vertical IKA mechanical overhead 
stirrer at 1000rpm, at an uncontrolled reaction temperature and without the control of the 
atmospheric environment (the latter two parameters were controlled in later studies). The 
next stage of the process involves neutralisation of the supersaturated solution by titration 
using 97.32g of 85% H3PO4 (JT Baker, Analyzed) at an addition rate of 1.5mL/min, 
controlled using a peristaltic pump.  All chemicals used were reagent grade. 0.28 mol 
(9.94g) NH4OH, was added to the HAp slurry after the 24h ripening period to stabilise 
the pH of the super-saturated solution to above pH 9. X-ray diffraction and pH readings 
obtained were used to follow the reaction and assess the composition, to determine when 
stoichiometric HAp was reached. Spray drying of the HAp slurry was then employed to 
evaporate the moisture content from the slurry. The spray dryer atomised the pre-HAp 
suspension via the controlled removal of water by temperature control and product 
collection into two different batch sizes (the parameter setting, of which are discussed in 
a later section). Analysing and correcting the viscosity of the final HAp slurry (to 2 – 3 
cst) prior to spray drying ensured that dense, micron-sized powder particles were 
obtainable [82, 108]. The actual spray drying parameters were set to control the 
morphology of the particles to obtain powders of a spherical shape, with a view to 
enhancing the flowability of the powder particles.  The dried powders were then sintered 
in a furnace at 1210ºC for 4h, ground using a mortar and pestle and sieved to eliminate 
any powders of particle sizes exceeding 100µm. A flow chart for this process is shown in 
Figure 3-1. 
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Figure 3-1: Flow chart of the HAp production process used in-house, as replicated on a 
laboratory scale, based on a current Irish based industrial process 
 
The preliminary investigation of this study involved analysing the HAp powder 
characteristics of international suppliers and comparing these against the HAp powder 
properties currently being produced in industry in Ireland. HAp was synthesised in-
house, within the Materials Processing Research Centre, under the same conditions as 
that disclosed by the HAp manufacturing company in Ireland; characterised and 
compared against that of the Irish HAp and also against those purchased by other various 
international suppliers. The HAp powders examined in this study were described in the 
following section. 
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3.3 CONTROL OF THE FACTORS AFFECTING CHEMICAL 
PRECIPITATION 
3.3.1 Chemical Precipitation Equipment 
A scaled down version of the chemical precipitation process, as used in Irish industry 
(see the experimental rig, Figure 3-2) was produced in the current research in order to 
examine the effect of the factors, which are considered to have a significant effect on the 
chemical precipitation process and thus the final HAp powder properties yielded. The 
drawings for this design can be referred to in Appendix A. The design of the 
experimental rig was developed by the author in order to accommodate the possibility in 
varying and ultimately controlling the factors, which affect the precipitation process 
(such as, temperature control, rate of reagent addition, stirring speed and atmospheric 
control).  
(A)       (B) 
 
Figure 3-2: AUTOCAD 2005 Drawings of the chemical precipitation rig designed for the 
investigation of HAp synthesis (3-D view (A) and 2-D plan and elevation view (B) 
 
Other important factors, controlling the process (such as, initial reagent concentrations 
and ripening/maturation time) did not influence the design of the rig, as these factors 
were considered to be independent of the rig design. 
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3.3.2 Temperature Control 
Precipitation temperature was controlled using a temperature controlled water bath (NE4-
28T Series) with precision as follows [155]: 
 Temperature range: +5°C - 99°C  
 Sensitivity/temperature stability: ±0.1°C at 45°C  
 Temperature uniformity: ±0.01°C at 45°C 
 
pH measurements were recorded via a Hanna HI 9813 Handheld pH, EC & TDS Meter 
with Probe (Hanna Instruments, Inc.) with an accuracy of pH: ± 0.2pH at ambient 
temperature. [156] 
 
3.3.3 Rate Of Acid Addition 
The rate of addition of acid reagent was controlled via a Watson Marlow 323D Series 
pump. Flow rates were obtained using silicone tubing with the pumphead rotating 
clockwise (15 – 220rpm). The range of flow rates may be controlled between 0.05 – 2000 
ml/min  [157]. 
 
3.3.4 Stirring Speed 
Powerful mechanical Heidolph (RZR1) and IKA (RW20) overhead stirrers were used to 
agitate the aqueous suspension of HAp during chemical precipitation. A design for the 
stirrer stand was constructed with the capacity to ensure that the stirring alignment was 
centred within the reaction vessel, in spite of changes to the slurry viscosity (see 
Appendix A for related drawings of this design). However, the positions of the overhead 
stirrers within the precipitating reactor vessels are also considered to influence the overall 
reaction. The optimum set-up for off-bottom suspension of the impeller location within 
the reactor vessel was found to be one-third that of the impeller diameter from the tank 
bottom [158]. To ensure a uniformly mixed suspension is achieved, the impeller location 
can be as low as one-third the impeller diameter off-bottom, or higher, depending on the 
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need for agitating minimum slurry levels within the tank [158]. Handling minimum levels 
is an important consideration for batch rather than continuous flow operations. The 
parameters based on the study of optimum impeller location are shown in Table 3-1 and 
Figure 3-3.  
 
Table 3-1: Impeller location parameters within the precipitating reactor (based on Figure 3-
3) 
Parameter Ratio Lower 
Limit 
Upper 
Limit 
Irish Industrial 
Setting 
Setting  
Impeller Diameter 
 
D/T 0.1 0.8 0.5 0.75 
Liquid Height Level 
 
Z/T 0.6 0.7 1.5 0.7 
Impeller Off-Bottom Clearance 
 
C/T 0.3D 1D 0.75D 0.5D 
Distance Between Multiple 
Impellers 
S 0.5D 2D 1.1D - 
 
 
 
Figure 3-3: Schematic of important mixing and impeller location parameters. Adapted from 
[159] 
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3.3.5 Atmospheric Control 
The precipitating reaction vessels were designed, to allow for the synthesis of HAp, 
under conditions of either an uncontrolled or inert atmospheric environment. To 
supplement a controlled atmospheric environment, the reactors were sealed, with a 
constant supply of N2 continuously pumped into the reactor so as to eliminate 
contamination of the HAp product and the likelihood of carbonate substitutions into the 
end apatite lattice, thus leading to microstructural imperfections. 
 
 
A schematic of the final chemical precipitation rig, with an overview of the control of the 
factors influencing the process and the methods for controlling them are shown in Figure 
3-4. 
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Figure 3-4: A 2-D schematic of the chemical precipitation rig (above) and an illustration of 
the rig in operation (below) using two precipitator reactors 
 
HDPE 
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3.4 MATERIAL CHARACTERISATION 
Characterisation of the HAp (in slurry and powder form) was conducted throughout 
various stages of the production of HAp and in the current research itself, respectively. 
Characterisation of the HAp in its slurry form, was analysed, through measuring its final 
pH value, density and viscosity, while characterisation of the HAp powders was carried 
out using, XRD, SEM, PSA, Helium Pycnometry, Mercury Porisometry, the BET method 
and powder rheology equipment. A biological evaluation of the powders was also 
investigated at the experimental design stage of the investigation and the procedures used 
in this study, is discussed in a later section (3.9). An overview of the sequence of 
characterisation events is illustrated in Figure 3-5. 
 
 
Figure 3-5: Overview of HAp synthesis route and materials characterisation
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3.5 THERMAL TREATMENT OF HAp POWDERS 
3.5.1 Spray Drying 
The HAp slurry was transported to the spray drier (Niro P-6.3) at a rate of 1L/min for 
atomization into fine, micron sized powder particles of spheroidal morphology. Spray 
drying was performed in a co-current flow dryer, in which the flow of the droplets in the 
chamber travels in the same direction as the flow of the hot air. A straight vane rotary 
atomizer was used to optimise the desired powder characteristics. The powder particles 
were collected at the base of the drying chamber. Air borne particles were separated from 
exhaust air by a cyclone. The dried powder samples were collected at their respective 
collection points from the drying chamber. The parameters set for all spray drying 
operations of the powder samples are shown in Table 3-2 as proposed through a recent 
study concerning a critical investigation into the spray drying technique [109]. This 
technique was used to prepare a HAp powder (HAp6: refer to Section 4.1) on a 
laboratory scale version, via the same processing conditions as that used in Irish industry 
to (i) compare against other commercially available HAp and (ii) identify the effect of the 
various synthesis conditions on the respective powder characteristics for each of the HAp 
studied. 
  
Table 3-2:  Parameters used in the operation of the spray dryer 
Parameter  Units Settings 
 
Inlet Temperature 
Outlet Temperature 
Cyclone  Pressure 
Av. Chamber Mass  
Av. Cyclone Mass   
Nozzle air Pressure 
Nozzle air Flow 
Slurry Feed  
 
ºC 
ºC 
mm H2O 
gram 
gram 
Bar 
% 
L/min 
 
170 
85 
40 
60 
38 
0.6 
75 
0.0456 
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3.5.2 Oven Drying 
All other HAp powders prepared (excluding HAp6) in the present study were oven dried 
as opposed to the aforementioned technique of spray drying (see Section 3.5). This 
involved filtering of the HAp precipitate (that is, in slurry form) from suction via vacuum 
filtration using whatman filterpaper and dried at 105ºCfor 24h. This method was selected 
based on previous published literature as shown in Table 3-3 as follows: 
 
Table 3-3: Previous settings implemented in published literature, for oven drying settings 
post chemical precipitation 
Reference Post precipitation steps and oven drying settings 
 
Afshar et al. [83] 1. Filtered via centrifugation/whatman filter paper 
2. Dried at 80ºC overnight 
 
Saeri et al. [84] 1. Filtered via centrifugation/whatman filter paper 
2. Washed by water and filtered again 
3. Dried at 80ºC overnight 
 
Santos et al. [56] 1. Supernatant decanted 
2. Vacuum filtration 
3. Washed repeatedly with DI water 
4. Filtered again 
5. Oven dried at 100ºC for 24h 
 
Bernard et al. [93] 1. Precipitate washed with DI water 
2. Vacuum filtration 
3. Heated to 900ºC 
 
Bouyer et al. [94] 1. Filtered via centrifugation 
2. Heated at 80ºC while stirred 
 
Lazic et al. [71, 79] 1. Washed with DDW 
2. Filtered through black band filter paper in N2 atmosphere 
 
Zhang et al. [28] 1. Filtered and washed with DDW & pure alcohol three times 
2. Dried at 80ºC overnight 
 
Smiciklas et al. [85] 1. Filtration via Buchner funnel 
2. Dried at 105ºC for 24h 
 
SRM 2910 [50] 1. Filtered 
2. Washed with acetone 
3. Dried at 105ºC for 24h 
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3.5.3 Sintering 
All HAp powder samples in this research (spray/oven dried) were sintered in order to 
improve the crystallinity of the end product, so as to satisfy the minimum criterion (>95% 
crystallinity) as set out by the FDA [137], ASTM F1185 [140] and also in ISO 13779-1 
[139]. The dried HAp powder samples were placed in a pre-programmed furnace, up to a 
maximum temperature of 1210ºC for a 30min period. The programme constituted of a 
ramping up and ramping down rate of 40ºC  and 5ºC per min, respectively, as can been 
seen in Figure 3-6 to simulate the conditions used in Irish industry. 
 
Control Symbol  
Heating up rate  
Temperature to stabilise at  
Time period to stabilise temperature at 
 
Cooling down rate  
Temperature to stabilise at  
Time period to stabilise temperature at 
Pr1 
Pl1 
Pd1 
 
Pr2 
Pl2 
Pd2 
2400 Degrees per hour 
1210 Degrees 
0.5    h 
 
300   Degrees per hour 
Ambient (~20⁰C) 
Ambient (~20⁰C) 
 Figure 3-6: Graphical display of the furnace programme (sintering times and 
temperatures) with legend 
The final HAp powders obtained after sintering were then ground down using a mortar 
and pestle in order to eliminate the agglomerates that had formed during the sintering 
process. This helped to enhance the resulting powder flowability. The HAp powders were 
finally sieved through a standard mesh to ensure that no final HAp powder particles 
exceeded 100 µm for successful plasma spraying application [130]. 
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3.6 EXPERIMENTAL DESIGN APPROACH 
The approach to implementing experimental design in this study was investigated over 
two stages. The first stage involved preliminary screening experiments, used to identify a 
subset of the original process variables that have significant main and interaction effects 
on the final HAp powder properties obtained from synthesis via the chemical 
precipitation method. In the second stage, the variables that were found to be statistically 
significant were resubmitted to an optimised experimental design with narrower 
differences between the levels, chosen according to the results of the screening fractional 
factorial experimental design, and then optimised through response surface methodology.  
A brief overview of each experimental design is described in this section as follows: 
 
 
Two-level k factors fractional factorial designs (2
k-m
) 
Factorial designs involve testing several (k) factors at two levels (high and low). A 
Fractional Factorial experiment (2
k-m
) uses only a half (2
k-1
), a quarter (2
k-2
), or some 
other division by a power of two of the number of runs that would be required for a Full 
Factorial Experiment. Thus, the number of runs required by full factorial designs increase 
geometrically as k is increased. It turns out, however, that when k is not small, the desired 
information can be often obtained by performing only a fraction of the full factorial 
design [160]. In practice, the number n=2
k
 of experiments increases rapidly with the 
number of factors. Moreover, a lot of calculated coefficients corresponding to 
interactions of second (and higher) order can be supposed to be not significant. 
Consequently, the aim of the fractional 2
k-m 
factorial design is to extract the part of 
experiments from the full factorial design which enables to obtain the main effects and 
some first order interaction. To construct a 2
k-m
 matrix one may start with a 2
k
 one and 
replace some interactions with the variables. 
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A two-level fractional factorial design for n runs and m factors has an n × m design 
matrix, X, with each level equal to ±1. The aliasing properties of two-level designs 
depend heavily on their J-characteristics [161, 162], where: 
 
                                          
n
p
kk XpiXpiiiJJi
1
11 ...),....,(
                           
Equation (3-1)
 
 
for i = (i1, i2, . . . , ik). The J-characteristic Ji evaluates the degree of k-factor aliasing 
between factors i1, i2, . . . , ik. If Ji = 0, there is no aliasing, if |Ji| = n, there is complete 
aliasing, and if 0<|Ji |<n, there is partial aliasing. 
 
A key characteristic of a fractional factorial design is its resolution, that is, the degree to 
which main effects and interactions can be independently estimated and interpreted. In 
different words, the resolution of a design indicates the order of effects that can be 
estimated and are not confounded with each other. Box et al. [163] describe the hierarchy 
of resolution fractional designs. For designs with Resolution I, no effect is independently 
estimable. Therefore, designs with Resolution I are not interesting. Similarly, Resolution 
II is largely useless. Main effects would be confounded with other main effects. In the 
analysis of metric outcome variables, the most useful fractional factorial designs have 
Resolution III, IV, and V. At Resolution III, main effects can be estimated, but they are 
confounded with two way interactions. More interesting is often Resolution IV. At this 
level, main effects can be estimated, and they are not confounded with any of the two-
way interactions. Two-way interactions, however, are confounded with each other. 
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Response surface methodology (RSM) 
Relationship between the experimental response and factors are not always linear and the 
factors at multiple levels have to be used to determine quadratic biiXi 2 or cubic biiiXi 3 
terms using RSM methodology. One such design; the Box–Behnken design, includes all 
middle points of the edges of the k factors cube (replicated center points are needed for 
orthogonality and useful to estimate the global standard deviation). These designs 
developed by Box and Behnken in 1960 [164]. They are constructed by first combining 
two-level factorial designs with incomplete block designs and then a specified number of 
centre points are added. 
 
3.6.1 Screening Experimental Design (Stage 1) 
In order to obtain an optimised set of process conditions for HAp synthesis via the 
chemical precipitation technique, a fractional factorial experimental design was used to 
evaluate the preliminary significance of the process variables, as well as the interactions 
effects between them. The screening experimental plan was based on the fractional 
factorial (Res
14
IV ) design (2
k-n
, k=6 and n=2; size of the fraction used; that is a quarter of a 
full factorial design of 64 experimental runs) in 16 experimental runs, with main and 
interaction effects evaluated, using Design Expert 7.1.4 software (Stat-Ease) to 
investigate the optimum HAp synthesis process parameters using the chemical 
precipitation route. The factors were investigated at two levels (that is, +1(high) and -
1(low)) and included, reaction synthesis temperature during precipitation, stirring speed, 
ripening time, acid addition rate, initial calcium
 
concentration, and atmospheric 
environment (that is, synthesis with and without a controlled atmospheric environment). 
This experimental design was used to identify the factors which have the most significant 
effect on the resulting HAp powder properties, such as: phase purity, crystallinity, 
crystallite size (L002 and L300), lattice parameters and particle size. This enabled a 
quantitative understanding of the relationship and interactions between the process 
parameters and their final HAp powder properties obtained. 
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The six experimental precipitation process parameters (found from literature and also in 
Irish industry), discussed above, were selected, each one at two levels, and these are 
indicated in Table 3-4. The minimum and the maximum possible level values selected for 
the screening experiments are also shown in Table 3-4 (denoted as -1 and +1), the levels 
of which are set outside the upper and lower range of that found in literature and industry. 
 
Table 3-4: Experimental factors and level of factors 
No Variable Symbol Level -1 Level +1 
A Reagent Addition Rate Vac 0.005 mol/min 0.01 mol/min 
B Temperature  To 20°C 60°C 
C Stirring Speed  Vst 600rpm 1500rpm 
D Ripening Time  tr 0.5h 48h 
E Initial Ca
2+
 Concentration Ca
2+
 0.1 mol/L 2 mol/L 
F Inert Atmosphere atm.  without N2 with N2 
 
Since the chemical precipitation route for the synthesis or phase evolution of HAp occurs 
in an aqueous suspension (analogous to that of room temperature, ~25°C); a lower 
synthesis temperature of 20°C was chosen as the minimum temperature of synthesis and 
60°C as the maximum, in order to investigate a broad region outside of the optimum 
synthesis temperature, as highlighted in existing literature (40°C) [87 - 90]. The stirring 
speed was set according to limits previously published [85].  
 
During precipitation, absorption of atmospheric CO2 may occur, which in the form of 
CO3
2-
 anion can be incorporated into the apatite crystal lattice. Experiments were 
performed with or without inert atmosphere to examine the significance of this 
parameter. Aging time plays an important role in the formation of highly crystallized 
products through phase evolution. During maturation, aggregation and crystal growth 
take place in the first 20h, after precipitation. After 20h, the crystal length and width are 
not significantly changed, and due to negative HAp solubility coefficient, this effect is 
more pronounced at room temperature [85]. Hence, an aging time of 48h was 
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investigated to examine whether any significant changes occur after this stage. The 
reaction yield and the reaction vessel capacity were taken into account in setting the 
minimum and the maximum molar concentrations of reagents: Ca(OH)2 and H3PO4. The 
raw materials Ca(OH)2 and H3PO4 react at a molar ratio of 5:3, according to the chemical 
equation 2.1 (as discussed in section 2.4.1):  
 
10Ca(OH)2+6H3PO4 → Ca10(PO4)6(OH)2+18H2O 
 
A second order linear polynomial (regression) model for the six factors investigated was 
used to describe the relationship for each of the several responses and tested factors, as 
follows: 
 
                                            jiijjj
XXbXbbY 0                      
Equation (3-2) 
 
Where i, j vary from 1 to the number of process variables; coefficient b0 is the mean of 
responses of all the experiment; bi coefficient represents the effect of the variable Xi, and 
bij, are the coefficients of regression which represent the effects of interactions of 
variables XiXj and ε is the experimental error, such that: 
 
Y1       = Cst+β1To+β2Vac+β3Vst+β4tr+β5Ca
2++β6atm+β7To.Vac + β8To. Vst +β9To. tr +β10To. Ca
2+
 + 
β11To.atm + β12Vac. Vst + β13Vac. tr + β14Vac. Ca
2+
 + β15Vac.atm + β16Vst. tr + β17Vst. Ca
2+
 
+ β18Vst.atm + β19tr. Ca
2+
 + β20tr.atm + β21 Ca
2+
.atm + experimental error 
Equation (3-3) 
 
Where Y1 is response 1, β1-β21 is the regression co-efficient, T0 is the reaction synthesis 
temperature, Vac is the acid addition rate, Vst is the stirring speed, tr is the ripening time, 
Ca
2+
 is the initial calcium concentration and atm. is the atmospheric control. 
 
This model was used to evaluate all the responses (Y1 – Y6) such as Y1 the phase purity, 
Xp (%), Y2 the crystallinity, Xc (%), Y3 the crystallite size in the 002 plane, Xs, L002 (nm), 
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Y4 the crystallite size in the 300 plane, Xs, L300 (nm), Y5 the a/c ratio and Y6 the particle 
size, Ps, (µm). The responses were measured in sequential order for each experiment and 
performed in triplicate. As discussed earlier, the fractional factorial experiment is 
generated from a full factorial experiment by choosing an alias structure. The alias 
structure determines which effects are confounded with each other, and the confoundings 
generated for the above model are represented in Table 3-5.  
 
Table 3-5: Alias structure for the screening factorial experimental design, confoundings 
Term Generator Confounded with Confounded with 
Vac a     
T0 b     
Vst c     
tr d     
cal abc     
atm bcd     
Vac*T0   Vst*cal   
Vac*Vst   T0*cal   
Vac*tr   cal*atm   
Vac*cal   T0*Vst tr*atm 
Vac*atm   tr*cal   
T0*Vst   Vac*cal tr*atm 
T0*tr   Vst*atm   
T0*cal   Vac*Vst   
T0*atm   Vst*tr   
Vst*tr   T0*atm   
Vst*cal   Vac*T0   
Vst*atm   T0*tr   
tr*cal   Vac*atm   
tr*atm   Vac*cal T0*Vst 
cal*atm   Vac*tr   
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The design matrices of experiments, in coded and real values, obtained according to the 
fractional factorial design, resolution IV, are shown in Table 3-6 and Table 3-7, 
respectively. The run order of experiments was run in a completely randomized order in 
order to assure that uncontrolled factors did not affect the final results obtained. 
 
Table 3-6: Design matrix for screening fractional factorial design, expressed as coded values 
Exp 
No 
Run  
No 
H3PO4 
addition rate 
(mole/min) 
Temperature 
(ºC) 
Stirring 
speed 
(rpm) 
Ripening 
time 
(h) 
calcium 
concentration 
(mol/L) 
atmosphere 
1 15 -1 -1 -1 -1 -1 + 
2 4 1 -1 -1 -1 1 + 
3 10 -1 1 -1 -1 1 - 
4 8 1 1 -1 -1 -1 - 
5 5 -1 -1 1 -1 1 - 
6 3 1 -1 1 -1 -1 - 
7 16 -1 1 1 -1 -1 + 
8 1 1 1 1 -1 1 + 
9 6 -1 -1 -1 1 -1 - 
10 2 1 -1 -1 1 1 - 
11 12 -1 1 -1 1 1 + 
12 14 1 1 -1 1 -1 + 
13 11 -1 -1 1 1 1 + 
14 13 1 -1 1 1 -1 + 
15 7 -1 1 1 1 -1 - 
16 9 1 1 1 1 1 - 
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Table 3-7: Design matrix for screening fractional factorial design, expressed as real values 
Exp 
No 
Run 
Order 
H3PO4 
addition 
rate 
(mole/min) 
Temperature 
(°C) 
Stirring 
speed (rpm) 
Ripening 
time (h) 
calcium 
concentration 
(mol/L) 
Inert 
atmosphere 
N1 15 0.005 20 600 0.5 0.1 yes 
N2 4 0.01 20 600 0.5 2 yes 
N3 10 0.005 60 600 0.5 2 no 
N4 8 0.01 60 600 0.5 0.1 no 
N5 5 0.005 20 1500 0.5 2 no 
N6 3 0.01 20 1500 0.5 0.1 no 
N7 16 0.005 60 1500 0.5 0.1 yes 
N8 1 0.01 60 1500 0.5 2 yes 
N9 6 0.005 20 600 48 0.1 no 
N10 2 0.01 20 600 48 2 no 
N11 12 0.005 60 600 48 2 yes 
N12 14 0.01 60 600 48 0.1 yes 
N13 11 0.005 20 1500 48 2 yes 
N14 13 0.01 20 1500 48 0.1 yes 
N15 7 0.005 60 1500 48 0.1 no 
N16 9 0.01 60 1500 48 2 no 
 
 
Figure 3-7 illustrates an overview of the complete production process implemented, so as 
to obtain the HAp in powder form from its aqueous suspension form at the chemical 
precipitation stage. The factors and responses are presented for the stages of the process, 
in which they are controlled and evaluated, respectively. 
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Figure 3-7: Overview of the production process in obtaining HAp in powder form and the 
process variables and responses evaluated at the screening fractional factorial design stage 
 
0.1 - 2M Ca(OH)2 solutions were prepared by adding CaO powders to 500mL of distilled 
water in a 1000mL-enclosed reactor and vigorously stirred with a vertical mechanical 
overhead stirrer between 600 - 1500rpm at the reaction temperature (20 - 100ºC) 
maintained by a thermostat-controlled water-bath. The H3PO4 acid was added to the 
Ca(OH)2 solution at an addition rate of 0.005 - 0.01mol/min using a peristaltic pump. 
Ripening periods of between 0.5 - 48h were investigated to monitor the maturation of 
HAp in the reaction vessel, while kept under continuous stirring conditions and reaction 
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temperature (as dictated by the experimental design). At the end of this ripening period, 
the aqueous suspension of HAp was filtered from suction via vacuum filtration and oven 
dried at 105ºC for 24h. Finally, all of the samples were sintered at 1210ºC for 4h to 
increase the final crystallinity obtained (ideally, >95%), ground using a mortar and pestle 
and sieved for particle size not exceeding 100µm (to suit plasma spraying application). 
 
3.6.2 Optimisation Experimental Design (Stage 2) 
A Box-Behnken experimental design (see Figure 3-8), with three levels on the three most 
influential factors was used to allow the estimation of a full quadratic polynomial model, 
including interaction effects in 17 experimental runs, with main and interaction effects 
evaluated using Design Expert 7.1.4 software to investigate an optimised set of 
conditions for HAp synthesis using the chemical precipitation route. Box-Behnken 
designs have two parts [165]; (i) centerpoints, and (ii) points lying on one sphere, equally 
distant from the centerpoint. The latter points consist of small two-level full factorials 
where some factors are fixed at their centre values. The number of centerpoints (five) was 
chosen to establish rotatability. The levels selected for the screening experiments are 
shown in Table 3-8 (denoted as -1, 0 and +1 for minimum, centerpoint and maximum 
values, respectively). 
 
The three key controllable process factors investigated, were selected, based upon the 
evaluation of the significant main and interaction effects of the preliminary screening 
phase, involving the screening experimental design and comprise of To: reaction 
synthesis temperature (40 - 60°C),  Vst: stirring speed (900 – 1500rpm) and tr: ripening 
time (24 – 48h). The processing region for the three process factor was limited to the 
region over which existing published literature has indicated as desirable values and was 
also selected based on the results as obtained at the preliminary screening stage of the 
design of experiments. The other parameters (Ca
2+
 conc. (2.0M), acid addition rate (0.01 
mol/min) with atmospheric control) were kept constant in all cases. 
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Table 3-8: Design optimisation of experiments: experimental factors and level of factors 
No Variable Symbol Level -1 Level 0 Level +1 
A  Temperature (ºC) To 40°C 50°C 60°C 
B  Stirring Speed (rpm) Vst 900rpm 1200rpm 1500rpm 
C  Ripening Time (h) tr 24h 36h 48h 
 
 
 
Figure 3-8: Graphical representation of the matrices of a box-behnken design [166] 
 
To optimise fully the responses (Y1 – Y6) evaluated, an appropriate approximation for the 
true functional relationship between the independent variables and the response surface 
was identified, using the following second order quadratic polynomial model for RSM 
box-behnken design, as follows:  
 
2
0 iiiijiijii XbXXbXbbY              
Equation (3-4) 
 
Where i, j vary from 1 to the number of process variables, coefficient b0 is the mean of 
responses of all the experiment, bi coefficient represents the effect of the variable Xi, and 
bij, are the coefficients of regression which represent the effects of interactions of 
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variables XiXj ,and  bii, are the coefficients of regression which represent the effects of 
interactions of the variable XiXi , and ε is the experimental error. 
 
This model was used to evaluate the same responses (Y1 – Y6) as that evaluated in the 
screening stages of the design, such as Y1 the phase purity, Xp (%), Y2 the crystallinity, 
Xc (%), Y3: crystallite size in the 002 plane, Xs, L002 (nm), Y4 the crystallite size in the 
300 plane, Xs, L300 (nm), Y5 the a/c ratio and Y6 the particle size, Ps, (µm). The responses 
were measured in sequential order for each experiment and performed in triplicate. The 
design matrix of experiments, in coded and real values, obtained according to the 
optimised box-behnken design, are shown in Tables 3-9 and 3-10, respectively.  
 
Table 3-9: Design matrix for optimisation box-behnken design, expressed as coded values 
Exp  
No 
Run  
No 
Temperature (°C) 
 
Stirring speed 
(rpm) 
Ripening  
time (h) 
1 5 -1 -1 0 
2 14 1 -1 0 
3 2 -1 1 0 
4 10 1 1 0 
5 4 -1 0 -1 
6 16 1 0 -1 
7 3 -1 0 1 
8 15 1 0 1 
9 12 0 -1 -1 
10 13 0 1 -1 
11 17 0 -1 1 
12 7 0 1 1 
13 1 0 0 0 
14 6 0 0 0 
15 8 0 0 0 
16 11 0 0 0 
17 9 0 0 0 
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Centerpoint runs were interspersed among the RSM experimental design setting runs for 
two purposes: (i) to provide a measure of process stability and inherent variability and (ii) 
to check for curvature. In an unblocked RSM design, the number of centerpoints controls 
other properties of the design matrix. The number of centre points can make the design 
orthogonal or have "uniform precision." Uniform precision ensures that the variance of 
prediction is the same at the centre of the experimental space as it is at a unit distance 
away from the centre. 
 
Table 3-10: Design matrix for optimisation box-behnken design, expressed as real 
values 
Exp  
No 
Run  
No 
Temperature (°C) 
 
Stirring speed 
(rpm) 
Ripening  
time (h) 
N1 5 40 900 36 
N2 14 60 900 36 
N3 2 40 1500 36 
N4 10 60 1500 36 
N5 4 40 1200 24 
N6 16 60 1200 24 
N7 3 40 1200 48 
N8 15 60 1200 48 
N9 12 50 900 24 
N10 13 50 1500 24 
N11 17 50 900 48 
N12 7 50 1500 48 
N13 1 50 1200 36 
N14 6 50 1200 36 
N15 8 50 1200 36 
N16 11 50 1200 36 
N17 9 50 1200 36 
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Figure 3-9 illustrates an overview of the complete production process implemented, so as 
to obtain the HAp in powder form from its aqueous suspension form at the chemical 
precipitation stage. The factors and responses are presented for the stages of the process, 
in which they are controlled and evaluated, respectively. The factors which remained 
constant are also presented. These factors were considered to exert a lower level of 
significance over the effects of the responses studied, as identified at the screening stage 
of the investigation. 
 
 
Figure 3-9: Overview of the production process in obtaining HAp in powder form and the 
process variables and responses evaluated at the optimisation box-behnken design stage 
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2M Ca(OH)2 solutions were prepared by adding CaO powders to 500mL of distilled 
water in a 1000mL-enclosed reactor and vigorously stirred with a vertical mechanical 
overhead stirrer between 900 - 1500rpm at the reaction temperature (40 - 60ºC) 
maintained by a thermostat-controlled water-bath. The H3PO4 acid was added to the 
Ca(OH)2 solution at an addition rate of 0.01mole/min using a peristaltic pump. Ripening 
periods of between 24 - 48h were investigated to monitor the maturation of HAp in the 
reaction vessel, while kept under continuous stirring conditions and reaction temperature 
(as dictated by the experimental design). At the end of this ripening period, the aqueous 
suspension of HAp was filtered from suction via vacuum filtration and oven dried at 
105ºC for 24h. Finally, all of the samples were sintered at 1210ºC for 4h to increase the 
final crystallinity obtained (ideally, >95%), ground using a mortar and pestle and sieved 
for particle size not exceeding 100µm. 
 
The average length of time, (inclusive of the ripening time, tr) to conduct the 16 and 17 
experimental runs for the screening (Fractional Factorial) and optimisation (Box-
Behnken) designs are outlined in Figure 3-10. The times are indicative of that allotted to 
each processing step in producing the HAp powder. 
 
Refer to Appendix B for a detailed overview on the model fitting, methods for 
determining the significance of the regression co-efficients (experimental factors), a 
description of the charts and plots presented in the following chapter and numerical 
optimisation using the numerical approach [160, 167]. 
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(A)         (B) 
     
 
Figure 3-10: Graphical presentation of the time factored for each process step in the production of HAp powder via the chemical 
precipitation method
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3.7 POWDER CHARACTERISATION METHODS AND EQUIPMENT 
 
3.7.1 X- Ray Diffraction 
All powder samples were analysed by conventional powder X-Ray diffractometry. X - 
Ray Powder Diffraction (XRPD) analysis is a powerful method by which X-rays of a 
known wavelength are passed through a powder sample to fully investigate its crystal 
structure. The wave nature of the X-rays means that they are diffracted by the lattice of 
the crystal to give a unique pattern of peaks of 'reflections' at differing angles and of 
different intensity, just as light can be diffracted by a grating of suitably spaced lines. The 
diffracted beams from atoms in successive planes cancel unless they are in phase, and the 
condition for this is given by the BRAGG relationship [5, 13, 15, 50, 136, 144]: 
 
                                                         sin2dn                                         Equation (3-5) 
 
where λ is the wavelength of the x-rays, d is the distance between different plane of 
atoms in the crystal lattice and θ is the angle of diffraction. The x-Ray detector moves 
around the sample and measures the intensity of these peaks and the position of these 
peaks (diffraction angle 2θ). The highest peak is defined as the 100% x peak and the 
intensity of all the other peaks are measured as a percentage of the 100% peak.  
 
X-ray diffraction studies on the powder samples were carried out using a high resolution 
Bruker Advance D8 XRD (See Figure 3-11) diffractometer in Bragg-Brentano geometry, 
with a CuKα monochromated beam (λ = 0.15406Ǻ) produced at 40kV and 40mA. The 
scanning range (2θ) was performed from 20º to 60º with a step size of 0.02° 2 theta/s 
[65]. XRD was used to assess the phases present, crystallinity and purity of the HAp 
powders as well as its crystallographic properties (such as, crystallite size and lattice 
parameters) in order to ensure compliance to regulatory requirements.  
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Figure 3-11: Bruker AXS D8 Advance XRD in the Materials Research Processing Centre, 
MPRC (left hand side) and typical features of the XRD equipment (right hand side) 
 
3.7.2 Phase Identification 
Phase identification was performed with reference to the library database supplied by the 
International Centre for Diffraction Data (ICDD) by directly comparing the X-ray 
diffraction patterns to the Joint Committee for Powder Diffraction Standards (JCPDS) 
files for HAp (JCPDS, Card No. 9-432) and also the common phases present within 
calcium phosphate based powders, such as, α-TCP (9-348), β-TCP (9-169), DCPA (9-
80), DCPD (9-77), OCP (26-1056), TTCP (25-1137) and CHAp (19-272) in order to 
obtain an indication of the relative proportions of phases present in the powders analysed. 
The list of peaks for HAp and the most important peaks of other calcium phosphates are 
given in Tables 3-12 and 3-13, respectively. The phases identified were also checked 
against that of the database supplied by the ICDD, using the software, Crystallographica-
Search-Match (CSM) (Oxford Cryosystems). 
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                         Table 3-11: ASTM Card No.9-432 for Hydroxyapatite 
d (Ǻ) I/Ii % Miller Indices 
5.250 5 (101) 
4.720 3 (110) 
4.070 9 (200) 
3.880 9 (111) 
3.510 1 (201) 
3.440 40 (002) 
3.170 11 (102) 
3.080 17 (210) 
2.814 100 (211) 
2.778 60 (112) 
2.720 60 (300) 
2.631 25 (202) 
2.528 5 (301) 
2.296 7 (212) 
2.262 20 (310) 
2.228 1 (221) 
2.148 9 (311) 
2.134 3 (302) 
2.065 7 (113) 
2.040 1 (400) 
2.000 5 (203) 
1.943 30 (222) 
1.890 15 (312) 
1.871 5 (320) 
1.841 40 (213) 
1.806 20 (321) 
1.780 11 (410) 
1.754 15 (402), (303) 
1.722 20 (004), (411) 
1.684 3 (104) 
1.644 9 (322), (223) 
1.611 7 (313) 
1.587 3 (501), (204) 
1.542 5 (420) 
1.530 5 (331) 
1.503 9 (214), (421) 
1.474 11 (502) 
1.465 3 (510) 
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Table 3-12: List of most important peaks for β-TCP; α-TCP, DCPA, DCPD, CHAp and DCP 
β - TCPa 
 
α - TCPb 
 
DCPAc 
 
DCPDd 
 
CHApe 
 
OCPf 
 
      d (Ǻ) I/Ii 
% 
Miller  
Indices 
d (Ǻ) I/Ii 
% 
Miller  
Indices 
d (Ǻ) I/Ii 
% 
Miller  
Indices 
d (Ǻ) I/Ii 
% 
Miller  
Indices 
d (Ǻ) I/Ii 
% 
Miller  
Indices 
d (Ǻ) I/Ii % Miller  
Indices 
6.49 15 (006) 7.31 25 (111) 6.74 13 (010), (110) 7.57 100 (020) 3.46 25 (002) 18.68 300 (100) 
5.21 20 (110) 4.00 20 (150) 3.48 13 (121) 4.24 100 (021) 2.78 100 (211), (112) 9.36 45 (200) 
4.05 15 (204) 3.91 40 (202) 3.37 70 020 3.05 75 (111), (041) 2.68 40 (300) 9.05 40 
 3.45 25 (1.1.10) 3.88 40 (241) 3.35 75 (110), (220) 2.93 50 (221) 2.23 16 (310) 5.52 25 
 3.21 55 (214) 3.69 40 (132) 3.33 17 (210) 2.62 50 (220), (151) 1.93 16 (232), (401) 3.66 30 
 3.01 15 (300) 3.66 17 (151), (222) 3.13 20 (111) 2.60 30 (202) 1.84 16 (213) 3.44 60 
 2.88 100 (2.1.10), (217) 3.01 20 (510) 2.96 100 (112), (112) 2.17 20 (151) 
   
3.42 50 
 2.76 20 (218) 2.95 20 (113) 2.94 35 (102) 2.15 17 (242) 
   
3.21 25 
 2.61 65 (220) 2.92 35 (402), (023) 2.75 20 (230) 1.82 20 (241) 
   
2.87 30 
 1.93 20 (4.1.10), (327) 2.91 100 (441), (170) 2.72 35 (200), (102) 
      
2.83 100 (260) 
1.90 15 (328) 2.86 30 (511) 2.25 15 (030) 
      
2.82 95 (320), (241) 
1.73 25 (2.2.20) 2.62 50 (043), (352) 2.50 15 (231), (022) 
      
2.78 45 
 
   
2.59 30 (080) 2.20 13 (003) 
      
2.75 35 
 
               
2.71 25 
 
               
2.67 50 (700) 
               
2.64 35 
 
                  
                  aA.S.T.M. card file No. 9 – 169;   bA.S.T.M. card file No. 9 – 348;   cA.S.T.M. card file No. 9 – 80;  dA.S.T.M. card file No. 9 – 77;  eCaronated apatite; A.S.T.M. card file No. 19 – 272  and  fA.S.T.M. card file No. 26 – 1056 
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3.7.3 Phase Purity 
The phase purity of the prepared HAp samples in this research were measured directly 
from the X-ray diffraction patterns. The equation used to calculate the percentage purity 
(Xp) of the HAp powders is represented as follows [142, 148]: 
 
                                       
100
A
A
  (%) X
C
C
p
impurityI
                            Equation (3-6) 
 
Where ΣAC is the sum of the area under all the HAp crystalline peaks and ΣIimpurity is the 
sum of the area under all of the impurities present in the sample between 20º to 60 º.  
 
Another method used to quantify each of the phases present was the Rietvled refinement 
method, based on approach that the experimental powder diffraction data is utilised 
without extraction of the individual integrated intensities or the individual structure 
factors, and all structural and instrumental parameters are refined by fitting a calculated 
profile to the observed data. The method relies on the simple relationship [168]: 
 
                                            
n
i
iippp ZMVSZMVSW
1
)(/)(                        Equation (3-7) 
 
where W is the relative weight fraction of phase p in a mixture of n phases, and S, Z, M, 
and V are the Rietveld scale factor, the number of formula units per cell, the mass of the 
formula unit (in atomic mass units) and the unit cell volume (in nm
3
), respectively. 
 
Rietveld analysis was undertaken using TOPAS R (Bruker-AXS) and the atomic 
structural models acquired from the ICDD. In these analyses, the amorphous component 
was described using an atomic model fixed to that of stoichiometric HAp but with a 
crystallite size similar in magnitude to that of the lattice parameters. This produced a 
diffraction pattern with the appearance of that from an amorphous material, that is, 
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significantly broadened and overlapped diffraction maxima. To provide appropriate and 
precise values of crystallite size, these parameter values were refined against diffraction 
data from an amorphous CaP phase. For all analyses of mixed phases, all the parameters 
(except for the scale factor) of the amorphous phase were fixed to these values. This may 
simplify the precise shape of scattering from the amorphous component, but can provide 
an approximate value for the density of the non-crystalline phase. An influential 
parameter in this analysis for accurate quantification is the appropriate choice of 
background which was determined empirically and represented by a 1
st
 order Chebchev 
polynomial. 
 
The fitting methodology was assessed for accuracy and reliability by repeated, 
independent determinations of known mixtures of amorphous and crystalline phases. The 
atomic model parameters (such as, atomic positions, thermal parameters and 
occupancies) were fixed throughout. This effectively fixed the absorption co-efficients 
for each phase present. The scale factors, lattice parameters, crystallite size and peak 
shapes were refined for all crystalline phases. The main advantage associate to this 
approach is that preferred orientation (PO) can also be included and accounted for in the 
fitting process based on spherical harmonics. 
 
 
3.7.4 Crystallinity 
The crystallinity is a complex concept integrating the effects on the XRD of crystal 
strain, diffraction domain size and crystal defects. However, in order to compare the 
‗crystallinity‘ of the synthetic HAp the following calculations were made based on the 
XRD patterns obtained between 20º to 60º (2θ). The percentage crystallinity (Xc) was 
determined using the following equation [5, 169]: 
 
                                            
100
A+A
A
  (%) X
AC
C
c
                            Equation (3-8) 
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Where ΣAC + ΣAA give the sum of the area under all the HAp crystalline and amorphous 
peaks and ΣAC yields the sum of the areas under the crystalline peaks present in the scan 
range between 20 º to 60º.  
 
3.7.5 Crystallite Size (L002 And L300) 
The crystallite size, in two reflection planes (L002 and L300) were calculated based on the 
extraction of information from the X – ray diffraction patterns. Based on Scherrer‘s 
formula, crystallite size can be calculated from the XRD peak broadness [5, 85]: 
 
                                                         D = 0.9α FWHMcos θ                           Equation (3-9) 
 
where D is the crystallite size (nm), α the wavelength of monochromatic X-ray beam 
(0.15406 nm for Cu Kα radiation), FWHM is the full width at the half maximum of the 
diffraction peak under consideration (rad), and θ the diffraction angle (º). 
 
 
3.7.6 Lattice Parameter Determination 
Theoretically, the lattice parameters (a and c) for the hexagonal crystal structure of HAp, 
are determined from the relationship between the distance, d, of two adjacent net planes 
and the (h k l) Miller Indices of the reflection planes and is given by the equation [5, 13]: 
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                            Equation (3-10) 
 
Where d is the lattice spacing, h, k, l is the Miller indices, a , c is the lattice parameters, λ 
is the wavelength (CuKα: λ = 0.15405nm) and 2θ is the diffraction angle. For the 
hexagonal unit cell, a = b, α = β = 90º, and γ = 120º and using Bragg‘s Law [5, 13] 
Equation (3-19) now takes the form: 
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                        Equation (3-11) 
 
Where the diffraction angle, θd, is given as a function of the Miller indices.  
 
The lattice parameters were evaluated in this investigation in order to assess the 
microstructural differences between the HAp samples evaluated and were determined by 
least square refinements from the well determined positions of the most intense 
reflections, which are processed using the least squares refinement software package 
CelRef 3.0. CelRef is a crystal cell parameters refinement program for powder X-rays or 
neutron diagram, using the least squares refinement method as follows [170, 171]: 
 
The expression of the measured Bragg angle θ is: 
 
                                                          θ = Γθ + Arcsin(λ/2d)                       Equation (3-12) 
                   
where d is the interplanar distance for (h,k,l), λ is the wavelength, and Γθ is the zero 
angular shift. This shift can be constant (goniometer error) or can vary with θ, if the a 
sample displacement e exists, such that: 
 
                                                               Γθ = e/R * cos(θ)            Equation (3-13) 
 
Where R is the diffractometer radius. 
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If a*, b*, c*, α*, β*, γ* are the reciprocal cell parameters then [171]: 
 
1/d**2= (ha*)**2+(kb*)**2+(lc*)**2+2hka*b*cosγ*+2klb*c*cosα*+2lhc*a*cosβ* 
                                                                                                     Equation (3-14) 
 
The above expression depends on N unknown values, belonging to the group (Γθ, l, a*, 
b*, c*, α*, β*, γ*) according to the crystal system and the parameters to be refined, (for 
example N can be 1 to 3 for cubic crystal or 6 to 8 for triclinic system). This expression is 
fitted on M observed values (M>N) by a non linear Least Square method (Gauss). From 
the reciprocal fitted parameters a*, b*, c*, α*, β*, γ*, the direct parameters a, b, c, α, β, γ 
are calculated. This is an iterative method, starting from raw values. The parameters 
standard errors are calculated as well as a mean square deviation [171]:  
 
                                                   R=sqrt[(θobs - θcalc)**2]/(N-M)                  Equation (3-15)                                                                                          
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3.7.7 Powder Morphology 
Scanning Electron Microscopy (SEM) was used in the present research due to the high 
resolution and depth of field generated by its images. The image is an artificial map of 
the surface, that is, there are no direct ray paths linking the specimen to the projected 
image, as is the case in optical and transmission microscopes. Instead, the area under 
observation is irradiated with a finely focused electron beam of between 10 – 25kV, 
which may be static or swept in a raster across the surface of the material in synchronism 
with a spot on a cathode ray tube (CRT). A detector monitors the scattered electron (SE) 
(including back scattered electron (BSE)) signals and the brightness of the spot on the 
CRT is controlled by an amplified version of the detected signal. The scan of the CRT is 
fixed and the effect of reducing the area scanned on the specimen is to increase the 
magnification of the map. The intensities of the SE and BSE generated are dependent on 
the angle of incidence between the beam and the specimen. This factor accounts for the 
contrast in topographical features for the specimen examined. The angle of incidence will 
vary because of the roughness of the material, leading to the development of contrast, 
which relates to the physical nature of the specimen. The surfaces facing the light source 
appear bright while those facing away range from grey to black. Hence, only the surfaces 
which face the detector provide a strong enough signals to obtain a useful image, while 
black are indicative of a tilted surface. 
 
A Cambridge/Leica Stereoscan 440 Scanning Electron SEM with image analysis and 
quantitative EDX capabilities (see Figure 3-12) was used in the present research to study 
the surface morphology and characteristics of the powder at an accelerating voltage of 
1.5kV [136]. These instruments allowed the examination of topography (that is, surface 
morphology of the powders) and overall elemental uniformity. The surface morphology 
of the HAp powders were of interest as their topology provides a good indication as to 
the type of reaction kinetics that may have been involved during synthesis via chemical 
precipitation and ultimately determines its capability to flow (that is, the HAp powder 
flowability) pre-plasma spraying. 
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The HAp powder samples are non-conducting, by nature. In order to prevent charging 
from occurring during examination, sample preparation for each HAp powder sample 
was undertaken. The first stage involved suspending HAp powder particles (~0.2g) in 
glue on an aluminium stub. The samples were allowed a sufficient period to dry (10min). 
after which, any excess powder was eliminated with an air hose at low pressure prior to 
the carbon coating process. The Edwards Scancoat six sputter coater (see Figure 3-12(a)) 
was used to apply a layer of carbon onto the HAp samples (2 – 3 min), in order to 
increase the electrical conductivity of the specimen sample during SEM operation (see 
Figure 3-12(b) and hence provide a clear analysis of the individual HAp powder particles 
and/or particle aggregates morphological properties.  
 
(A)       (B) 
  
Figure 3-12: The edwards scancoat six sputter coater (left hand side) and the stereoscan 440 
scanning electron microscopy (right hand side) 
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3.7.8 Mean Particle Size and Particle Size Distribution Analysis 
Particle size analysis was performed in this research, via a single lens laser diffraction 
system, using a small helium neon laser of the order of 2 mW power to measure the size 
of particles. It operates on the principle of laser scattering using Mie theory and 
Fraunhofer analysis [172]. The light from the low power Helium-Neon laser is used to 
form a collimated and monochromatic beam of light (typically, 18 mm in diameter). This 
beam of light is known as the analyser beam and any particles present within it, scatter 
this laser light. The particles are introduced to the analyser beam by the sample 
presentation modules or by direct spraying   through the measurement area [173]. Laser 
scattering consists of a two-stage process aimed at measuring the low angle scattering 
characteristic of the sample particles. The measurement is in two stages since the sample 
measurement also contains light picked up from other sources (such as, daylight and flare 
off optical surfaces). Separate measurement of these non-sample scattering sources make 
it is possible to subtract out this contribution from the sample measurement [173]. Figure 
3-13 illustrates the Fourier Optics optical configuration employed by the Malvern 
Mastersizer. The scattered light data is then transferred to the software running on the PC. 
The knowledge gained from the scattering theory and particle properties was used to 
transform the scattered light data to a distribution of particle size information. 
 
Particle size analysis using the wet method for powder sample preparation can be 
achieved in either two ways: (i) low-interfacial tension liquid/gaseous by wetting agents 
and (ii) low-interfacial tension solid/liquid by hydrophillizing agents. The determination 
of mean particle size and particle size distributions were carried out using a Malvern 
Mastersizer Type S Laser Diffractometer (see Figure 3-14) in order to analyse the various 
HAp samples for their powder; mean particle sizes at production stages post thermal 
treatment, through spray drying. The Malvern Mastersizer S offers the widest dynamic 
range at 0.05 to 3500 microns, excellent repeatability, and flexibility in sample handling. 
Wet and dry powder analysis methods are available using this instrument. Wet methods 
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of sample dispersion are preferred as this avoids segregation errors associated with the 
dry method of powder analysis [173]. 
 
Figure 3-13: Optical Set-Up: Particles are in parallel beam before and within working 
distance where 1 is the Detector, 2 is the Fourier Lens, 3 is the Particle ensemble, 4 is the 
working distance and 5 is the focal distance [173] 
 
 
The following procedure was used to prepare the HAp powder particle samples as 
dispersed solutions for examination in the Malvern Mastersizer. The dispersant agent was 
selected in accordance to ISO 14887 [174] and the method used in the sample preparation 
for analysing the particle size analysis via the wet method, is as follows:  
 
1. 1 g of sodium hexametaphosphate was mixed intensively via a magnetic stirrer in 
1000ml of deionised water to act as a dispersant. 
2. 0.5 g of the HAp powder sample was dispersed in 30ml of the above prepared 
dispersant in an 80 - 100ml heavy-duty beaker. 
3. The suspension was then stirred again using a magnetic stirrer for a period of more 
than 2 min to ensure that the HAp powder and dispersant had formed a suspension. 
4. The stirred suspension was then placed in an ultrasonic bath for a 5 min period (see 
Figure 3-15). 
 
CHAPTER 3: Experimental Equipment, Procedures And Materials Characterisation 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-127- 
 
Figure 3-14: External view of the Malvern Mastersizer particle size analyser and sample 
preparation unit 
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According to ISO 14887 [174], complete dispersion occurs in a liquid when the 
individual particles that made up the original clumps have become separated, move 
independently of one another and remain separated. Successful particle size analysis has 
a number of pre-requisites, such as: (i) representative samples and delivery of samples to 
the sample system, (ii) transportation and dispersion of the sample to the laser in a 
statistically representative manner, (iii) material analysis using the appropriate optical 
presentation model and (iv) correlation of data to historical data from alternative 
techniques [175]. 
 
 
 
 
Figure 3-15: Ultrasonic waterbath 
  
CHAPTER 3: Experimental Equipment, Procedures And Materials Characterisation 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-129- 
3.7.9 Surface Area Measurement Of HAp Using The Brunnauer Emett Teller 
(B.E.T.) Method   
 
Brunnauer Emett Teller (B.E.T.) surface area analysis is considered the standard 
technique in evaluating the specific surface area of a material, which utilises low 
temperature gas adsorption or the uptake of a gas on the powders surface. The specific 
surface area of the HAp powders were measured using a Gemini 2375 Analyser, 
(Micromeritics Instruments Inc., Norcross, GA) (see Figure 3-16) with liquid nitrogen 
used as coolant. This standard method for measurement of specific surface area is based 
on the physical adsorption of nitrogen on the solid surface using the B.E.T. method [176].  
 
 
Figure 3-16: Micromeritics Gemini 2375 Analyzer 
The total surface area (St), of a solid material can be expressed as the product of the 
number of molecules of adsorbate in a monolayer, Nm, and the effective cross – sectional 
area of the adsorbate molecule, ACS, that is [176]: 
 
                                                            CSmt
ANS
                                       Equation (3-16) 
CHAPTER 3: Experimental Equipment, Procedures And Materials Characterisation 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-130- 
As the pressure is increased during the B.E.T. process, adsorption of a vapour (nitrogen) 
onto a solid surface occurs until the surface becomes progressively coated with the 
adsorbate. The BET theory was originally proposed in 1938 [176] and is still the most 
generally used method for calculating the weight of adsorbant on a monolayer, Wm. 
Nitrogen is the most commonly used as it adsorbs easily onto most solid surfaces and its 
cross sectional area is well established. The determination of the surface area using BET 
theory requires the application of the B.E.T. equation [176]:  
 
                                    00
11
}1)/[(
1
P
P
CW
C
CWPPW mm                          Equation (3-17) 
 
In which W is the weight of vapour adsorbed, P/P0 is the B.E.T. constant, and Wm is the 
weight of adsorbate in a monolayer [176]. A plot of 1/W (Po/P-1) versus P/Po, will yield 
a straight line in the range 0.05 P/Po 0.35 with slope [176]: 
 
                                                           
CW
C
s
m
1
                                             Equation (3-18) 
and intercept, i 
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Solving equations 3-18 and 3-19 gives: 
 
                                                           is
Wm
1
                                     Equation (3-20) 
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In establishing Wm, the sample surface area can be calculated using the following 
equation: 
                                                    M
ANW
S CSmt
                                            Equation (3-21) 
 
Where ACS is the cross-sectional area of a molecule of adsorbate, M  is the molecular 
weight of an adsorbate molecule, and N is Avogrado‘s number. The specific surface area 
can be determined by dividing St by the weight of the sample.  
 
The HAp powder samples were prepared by out-gassing the material at a temperature of 
200ºC to remove any surface organic or moisture contaminants present. This ensured 
maximum accuracy and reproducibility. Additionally, out-gassing prevents contaminants 
entering the detector causing noise and erroneous signals. The specific surface area was 
calculated as per unit weight of the powder. This analysis complements the particle size 
distribution providing information about the presence of internally finer particles. It is 
accepted that the smaller the particle size, the greater the specific surface area. However, 
the specific surface area is also dependent on the particle shape, size and its distribution 
and surface conditions [177]. The B.E.T. method is used amongst the vast majority of 
works due to its ease of use, its definitiveness and its ability to accommodate each of the 
five isotherm types.  
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3.7.10 Density Measurements 
The density of the HAp powder samples were measured using a Helium Pycnometer, 
Micromeritics AccuPyc 1330 He-pycnometer, Micromeritics Instruments Inc., Norcross, 
GA (see Figure 3-17). The AccuPyc works by measuring the amount of displaced gas. 
The pressures observed upon filling the sample chamber and then discharging it into a 
second empty chamber allow computation of the sample solid phase volume. Gas 
molecules rapidly fill the tiniest pores of the sample; only the truly solid phase of the 
sample displaces the gas with an accuracy of +/- 0.03% [178]. The sample size of HAp 
powder required is between 1 - 5g of dry substance with a preferable volume size of 
between 7.5 - 75 cm³. The instrument automatically purges water and volatiles from the 
sample and then repeats the analysis until successive measurements converge upon a 
consistent result.  
 
The acceptable limits of density (g/cm
3
) for the HAp (both, in powder and coating form) 
are reported in accordance to the "Calcium Phosphate (Ca-P) Coating Draft Guidance for 
Preparation of FDA Submissions for Orthopaedic and Dental Endosseous Implants" 
[137]. Acceptable ranges of HAp powder densities are quoted in Table 2-19 [50, 137]. 
These values are found to correlate well with that of the theoretical density value of 
hexagonal HAp (3.156 g/cm
3
), which is calculated based on its crystal structure 
parameters [143].  
 
Particle size, particle size distribution (PSD), average porosity size, overall pore volume 
and the total surface area of the HAp powder also provide for additional information 
required in accordance to the 510(K) Information needed for HAp coated orthopaedic 
implants [137]. 
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Figure 3-17: Micromeritics AccuPyc 1330 Helium Pycnometer for small sample volume (left 
hand side) and large sample volume (right hand side) 
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3.7.11 HAp Rheology 
A. HAp Slurry Density 
The bulk density of the HAp in slurry form (that is, post chemical precipitation) was 
measured, using a beaker of a known volume and mass. An average of three readings was 
recorded for every sample, with the results calculated in g/cm
3
. 
 
B. HAp Slurry Rheology 
Rheology is a science of deformation and flow of materials. The principal theoretical 
concepts are kinematics, dealing with geometrical aspects of deformation and flow; 
conservation laws, forces, stress and energy interchanges; constitutive relations special to 
classes of bodies. The constitutive relations, namely, the relations between stress, strain 
and time for a given test sample, serve to link motion and forces to complete the 
description of the flow process, which may then be applied to solve complex engineering 
problems. There exists, the Newtonian and non-Newtonian fluids, based on the 
constitutive relations. For the fluids, the viscosity η, is defined as [179]:  
 
   η    =                     Shear stress                                    Equation (3-22) 
                           Rate of Shear strain 
 
In the case of Newtonian fluids, η is constant. For non-Newtonian fluids, η is variable, 
which means that the shear stress (s) varies with the rate of shear strain (c). It is generally 
accepted, however that most semisolids, such as slurries, exhibit properties of non-
Newtonian fluids [179, 180]. The information for characterization of the rheology of non-
Newtonian slurries is outlined in Figure 3-18(a). However, time-dependent non-
Newtonian fluids are usually encountered in fine and concentrated aqueous suspensions. 
Time-dependent non-Newtonian fluids may be characterised according to viscosity with 
time under conditions of shear rate and sub-divided into two categories, such as, 
thixotropic and rheopectic. A thixotropic fluid undergoes a decrease in viscosity with 
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time, when subjected to constant shear, whereas a rheopectic fluid‘s viscosity increases 
with time as it is sheared at a constant rate (Figure 3-18(b)) 
 
 
Figure 3-18:  Shear stress versus shear rate curves for time-independent non-Newtonian 
slurries (A) and Viscosity versus time curves at a given shear rate for time – dependent non-
Newtonian slurries (B)  
 
The behaviour of HAp aqueous suspensions is quite complex as a result of the changes in 
the concentration of the hydroxylic groups on the surface due to the suspension 
parameters. However, rheology is the most sensitive method for material characterisation, 
since flow behaviour is responsive to properties, such as molecular weight and molecular 
weight distribution. As a consequence, rheology measurements are useful in following 
the course of a chemical reaction. Such measurements can be employed as a quality 
check during production or to monitor and/or control a process. The rheological 
behaviour of a HAp slurry may also be indicative of interparticle interaction or 
aggregation in the slurry itself, further enhancing the requirement to control this 
parameter within industrial processes (such as, the transportation of the HAp slurry into a 
spray dryer). However, the rheological properties for aqueous suspensions of HAp are 
highly complicated and there is no singular parameter that can explain it. The physical 
and chemical properties of the HAp slurry, such as solids content, particle size and 
distribution, particle shape, pH value, shear rate, slurry temperature, all have a significant 
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effect on slurry rheology due to the change or modification in surface property [179, 
180]. As known, fine particles (<1 micron) in a suspension attract each other by van der 
Waals attractive forces to form aggregates, which evidently increase the resultant velocity 
of the HAp suspension. In general, the HAp slurry flowability can be improved by 
decreasing the slurry viscosity and by reducing or eliminating the shear yield stress in 
order to increase the product fineness. 
 
Rheological characteristics of aqueous suspensions of HAp slurry (such as, slurry 
viscosities and flow behaviour) were conducted using the RI-2-M Rheometer, Rheology 
International Series 2 (see Figure 3-19) with cone and plate measuring geometry; with 
diameter 25 mm and 0.1 rad cone angle. Pre-shearing was done for 1 min prior to 
recording of all measurements (that is, each shear rate was given a time lag of 1 min to 
establish an equilibrium). All measurements were performed at 25 (+/-0.2°C) and 
conducted in triplicate. 
 
(i) Cone And Plate Viscometer 
As previously identified, the present investigation utilised the cone and plate rotational 
type viscometer in order to measure the absolute viscosities of various HAp slurries. A 
schematic representation of the cone and plate geometry is illustrated in Figure 3-20.  The 
cone and plate geometry is particularly suitable for advanced rheological analysis of non-
Newtonian fluids.  
 
The absolute viscosity for HAp slurry samples (0.5mL) were measured under conditions 
of defined shear rate and shear stress, where shearing of the fluid is achieved by the 
action of the rotating cone spindle. The RI-2-M model has the capacity to generate shear 
rates in the range of 0.2 sec-1 to 3,750 sec-1, and measure viscosities ranging from 103 
mPa.s to 513,345 mPa.s [181]. 
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Figure 3-19: Methods of measuring the viscosity for the HAp slurries using the cone and 
plane rotational viscometer 
 
 
The equipment is calibrated prior to recording each viscosity measurement, through using 
the inbuilt autozero function; after setting the minimum distance between the cone and 
plate sample (0.1mm). The value which displays after Autozero (0.0mm) is an electronic 
value within the transducer arising from the test, and is either added or subtracted from 
all test values until the next autozero calibration is performed. This ensures that complete 
instrument accuracy was sustainable over long operating periods. 
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Figure 3-20: Cone and plate geometry – rotational type viscometer 
 
 
The absolute viscosity of the HAp slurry, determined using a cone and plate geometry 
can be calculated using the following equation [182]: 
 
                                                         
32
3
R
T
a
                                     Equation (3-23) 
              
Where;      R cone radius    m 
   cone angle   radians 
    shear rate   s-1  
   shear stress   Pa 
  Ω angular velocity of cone rad/s 
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C. HAp Powder Rheology 
A Hall flowmeter (designed and manufactured by the author) was used to determine the 
flowability of the HAp powders, post thermal treated (that is, post - sintering), in 
accordance with ASTM B213-03 [183].  
 
The ability of the HAp powder to flow is a function of interparticle friction. As 
interparticle friction increases, the flow is disturbed (that is, slowed). Extremely fine 
powders may not flow. Factors affecting the flow rate are humidity and moisture content, 
such that, wet or moist powders may not flow. The Hall flowmeter funnel consists 
primarily of a calibrated orifice of 2.54mm in diameter and the distance between the 
orifice and the top of the beaker is 125.4mm. Blocking the discharge orifice (of the HAp 
powder) at the bottom of the funnel with a dry finger, a pre-measured mass of HAp 
powder (10.0g) as sampled into a clean weighing dish (beaker), was carefully poured into 
the centre of the flowmeter funnel, without any tapping, vibration or movement of the 
funnel. The empty beaker was then placed under the funnel orifice. The stopwatch was 
started; simultaneous to removing the finger from under the orifice. The time was 
recorded, to the instant of the last powder exiting the funnel orifice, to the nearest 0.1s. 
 
The measurements were recorded in triplicate. A schematic of the Hall flowmeter 
manufactured for this investigation with the drawings pertaining to the required 
dimensions, as specified in ASTM B213- 03 is illustrated in Figure 3-21 (Refer also to 
Appendix C) 
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(A)      (B) 
 
Figure 3-21: Autocad 2005 Drawing of the Hall Flowmeter (A) and a photographic 
illustration of the apparatus in use (B) 
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3.8 BIOLOGICAL RESPONSE OF HAp POWDERS 
3.8.1 Osteoblast Cells  
MG-63 osteoblast-like cells, originally isolated from a human osteosarcoma [184], were 
used for these experiments. MG63 have been well characterised, and widely used for the 
testing of biomaterials. MG-63  (American Type Culture Collection: ATCC number CRL 
1427) cells were cultured in Dulbecco‘s modified Eagle medium (DMEM, Invitrogen, 
France) supplemented with 10% Fetal calf serum (FCS, Invitrogen, France) and 0.5% 
antibiotics (penicillin-streptomycin, Invitrogen, France). Cells were maintained at 37ºC in 
a fully humidified atmosphere (see Figure 3-22) at 5% CO2 in air. At confluence (that is, 
the state in which cells have grown to full capacity and no additional surface area space is 
present), cells were harvested with 0.1% trypsin-EDTA solution in phosphate-buffered 
saline (PBS, pH 7.4) at 37ºC for 5min, centrifuged to pellet the cells, and resuspended in 
DMEM with the FCS and antibiotics. 
 
 
Figure 3-22: Humidified Incubator 
 
After cell passaging (a technique whereby cells are maintained under cultured conditions 
for an extended period of time, at 90-100% confluency), HAp was added to the cell 
culture medium and seeded in to a 24-well plate, in order to study the cell proliferation 
and viability. The HAp/Cell Culture medium was also fixed onto Thermanox® (a cell 
culture plastic specially made for cell culture and SEM observation) to investigate the 
resulting cell morphology (see Figure 3-23).  
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3.8.2 Cell Proliferation 
2mg of HAp powder particles were added to 2mL of cell culture medium and seeded at a 
density of 20,000 cells per well. As a control measure; two commercially available 
powders (HAp1 and HAp5) were added to the cell culture plates and evaluated against 
the HAp produced in-house under various synthesis conditions.  The plates were 
incubated at 37ºC with 5% CO2 for 1, 4, 7, 14, and 28 days. At each culture period, cells 
were detached with 0.1% trypsin-EDTA solution in phosphate buffered solution (PBS, 
pH 7.4) at 37ºC for 5min. 
 
 
Figure 3-23: 24-well plate and optical microscope 
 
Before counting, the cell suspension was stained with 0.1mL of Trypan Blue solution and 
allowed to stand at 37ºC for 5 min. Trypan Blue is a vital dye. The reactivity of Trypan 
blue is based on the fact that the chromopore is negatively charged and does not interact 
with cells unless their membranes damaged. Therefore, cells which exclude the dye are 
viable. 
 
The cell number was determined by counting with a Malassez hemacytometer (see Figure 
3-24) under phase contrast microscope (see Figure 3-23), and all counting‘s were run in 
triplicate. As outlined previously, the non-viable cells were denoted by the presence of a 
stained while the viable cells excluded this stain. 
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Figure 3-24: Malassez hemacytometer 
 
 
3.8.3 Cell Viability 
The cell viability was performed with the Cell Titer 96® Aqueous One Solution Cell 
Proliferation Assay (Promega, France), according to manufacturer‘s instructions [185]. 
The concept is based on an enzymatic reduction of a tetrazlium salt. This test is a 
colorimetric method for determining the viability of cells. The conversion of methyl 
thiazol sulphate (MTS) into aqueous soluble formazan is accomplished by dehydrogenase 
enzymes found in metabolically active cells. The intensity of the colour is proportional to 
the number of living cells in culture and can be measured at a wavelength of 490nm. 
Briefly, supernatant of each condition was cultured for 48h with cells on 96 wells plate. 
After 48h, the medium was replaced by freshly prepared MTS for 5h, the plate was 
incubated at 37ºC to develop the colour, and the plate was read at 490nm in an enzyme-
linked immunosorbent assay (ELISA) plate reader (see Figure 3-25) for absorbence 
measurements [74]. 
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Figure 3-25: ELISA plate reader 
 
3.8.4 Cell Morphology  
SEM observations were performed to evaluate the morphology of the cells. Assays were 
run in triplicate and the data were analyzed using Student t test and significance was 
considered to be achieved at p < 0.05. 
 
 
3.9 SUMMARY 
The experimental equipment, procedures and characterisation techniques outlined in this 
chapter were then used to assess the HAp powder characteristics in the next chapter, with 
a view to investigating the optimisation of HAp powder for orthopaedic application via 
the thermal spraying technique.
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4 RESULTS AND DISCUSSION 
  
4.1 INTRODUCTION 
HAp coatings have been widely used in orthopaedic applications to improve the 
biocompatibility of metallic implants. Studies have shown that essential properties for 
good coating performance include a high degree of crystallinity, a low porosity level, a 
high coating purity, high cohesion strength and a high degree of adhesion. However, it is 
difficult to achieve these properties by varying the spraying parameters alone. In addition 
to these process parameters, the HAp powder characteristics have a major influence over 
the final coating quality.  
 
The present study aims to investigate the physico-chemical and biological powder 
properties of HAp synthesised via the chemical precipitation method using Ca(OH)2 and 
H3PO4, as precursor materials: with the aim to produce HAp powder of optimum 
properties, pertinent to highly successful coating application via the plasma spraying 
method onto orthopaedic implants. The optimised powders were also aimed at satisfying 
criterion as set out by ISO 13779-1 [139], ASTM F1185 [140] and the Food and Drug 
Administration [137], in the US, to ensure the potential marketability of the produced 
powders.  
 
The preliminary investigation of this study involved analysing the HAp powder 
characteristics of international suppliers and comparing these against the HAp powder 
properties currently being produced by industry in Ireland. HAp was synthesised in-
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house, within the Materials Processing Research Centre, under the same conditions as 
that disclosed by the HAp manufacturing company in Ireland: characterised and 
compared against that of the Irish HAp and also against those purchased by other various 
international suppliers. The HAp powders examined in this study were as follows: 
 
HAp1:  Irish HAp (Undisclosed Company) 
HAp2:  American HAp (Undisclosed Company) 
HAp3:  Japanese HAp (Tomito®) 
HAp4:  Netherlands HAp (CAMCERAM®) 
HAp5:  British HAp (Plasma Biotal®) 
HAp6:  In-house HAp 
 
(HAp3 – HAp5 are commercially available powders, while HAp1 and HAp2 are applied 
as orthopaedic coatings at their respective industrial site). 
 
The preliminary characterisation of the above HAp powders is presented, with the results 
obtained grouped into the following categories: 
 
HAp Physicochemical Powder Properties: 
1. XRD Diffraction 
a. Phase Composition and Purity 
b. Crystallinity  
c. Lattice Parameters and Crystallite Size 
 
2. Particle Size and Specific Surface Area Analysis 
a. Particle Size and Specific Surface Area 
b. Particle Size Distribution 
 
3. HA Powder Density 
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4. SEM Micrographs 
a. Powder Morphology 
b. Particle Size 
 
Rheological Evaluation of HAp: 
 
1. HA Slurry Density 
2. HA Slurry Rheology 
3. HAp Powder Flowability  
 
A rheological evaluation of the HAp (in slurry form) was investigated during the course 
of the chemical precipitation reaction to examine the influence of the slurry viscosity on 
the spray drying stage of HAp powder production. 
 
The review of literature and the preliminary investigation of this study were used to 
identify the most important synthesis parameters of chemical precipitation influencing the 
final HAp powder characteristics. These critical parameters were investigated further 
using design of experiments. A Fractional-Factorial (Res IV) screening design (2
6
) with 
main and interaction effects, with the six critical variables, at two levels, was used to 
screen a large number of the precipitation process variables in order to determine their 
effect on the final HAp powder characteristics (16 experiments). The six factors 
investigated were: T0 synthesis temperature (ºC), Vst stirring speed (rpm), Vac  acid 
addition rate (mol/min), tr ripening time (h), Ca
2+
 initial calcium concentration (M) and a 
qualitative factor examining the presence of a controlled/uncontrolled environment. This 
experimental design highlighted the factors that have the most significant affect on HAp 
precipitation process parameters, which was then used to build an optimisation 
experimental design based on the Box-Behnkhen optimisation model (17 experiments). 
Linear and quadratic polynomial equations for predicting the phase composition, 
crystallinity, crystallite size, lattice parameters and particle size were developed for both 
the screening and optimisation designs, enabling the final determination of a set of 
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idealised precipitation process parameters to obtain reproducible, highly desirable HAp 
feedstock specific for plasma spraying application. To validate the results obtained from 
both the screening and optimisation experimental designs, three extra confirmatory tests 
were conducted and the HAp powders yielded were characterised and compared against 
the previous results as obtained from both experimental designs. 
 
An investigation was also conducted to study the possible mechanism of various HAp 
with different crystallinity, morphology and particle size on a well studied osteoblast-like 
cell line (MG-63) commonly used to test in vitro bone - biomaterials biocompatibility. 
The HAp properties were controlled via modulating the chemical precipitation 
experimental parameters (such as, synthesis temperature, stirring speed, acid addition 
rate, ripening time, and initial calcium concentration) of the synthesis process. Eight 
variations of HAp powders were used in this study. The cell morphology was assessed 
using the scanning electron microscope (SEM), the cell proliferation and viability by 
biological techniques. 
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4.2 ANALYSIS OF HAp POWDER CHARACTERISTICS 
In order to determine an optimum set of precipitation process parameters capable of 
synthesising HAp possessing ideal physicochemical powder characteristics; the most 
influencing reaction parameters must firstly be identified. A comparative analysis of the 
HAp powder characteristics amongst international (commercial) suppliers of HAp was 
undertaken with a view to benchmarking HAp1 and HAp6 powders against each other. 
To characterize these powders, XRD analyses were performed to determine: the phase 
composition, purity, crystallinity, lattice parameters and crystallite size. In addition, the 
powder particle size, particle size distribution and specific surface area were measured 
using Laser Diffraction and BET method, respectively. The final HAp powder density, 
prior to plasma spray coating application onto orthopaedic implants was measured using 
Helium Pycnometry, while the morphology of the powders were observed using SEM. 
4.2.1 Phase Identification And Phase Purity 
The XRD patterns of the final sintered HAp powders (HAp1 – HAp6) are illustrated in 
Figure 4-1 (refer to Sections 3.8.1 – 3.8.3). Details of the process parameters used in 
producing HAp2 – 5 are unknown. However, what is known is discussed in the following 
section. The diffraction patterns are found to typically agree with those published in 
literature [2, 5, 13, 56, 85]. All the XRD patterns obtained have characteristic peaks 
consistent with the International Centre for Diffraction Data (ICDD) files for calcium 
phosphates. The predominant phase, as expected, was confirmed with JCPDS file no. 9-
432 (refer to section 3.8.2) for stoichiometric HAp. This suggest that no foreign elements, 
such as sodium (Na
2+
), ammonium (NH4
+
), potassium (K
+
), chloride (Cl
-
) and nitrate 
(NO3
-
) ions were involved in the reaction synthesis, since there is strong evidence to 
suggest that these ions are easily incorporated into the crystal lattice leading to the 
formation of non-stoichiometric HAp [5]. The absence of such elements may be 
attributed to the purity of the raw precursor materials used in the reaction synthesis. It is 
known that chloride ions enter the crystal lattice substituting hydroxyl groups, while 
potassium ions are found to substitute calcium ions into the HAp crystal lattice forming 
locally non-stoichiometric HAp islands in the bulk crystal. In order to avoid 
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contamination of the product, the use of calcium nitrate and phosphoric acid instead of 
calcium chloride salts and potassium dihydrogen phosphate, respectively are 
advantageous as the presence of potassium ions is avoided and the nitrate ions are too 
large to substitute hydroxyl groups in the crystal lattice of HAp. These substitutions were 
avoided in the preparation of HAp1, HAp2 and HAp6, since the reactants used were 
Ca(OH)2 and H3PO4. 
 
Figure 4-1: Comparison of x-Ray diffraction patterns for HAp1 – HAp6 powders in 2-D 
(below) and 3-D (above) 
 
For all HAp powders studied, no trace elements of CaO were observed. This indicates 
that either a small level or no carbonation of the HAp occurred during the reaction 
synthesis [5, 7]. For all the HAp powders analysed, no significant amounts of foreign 
elements were observed. However, one such secondary phase (β – TCP) was observed 
[186]. The diffraction patterns show that the amount of this phase varies with the HAp 
origin. HAp6 contains the highest content of β-TCP, while HAp1, HAp3 and HAp5 
2Ө 
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contain only minor traces of this phase. The apparition of β-TCP can be attributed to (i) a 
high sintering temperature (>1200ºC), as it has been reported that stoichiometric HAp 
can readily decompose to TCP, ACP and/or CPP at this sintering temperature [87] and 
(ii) the Ca-deficient nature of the HAp resulting in the production of secondary phases 
post sintering, at temperatures, starting as low as 700ºC [98]. The obtained degrees of 
purity are listed in Table 4-1. According to purity, the HAp powders can be classified as 
follows: HAp2 = HAp4 > HAp5 > HAp3 > HAp1 > HAp6. The synthesis of Ca-deficient 
HAp1, HAp2 and HAp6 can be explained by: 
   
Low reaction synthesis temperature (~20ºC): implemented at ambient temperature. 
Numerous researchers have studied the effect of this parameter on the HAp 
stoichiometry. Increasing the reaction temperature has had a favourable effect on the end 
stoichiometry of phase pure HAp [79, 87 - 90], and at a critical temperature, pure HAp 
can be formed.  
  
Insufficient stirring speed (1000rpm): In cases of low temperature synthesis, stirring in 
the maturation stage has shown to play an essential role in obtaining the required 
stoichiometry [78]. Insufficient stirring has been shown to produce thermally unstable 
HAp, where decomposition occurs into a mixture of HAp and TCP.  Afshar et al. [83] 
found that increasing the stirring speed from 500 to 2000rpm, decreased significantly the 
amount of CaO present in their sintered HAp samples, producing Ca-dHAp. Both 
Monetite (DCPA) and Brushite (DCPD) formation is favoured by insufficient mixing of 
calcium solution as the orthophosphoric solution is added. 
 
Reactant addition time: HAp crystallisation obeys the Ostwald rule of stages [78], so it 
is usually formed upon recrystallisation of precursor phases such as OCP, DCPA, DCPD 
and ACP.  Direct HAp formation is only found for low reactants concentration where the 
solution was undersaturated or slightly supersaturated with respect to the precursor phase.  
The HAp obtained through precursor phases is Ca-dHAp and requires long maturation 
times to approach stoichiometry. The supersaturation may be kept low by ensuring that 
the rate of addition of reactants is lower than the rate of crystallisation.
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Table 4-1: Results for XRD analysis of HAp1 – HAp6 powder samples 
HAp Powder Phases Present Crystallinity, 
(%) 
 
Purity, (%) Crystallite Size 
(nm) 
Lattice Parameters 
(nm) 
   Xc  Xp L002 L003 a  c 
HAp1  HAp + β-TCP + α-TCP 
 
 
93.94(±2) 97.36(±2) 62.23(±0.04) 81.17(±0.04) 9.4050(±0.04) 6.7943(±0.04) 
HAp2  HAp 
 
 
95.47(±2) 100.00(±2) 63.86(±0.04) 76.86(±0.04) 9.4294(±0.04) 6.9022(±0.04) 
HAp3 HAp + β-TCP + α-TCP 
 
 
98.85(±2) 98.21(±2) 45.06(±0.04) 48.42(±0.04) 9.4286(±0.04) 6.8877(±0.04) 
HAp4 HAp  
 
 
98.75(±2) 100.00(±2) 66.72(±0.04) 74.63(±0.04) 9.4263(±0.04) 6.8944(±0.04) 
HAp5 HAp + β-TCP  
 
 
97.31(±2) 99.56(±2) 66.24(±0.04) 69.27(±0.04) 9.4312(±0.04) 6.8875(±0.04) 
HAp6 HAp + β-TCP + α-TCP 
 
 
95.49(±2) 90.44(±2) 62.23(±0.04) 81.17(±0.04) 9.4642(±0.04) 6.8822(±0.04) 
 
 
  
 
 
 
 
 
     
Stoichiometric  
HAp [13] 
HAp  
 
100% 100%  - 9.4420 6.8800 
 
CHAPTER 4: Results And Discussion 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-153- 
Addition times of 60min or longer are required to obtain a well crystallised HAp product. 
Addition times of 30min, adversely have been found to result in a mixture of HAp and 
ACP. The measured pH at the end of the synthesis, is strongly linked to the reactant 
addition rate; a key parameter which can be used to determine the purity of the as 
synthesised and also for the stabilisation of the suspension. Bouyer et al. [94] state that 
when the addition rate of the phosphoric acid is very high (Vadd = 2400mL/min, the 
synthesis reaction conversion decreases and there is some Ca(OH)2 appearing in the 
product, while below 100mL/min, the conversion rate of the reaction is 100%. 
 
Sintering Temperature: The effect of the sintering temperature on the phase purity of 
HAp6 was investigated in this study and can be seen in Table 4-2. The results indicate 
that the purity of the spray dried HAp is lower than the sintered HAp, while a significant 
level of β-TCP was only evident in the post sintered HAp powder (see Figure 4-2).  
 
Table 4-2: Effect of sintering on the crystallinity and phase purity of HAp 
HAp6 Crystallinity, Xc (%) Purity, Xp (%) 
Spray Dried Chamber  33.45 (±2) 97.08(±2) 
Spray Dried Cyclone  38.32(±2) 96.07(±2) 
Sintered (2:1 ratio; Chamber: Cyclone)            95.49(±2)            90.44(±2) 
   
It has been reported that TCP appears, as a result of sintering temperatures reaching in 
excess of 1000ºC [2]. The sintering of pure stoichiometric HAp powder yields pure dense 
HAp ceramics with superior mechanical properties; whereas the sintering of non-
stoichiometric HAp causes other phases to be formed: TTCP and/or CaO if the Ca/P 
molar ratio exceeds 1.67 and α- and/or β-TCP if the Ca/P molar ratio is below 1.67 [79]. 
OCP (Ca/P = 1.33) formed at the beginning of the precipitation reaction is so unstable 
that it quickly transforms to ACP (Ca/P = 1.5) very quickly [91]. ACP then transforms to 
Ca-dHAp gradually to become stable HAp. ACP is composed of free radicals of OH  
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and HPO4
2-
 and DAP had radicals of OH  and HPO4
2-
, while HAp had no radicals of 
HPO4
2-
 but higher peaks of OH . Figure 4-2 illustrates that sintering parameters have a 
significant effect on the final purity of the HAp. This behaviour can be due to the fact that  
the decomposition of Ca-dHAp in the temperature range 22-900ºC takes place according 
to the following reaction [79]: 
  
 26410649264410 )()()1()()()()()( OHPOCaxPOxCaOHPOHPOCa xxxx    
                                                                                                                        Equation (4-1) 
 
Samples with an excess of Ca(OH)2 during thermal treatment, result in the presence of  
CaO. At higher temperatures of 1200ºC further decomposition occurs according to the 
following reaction [79]: 
 
OHOPCaPOCaOHPOCa 292424326410 )()(2)()(  
                                                                                                                        Equation (4-2) 
 
The extent of the reaction is dependent on the initial stoichiometry of the HAp. Ca-dHAp 
shows high degradation tendency, while in the case of stoichiometric HAp some loss of 
OH
-
 groups occur. In order to eliminate contamination during synthesis of the HAp, the 
use of calcium nitrate and phosphoric acid instead of calcium chloride salts and 
potassium dihydrogen phosphate, respectively are advantageous because the presence of 
potassium ions is avoided and the nitrate ions are too large to substitute hydroxyl groups 
in the crystal lattice of HAp. The synthesis route has a great effect on the final HAp 
purity [26]. The purity of HAp3 was greater than that of HAp1 and 6 (see Table 4-1). The 
elevated temperature at which the HAp was synthesised via the hydrothermal method 
may be accounted for in respect to the high purity obtained. The preparation route for 
HAp3 and 4, internationally marketed powders are undisclosed. 
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4.2.2 Crystallinity  
The calculated crystallinity for the various HAp powders are outlined in Table 4-1 (refer 
to Sections 3.8.1 and 3.8.4). All powders, except for HAp1 and 6 have crystallinity‘s 
greater than 95%, the minimum requirement as set out by the FDA [137]. HAp4 and 
HAp5 appear to possess a greater degree of crystallinity than HAp3 since narrower peaks 
are indicative of a more crystalline HAp (larger crystallite size) whereas broad peaks 
represent lower levels of crystallinity [2]. 
 
The effect of heat treatment on crystallinity can be seen in Figure 4-2 where the sintering 
of spray dried HAp particles at 1210ºC resulted in a considerable increase in crystallinity. 
Spray dried HAp possessed a crystallinity of 71.06(±2)%, while sintered HAp attained 
levels of crystallinity of 92.60(±2)%; an increase of up to 21%. The sintered HAp powder 
 
 
Figure 4-2: HAp6: Spray dried and final sintered HAp xrd patterns 
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also showed a substantial increase in peak height and an associated drop in peak width, 
corresponding to its increase in crystallinity. These results illustrate the significance of 
the sintering stage in increasing crystallinity to that as specified by ASTMF1185-03 and 
the FDA. Figure 4-3 illustrates the purity as a percentage versus crystallinity as a 
percentage. Although the purity of HAp6 is lower than the minimum requirement of 95% 
purity, it has a high level of crystallinity (95.59±2%). The order of crystallinity according 
to Table 4-1 follows the order: HAp3 > HAp4 > HAp5 > HAp6 > HAp2 > HAp1 
 
 
Figure 4-3: Purity versus crystallinity for HAp1 – HAp6 
 
The only powder failing to reach the required level of crystallinity is HAp1. Adversely, 
HAp6 is the only powder failing to satisfy the minimum requirement of 95% purity, with 
HAp1 meeting this requirement (97.36±2%). HAp2-5, on the other hand all meet the 
minimum requirements of 95% purity and crystallinity. 
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4.2.3 Lattice Parameters And Crystallite Size  
The crystallographic characteristics of the HAp, with regards their lattice parameters and 
crystallite size were analysed and are presented in Table 4-1, which summarises the 
lattice parameters for the HAp powders analysed in this study (refer to Sections 3.8.5 and 
3.8.6). It is well known that changes in lattice parameters indicate a possible deviation 
from stoichiometry. It is suggested elsewhere that an increase in the lattice parameter c 
with a reduction in lattice parameter a indicates either (i) a change in the Ca/P ratio in the 
HAp; (ii) a change in the Ca/OH ratio in the HAp, or (iii) a substitution of OH groups by 
CO3 groups [13]. Cases (i) and (ii) suggest the occurrence of an altered composition on 
account of precipitation of the impure phases present in the HAp. Case (iii), suggests that 
the HAp may have reacted with CO2 in the air, indicative of an uncontrolled atmospheric 
environment. The highest lattice parameter in the a-axis of HAp6 in comparison to the 
pure HAp2 and HAp4 confirms the Ca-deficient nature of this powder. Similar results 
were reported by Aizawa et al. [95], demonstrating that the lattice parameters for Ca-
dHAp increases in the a-axis direction with decreasing purity, but decrease in the c-axis 
direction. Figure 4-4 illustrates the increase of the a/c ratio increases with decreasing 
HAp purity. 
 
Figure 4-4: a/c ratio against HAp purity for HAp1 – HAp6 
 
Table 4-3 evaluates the deviation from stoichiometric HAp of the HAp powders studied. 
HAp2 to 5 demonstrate a contraction in the a-axis and an expansion in the c-axis HAp. 
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HAp1 demonstrates a contraction of both the a- and c-axis, while HAp6 demonstrates an 
expansion in both axes. It has been reported that a decrease in the a-axis coupled with an 
increase in the c-axis may be attributed to either F or CO3 substitution for PO4
3-
, on 
account of the atmospheric environment [69]. The increase in the a-axis of HAp6 with 
decreasing purity may be due to incorporation of HPO 24  into the Ca-dHAp structure.  
 
Table 4-3: Evaluation of deviation from the lattice parameters associated to stoichiometric 
HAp (a: 9.442nm and c: 6.889nm [64]), + expansion, - contraction 
 
Lattice Parameter Change 
 
  a-axis c-axis 
HAp1 - - 
HAp2 - + 
HAp3 - + 
HAp4 - + 
HAp5 - + 
HAp6 + + 
 
Pang and Bao [90] state that the crystallite sizes of as-prepared HAp increase with the 
increase of the reaction synthesis temperature, the higher the reaction synthesis 
temperature, the larger the crystallite size of the crystal formed. This theory is also 
confirmed in studies conducted by Smiciklas et al. [85]. This explains the similar 
crystallite sizes obtained for the HAp1, HAp2 and HAp6 powders, since all three HAp 
were prepared at ambient temperature of same synthesis route as opposed to the other 
HAp with unknown processing parameters. Spray dried HAp with a crystallite size (L300) 
of ~41nm was found to increase to ~81nm post sintering.  Pang and Bao [90] found that 
the crystallite size values increase for HAp with lower crystallinity and smaller crystallite 
sizes but decreased for those with high crystallinity and larger crystallite sizes since a 
large amount of relatively smaller new crystallites are formed during calcinations. This 
phenomenon has also been shown by other researchers for Ca-dHAp. 
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4.2.4 HAp Particle Size (PS) And Specific Surface Area (SSA)  
There are many advantages to reducing the granule size of HAp powder particles (refer to 
Section 3.8.8). In general, the smaller the granule size, the higher the specific surface area 
and the higher the bonding capacity. Powder particle size is larger than its primary 
crystallite size due to the processing conditions of the precipitate to produce the powder. 
Particle size is dependent upon reaction synthesis temperature [89], acid addition rate 
[83], and ripening time [90].  Table 4-4 outlines the average of three results recorded for 
mode, mean particle sizes and the percentage (10, 50 and 90%) of powder particles 
within a specific range for the several powders analysed (HAp1 – HAp6) prior to plasma 
spraying application and also post spray drying (HAp1 and HAp6). Figure 4-5 
graphically compares the mean particle sizes obtained for the micron sized HAp powders 
analysed. The order of mean particle size and specific surface area from the largest is as 
follows:  
Particle Size (µm)  =  HAp5 → HAp4 → HAp2 → HAp1 → HAp3 → HAp6 
SSA (m
2
/g)  = HAp5 → HAp1 → HAp6 → HAp3 → HAp2 → HAp4 
 
All the HAp powder particles analysed have 90% of their particles <100μm, which is a 
requirement for successful coating application via thermal plasma spraying onto 
orthopaedic implants [87, 113]. The difference between the observed and reported values 
for HAp particle size in literature can be attributed to the different synthesising routes and 
conditions implemented. The absence of particles with diameters less than their 
calculated crystallite size suggests that there is no suspended single crystallite of HAp in 
any of the samples analysed. The results for the particle sizes obtained may be accounted 
for by: 
Synthesis (Reaction) Temperature 
The smallest particle size of HAp1, HAp2 and HAp6 can be attributed to the low reaction 
temperature (T = 20ºC). Similar results reported [22, 89, 94] have indicated that an 
increase of the synthesis temperature results in a decrease of the SSA of the powder 
particles and hence, an increase in particle size. It is known, in this study, that HAp5 is 
produced via the hydrothermal method and subsequently 
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Table 4-4: Particle size analysis results and specific surface area of HAp1 – HAp6 
HA Powder Diameter (μm) on: Mean 
 
Mode 
 
Specific Surface 
Area 
10% 50% 90% (μm)  (μm) (m2/g) 
 
HAp1 
 
5.70 18.86 41.83 21.94 21.26 
 
0.63 
 
 
HAp2 
 
8.38 23.09 52.13 27.48 52.13 0.02 
 
HAp3 
 
0.83 
 
16.74 
 
36.70 
 
18.28 
 
24.31 
 
1.28 
 
 
HAp4 
 
12.27 
 
31.59 
 
61.15 
 
36.31 
 
41.43 
 
0.01 
 
 
HAp5 3.38 36.83 69.22 37.91 48.27 
 
0.53 
 
 
HAp6 
 
4.33 11.64 24.91 13.39 26.20 1.63 
HAp1:  Spray Dried HAp Powder 
 
Chamber   Powder 
 
3.36 12.45 27.44 14.33 16.18 - 
 
Cyclone Powder 
 
4.61 10.78 19.31 11.51 10.90 - 
HAp6:  Spray Dried HAp Powder 
 
Chamber   Powder 
 
1.68 6.55 20.49 9.22 7.72 1.42 
 
Cyclone Powder 
 
2.39 8.10 19.23 9.76 12.21 1.24 
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synthesised at a high reaction synthesis temperature (≤300ºC). This may be attributed to 
its larger mean particle size of 37.91µm. The higher the reaction synthesis temperature, 
the higher the particle size obtained as a result of the increase in temperature, activating 
its subsequent particle growth. 
 
Reactant Concentration 
The large particle size of HAp4 and HAp5 can be attributed to the high reactant 
concentration. It has been observed that when the reactant concentration is high, the 
precipitates selectively grow quicker along the c-axis compared to the a-axis resulting in 
high aspect ratio HAp particles [89]. 
 
Figure 4-5: Comparison of mean particle size and specific surface area for HAp1 – HAp6  
 
Reactant Addition Rate 
The large particle size of HAp4 and HAp5 can be attributed to the low rate of acid. 
Bouyer et al. [94] show that a low reactant addition rate seems to give an opposite effect 
on the HAp particle SSA. This is also confirmed by Afshar et al. [83] who state that the 
particle size of HAp increases as the acid addition rate is lowered. 
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Sintering Temperature 
The sintering temperature is also found to have an impact on the final HAp powder 
particle size obtained. Sintering carried out on HAp6 at 1200ºC, increased the average 
particle size from ~9.22μm to ~13.39μm, while HAp1 increased its particle size from 
between 11 – 14μm up to ~21.94μm. These results are in agreement with Kothappli et al. 
[89] since both HAp1 and HAp6 are found to possess the highest SSA as opposed to 
HAp2, HAp4 and HAp5. A high initial SSA (therefore, low particle size) and chemical 
purity are thought to favour sinterability of HAp [89] and hence the results obtained for 
HAp6 appear favourable. The Herring law of sintering [89] suggests that the sintering 
rate at a given temperature is inversely proportional to the square of the powder particle 
size. Thus, the smaller the agglomerate size, the easier for the powder to achieve high 
density at the same sintering temperature. Due to a large SSA, small precipitates are more 
likely to form large agglomerates so as to minimize their surface energy [89]. This is also 
in agreement with Gibson et al. [187] who also reported that smaller particles appeared to 
form into large agglomerates with rough surfaces, which is indicative of high surface 
areas.  
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4.2.5 Particle Size Distribution (PSD)  
A graphical comparison of the particle size distributions attained for HAp powders 
(HAp1 – HAp6) analysed in this study is shown in Figure 4-6 (refer to Section 3.8.8). A 
comparison of the PSD for HAp3, HAp4 and HAp5 is illustrated in Figure 4-7(a). Both 
HAp4 and HAp5 demonstrate a unimodal distribution, while HAp3 demonstrates a 
bimodal distribution. This can be explained by the agglomeration of this powder on 
account of its extremely fine particle size [89]. 
 
 
Figure 4-6: Comparison of particle size distributions obtained for HAp1 – HAp6 
 
A comparison of the PSD for HAp1, HAp2 and HAp6 is illustrated in Figure 4-7(b). 
Again, HAp1 and HAp2 exhibit a unimodal distribution, while HAp6 exhibits a bimodal 
distribution. This result obtained for HAp6 correlates well with the result of HAp3 as 
established above, where the low particle sizes of both these HAp are attributable to the 
significance of their bimodal PSD.  
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(A) 
 
 
(B) 
 
Figure 4-7: Comparison of PSD for HAp3, 4 and 5 (A) and comparison of PSD for HAp1, 2 
and 6 (B) 
 
Figure 4-8  illustrates the effect of sintering on PSD for both chamber and cyclone spray 
dried HAp powder particles. The cyclone spray dried HAp6 powder presents a unimodal 
distribution before and after sintering, while the chamber spray dried HAp6 powder 
attains a bimodal distribution post sintering. Prior to sintering, the cyclone spray dried 
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HAp6 powder possessed a mean particle size of 9.76μm while its chamber spray dried 
powder had a mean particle size of 9.22μm. The finer particle size of the chamber spray 
dried HAp signifies that agglomeration of its fines resulted (accounted for by its bimodal 
distribution).   
 
 
Figure 4-8: Effect of sintering on particle size distribution for spray dried chamber HAp6 
(SDCHHAp6) and the spray dried cyclone HAp6 (SDCYCHAp6) powders 
 
 
Figures 4-9 and 4-10 show the PSD distribution of the six  HAp powders (HAp1 – HAp6) 
analysed along with their cumulative frequency curves in accordance to ISO 9276 – 1 
[188]. 
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Figure 4-9: Particle size distribution graphs: histogram and cumulative distribution for 
HAp1 - 3 
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Figure 4-10: Particle size distribution graphs: histogram and cumulative distribution for 
HAp4 - 6 
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4.2.6 HAp Powder Density  
Highly dense HAp powders are desirable to prevent the preparation of human fluid into 
the interfacial area between the HAp coating and Ti-alloys in the hip joint replacement 
[189]. The theoretical value for dense HAp is calculated as 3.16g/cc (see section 3.8.10). 
FDA [137] regulations, however, require a minimum density of 3.05g/cc for HAp 
powders for coating application onto orthopaedic implants. Therefore, all the HAp 
powders analysed in this study are within these required specifications.  
 
All the HAp powders (see Table 4-5), appear to exceed the theoretical value for HAp 
density, with the exception of HAp1 and HAp. HAp3 and HAp6 exhibit highly dense 
sintered powders. This may be accounted for by their finer particle size.  
 
Table 4-5: Comparison of HA powder density measurements using helium pycnometry 
HAp Powder 
 
                              Pycnometric Density (g/cm
3
) 
 
HAp1 
 
3.08 
HAp2 
 
3.11 
HAp3 
 
3.47 
HAp4 
 
3.20 
HAp5 
 
3.28 
HAp6 
 
3.33 
 
 
Figure 4-11 illustrates the comparison of HAp density obtained for all HAp powders 
analysed. The low density values observed for HAp1 and HAp2 correspond well with the 
argument set above, since the particle sizes for these powders are 21.94μm and 27.48μm, 
respectively. HAp3 and HAp6, alternatively, demonstrate a higher sintered density with 
particle sizes of 18.28μm and 13.39μm, respectively. 
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Figure 4-11: Comparison of powder density for HAp1 – HAp6 
 
The green density (pre-sintered) for HAp is compared against sintered density in Table 4-
6 for HAp6 (that is, in-house HAp) and may also be viewed graphically in Figure 4-12. 
Sung et al. [114] suggests that HAp consisting of finer particle size have a much higher 
SSA, which is the driving force for solid state sintering and the amount of surface energy 
decrease is proportional to the free energy decrease for the sintering reaction. The 
chamber spray dried powder studied in HAp6 exhibits a higher increase in density than 
the cyclone spray dried powders post sintered. The green density of the spray dried HAp 
can be increased with increased solids concentration of the feed slurry. However, 
sintering behaviour can be controlled by varying the particle size, which may be realised 
by altering the reaction process parameters. 
 
Table 4-6: Effect of sintering treatment on the resulting HAp6 powder density 
Post Spray Dry Post Sintering 
Chamber HAp6 (g/cm
3
) 
 
Cyclone HAp6 (g/cm
3
) 
 
2.91 
 
 
3.47 
 
3.23 
 
 
3.33 
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Figure 4-12: Effect of heat treatment (1200ºC) on the resulting density obtained for HAp6 
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4.2.7 HAp Powder Morphology  
It is known that spherical powders, in general, have better rheological properties than 
irregular powders and, thus, produce better coatings for hip implants [2]. In order to 
produce dense, high-quality materials for special-purpose, it is very important to predict 
or control granule morphology (refer to Section 3.8.7) [110].  
 
Table 4-7 and Figure 4-13 compare the morphological properties for each of the six HAp 
analysed. HAp4 is found to possess the most ideal spherical and regular shaped particles 
indicative of enhanced rheological properties. HAp3 also appears to posses this attribute, 
although its surface morphology appears less smooth and regular in comparison to HAp4.  
This may also be attributed to the fact that the powders may have been synthesised at a 
higher reaction synthesis temperatures, endured longer maturation/ripening times, lower 
initial calcium concentrations and idealised spray drying condition (if implemented).  
 
Table 4-7: Comparison of HAp morphology in terms of regularity and smoothness (- 
indicates highly irregular/smooth, + indicating regular/smooth, ++ indicating increased 
regularity/smoothness and +++ indicating highly desirable levels of regularity/smoothness) 
 
HAp Sample 
 
Purity (%) 
 
Regularity 
 
Smoothness 
 
HAp1 
97.36(±2) 
+ 
 
+ 
 
HAp2 
100.00(±2) 
++ 
 
+ 
 
HAp3 
98.21(±2) 
++ 
 
++ 
 
HAp4 
100.00(±2) 
+++ 
 
+++ 
 
HAp5 
99.56(±2) 
- 
 
++ 
 
HAp6 
90.44(±2) 
+ 
 
+ 
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(A)     HAp1 
 
          HAp2 
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(B)     HAp3 
 
          HAp4 
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(C)     HAp5 
 
          HAp6 
 
Figure 4-13: SEM micrographs of HAp1 – HAp2 (A), HAp3 – HAp4 (B) and HAp5 – HAp6 (C) 
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Post heat-treatments (such as, flame spheroidisation) may also have been implemented in 
order to enhance its spherical nature. HAp5 appears the most irregular in shape. This may 
be explained by the hydrothermal route in which the powders were prepared, since it is 
well known that this synthesis method produces needle shaped particles [23]. HAp1 and 
HAp6 have similar morphology, with regular shape agglomerated particles, but with a 
lower surface smoothness than that of HAp3 and HAp4. An increase in the synthesis 
temperature, ripening time and decrease in calcium concentration may thus be required in 
order to increase the surface smoothness. The effect of sintering on the powder 
morphology for HAp1 and HAp6 is demonstrated in Figures 4-14 and 4-15, respectively. 
This processing step has a significant effect on altering the final morphology of the 
powders prior to spray drying. 
 
Kothapalli et al. [89] also demonstrate that an increase in synthesis temperature increases 
the size of HAp precipitates. At a high reaction synthesis temperature, the rate of particle 
ripening was high and the precipitates grew large during the allotted time. For irregular 
shaped (rod-like) particles, the length and the breadth of the HAp particles are found to 
increase with the temperature, while the aspect ratio is also found to increase. The key 
factors to controlling the HAp aspect ratio are (i) reaction synthesis temperature, (ii) pH 
and (iii) initial reactant concentrations. A low synthesis temperature, is found to result in 
needle-shaped particles [94]. Increasing the synthesis temperature changes the particles 
from a needle-shaped morphology to a more regular shaped with a lower aspect ratio, 
closer to 1 (ideal).  
 
The key factors controlling the morphology of the powders can vary with: 
 
Spray Drying Conditions 
Spray drying process conditions, such as droplet size, initial solid concentration, viscosity 
of liquid and drying temperature can have an impact upon the end morphology of the 
spray dried powder. Luo et al. [108] controlled the morphology of HAp powders, with 
spray drying as the controlling step to produce solid spheres by varying the atomization 
pressure and the concentration of the feed slurry. 
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Reaction Synthesis Temperature 
It is known that the precipitation reaction temperature is found to induce an enhanced 
spherical morphology [87 - 90] for wet chemical precipitation reactions involving raw 
chemicals such as, Ca(OH)2 and H3PO4. It has been shown that needle-shaped particles 
are likely to form at low reaction temperatures attaining a high aspect ratio, which 
changes to spheroidal when the precipitation temperature is increased to temperatures 
reaching 100 °C [88, 94]. Kumar et al. [88] accounted the change in the morphology by  
 
 
Figure 4-14: Effect of heat treatment on HAp1 powder morphology 
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the reaction temperature as the driving force for the HAp precipitation and the 
supersaturation level of Ca
2+ 
and PO4
3-
 ions with respect to HAp. The analysis indicated 
that the supersaturation level of the reactants, especially the concentration of Ca
2+
 ions, 
played a predominant role on the precipitate morphology for this classical acid-base 
reaction. Pang et al. [90] also suggests that an increase of reaction temperature produce 
more regular shapes particles and clearer contours with less aggregation. 
 
 
Figure 4-15: Effect of heat treatment on HAp6 powder morphology 
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Ripening Time 
Ripening time (maturation phase of HAp during chemical precipitation) is another factor 
controlling the morphology of HAp particles synthesised. Pang et al. [90] observed that 
increased ripening times have an effect on HAp morphology enhancing a more regular 
and smooth-like appearance. This is explained by the mechanism of crystal growth in 
solution. Chemical precipitation often experiences high-reaction induced supersaturation 
leading to high nucleation rates. In this case, a crystal nucleus possesses a rough surface 
due to the rapid production of insoluble materials. This rough surface favours conditions 
for crystal growth as the molecules adding on it has greater sticking probability. 
However, as the crystal continues to grow, it attains a smoother surface resulting in the 
slow down of crystal growth. 
 
Reactant Concentration 
The reactant concentration has also been proven to affect the morphological properties 
for HAp powder particles. Kothapalli et al. [89] observed that high reactant 
concentrations resulted in particles with higher aspect ratios. The purity of the powders is 
also thought to control the morphological properties of HAp. 
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4.2.8 HAp Powder Flowability  
The flowability of the HAp powders was determined according to ASTMB213-03 [183] 
and can be seen in Figure 4-16 (refer to Sections 3.8.11).  There exists a direct correlation 
between the particle size and the resulting powder flowability. For large powder particles 
(HAp3, HAp4 and HAp5) the flow rate of the powders ranges between 0.17 to 0.20g/s, 
whereas the finer powder particles (HAp1, HAp3 and HAp6) demonstrate a flow rate 
ranging between 0.12 to 0.15g/s. All powder flows were observed to flow in a 
discontinuous flow (that is, a pulsating manner), the degree of which was dependent on 
the morphology of the tested powder. These results show a good correlation between 
those published in previous work undertaken by Kweh et al. [2] where the effect of spray 
drying was examined with respect to powder flowability. The poor flowability of HAp3 
may be attributed bimodal particle size distribution as its mean particle size and 
morphology appear to favour an enhanced flowability. 
 
 
Figure 4-16: Powder flowability measurements recorded using the Hall flowmeter device 
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4.3 HAp SLURRY RHEOLOGICAL PROPERTIES 
In addition to the HAp synthesis reaction conditions, the final quality of the HAp powder 
is also influenced by the spray drying conditions. However, the rheological properties of 
the HAp slurry pre spray drying is also found to have an effect on the final spray dried 
powder properties yielded. In order to ensure, an optimum viscosity is achieved prior to 
the spray drying stage, the evolution of the suspensions rheology during HAp synthesis 
was studied. Rheology measurements are a useful tool in following the course of a 
chemical reaction. The results obtained in this study are presented in Table 4-8 and 
Figure 4-17, respectively. A marked increase of the HAp1 slurry viscosity throughout the 
stages of its synthesis is observed during the course of the Irish industry‘s chemical 
precipitation reaction method. The dynamic viscosity was found to increase from around 
16 – 18 mPa.s, during calcium hydroxide formation to 38 mPa.s after a 24h maturation 
phase. Similar results were reported by Tian et al. [97] who demonstrated how viscosity 
is a function of particle size.  
 
Table 4-8: Rheological properties obtained for HAp1 during chemical precipitation  
 CaO & H2O Mix H3PO4 Addition 24h Maturation  
Density (kg/m
3
) 1075.59 1107.60 1118.95 
Viscosity (mPa.s) 16 - 18 24 - 29 26 - 38 
Temperature (ºC) 31 - 33 44 - 47 31 - 32 
pH 12 - 12.6 12.5 - 11.3 11.3 – 11.4 
 
The pH and the synthesis temperature of the chemical reaction were also observed at 
three stages; stage 1: calcium hydroxide formation; stage 2: orthophosphoric acid 
addition and stage 3: post 24 maturation of acid addition. As expected, the initial pH of 
the HAp1 slurry at stage 1 was found to stabilise between 12 – 12.6, decreasing to 
between 12.6 – 11.2 with subsequent additions of acid and finally stabilised at pH 11 for 
stage 3. While the synthesis temperature was uncontrolled, the temperature of the HAp1 
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slurry was found to alter during the course of the chemical reaction, varying between 31 - 
33ºC, with a slight increase resulting from acid additions by up to 14ºC. Figure 4-17 
presents a graphical illustration of the rheological results, suggesting a linear relationship 
between the dynamic viscosity of the HAp1 slurry was achieved through the three stages 
of the synthesis route. 
 
Figure 4-17: Graphical results of rheology (viscosity, temperature & pH) for HAp1 
 
Appendix D illustrates the flow curves of the HAp slurry throughout the stages of HAp1 
synthesis, using the chemical precipitation technique. The flow curves describe the 
variability of viscosity with solids concentration and particle size distribution. This 
comportment has already been described by Chow et al. [35]. Time-dependent behaviour 
was exhibited for all HAp1 slurry analyses during HAp synthesis. During calcium 
hydroxide formation dilatent behaviour of the HAp slurry was most evident, while 
additions of orthophsophoric acid exhibited a thixotropic behaviour. 
  
0
5
10
15
20
25
30
35
40
45
50
Ca(OH)2 Mix H3PO4 Addition 24h Ripening
Viscosity mPa.s Temperature (ºC) pH
CHAPTER 4: Results And Discussion 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-182- 
4.3.1 HAp Slurry Density 
In order to calculate the kinematic viscosity of the HAp slurry, and compare against 
desirable levels, as reported elsewhere by Luo et al. [82, 108]; the HAp slurry density 
was measured during the wet chemical synthesis of HAp1 and HAp6 (see Table 4-8 and 
Figure 4-18). The results indicate the increase of density during the preparation of HAp.   
 
 
Figure 4-18: Comparison of slurry density for HAp1 and HAp6 
 
The density obtained at the initial stage (that is, stage 1), where calcium hydroxide is 
produced, varies at 1.06 g/cc
 
for HAp6 slurry and 1.08 g/cc for HAp1 slurry (the initial 
density of the CaO is 1.99g/cc while that of DI water is 1.00g/cc). Thus, the density for 
this first stage of HAp synthesis is similar to that of pure DI water, while additions of the 
acid and subsequent stages of the maturation stage of HAp resulted in a slight increase of 
density for both HAp slurries to 1.14 g/cc and 1.16 g/cc for HAp6 and HAp1 slurries, 
respectively (the initial density of H3PO4 (85% purity) between 25 ºC to 40ºC, ranges 
between 1.69 g/cc to 1.69 g/cc, respectively). This behaviour is due to the increase of the 
powder particle size. Previous research has demonstrated that the density of the HAp 
slurry significantly impacts upon the final HAp powder particle size obtained. 
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4.3.2 HAp Slurry Rheology 
The kinematic viscosities (that is, the ratio of dynamic viscosity to density) of HAp1 and 
HAp6 are calculated and compared against the range of kinematic viscosities, proposed in 
work carried out by Luo et al. [108] to aid in producing highly dense HAp powder 
particles of a controlled (spherical) morphology, in the desired micron range for plasma 
spray onto orthopaedic implants (see Table 4-9 and Figure 4-19).  
 
Table 4-9: Kinematic viscosity calculations for HAp1 and HAp6 
  HAp1 slurry HAp6 slurry 
Density (g/cc) CaO & H2O Mix 1.08 1.06 
 H3PO4 Addition 1.11 1.09 
 24h Maturation 1.12 1.11 
 Pre-Spray Dry Mix 1.16 1.14 
    
Dynamic Viscosity 
(mPa.s) 
CaO & H2O Mix 
16 16 
 H3PO4 Addition 26 26 
 24h Maturation 36 34 
 Pre-Spray Dry Mix 75 57 
    
Kinematic Viscosity (cst) CaO & H2O Mix 14.65 14.87 
 H3PO4 Addition 23.26 23.36 
 24h Maturation 32.56 30.21 
 Pre-Spray Dry Mix 64.66 49.91 
 
 
The results indicate that both HAp1 and HAp6 slurries are within the optimum range 
after the maturation phase of 24h.  However, further mixing of the HAp slurry prior to 
spray drying was found to significantly increase the kinematic viscosity of both HAp1 
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and HAp6. An unexpected high kinematic viscosity of the HAp1 pre – spray dry slurry 
mixture was observed at ~75cst and outside the range recommended by Luo et al. [108]. 
This may be attributed to the fact that the HAp1 slurry was not spray dried immediately 
post 24h maturation, but instead allowed to continue its chemical reaction under 
agitation. 
 
 
Figure 4-19: Kinematic viscosities for HAp1 and HAp6 
 
Figure 4-19 highlights the requirement to control the kinematic viscosity of the HAp 
slurry (0.5 – 50cst) prior to spray drying in order to ensure that highly dense HAp of a 
spherical morphology is produced [108]. This is achieved through additions of distilled 
water to the HAp slurry mixture before the spray drying process [109].  
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4.3.3 Summary 
A summary of the findings for this study are outlined in the list below and demonstrates 
how each powder characteristic varies for each case of response investigated. This can be 
attributed to the variance in the powder synthesis route used in obtaining each of the 
powders. While the routes used to synthesise HAp3 and HAp4 are unknown, it is known 
that the hydrothermal route was used to produce the commercial powder HAp5, while the 
chemical precipitation technique was used in producing the remaining HAp powders 
(HAp1, HAp2 and HAp6). 
 
(A)  Phase Purity HAp2 = HAp4  > HAp5  > HAp3  > HAp1  > HAp6   
(B) Crystallinity HAp3  > HAp4  > HAp5  > HAp6  > HAp2  > HAp1   
(C) a/c ratio HAp1  > HAp6  > HAp5  ~ HAp3  > HAp4  > HAp2  
(D) Mean Particle Size HAp5 > HAp4 > HAp2 > HAp1 > HAp3 > HAp6 
(E) Particle Surface Area HAp5 > HAp1 > HAp6 > HAp3 > HAp2 > HAp4  
(F)  Powder Density HAp3 > HAp6 > HAp5 > HAp4 > HAp2 > HAp1  
(G) Powder Morphology 
(Regularity) 
(Smoothness) 
 
HAp3 = 
HAp3 =  
 
HAp4 > 
HAp4 > 
 
HAp2 > 
HAp5 > 
 
HAp1 = 
HAp1 = 
 
HAp6 > 
HAp6 = 
 
HAp5  
HAp2  
(H) Powder Flowrate HAp5 = HAp4 > HAp2 > HAp1 > HAp3 > HAp6  
 
However, comparing the powders of the same synthesis route (HAp1, HAp2 and HAp6) 
also shows a significant variance between the responses obtained and for this reason, the 
variance of the process parameters can have an effect on altering the final powder 
characteristics. To ensure that HAp possessing all of the optimum responses required 
(phase purity and crystallinity, both >95%, particle size <100µm, ↑density, ↑powder 
flowrate, ↑surface smoothness, where ↑ denotes that a high results is desired) are 
obtained, it is critical to control the process parameters which have an effect on one or 
more of each of these responses and hence the requirement for an optimisation study, 
which is investigated in the following sections. 
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4.4 SCREENING OF CHEMICAL PRECIPITATION PROCESS 
PARAMETERS 
In this section, the experimental design used, the range of each chemical precipitation 
process parameter and experimental layout are presented. This section demonstrates the 
results for the screening of the most significant chemical precipitation process 
parameters, in terms of the ANOVA analysis for each response investigated, and the 
validation of the models produced. The effects of the process parameters on each 
response are described and discussed. Furthermore, the results of the phase purity, 
crystallinity, crystallite size, lattice parameters and particle size are illustrated and 
discussed to distinguish the effects of the process parameters on the final HAp powder 
properties obtained.  
 
To screen the most significant chemical precipitation process parameters, the design of 
experiments was based on a fractional-factorial design, (2
6
), with main and interaction 
effects, with the six influencing variables, at two levels, in sixteen runs used to identify 
how influential the process parameters are in terms of satisfying regulatory requirements 
and the synergism between these factors and hence the optimal conditions.  Six 
experimental precipitation process parameters were selected, each one at two levels, and 
these are indicated in Table 4-10. The minimum and the maximum possible level values 
were selected for the screening experiments and are shown in Table 4-10 (denoted as -1 
(min. level) and +1 (max. level). 
 
Table 4-10: Experimental factors and level of factors 
No Variable Level -1 Level +1 
A Reagent Addition Rate, Vac 0.005 mol/min 0.01 mol/min 
B Reaction Temperature, To 20°C 60°C 
C Stirring Speed, Vst 600rpm 1500rpm 
D Ripening Time, tr 0.5h 48h 
E Initial Ca2+ Concentration, Ca2+ 0.1 mol/L 2 mol/L 
F Inert Atmosphere, (atm) without N2 with N2 
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The experiments were carried out according to the design matrix shown in Table 4-11 in 
a fully randomised order to avoid any systematic error. For this screening evaluation, 
several mathematical models were developed successfully to predict the following 
responses: phase purity (Xp), crystallinity (Xc), crystallite size (Xs, L002 and L300), lattice 
parameters (a and c) and the powder particle size (Ps). The responses obtained were 
calculated according to the experimental design matrix, characterized as per experimental 
methods outlined in Chapter 3 and are discussed in the following sections. The averages 
for three measurements for each response are presented in Table 4-12. Also refer to 
Appendix E for a detailed analysis of the repeated results. 
 
Table 4-11: Fractional-Factorial (Res IV) experimental design, real values 
Sample Vac 
(mol/min) 
To  
(°C) 
Vst 
 (rpm) 
tr (h) Ca
2+ 
(mol/L) 
atm 
 
N1 0.005 20 600 0.5 0.1 yes 
N2 0.01 20 600 0.5 2 yes 
N3 0.005 60 600 0.5 2 no 
N4 0.01 60 600 0.5 0.1 no 
N5 0.005 20 1500 0.5 2 no 
N6 0.01 20 1500 0.5 0.1 no 
N7 0.005 60 1500 0.5 0.1 yes 
N8 0.01 60 1500 0.5 2 yes 
N9 0.005 20 600 48 0.1 no 
N10 0.01 20 600 48 2 no 
N11 0.005 60 600 48 2 yes 
N12 0.01 60 600 48 0.1 yes 
N13 0.005 20 1500 48 2 yes 
N14 0.01 20 1500 48 0.1 yes 
N15 0.005 60 1500 48 0.1 no 
N16 0.01 60 1500 48 2 no 
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Table 4-12: Phase purity (Xp), crystallinity (Xc), crystallite size (Xs, L002 and L300), lattice parameter ratio (a/c) and mean particle size (Ps) 
of the different HAp samples for various conditions of acid addition (Vac),  temperature (To), stirring speed (Vst), ripening time (tr), 
calcium conc. (Ca
2+
) and atmospheric control (atm) 
Sample  Purity,            
Xp, (%)  
Crystallinity, 
Xc, (%) 
Crystallite 
Size, Xs, L002 
(nm) 
Crystallite Size, 
Xs, L300 
(nm) 
Lattice 
Parameter, a 
Lattice 
Parameter,  c 
Mean Particle Size, Ps  
(µm) 
N1 44.25 72.23 61.47 56.09 9.4243 6.8953 58.60 
N2 21.15 80.62 59.44 66.91 9.4625 6.8965 38.03 
N3 83.19 45.69 90.48 126.35 9.4805 6.9049 23.28 
N4 65.02 67.38 54.50 86.23 9.4828 6.8814 48.82 
N5 44.01 54.85 98.79 139.70 9.4072 6.8817 54.94 
N6 42.29 57.68 76.03 82.49 9.4168 6.8570 57.77 
N7 63.59 76.49 59.04 87.96 9.4312 6.8890 19.96 
N8 50.21 61.29 51.44 64.35 9.4462 6.8961 22.65 
N9 86.37 58.50 41.60 58.84 9.4264 6.8749 63.83 
N10 44.88 73.21 54.77 10.73 9.4871 6.8882 30.81 
N11 74.85 71.74 60.82 73.91 9.4255 6.8820 20.74 
N12 53.77 79.65 44.28 75.14 9.4300 6.8819 50.69 
N13 38.14 80.58 52.20 70.61 9.4150 6.8808 34.38 
N14 100.00 86.32 57.11 64.25 9.4145 6.8805 53.48 
N15 44.27 90.95 69.45 76.04 9.4173 6.9009 36.15 
N16 98.89 95.19 107.92 90.53 9.4296 6.8723 15.38 
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Statistical analysis of the obtained data was performed using the Design Expert 7.1
® 
(Stat-Ease, Inc.) software. Analysis of the regression coefficients of the linear  
polynomial models describing the relationship between the responses of purity (Xp), 
crystallinity (Xc), crystallite sizes (Xs, L002 and L300), lattice parameters (a and c) and 
mean particle size (Ps) against the six factors (Vac, To, Vst, tr, Ca
2+
, atm) are presented in 
the following section.   
 
4.4.1 Development Of Phase Purity Model 
As a result of analysing the measured responses using the Design Expert software, the 
test for significance of the regression models and the test for significance on individual 
model co-efficients were performed using the same statistical software package for all 
responses. By selecting the backward regression method, the insignificant model terms 
(P<0.05), were automatically eliminated. The resulting ANOVA table (Tables 4-13) for 
the reduced linear phase purity model outlines the analysis of variance for this response 
and show the significant model terms affecting the phase purity. This table also shows 
other adequacy measures, such as, R
2
, Adjusted R
2
 and Predicted R
2
. All the adequacy 
measures should converge close to 1, which is in reasonable agreement in indicating 
adequate models [160]. The Adequate Precision in this case is 34.562. An Adequate 
Precision ratio of greater than 4 indicates adequate model discrimination [160].  
 
The analysis of variance, indicates, that for the phase purity model, all of the chemical 
precipitation parameters have an effect on the resulting phase purity model, either as a 
main or interaction effect with another parameter. The main effects of the reaction 
synthesis temperature (To), ripening time (tr), calcium concentration (Ca
2+
), presence of 
an atmospherically controlled environment (atm.) and the two way interaction effects of 
acid addition rate and stirring speed (Vac* Vst), acid addition rate and ripening time (Vac* 
tr), acid addition rate and calcium concentration (Vac* Ca
2+
), reaction temperature and 
ripening time (To* tr), reaction temperature and a controlled environment (To* atm.) and 
the three way interaction of acid addition rate, reaction temperature and controlled 
environment (Vac* To* atm.) are the most significant model terms associated with phase 
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purity.  The final mathematical models in terms of coded and actual factors, for an atm. 
(with or without) as determined by the design expert software are shown in Equations 4-3 
to 4-5.   
 
Table 4-13: ANOVA table for phase purity reduced linear polynomial model 
Source Sum of  
squares 
d.f. Mean Square F value Prob >F 
Model (Significant) 
To 
tr 
Ca2+ 
atm. 
Vac * Vst 
Vac * tr 
Vac * Ca
2+ 
To * tr 
To * atm. 
Vac * To * atm. 
Residual 
Corrected total 
7979.02 
794.03 
1015.50 
122.31 
247.69 
2632.28 
760.05 
142.06 
728.09 
76.18 
1460.82 
39.31 
8018.33 
10 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
5 
15 
797.90 
794.03 
1015.50 
122.31 
247.69 
2632.28 
760.05 
142.06 
728.09 
76.18 
1460.82 
7.86 
101.49 
101.00 
129.17 
15.56 
31.50 
334.81 
96.68 
18.07 
92.61 
9.69 
185.81 
 
<0.0001 Significant 
0.0002 
<0.0001 
0.0109 
0.0025 
<0.0001 
0.0002 
0.0081 
0.0002 
0.0265 
<0.0001 
R
2
 = 0.9951; predicted R
2
 = 0.9498; adjusted R
2
 = 0.9853; adequate precision = 34.562  
 
Phase Purity, Xp, (%) = 59.68  
+ 7.04  *To  
+ 7.97  *tr 
– 2.76  *Ca2+ 
+ 3.93  *atm. 
+ 12.83 *Vac* Vst  
+ 6.89  *Vac* tr  
– 2.98  *Vac* Ca
2+
  
– 6.75  *To* tr 
+ 2.18  *To* atm.  
+ 9.56  *Vac* To* atm.     Equation (4-3) 
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For an uncontrolled atmospheric environment: 
Phase Purity,  = +70.50227 
Xp, (%) +1.96035   * Reaction Temp 
  +0.032905   * Ripening Time 
  +6.49911   * Ca
2+
 Conc. 
  +11.40128   * H3PO4 addition rate * Stirring Speed 
  +116.08032   * H3PO4 addition rate * Ripening Time 
  -1254.60263   * H3PO4 addition rate * Ca
2+
 Conc. 
  -0.014202   * Reaction Temp * Ripening Time              Equation (4-4)     
           
For a controlled (inert) atmospheric environment: 
Phase Purity,  = +188.45472 
Xp, (%) -0.68800   * Reaction Temp 
  +6.49911   * Ca
2+
 Conc. 
  +0.032905   * Ripening Time 
  +11.40128   * H3PO4 addition rate * Stirring Speed 
  +116.08032   * H3PO4 addition rate * Ripening Time 
  -1254.60263   * H3PO4 addition rate * Ca
2+
 Conc. 
  -0.014202   * Temp * Ripening Time     Equation (4-5)     
 
Figure 4-20 shows the relationship between the actual and predicted values of phase 
purity. This figure indicates that the developed model is adequate, since the residuals in 
the prediction of each response are small, with the residuals tending to be close to the 
diagonal line. 
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Figure 4-20: Scatter diagram for phase purity 
 
 
4.4.2 Effect Of Process Parameters On Phase Purity 
Deviation from stoichiometric HAp is due to the presence in the crystal lattice of 
vacancies and ion substitutes, such as carbonates and hydrogen phosphates, which are 
usually introduced into the precipitating system with the reactants. Ca-dHAp suffers from 
significant changes in its crystallographic characteristics, in comparison to pure 
stoichiometric HAp. Since, it is well known that the neutralisation of calcium hydroxide 
with orthophosphoric acid leads to non-stoichiometric HAp, control of the process 
parameters affecting the purity is critical in obtaining high levels of purity (>95%). This 
section discusses the effect of the process variables (using the crystallinity model 
developed in the previous section)  on the final phase purity of HAp.  
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The phase purity is directly related to all of the process variables investigated, either as a 
main or as part of an interaction effect, as stated earlier. The reason for predicting the 
phase purity is to develop a model, to aid in the selection of an appropriate range for the 
optimisation stage (at a later stage). The pareto chart for the phase purity model, as 
illustrated in Figure 4-21, highlights the order of the significant main and interaction 
parameter effects, which ultimately affect the phase purity  model.  
 
 
Figure 4-21: Pareto chart, examining the level of main and interaction effects (orange: 
positive effect and blue: negative effect) of the process parameter on the phase purity: 
where A is Vac, B is To, C is Vst, D is tr, E is Ca
2+
 conc. and F is atm. 
 
The order of the level of significance of the positive effects of the chemical precipitation 
process parameters on the phase purity follows the order:  (Vac* Vst) > (Vac* To* atm.) > 
(tr) > (To) > (Vac* tr) > (atm.) > (To* atm.) while the order of the level of significance of 
the negative effects on the phase purity is as follows:  (To* tr) > (Vac* Ca
2+
) > (Ca
2+
). 
Hence, if high levels of phase purity are to be obtained, the top four most influencing 
effects for control are as follows: 
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1. Acid addition rate * Stirring Speed↑ (Two-way interaction effect) 
2. Acid addition rate * Reaction temperature * atmospheric control↑ (Three-way interaction effect) 
3. Ripening time↑ (Main effect) 
4. Reaction temperature↑ (Main effect) 
Where ↑ denotes a high level and ↓ denotes a low level is required. 
 
The primary factor most affecting the phase purity appears to be the two-way interaction 
effect between the acid addition rate and the stirring speed. The stirring speed should be 
high enough to prepare a good homogeneous media for preparation of HAp [83], with 
both monetite and brushite formation favoured by sufficient mixing of the calcium 
solution as the orthophosphoric solution is added. When it is not distributed 
homogenously, the PO4
3-
 ion concentration can build up and a localized low pH will be 
established. This part of the reaction vessel is richer in PO4
3-
 and provides conditions for 
the formation of soluble precipitates. The model indicates therefore, that with an increase 
in acid addition rate, it is imperative to also increase the stirring speed to obtain a high 
level of HAp purity. 
 
The second factor most affecting the phase purity is a three-way interaction effect 
between the acid addition rate, the reaction temperature and the atmospheric control. 
Seckler et al. [78] have reported that the main phase formed at room temperature is ACP 
with minor amounts of HAp, while the amounts of HAp present increased with an 
increase in temperature. The model indicates that use of a controlled inert environment 
and acid addition rate is favoured by use of a high reaction temperature to ensure 
impurities incorporated into the reaction vessel are kept at a minimum.  
 
The ripening time and reaction temperature are the third and forth most significant effects 
(main), respectively and correlate well with evidence provided by Liu et al. [91] in 
demonstrating the significance of the ripening time with respect to purity, for the full 
conversion of precursor phases, such as: OCP, DCPD and ACP to phase pure HAp, while 
the lifetime of the metastable amorphous precursor in aqueous solution has been reported 
to be a function of the reaction synthesis temperature.  
CHAPTER 4: Results And Discussion 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-195- 
Figure 4-22 shows a perturbation plot highlighting the effect of all parameters on the 
phase purity. The perturbation plot allows the effect of all the factors at a particular point 
in the design space to be compared. This type of display does not show the effect of 
interactions. Instead, the lines represent the behaviours of each factor while holding the 
others in a constant ratio (centre point by default). In the case of more than one factor this 
type of display could be used to find those factors that most affect the response. The 
significant interaction (between the rate of acid addition and the stirring speed) most 
affecting the phase purity is shown in Figure 4-23, under an uncontrolled and controlled 
(inert) atmosphere. 3-D and 2-D contour plots are presented in Figure 4-24(a) to (c), and 
highlight the positive influence of increasing both the reaction synthesis temperature and 
the ripening time. However, a decrease in the calcium concentration is required in order 
to ensure high levels of phase purity are attained. A ripening time of at least 24h proved 
difficult in attaining a minimum of 95% purity at ambient reaction temperatures. Instead, 
higher levels of a reaction temperature are necessary in order to correct this. It is also 
evident that the presence of a controlled (inert) environment has a positive effect on the 
final purity obtained. 
 
(A) 
 
(B) 
 
Figure 4-22: Perturbation plot showing the effect of all the parameters on the phase purity 
under (A) an uncontrolled environment and (B) a controlled (inert) environment 
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(A) Uncontrolled atmosphere 
 
 
 
(B) Controlled atmosphere 
 
 
 
 
Figure 4-23: Interaction plot showing the most significant interaction effects of Vac and Vst  
on the phase purity for (A) an uncontrolled atmospheric environment and (B) a controlled 
inert environment for low (left hand side) and high (right hand side) remaining factors 
 
The model also demonstrates that low temperature synthesis at a low stirring speed 
results in low levels of HAp purity (that is, a mixture of HAp and β-TCP), while using a 
high synthesis temperature and stirring speed can increase the final purity. 
 
A comparison of the effect of the chemical precipitation parameters between the powders 
obtained at lowest (N2) and highest purity (N14 and N16, with a minimum of 95% 
purity, as required per regulations reviewed in section 2.12) is reviewed in Table 4-14. 
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 (A) Vst.: 600rpm 
 
 
(B) Vst.: 1050rpm 
 
 
(C) Vst.: 1500rpm 
  
Figure 4-24: 3D surface and 2D contour plots of phase purity at (A) a stirring speed of 
600rpm; (B) a stirring speed of 1050rpm and (C) a stirring speed of 1500rpm (under a 
controlled environment at tr = 48h and Ca
2+
 = 2.0M)  
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The purity values obtained have been verified by Rietveld refinement and shows N14 as 
the only powder to have attained 100 wt. % purity. The second highest level of purity 
obtained was for N16: with 98.89 wt. % HAp and 1.11 wt% CaO. The lowest level of 
purity obtained, however, was for N2: with only 21.15 wt. % HAp evident. Instead, its 
predominant phase consists of 65.54 wt. % β-TCP. Comparing the chemical precipitation 
parameters of N2 against the more pure HAp powders (N14 and N16) therefore, 
demonstrates the requirement of a higher stirring speed and ripening time in obtaining 
increased levels of phase purity. This concept has been previously discussed in relation to 
studies conducted by Afshar et al. [83] confirming that the stirring speed should be high 
enough to prepare a good homogeneous media for preparation of HAp. Comparing N14 
with N16 shows how a low calcium concentration is favoured for high levels of purity, 
which correlates well with that proposed by Guilietti et al. [86] who maintain that high 
purity levels can be attained, when precipitation is conducted at low supersaturation 
levels. Comparing the effect of the atmospheric control on the final purity also confirms 
that the presence of a controlled (inert) environment can also have a positive influence on 
the final phase purity. 
 
Table 4-14: Effect of the chemical precipitation parameters (factors) studied on the purity 
(response) 
 Factors Response 
Sample Vac 
(mol/min) 
To  
(°C) 
Vst 
 (rpm) 
tr  
(h) 
Ca
2+ 
(mol/L) 
atm. 
 
Xp 
(%) 
N2 0.01 20 600 0.5 2 + 21.15  
N14 0.01 20 1500 48 0.1 + 100.00 
N16 0.01 60 1500 48 2 - 98.89 
 
Figure 4-25 shows 2-D and 3-D illustrations of the comparison between the XRD 
patterns obtained for the three powder samples, N2, N14 and N16 under discussion. With 
respect to purity, the only two samples in this study to satisfy regulatory requirements 
(min. 95%) in the order of most pure is N14 > N16. Refer to Appendix F for XRD 
patterns relating to all 16 sets of conditions outlined in the design matrix (see Table 3.7). 
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(A) 
 
(B) 
Figure 4-25: (A) 3-D illustration and (B) 2-D illustration comparing XRD patterns obtained 
for N2, N14 and N16 
β-TCP 
2Ө 
N2 
N14 
N16 
HAp 
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4.4.3 Development Of Crystallinity Model 
As a result of analysing the measured responses using the Design Expert software, the fit 
summary selects the highest order polynomial where the additional terms are significant 
and the model is not aliased. By selecting the manual regression method, the insignificant 
model terms (P<0.1), with less than a 5% contribution were eliminated. The precent 
contribution is obtained from adding up the total sum of squares and then taking from 
each term‘s sum of squares and dividing by the total to get a percentage. Table 4-15 
presents the ANOVA results for the crystallinity and shows the significant model terms. 
The same tables show also the other adequacy measures R
2
, Adjusted R
2
 and Predicted 
R
2
. All the adequacy measures are close to 1, which is in reasonable agreement and 
indicate adequate models [160]. The Adequate Precision is 9.805. An Adequate Precision 
ratio of greater than 4 indicates adequate model discrimination [160].  
 
The analysis of variance for the crystallinity model indicates that all of the chemical 
precipitation parameters have an effect on the resulting crystallinity model, either as a 
main or interaction effect with another parameter. The main effects of the acid addition 
rate (Vac), stirring speed (Vst), ripening time (tr), controlled atmosphere (atm.) and the two 
way interaction effects of acid addition rate and stirring speed (Vac* Vst), acid addition 
rate and calcium concentration (Vac* Ca
2+
), reaction temperature and ripening time (To* 
tr), reaction temperature and a controlled environment (To* atm.) are the most significant 
model terms associated with achieving high levels of crystallinity (>95%). The final 
mathematical models in terms of coded and actual factors (with and without atmospheric 
control) as determined by the Design Expert software are shown in Equations 4-6 to 4-8.   
 
Figure 4-26 shows the relationship between the actual and predicted values of 
crystallinity. This figure indicates that the developed model is adequate, since the 
residuals in the prediction of each response are small, with the residuals tending to be 
close to the diagonal line. 
 
CHAPTER 4: Results And Discussion 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-201- 
Table 4-15: ANOVA table for crystallinity reduced linear polynomial model 
Source Sum of  
squares 
d.f. Mean Square F value Prob >F 
Model (Significant) 
Vac 
Vst 
tr 
atm. 
Vac * Vst 
Vac * Ca
2+ 
To * tr 
To * atm. 
Residual 
Corrected total 
2596.23 
158.20 
184.57 
898.69 
268.06 
189.81 
260.83 
178.59 
457.48 
244.10 
2840.33 
8 
1 
1 
1 
1 
1 
1 
1 
1 
7 
15 
324.53 
158.20 
184.57 
898.69 
268.06 
189.81 
260.83 
178.59 
457.48 
34.87 
9.31 
4.54 
5.29 
25.77 
7.69 
5.44 
7.48 
5.12 
13.12 
0.0041 Significant 
0.0707 
0.0549 
0.0014 
0.0276 
0.0524 
0.0291 
0.0581 
0.0085 
R
2
 = 0.9141; predicted R
2
 = 0.5510; adjusted R
2
 = 0.8158; adequate precision = 9.805  
 
Crystallinity, = 72.02  
Xc, (%)  +3.14  *Vac  
+ 3.40  *Vst 
+ 7.49  *tr 
– 4.09  *atm. 
– 3.44  *Vac* Vst   
+ 4.04  *Vac* Ca
2+
  
+ 3.34  *To* tr  
+ 5.35  *To* atm.       Equation (4-6)     
 
For an uncontrolled atmospheric environment: 
Crystallinity,  = +37.69018 
Xc, (%) +4509.69603   * H3PO4 addition rate 
  +0.030509   * Stirring Speed 
  +0.11365   * Ripening Time 
  -3.06155   * H3PO4 addition rate * Stirring Speed 
  +35.51526   * H3PO4 addition rate * Ca
2+
 Conc.   
+5.04780E-003 * Reaction Temp * Ripening Time              Equation (4-7)     
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For a controlled (inert) atmospheric environment: 
 Crystallinity,  = +8.11504 
Xc, (%) +4509.69603   * H3PO4 addition rate 
  +0.030509   * Stirring Speed 
  +0.11365   * Ripening Time 
  -3.06155   * H3PO4 addition rate * Stirring Speed 
  +35.51526   * H3PO4 addition rate * Ca2+ Conc.  
  +5.04780E-003 * Reaction Temp * Ripening Time              Equation (4-8)     
 
 
 
 
 
 
 
Figure 4-26: Scatter diagram for crystallinity 
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4.4.4 Effect Of Process Parameters On Crystallinity 
The crystallinity of the HAp is one of the deciding factors for (i) producing thermally 
stable HAp and (ii) determining its rate of dissolution in its physiological environment. 
Difficulties in preparing synthetic HAp crystals from aqueous solutions are primarily 
caused by the high affinity of the material to some ions, the complex nature of the 
calcium phosphates system, and the role of the kinetic parameters. Therefore, in order to 
produce HAp with predictable crystallinity; reactant concentrations, reaction synthesis 
temperature, stirring speed, ripening time and the presence of an inert environment 
should be effectively designed to obtain high levels of crystallinity (>95%). This section 
discusses the effect of the most significant process variables (using the crystallinity 
model developed in the previous section) on the final crystallinity obtained for HAp. The 
crystallinity is directly related to all of the process variables investigated in this study, 
either as a main or included in an interaction effect, as stated earlier. The reason for 
predicting the crystallinity, at this stage, is to develop a model, to aid in the selection of 
an appropriate range for the optimisation stage (at a later stage). The pareto chart for the 
crystallinity model, as illsutrated in Figure 4-27, highlights the order of the significant 
main and interaction parameter effects, which ultimately affect the crystallinity  model.  
 
The order of the level of significance of the positive effects of the chemical precipitation 
process parameters on crystallinity follows the order:  (tr) > (To* atm.) > (Vac* Ca
2+
) > 
(Vst) > (To* tr) > (Vac) while the order of the level of significance of the negative effects 
on the phase purity is as follows: (atm.) > (Vac* Vst) .  
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Figure 4-27: Pareto chart, examining the level of main and interaction effects (orange: 
positive effect and blue: negative effect) of the process parameter on the crystallinity; where 
A is Vac, B is To, C is Vst, D is tr, E is Ca
2+
 conc. and F is atm. 
 
 
Hence, if high levels of crystallinity are to be obtained, the top four most influencing 
effects for control are as follows: 
 
1. Ripening time↑ (Main effect) 
2. Reaction temperature * atmospheric control↑ (Two-way interaction effect) 
3. Atmospheric control↓ (Main effect) 
4. Acid addition rate * Calcium concentration↑ (Two-way interaction effect) 
 
As expected, the primary factor most affecting the crystallinity, confirms the ripening 
time as the most critical factor for controlling the resultant percentage crystallinity. The 
crystalline behaviour as a function of ripening time is attributed to the mechanism of 
crystal growth in solution, since it is well known that the precipitation of particles 
involves nucleation and growth from a supersaturated solution.  
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The second most important effect involves a two-way interaction effect between the 
reaction temperature and atmospheric control. An increase in precipitation reaction 
temperature has elsewhere been reported [71, 85, 90] to further enhance the final 
crystallinity. In order for an increase in this parameter to take effect in this model, 
however, requires the simultaneous use of a controlled inert environment. Although, as a 
main effect, this parameter is found to decrease the crystallinity. The fourth most 
significant factor effecting the crystallinity is the two-way interaction effect involving 
both reagents: the acid addition rate and the calcium concentration, showing that an 
increase in both parameters can favour an increase in crystallinity. 
 
Comparing the models for phase purity and crystallinity, it is clear that they both share 
the same dependency on the main effect of ripening time (tr) and a controlled 
environment (atm.) to reach optimal levels for each response. The interaction effects of  
the acid addition rate and stirring speed (Vac* Vst), acid addition rate and calcium 
concentration (Vac* Ca
2+
), reaction temperature and ripening time (To* tr), and reaction 
temperature and controlled environment (To* atm.) are also common interaction effects 
for both phase purity and crystallinity models which were found to significantly affect 
end result for both responses. Figure 4-28 shows a perturbation plot highlighting the 
effect of all parameters on the crystallinity. The most significant interaction effect 
(between the reaction synthesis temperature and the presence of an inert environemnt) 
affecting the crystallinity is shown in Figure 4-29. Contour plots examining the main 
interaction effects are shown in Figure 4-30.  This figure shows that the crystallinity 
(synthesised under a controlled inert environment) increases directly, with an increase in 
the acid addition rate, stirring speed and ripening time.  
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(A) 
 
(B) 
 
Figure 4-28: Perturbation plot showing the effect of all the parameters on the crystallinity 
under (A) an uncontrolled environment and (B) a controlled (inert) environment  
 
(A)
 
(B) 
 
Figure 4-29: Interaction plot showing the most significant interaction effects of To and atm.  
on the phase purity for (A) an uncontrolled atmospheric environment and (B) a controlled 
inert environment (all other factors at upper level) 
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(A) Ripening Time: 0.5h 
 
 
(B) Ripening Time: 24h 
  
(C) Ripening Time: 48h 
 
 
Figure 4-30: 3D surface and 2D contour plots of crystallinity at (A) a ripening time of 0.5h; 
(B) a ripening time of 24h and (C) a ripening time of 48h (under a controlled environment 
at To = 60⁰C and Ca
2+
 = 2.0M) 
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Synthesis under an inert environment, as found to have a positive interaction effect with 
the reaction temperature influencing the final crystallinity, is shown in Figure 4-31. The 
crystallinity model dictates that an increase in the ripening time is the most significant 
parameter to enhance the end crystallinity of HAp and that this effect is more significant 
under a low reaction synthesis temperature (that is, its dependency for an increased 
ripening time is promoted). The interaction effect between the synthesis temperature and 
ripening time is small in comparison to the effect of the ripening time on the final 
crsyatllinity. However, it may be explained by the fact that an increase in temperature 
results in both a shortening of the induction time and an increase in the rate of crystal 
proliferation.  
 
(A) 
 
(B) 
 
Figure 4-31: 2D contour plots of crystallinity under (A) an uncontrolled environment and 
(B) an inert environment (at To = 60⁰C, Ca
2+
 = 2.0M and tr = 48h) 
 
A comparison of the effect of the chemical precipitation parameters between the powders 
obtained at lowest (N3) and highest crystallinity (N14 and N16) is reviewed below in 
Table 4-16. However, it is evident that the only powder synthesised in this study meeting 
the required minimum of 95% crystallinity is N16. Comparing the chemical precipitation 
parameters of N3 against the more crystalline HAp powders (N14 and N16) demonstrates 
the requirement of a higher stirring speed (Vst), reactant concentration (Ca
2+
 and Vac) and 
ripening time (tr) in obtaining increased levels of crystallinity. Comparing N14 and N16 
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also confirms that an increase in the reaction synthesis temperature may exert a positive 
influence on the final crystallinity, while the presence of a controlled environment is 
found to have an insignificant effect on achieving a high level of crystallinity. However, 
while the calculated crystallinity value for N14 is lower than N16, its XRD pattern (refer 
to Figure 4-26) is indicative of a highly crystalline HAp. This may be attributed to its 
calculation based upoon aggregates of its crystallites (mean powder particle size, Table 4-
23) as opposed to its primary crystallite size.  
 
Table 4-16: Effect of the chemical precipitation parameters (factors) studied on the 
crystallinity (response) 
 Factors Response 
Sample Vac 
(mol/min) 
To  
(°C) 
Vst 
 (rpm) 
tr  
(h) 
Ca
2+ 
(mol/L) 
atm. 
 
Xc 
(%) 
N3 0.005 60 600 0.5 2 - 45.69 
N14 0.01 20 1500 48 0.1 + 86.32 
N16 0.01 60 1500 48 2 - 95.19 
 
Figure 4-25 shows a 2-D illustration of the comparison in crystallinity between the XRD 
patterns obtained for the least and most crystalline powder samples synthesised in this 
study (that is, N3 and N16).  
 
 
 
Figure 4-32: 2-D illustration comparing XRD diffraction patterns obtained for N3 and N16 
 
2Ө 
N3 
N16 
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4.4.5 Development Of Crystallite Size Models (L002 and L300) 
The same steps and adequacy tests, which were outlined earlier, were followed and 
performed at this point. The manual regression method was used to eliminate the 
insignificant model terms (P<0.1) with less than a 5% contribution. A logit power 
transformation was used to develop the L300 model, where the response is bounded 
between a lower and upper limit of 10 and 140, respectively, since it possessed a ratio of 
maximum to minimum responses of 13.0181. A ratio greater than 10 indicates that a 
transformation is required. Therefore, a ratio of 2.5945 for the L002 model suggested that 
a transformation would have little effect and was not used in this case. Tables 4-17 and 4-
18 presenting the resulting ANOVA tables and the other adequacy measures for the 
crystallite size models in the 002 and 300 (that is L002 and L300) planes, are considered 
here. The analysis of variance, indicates, that for the crystallite size model for the L002 
plane, all of the chemical precipitation parameters have a significant effect on the 
resulting a/c ratio model, either as a main or interaction effect with another parameter. 
The main effects of the stirring speed (Vst), ripening time (tr), calcium concentration 
(Ca
2+
), atmospheric control (atm.) and the two way interaction effects of acid addition 
rate and ripening time (Vac* tr), reaction temperature and ripening time (To* tr) and 
reaction temperature and atmospheric control (To* atm.) are the most significant model 
terms associated with affecting the resulting crystallite size in the 002 plane. On the other 
hand, the significant main effects on the crystallite size in the 300 plane is the acid 
ripening time (tr), acid addition rate (Vac) and stirring speed (Vst), while two way 
interactions between the acid addition rate and the reaction temperature (Vac * To), acid 
addition rate and calcium concentration (Vac* Ca
2+
), acid addition rate and atmospheric 
environment (Vac * atm.) and reaction temperature and ripening time (To * tr) is also 
found to be an influencing factor for this response. A three way interaction effect 
between the acid addition rate, reaction temperature and the atmospheric environment 
(Vac * To * atm.) was also noted.   The final mathematical models for the crystallite size 
response, L002 in terms of coded and actual factors as determined by the Design Expert 
software are shown in Equations 4-9 to 4-11. While, the final mathematical models in 
terms of coded and actual factors for L300 are presented in Equations 4-12 to 4-14. 
 
CHAPTER 4: Results And Discussion 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-211- 
Table 4-17: ANOVA table for crystallite size, L002 reduced linear polynomial model 
Source Sum of  
squares 
d.f. Mean Square F value Prob >F 
Model (Significant) 
Vst 
tr 
Ca2+ 
atm. 
Vac * tr 
To * tr 
To * atm. 
Residual 
Corrected total 
4947.74 
684.52 
248.46 
789.42 
1364.26 
734.29 
856.21 
270.58 
525.61 
5473.35 
7 
1 
1 
1 
1 
1 
1 
1 
8 
15 
706.82 
684.52 
248.46 
789.42 
1364.26 
734.29 
856.21 
270.58 
65.70 
10.76 
10.42 
3.78 
12.02 
20.76 
11.18 
13.03 
4.12 
 
0.0016 Significant 
0.0121 
0.0877 
0.0085 
0.0019 
0.0102 
0.0069 
0.0769 
 
 
R
2
 = 0.9040; predicted R
2
 = 0.6159; adjusted R
2
 = 0.8199; adequate precision = 11.085 
 
 
 
Table 4-18: ANOVA table for crystallite size, L300 reduced linear polynomial model 
Source Sum of  
squares 
d.f. Mean Square F value Prob >F 
Model  
Vac 
Vst 
tr  
Vac * To 
Vac * Ca
2+ 
Vac * atm. 
To * tr 
Vac * To * atm. 
Residual 
Corrected total 
64.90 
9.57 
6.86 
11.67 
4.31 
12.63 
7.95 
5.65 
6.25 
4.27 
69.17 
8 
1 
1 
1 
1 
1 
1 
1 
1 
7 
15 
8.11 
9.57 
6.86 
11.67 
4.31 
12.63 
7.95 
5.65 
6.25 
0.61 
13.29 
15.68 
11.24 
19.11 
7.06 
20.70 
13.03 
9.26 
10.23 
 
0.0014 Significant 
0.0055 
0.0122 
0.0033 
0.0326 
0.0026 
0.0086 
0.0188 
0.0151 
 
R
2
 = 0.9382; predicted R
2
 = 0.6773; adjusted R
2
 = 0.8676; adequate precision = 19.161 
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Crystallite Size, = 64.96  
L002 (nm)  + 6.54  *Vst 
- 3.94  *tr 
+ 7.02  *Ca
2+
 
+ 9.23  *atm. 
+ 6.77  *Vac* tr  
+ 7.32  *To* tr       
+ 4.11  *To* atm.                                                        Equation (4-9) 
 
 
For an uncontrolled atmospheric environment: 
Crystallite Size, = +44.94738 
L002 (nm) +0.014535   * Stirring Speed 
- 0.87066   * Ripening Time 
 +7.39386   * Ca
2+
 Conc. 
  +40.94013   * H3PO4 addition rate * Ripening Time 
  +9.94218E-003 * Reaction Temp * Ripening Time            Equation (4-10) 
 
 
For a controlled (inert) atmospheric environment: 
Crystallite Size, = +46.96590 
L002 (nm) +0.014535   * Stirring Speed 
- 0.87066          * Ripening Time 
 +7.39386   * Ca
2+
 Conc. 
 +40.94013   * H3PO4 addition rate * Ripening Time 
 +9.94218E-003 * Reaction Temp * Ripening Time            Equation (4-11) 
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Logit (Crystallite Size, L300 (nm)) =  
Ln[(Crystallite Size, L300 – 10.00)/(140.00 – Crystallite Size, L300)] =  
+0.15 
   – 0.77  *Vac 
   + 0.65  *Vst 
– 0.85  *tr 
+ 0.52  *Vac * To 
– 0.89  *Vac * Ca
2+
 
– 0.71  *Vac * atm. 
+ 0.59  * To * tr 
+ 0.62  *Vac* To * atm.
                 
Equation (4-12) 
 
For an uncontrolled atmospheric environment: 
Logit (Crystallite Size, L300 (nm)) =  
Ln[(Crystallite Size, L300 – 10.00)/(140.00 – Crystallite Size, L300)] =  
 +1.81027 
  -235.26182   * H3PO4 addition rate 
  +1.45519E-003 * Stirring Speed 
-0.071007   * Ripening Time 
-1.73988   * H3PO4 addition rate * Reaction Temp. 
 -12.33184   * H3PO4 addition rate * Ca
2+ 
Conc.          
+8.76279E-004 * Reaction Temp. * Ripening Time           Equation (4-13) 
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For a controlled (inert) atmospheric environment: 
Logit (Crystallite Size, L300 (nm)) =  
Ln[(Crystallite Size, L300 – 10.00)/(140.00 – Crystallite Size, L300)] =  
+1.81027 
  -349.78734   * H3PO4 addition rate 
  +1.45519E-003 * Stirring Speed 
-0.071007   * Ripening Time 
-1.54575   * H3PO4 addition rate * Reaction Temp. 
 -12.33184   * H3PO4 addition rate * Ca
2+ 
Conc.          
+8.76279E-004 * Reaction Temp. * Ripening Time           Equation (4-14) 
 
  
The validity of the models developed can be drawn also from Figures 4-33(a) and (b), 
which present the relationship between the measured and predicted values of the 
crystallite sizes in the two planes 002 and 300. These scatter diagrams indicate that the 
above mathematical models show a good agreement between the measured and estimated 
values of the above mentioned responses. 
 
(A) 
 
(B) 
 
Figure 4-33: Scatter diagram for (A) crystallite size, L002 and (B) crystallite size L300  
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4.4.6 Effect Of The Process Parameters On The Crystallite Size 
The pareto charts for the crystallite size models for both the L002 and L300 planes, as 
illustrated in Figure 4-34(a) and (b), highlight the most  significant parameters  with 
either a positive or negative effect on each model. The order of the level of significance 
of the positive effects on the L002 model, from the most significant,  follows the order:  
(atm.) > (To* tr) > (Ca
2+
) > (Vac* tr) > (Vst)  > (To * atm.),  while the only negative effect 
to significantly affect the L002 model is the ripening time (tr). The order of the level of 
significance of the most significant positive effects on the L300 model follows the order: 
(Vst) > (Vac * To * atm.) > (To * tr) > (Vac * To), while the order of the level of most 
significant negative effects follows the order: (Vac* atm.) > (tr) > (Vac) > (Vac* atm.) for 
the L002 model. 
 
(A) 
 
(B) 
 
Figure 4-34: Pareto chart, examining the level of main and interaction effects (orange: 
positive effect and blue: negative effect) of the process parameter on (A) crystallite size in 
the 002 plane and (B) crystallite size in the 300 plane; where A is Vac, B is To, C is Vst, D is tr, 
E is Ca
2+
 conc. and F is atm. 
 
Hence, if high levels of crystallite size in both planes are to be obtained, the top four most 
influencing effects for controlling both responses are as follows: 
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For Crystallite Size, L002 -  
1. Atmospheric Environment↑ (Main effect) 
2. Reaction temperature * Ripening time↑ (Two-way interaction effect) 
3. Calcium concentration↑ (Main effect) 
4. Acid addition rate * Ripening time↑ (Two-way interaction effect) 
 
For Crystallite Size, L300 -  
1. Acid addition rate * Calcium concentration↓ (Two-way interaction effect) 
2. Ripening time↓ (Main effect) 
3. Acid addition rate↓ (Main effect) 
4. Acid addition rate * Atmospheric environment↓ (Two-way interaction effect) 
 
Firstly, the top four most influencing effects are not similar in both cases of crystallite 
size for the two plane investigated. The factor most affecting the crystallite size in the 
002 plane is the use of a controlled inert environment. The model dictates that the 
implementation of this parameter will increase the crystallite size in this plane. This 
theory is in good agreement with a similar finding by Smiciklas et al. [85] where a 
resulting increase of crystallite size for this plane was also reported, from the use of an 
inert atmosphere. The second most influencing factor for this plane is the two-way 
interaction effect between the reaction temperature and the ripening time. Smiciklas et al. 
[85] examined the effect of both factors as a main effect and reported that an increase in 
both contributed to an increase in the crystallite size for this plane. The third most 
influencing factor is the calcium concentration, for which an increase of this parameter 
can also produce a larger crystallite size for this plane. However, in comparison an 
increase of calcium concentration (interacting with the acid addition rate) can reduce the 
crystallite size in the 300 plane. Both results agree well with findings reported in a similar 
study [85]. The fourth most influencing factor is the two way interaction between the acid 
addition rate and the ripening time. Again, it has reported that both of these factors 
investigated as main effects can increase the crystallite size for this plane. 
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In contrast, a reduction of all four most influencing factors can acquire a larger crystallite 
size for the 300 plane. These findings correlate well with those reported by Smiciklas et 
al. [85], with the exception of ripening time, where it was reported that an increase was 
required for an increase in crystallite size for the 300 plane. The stirring speed is not 
found to be included as one of the four most influencing factors for both responses. 
However, it is shown to be the fifth for both, with a similar magnitude of positive 
influence (refer to Figures 4-34(a) and (b)).  
 
Figure 4-35 and 4-36 show the perturbation plots highlighting the effect of all the 
parameters on the crystallite size in the 002 and 300 plane, respectively.  
 
 
(A) 
 
 
(B) 
 
Figure 4-35: Perturbation plot showing the effect of all the parameters on the crystallite 
size, L002 under (A) an uncontrolled environment and (B) a controlled (inert) environment 
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(A) 
 
(B) 
 
Figure 4-36: Perturbation plot showing the effect of all the parameters on the crystallite 
size, L300 under (A) an uncontrolled environment and (B) a controlled (inert) environment 
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4.4.7 Development Of Lattice Parameter Ratio Model 
As indicated earlier, the test for significance of the regression models and the test for 
significance on individual model coefficients were performed using the Design Expert 
statistical software. Selecting the backward regression method allowed for the 
elimination of the insignificant model terms, automatically. The ANOVA table for the 
reduced linear model relating to the response of the lattice parameter ratio (a/c) was 
abstracted and is presented in Table 4-19. For this model, the ‗Prob. > F‘ value does not 
exceed 0.1, which indicates that the models are statistically significant. Also the terms in 
this model has a significant effect on the response being investigated. The same tables 
show also the other adequacy measures such as the R
2 
(the measure of the amount of 
variation around the mean explained by the model), adjusted R
2
 (the measure of the 
amount of variation around the mean explained by the model adjusted for the amount of 
terms) and predicted R
2 
values (the measure of the amount of variation in new data 
explained by the model). The entire adequacy measures are close to 1.00, which is in 
reasonable agreement and indicates adequate models are found for each response. The 
adequate precision compares the range of the predicted value at the design points to the 
average prediction error. In this case, the value of adequate precision is 16.042. An 
adequate precision ratio above 4 indicates adequate model discrimination.  
 
The analysis of variance, indicates, that for the lattice parameter ratio (a/c) model, all of 
the chemical precipitation parameters, with the exclusion of atmospheric control have a 
significant effect on the resulting a/c ratio model, either as a main or interaction effect 
with another parameter. The main effects of the reaction temperature (To), stirring speed 
(Vst), ripening time (tr), calcium concentration (Ca
2+
) and the two way interaction effects 
of acid addition rate and reaction temperature (Vac* To), acid addition rate and stirring 
speed (Vac* Vst), acid addition rate and calcium concentration (Vac* Ca
2+
) are the most 
significant model terms associated with altering the lattice parameter ratio. It is clear that 
all the significant interaction effects included in the model involve the acid addition rate 
as an influencing variable to affect the resulting a/c ratio and hence it‘s crystallographic 
structure.  
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The final mathematical model for the lattice parameter ratio response in terms of coded 
factors, as determined by the Design Expert software is shown in Equation 4-15. While, 
the final mathematical models in terms of actual factors are presented in Equations 4-16. 
 
Table 4-19: ANOVA table for a/c ratio reduced linear polynomial model 
Source Sum of  
squares 
d.f. Mean Square F value Prob >F 
Model 
To 
Vst 
tr 
Ca2+ 
Vac * To 
Vac * Vst 
Vac * Ca
2+ 
Residual 
Corrected total 
0.0001630 
0.0000092 
0.0000480 
0.0000851 
0.0000054 
0.0000041 
0.0000039 
0.0000074 
0.0000047 
0.0001702 
7 
1 
1 
1 
1 
1 
1 
1 
8 
15 
0.00002329 
0.00000915 
0.00004796 
0.00008510 
0.00000541 
0.00000410 
0.00000390 
0.00000743 
0.00000090 
25.93 
10.19 
53.40 
94.75 
6.02 
4.57 
4.34 
8.27 
<0.0001 Significant 
0.0128 
<0.0001 
<0.0001 
0.0397 
0.0651 
0.0707 
0.0207 
R
2
 = 0.9578; predicted R
2
 = 0.8312; adjusted R
2
 = 0.9209; adequate precision = 16.042 
 
a/c ratio = 1.37  
– 7.563e-004  * To 
– 1.731e-003  * Vst 
– 2.306e-003  * tr 
+ 5.812e-004  * Ca
2+
 
+ 5.063e-004  * Vac* To 
– 4.937e-004  * Vac* Vst 
– 6.812e-004  * Vac* Ca
2+           
Equation (4-15) 
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 a/c ratio = +1.38138 
 -1.26577E-004   * Reaction Temp 
 -1.22065E-006   * Stirring Speed 
 -9.71053E-005   * Ripening Time 
 +2.61393E-003 * Ca
2+
 Conc. 
 +0.011835    * H3PO4 addition rate * Reaction Temp 
 -3.50210E-004   * H3PO4 addition rate * Stirring Speed 
 -0.26694    * H3PO4 addition rate * Ca
2+
 Conc.         Equation (4-16) 
 
Figure 4-37 shows the relationship between the actual and predicted values of the lattice 
parameter ratio. This figure indicates that the developed model is adequate, since the 
residuals in the prediction of each response are small, with the residuals tending to be 
close to the diagonal line. The range of values appears to lie in three clusters between a 
minimum of ~1.369, an average of ~1.374 and a maximum value of ~1.378. 
 
 
 
Figure 4-37: Scatter diagram for lattice parameter ratio 
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4.4.8 Effect Of The Process Parameters On The Lattice Parameter Ratio 
The pareto chart for the lattice parameter ratio model, as illustrated in Figure 4-38, 
highlights the most  significant parameters affecting the model. The order of the level of 
significance of the positive effects of the chemical precipitation process parameters on 
the a/c ratio follows the order:  (Ca
2+
) > (Vac* To) while the order of the level of 
significance of the negative effects on the lattice parameter ratio is as follows: (tr) > (Vst) 
> (To) > (Vac* Ca
2+
) > (Vac* Vst). 
 
 
Figure 4-38: Pareto chart, examining the level of main and interaction effects (orange: 
positive effect and blue: negative effect) of the process parameter on the lattice parameter 
ratio; where A is Vac, B is To, C is Vst, D is tr and E is Ca
2+
 Conc. 
 
Although, if a low lattice parameter ratio is required, the top four most influencing effects 
for controlling this response are as follows: 
  
1. Ripening time↑ (Main effect) 
2. Stirring speed↑ (Main effect) 
3. Reaction temperature↑ (Main effect) 
4. Acid addition rate * Calcium concentration↑ (Two-way interaction effect) 
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The factor most affecting the lattice parameter ratio is the ripening time. Increasing the 
ripening time indicates that a decrease in the ratio can be achieved, representing a 
contraction in the a direction and an expansion in the c direction. On the other hand, β-
TCP is promoted with an expansion in the a direction and a contraction in the c direction 
[64]. The second and third highest factors most affecting the lattice parameter ratio is the 
stirring speed and reaction temperature, respectively. Increasing both parameters can 
result in a decrease of the lattice parameter ratio response. The fourth highest significant 
effect involves a two-way interaction between the acid addition rate and the calcium 
concentration. A combined increase of both these parameters can also result in a decrease 
of the lattice parameter ratio.  
 
Figure 4-39 shows a perturbation plot highlighting the effect of all parameters on the 
lattice parameter ratio. Contour plots examining the main interaction effects are shown in 
Figure 4-40. A study of the qualitative effects of the chemical precipitation parameters on 
the resulting crystal structure (see Table 4-20) for each experimental conditions, with 
regards the resultant changes in lattice parameters on account of some substitutions for 
Ca
2+
, PO
3
4  or OH
-
 of the calcium phosphate apatite, yielded the following conclusions: 
(i) eleven of the experiments (N1-N6, N8-N9 and N11-N13) resulted in an expansion in 
the a-axis and a contraction in the c-axis on account of undesirable ionic substitutions, 
(ii) four of the experiments (N7, N14-N16) resulted in a contraction of both the a- and c-
axis and (iii) one experiment (N10) accounted for an expansion in both the a- and c-axis. 
Both an expansion in the a-axis and a contraction in the c-axis and a contraction in both the 
a- and c-axis may be accounted for by the following heterionic exchanges / ionic 
substitutions outlined in Table 4-21.   
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Figure 4-39: Perturbation plot showing the effect of all the parameters on the lattice 
parameter ratio 
 
 
Table 4-20: Study of the qualtitative effect of the chemical precipitation process parameters 
on changes in the lattice parameters (a- and c-) 
 Lattice Parameter Change 
  a-axis c-axis 
N1 + - 
N2 + - 
N3 + - 
N4 + - 
N5 + - 
N6 + - 
N7 - - 
N8 + - 
N9 + - 
N10 + + 
N11 + - 
N12 + - 
N13 + - 
N14 - - 
N15 - - 
N16 - - 
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(A) Ripening Time: 48h 
 
(B) Ripening Time: 24h 
 
 
(C) Ripening Time: 0.5h 
 
 
Figure 4-40: Effect of Vac and To on the lattice parameter ration at (A) a ripening time of 
48h; (B) a ripening time of 24h and (C) a ripening time of 0.5h, (under a controlled 
environment at Vst = 1500rpm and Ca
2+
 = 2.0M)
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Table 4-21: Heterionic exchanges and ionic substitutions and their effect on the crystal 
structure [64] 
Ion Exchange 
for 
Ion 
radius 
(nm) 
Inclusion 
type 
Lattice 
parameter 
change 
Effect on crystal structure 
CO
2
3
 OH  
 
 
 A-Type 
Substitution 
a+  c- C at Ca hexagonal centre, tilted at 
30° 
Cl  OH  
 subst/surf a+  c-  
 
Zn  0.74  a+  c- -Decreases crystallinity 
-Promotes β-TCP 
 
Co  0.70  a+  c- -Decreases crystallinity 
-Promotes β-TCP 
 
Ni  0.69  a+  c- -Decreases crystallinity 
-Promotes β-TCP 
 
Cr  0.63  a+  c- -Decreases crystallinity 
 
      
Mg
2
 Ca
2
 
0.66 subst/surf a-  c- -Increases solubility 
-Inhibits ACP ->HAp 
-Decreases crystallinity 
-Promotes β-TCP 
 
Cd
2
 Ca
2
 
0.97 subst a-  c- -Decreases crystallinity 
 
Mn
2
 Ca
2
 
0.80 subst a-  c- -Decreases crystallinity 
-Subst Ca I in fluoro. And Ca II in 
chloro.  
Cu  0.97  a-  c- -Decreases crystallinity 
-Reduces bone resorption 
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4.4.9 Development Of Particle Size Model 
As with all the preceding models, the test for significance of the regression models 
and the test for significance on individual model coefficients were performed using 
the Design Expert statistical software. Selecting the backward regression method 
allowed for the elimination of the insignificant model terms, automatically. The 
ANOVA table for the reduced linear model relating to the particle size response is 
abstracted and presented in Table 4-21. For this model, the ‗Prob. > F‘ value does not 
exceed 0.05, which indicates that the model developed is statistically significant. 
Also, the terms in this model have a significant effect on the response under 
investigation. The same tables show also the other adequacy measures such as the R
2
, 
adjusted R
2
 and predicted R
2 
values. The entire adequacy measures are close to 1.00, 
and indicates adequacy of the model found for the particle size response. In this case 
the value of adequate precision is 18.284. An adequate precision ratio above 4 
indicates adequate model discrimination.  
 
The analysis of variance, indicates, that for the particle size model, all of the chemical 
precipitation parameters have a significant effect on the resulting model, either as a 
main or interaction effect with another parameter. The main effects of the reaction 
temperature (To), stirring speed (Vst), calcium concentration (Ca
2+
), atmospheric 
control (atm.) and the two way interaction effects of acid addition rate and reaction 
temperature (Vac* To), acid addition rate and calcium concentration (Vac* Ca
2+
), acid 
addition rate and atmospheric environment (Vac * atm.) and the reaction temperature 
and ripening time (To * tr) are the most significant model terms associated with 
affecting the particle size. The final mathematical model for the particle size response 
in terms of coded factors, as determined by the Design Expert software is shown in 
Equation 4-17. While, the final mathematical models in terms of actual factors are 
presented in Equations 4-18 and 4-19 for the response on the particle size, under an 
uncontrolled and inert atmospheric environment, respectively. 
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Table 4-22: ANOVA table for particle size reduced linear polynomial model 
Source Sum of  
squares 
d.f. Mean Square F value Prob >F 
Model 
To 
Vst 
Ca2+ 
atm. 
Vac * To 
Vac * Ca
2+ 
Vac * atm. 
To * tr 
Residual 
Corrected total 
3831.58 
1485.52 
100.45 
1389.24 
65.81 
298.17 
215.28 
200.15 
76.96 
82.14 
3913.73 
8 
1 
1 
1 
1 
1 
1 
1 
1 
7 
15 
478.95 
1485.52 
100.45 
1389.24 
65.81 
298.17 
215.28 
200.15 
76.96 
11.73 
40.82 
126.60 
8.56 
118.39 
5.61 
25.41 
18.35 
17.06 
6.56 
<0.0001 
<0.0001 
0.0222 
<0.0001 
0.0497 
0.0015 
0.0036 
0.0044 
0.0375 
R
2
 = 0.9790; predicted R
2
 = 0.8903 ; adjusted R
2
 = 0.9550; adequate precision = 18.284 
 
Particle Size, = 39.34  
Ps (μm)  – 9.64  * To  
– 2.51  * Vst  
– 9.32  * Ca2+  
+ 2.03  * atm. 
+ 4.32  * Vac* To  
– 3.67  * Vac* Ca
2+
  
– 3.54  * Vac* atm.  
+ 2.19  * To * tr   
                                                                          
Equation (4-17) 
 
For an uncontrolled atmospheric environment: 
Particle Size  = +62.12231 
Ps (μm) -0.92449   * Reaction Temp 
  -5.56806E-003  * Stirring Speed 
  +4.14248   * Ca
2+
 Conc. 
  +59.20540   * H3PO4 addition rate * Reaction Temp 
  -1860.13802   * H3PO4 addition rate * Ca
2+
 Conc. 
  +5.50000E-005 * Reaction Temp * Ripening Time       Equation (4-18) 
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For a controlled (inert) atmospheric environment: 
Particle Size,  = +87.39981 
Ps (µm) -0.92449   * Reaction Temp 
  -5.56806E-003  * Stirring Speed 
  +4.14248   * Ca
2+
 Conc. 
  +59.20540   * H3PO4 addition rate * Reaction Temp 
  -1860.13802   * H3PO4 addition rate * Ca
2+
 Conc. 
  +5.50000E-005 * Reaction Temp * Ripening Time       Equation (4-19) 
 
Figure 4-41 shows the relationship between the actual and predicted values of the 
particle size. This figure indicates that the developed model is adequate, since the 
residuals in the prediction of each response are small, with the residuals tending to be 
close to the diagonal line.  
 
 
 
 
Figure 4-41: Scatter diagram for particle size 
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4.4.10 Effect Of The Process Parameters On The Particle Size 
Particle size has a great effect on the final quality of the plasma sprayed HAp coating. 
The particle size will affect their melting characteristics within the plasma flame. Fine 
particles experience good heat transfer from the plasma flame causing them to melt, 
producing a dense coating with low porosity. Extremely fine particles, however, may 
evaporate before reaching the substrate. Very large particles (>100µm) are to be 
avoided, as they often remain unmelted. Unmelted particles may damage the coating 
surface by rebounding off it or may remain weakly connected to the rest of the 
coating, thus, reducing coating tougnhess [24, 103, 130]. Furthermore, 
osteoconductivity, solubility, sinterability and mechanical reliability of the HAp can 
be promoted by controlling its particle size [59]. The particle size distribution also 
influences the coating quality. During plasma spraying, HAp, of a narrow particle size 
range has better flow behaviour, in comparison to mixed sizes, comprising of both 
large and fine particles [24]. These studies clearly demonstrate the necessity in 
tailoring the HAp particle size and particle size distribution 
 
The pareto chart for the particle size model, as illustrated in Figure 4-42, highlights 
the most  significant parameters affecting the model. The order of the level of 
significance of the positive effects of the chemical precipitation process parameters on 
the actual particle size follows the order:  (Vac* To) > (To * tr) > (atm.) while the order 
of the level of significance of the negative effects on the lattice parameter ratio is as 
follows: (To) > (Ca
2+
) > (Vac* Ca
2+
) > (Vac* atm.) > (Vst). 
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Figure 4-42: Pareto chart, examining the level of main and interaction effects (orange: 
positive effect and blue: negative effect) of the process parameter on the particle size; 
where A is Vac, B is To, C is Vst, D is tr, E is Ca
2+
 conc. and F is atm. 
 
Hence, if low particle sizes are to be obtained, the top four most influencing effects 
for controlling this response are as follows: 
  
1. Reaction temperature↑ (Main effect) 
2. Calcium Concentration↑ (Main effect) 
3. Acid addition rate * Reaction temperature↓ (Two-way interaction effect) 
4. Acid addition rate * Calcium concentration↑ (Two-way interaction effect) 
 
The top two most influencing factors affecting the particle size is the reaction 
temperature and calcium concentration, indicating an increase in both factors can 
result in a decrease for this response. However, the third most influencing effect 
suggests that the reaction temperature is also involved in an interaction effect with the 
acid addition rate and a reduction in both can yield higher powder particle sizes, as 
expected from literature [23]. The fourth most significant effect involves another two-
way interaction between the acid addition rate and the calcium concentration, 
requiring an increase for a reduction in particle size.  
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Figure 4-43 shows a perturbation plot highlighting the effect of all parameters on the 
particle size under (a) an uncontrolled atmosphere and (b) a controlled inert 
environment. Contour plots examining the most significant effects are shown in 
Figure 4-44. These plots indicate that a larger particle size results when the addition 
rate of the acid is lowered and this phenomenon agrees well with that hypothesised by 
Afshar et al. [83]. The model also demonstrates that the lower acid addition rate 
coupled with a lower synthesis temperature is favoured in producing larger size HAp 
particles. However, the calcium concentration is shown to also play a major role in 
determining the final particle size. 
 
(A) 
 
(B) 
 
Figure 4-43: Perturbation plot showing the effect of all the parameters on the particle 
size under (A) an uncontrolled environment and (B) a controlled (inert) environment 
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(A) Ca
2+
 Conc.: 2.0M 
  
(B) Ca
2+
 Conc.: 1.0M 
 
 
(C) Ca
2+
 Conc.: 0.1M 
 
 
Figure 4-44: 3D surface and 2D contour plots of particle size at (A) a Ca
2+
 conc. of 2.0M; 
(B) a Ca
2+
 conc. of 1.0M and (C) a Ca
2+
 conc. of 0.1M (under a controlled environment 
at Vst = 1500rpm and tr = 48h) 
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Table 4-23 outlines the average of three results recorded for mode, mean particle sizes 
and the percentage (10, 50 and 90%) of powder particles within a specific range. 
Figure 4-45 graphically compares the mean particle sizes obtained for the micron 
sized HAp powders analysed with and without a controlled (inert) environment. The 
order of mean particle size from the largest is as follows:  
 
N9 → N1 → N6 → N5 → N14 → N12 →N4 → N2 → N15 → N13 → N10 → N3 
→ N8 → N11 → N7 → N16 
 
The largest particle sizes (such as, N1, N5, N6, N9 and N14) were all synthesised at a 
reaction synthesis temperature of 20ºC, while the lowest particle sizes (such as, N3, 
N7, N8, N11 and N16) were synthesised at a higher reaction synthesis temperature of 
60ºC. Adversely, previous literature highlights that during the course of precipitation, 
the particle size increases with an increase in temperature. An increase in the 
temperature, coupled with an increase in the calcium concentration (N6 to N8) and 
(N14 to N16) also demonstrates an increase in particle size, while lowering the acid 
addition rate is shown to also result in an increase of particle size (N4 to N1) and 
(N16 to N14).   
(A) (B) 
  
Figure 4-45: Comparison of the mean particle size results for HAp samples synthesised 
in (A) an uncontrolled atmosphere and (B) a controlled (inert) atmospheric environment 
 
Consequently, there is a strong indication that a high reactant concentration, low acid 
addition rate and high synthesis temperature are the controlling factors in increasing 
the HAp powder particle size.  The majority of the powders synthesised in this study, 
possess a narrow particle size distribution, as indicated in Figures 4-46 to 4-48. The 
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powders demonstrating a large particle size distribution (N11>N10>N2>N13>N8) are 
believed to have decreased flow behaviour during plasma spraying as opposed to a 
narrow particle size distribution. The order suggests that the powders synthesised 
under the lower level of stirring speed (600rpm) may have affected this distribution. 
 
Table 4-23: Particle size analysis results: percentage diameter under 10, 50 and 90% 
micrometer, mean particle size, mode particle size and specific surface area data of the 
different HA samples for sixteen conditions of Fractional-Factorial (Res IV) 
experimental design 
HAp 
Powder 
Median 
 
Diameter (μm) on: Mean 
 
Mode 
 
(μm) 10% 50% 90% (μm) (μm) 
N1 
 
20.00 14.33 52.98 111.21 58.60 76.32 
N2 
 
6.44 3.41 26.83 90.06 38.03 65.51 
N3 
 
9.24 4.71 19.44 47.76 23.28 30.53 
N4 
 
7.29 5.36 36.57 104.67 48.82 56.23 
N5 
 
11.13 6.53 48.61 110.01 54.94 76.32 
N6 
 
15.97 9.88 50.42 116.82 57.77 76.32 
N7 
 
10.07 5.64 16.06 39.43 19.96 19.31 
N8 
 
4.88 2.11 15.12 54.74 22.65 35.56 
N9 
 
8.10 7.96 56.15 130.35 63.83 88.91 
N10 
 
4.81 2.35 19.56 76.76 30.81 56.23 
N11 
 
4.11 1.71 11.71 54.36 20.74 12.21 
N12 
 
11.69 6.83 42.44 107.39 50.69 65.51 
N13 
 
6.01 2.99 23.51 82.23 34.38 56.23 
N14 
 
9.01 8.96 47.55 106.80 53.48 76.32 
N15 
 
8.24 8.43 30.79 70.92 36.15 41.43 
N16 
 
3.78 2.97 10.76 32.96 15.38 12.21 
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(A) 
 
(B) 
 
Figure 4-46: Comparison of particle size distributions obtained for screening 
experimental HAp powders synthesised under (A) an uncontrolled atmospheric 
environment and (B) a controlled (inert) environment  
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Figure 4-47: Comparison of particle size distributions obtained for screening 
experimental HAp powders synthesised under an uncontrolled atmospheric 
environment 
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Figure 4-48: Comparison of particle size distributions obtained for screening 
experimental HAp powders synthesised under a controlled (inert) environment 
 
 
 
 
 
  
N8 
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4.4.11 Morphological Evaluation Of the HAp Powders 
According to Kweh et al. [2], HAp powders of a spherical morphology produce 
excellent heat transfer characteristics and consistent melting behaviour, which 
increase the deposition efficiency of the HAp powder through plasma spray onto 
orthopaedic implants and decrease coating porosity. There is also evidence suggesting 
that angular Ca-dHAp powders produce relatively poor coating characteristics with 
large pores and cavities [21]. A poor structural integrity is attributed to the limited 
inter-particle cohesion. Some microstructural improvements are observed in using 
spherical powders with Joseph et al. [190] demonstrating that the surface morphology 
of HAp exerts a considerable influence on controlling the rheology of a HAp-HDPE 
composite. 
 
The SEM micrographs of the HAp powders in Figure 4-49 and 4-50 reveal how the 
HAp powders can vary according to the process parameters implemented. An increase 
of the synthesis temperature (N1 to N4 and N14 to N16) is found to lead to more 
regular spherical HAp particles (see Figure 4-51). It has been reported elsewhere,
 
that 
a low synthesis temperature results in HAp crystals possessing a needle-shape like 
morphology [94]. Pang and Bao [90] found that the particles synthesised at low 
reaction temperature were a bit thinner and longer, with more irregular and less clear 
contours. Also the particles showed a higher tendancy towards agglomeration. 
Moreover, they noticed that the change from irregular to regular particle morphology 
with the increase in synthesis temperature corresponds to the increase in the 
crystallinity of the HAp crystals, that is, more regular shape of the particles was 
observed when the powders had higher crystallinity. Hence, it is clear that the 
influence of the chemical precipitation process parameters on the morphology of the 
HAp powders must be inviestigated.  
 
A qualitative examination of the effect of increasing the reaction synthesis 
temperature, coupled with an increase in the acid addition rate (N1 to N4 and N9 to 
N12) demonstrates how the powder particle size increases, as a result. Therefore, 
while a higher reaction synthesis temperature, is thought to increase the particle size, 
the effect of increasing the acid addition rate is more significant in controlling the 
particle size. Instead, the lower acid addition rate appears to be the more controlling  
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N3 
 
N4 
 
N5 
 
N6 
 
N9 
 
N10 
 
N15 
 
N16 
 
Figure 4-49: Comparison of the powder morphology for HAp samples synthesised under 
uncontrolled environment   
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N1 
 
N2 
 
N7 
 
N8 
 
N11 
 
N12 
 
N13 
 
N14 
 
Figure 4-50: Comparison of the powder morphology for HAp samples synthesised under 
a controlled (inert) environment  
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factor in increasing the particle size, as previosuly demonstrated by Afshar et al. [83].  
The results for particle size and powder morphology also indicate how a lower 
calcium concentration favour an increase in particle size (N6 to N8 and N14 to N16). 
 
(A) Reaction Temperature (20ºC) 
N1 
 
(B) Reaction Temperature (60ºC) 
N4 
 
N14 
 
N16 
 
Figure 4-51: Effect of reaction synthesis temperature at (A) 20ºC and (B) 60ºC on 
powder morphology 
 
Both N4 and N16 where also synthesised under a controlled inert environment, which 
may also suggest that it may be an influencing factor in controlling the morphological 
properties of the powder particle. Visible colour changes from white to light blue 
were evident after the sintering stages of the HAp powder (N12 and N13). According 
to Gross et al. [70], these colour changes are due to the presence of transitional 
elements located in the crystal lattice structure. Although they may not have any 
significant effect on the biocompatibility of HAp, the FDA criterion requires powders 
of a pure white colour [137]. 
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4.4.12 Powder Flowability Evaluation 
The flowability of the powders, as determined according to ASTMB213-03 [183] can 
be seen in Figure 4-52.  As discussed previously, there exists a direct correlation 
between the particle size and the resulting powder flowability. For large powder 
particles (N1, N5, N6, N9, N14) the flow rate of the powders ranges between 0.24 to 
0.28 g/s, whereas the finer powder particles (N3, N7, N8, N10, N11, N13, N16) 
demonstrate a flow rate ranging between 0.186 to 0.19 g/s. All powder flows were 
observed to flow discontinuously (that is, in a pulsating manner), the degree of which 
was dependent upon its morphology. The flowability of the powder studied in this 
investigation follow the same order as that of the mean particle size:  
 
N9 → N1 → N6 → N5 → N14 → N12 →N4 → N2 → N15 → N13 → N10 → N3 
→ N8 → N11 → N7 → N16 
 
 
Figure 4-52: The powder flow rate as a function of the powder particle size 
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4.4.13 Main Findings Of Screening (Stage I) In Experimental Design 
The critical responses for design control in this study are primarily the HAp phase 
purity and crystallinity (both >95% to aid in satisfying regulatory requirements) and 
particle size (<100µm) for plasma spraying application) obtained as a result of 
varying the factors between the two levels investigated. As previously indicated (refer 
to Table 4-21), a reduced lattice parameter ratio would indicate a decrease in the a 
direction and an increase in the c direction, which appears more favourable than an 
increased level of a/c ratio, which is shown to effectively decrease the crystallinity 
response [64]. Table 4-24(a) outlines the effect (main and interaction) of the top four 
most significant factors influencing the final desired responses, based on the models 
developed in the preceding sections. Hence, the increase or decrease of the top four 
most influencing main and interaction effects to obtain ↑phase purity, ↑crystallinity, 
↑crystallite size, ↓a/c ratio and ↓particle size are depicted in Table 4-24(a). To achieve 
these desired responses, it appears that an increase in the majority of the main factors 
is required. Use of a controlled atmospheric environment is compromised between 
requirement for ↑phase purity and a ↑crystallinity. However, experiment N16 
demonstrates that its synthesis with a controlled environment results in values >95% 
for both responses. Calcium concentration and acid addition rate, however appear to 
have little effect on the final powder characteristics, with the acid addition rate 
controlling only the crystallographic properties in comparison to the remaining three 
factors (that is, reaction temperature, stirring speed and ripening time). 
 
Table 4-24(b) outlines the requirement of the three most critical process parameters 
affecting three or more responses to obtain the desired final powder characteristics. In 
summary, all of the factors studied have an impact (of minor and major significance) 
on one or more of the responses investigated, either as a main or interaction effect. 
Both the ripening time and stirring speed significantly affect the majority of the 
responses (effecting five responses), with the reaction temperature also having a 
significant effect on the purity, a/c ratio and particle size. However, from Table 4-
24(a), the interaction effect of the acid addition rate and calcium concentration is also 
shown to effect three of the responses, but the inclusion of these factors (to attain this 
interaction) would produce an optimisation design (Box-Behnken) taking account of 
all the factors (with the exclusion of atmospheric control), analogous to the screening 
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design (Fractional-Factorial) and this would require a minimum of 45 experiments 
instead of the 17 experiments used (using 5 centre points in both instances).  
 
Therefore, the optimisation design of experiments in Section 4.6 will not include the 
latter two effects. At this stage, it must be noted that the models produced as a result 
of eliminating these two effects may not be as statistically relevant as those produced 
at for the screening design. However, this will allow researchers to predict the ideal 
settings for the reaction temperature, stirring speed and ripening time effects and 
whether any interactions occur between the three parameters. 
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Table 4-24: Summary of findings after the screening stage of experimental design 
(A) Responses 
 ↑Purity ↑Crystallinity ↑Crystallite Size ↓a/c ratio ↓Particle Size 
Effects Xp Xc L002 L300  Ps 
Main 
(A) Vac    ↓   
(B) To ↑    ↑ ↑ 
(C) Vst    ↑ ↑  
(D) tr ↑ ↑  ↓ ↑  
(E) Ca
2+
   ↑   ↑ 
(F) atm.  ↓ ↑    
Interaction 
A * C ↑      
A * B       
A * C       
A * D   ↑    
A * E  ↑   ↑ ↑ 
A * F       
B * D   ↑    
B * F  ↑     
A * B * F ↑      
 
 
(B) Responses 
 ↑Purity ↑Crystallinity ↑Crystallite Size ↓a/c ratio ↓Particle Size 
Effects Xp Xc L002 L300  Ps 
Main 
(B) To ↑    ↑ ↑ 
(C) Vst  ↑ ↑ ↑ ↑ ↑ 
(D) tr ↑ ↑ ↓ ↓ ↑  
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4.5 INFLUENCE OF HAp PARTICLE SIZE, CRYSTALLINITY AND 
MORPHOLOGY ON OSTEOBLAST BEHAVIOUR  
The aim of the following investigation is to study the possible mechanism of various 
HAp with different crystallinity, morphology and particle size on a well studied 
osteoblast-like cell line (MG-63) commonly used to test in vitro bone-biomaterials 
biocompatibility. The HAp properties were controlled via modulating the 
experimental parameters (reaction synthesis temperature, reactant concentration, acid 
addition rate, stirring speed and ripening time) of the synthesis process. Powders were 
synthesised without the presence of a controlled environment, since it was found to 
have a negative effect on the final crystallinity. Eight kinds of HAp were used in this 
study, obtained at the screening (stage 1) investigation and produced through 
implementing the process parameters outlined in Table 4-25. HAp1 (Irish industry 
Hap powder) and HAp5 (British commercial HAp powder) (see section 4.1) were 
used as the control powders in this study to compare the powders produced against 
industrial and commercial powders. 
 
Table 4-25: Experimental conditions used to produce various types of HAp for 
biological evaluation 
Exp 
Name 
H3PO4 addition 
rate  
(mol/min) 
Temperature 
( ºC) 
Stirring speed 
(rpm) 
Ripening time 
(h) 
Calcium 
concentration 
(M) 
N3 0.005 60 600 0.5 2 
N4 0.1 60 600 0.5 0.1 
N5 0.005 20 1500 0.5 2 
N6 0.1 20 1500 0.5 0.1 
N9 0.005 20 600 48 0.1 
N10 0.1 20 600 48 2 
N15 0.005 60 1500 48 0.1 
N16 0.1 60 1500 48 2 
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4.5.1 Physico-Chemical Characterisation of HAp Powders 
(A) Crystallinity 
The crystallinity of the control powders and the eight various types of HAp are 
presented in Table 4-26. These may be classified from the lowest level of 
crystallinity, as follow:  
 
N3 < N5 < N6 <N4 < N9 < N10 < N15 < HAp1 < HAp5 < N16. 
 
Table 4-26: Overview of the crystallinity for the various HAp and control HAp powders 
HAp  Crystallinity (%) Control HAp 
Powders 
Crystallinity (%) 
N3 45.69 ±2 HAp1 93.94 ±2 
N4 67.38±2 HAp5 97.31 ±2 
N5 54.85 ±2   
N6 57.68 ±2   
N9 58.50 ±2   
N10 73.21 ±2   
N15 90.95 ±2   
N16 99.33 ±2   
 
(B) Particle size analysis 
The mean particle size and specific average surface area results are shown in Table 4-
27 and Figure 4-53 (as represented earlier in Table 4-23). The HAp mean particle size 
varies from 15.38 µm for N16 to 63.83 µm for N9. The HAp powders are classified 
from the finest particle size, as follow:  
 
N16 < HAp1 < N3 < N10 < N15 < HAp5 < N4 < N5 < N6 < N9. 
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Table 4-27: Particle size evaluation for control powders and various HAp 
HAp 
Powder 
Diameter (μm) on: Mean 
 
Mode 
 
SSA  
10% 50% 90% (μm)  (μm)  (m2/g) 
N3 4.71 19.44 47.76 23.28 30.53 0.65 
N4 5.36 36.57 104.67 48.82 56.23 0.82 
N5 6.53 48.61 110.01 54.94 76.32 0.54 
N6 9.88 50.42 116.82 57.77 76.32 0.38 
N9 7.96 56.15 130.35 63.83 88.91 0.74 
N10 2.35 19.56 76.76 30.81 56.23 1.25 
N15 8.43 30.79 70.92 36.15 41.43 0.73 
N16 2.97 10.76 32.96 15.38 12.21 1.59 
HAp1 5.70 18.86 41.83 21.94 21.26 0.63 
HAp5 3.38 36.83 69.22 37.91 48.27 0.53 
 
 
 
 
(A)                    (B) 
  
Figure 4-53: Comparison of (A) particle size distribution and (B) mean particle size for 
HAp   
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(C) Cell content and viability 
Figure 4-54 shows the proliferation of MG-63 osteoblast-like cells in contact with the 
various HAp (N3, N4, N5, N6, N9, N10, N15 and N16) compared to proliferation on 
both industrial and internationally marketed powders, HAp1 and HAp5, respectively. 
Osteoblast-like cells proliferated without any contact with HAp was used as a control 
(Te). Initially, the cell population was 20,000 cells per well. Thus, it is evident, that 
the additions of the various HAp particles to the osteoblast culture significantly 
affected cell counts, particularly after 14 days. Changes in cell populations of various 
preparations at 1 day, 7 days and 14 days were all statistically significant (p< 
0.00001) by ANOVA test. These results suggest that both the HAp powders and the 
controls are favourable for MG-63 differentiation.  
 
 
Figure 4-54: Proliferation of MG-63 osteoblast-like cells cultured on marketed HAp1 
and HAp5 (control) and on various HAp at 0, 1, 7 and 14 days 
 
Concerning the cell-viability, Figure 4-55 indicates that there is no significant 
difference, when the MG-63 osteoblast like cells are cultured on either the controls or 
the various HAp after an incubation period of 1 day. Instead, the effect becomes more 
significant between incubation periods of 4 and 7 days. N16 after 7 days appears to 
suggest that powders possessing a higher crystallinity have the capacity to yield 
higher counts of cell viability.  
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(A) Incubation Time: 1 day 
 
(B) Incubation Time: 4 days 
 
                                           (C) Incubation Time: 7 days 
 
 
Figure 4-55: Cell viability of MG-63 cells cultured on marketed HAp (controls) and on 
various types of HAp from 1 to 7 days. The optical density was measured at 490 nm by 
ELISA reader. No significant difference in optical density between HAp powders and 
control at each culture period were observed using Student t test (p > 0.05) after 1 days 
incubation only.  
 
The most significant change, however, occurred in cell populations in contact with 
N9, N10, N15, N16. However, a non significant change was evident among the 
powders with particle sizes larger than about 50 microns. The reduction in growth rate 
of the cells seen in these experiments could be due to an increase in the death rate of 
the cells to a decrease in their mitotic rate [191]. Decrease in cell number after 
exposure to the test material can be used as a marker for toxicity [192].   
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4.5.2 Influence Of HAp Particle Size  
The cells behaviour in contact with HAp1, HAp5, N3, N4, N5 and N6 can be 
explained by the finer particle size of these powders in direct comparison to the four 
others. These results reflect the classical data: fine particles are generally related to a 
higher inflammatory cytokine rate in culture [193], or to an increase of bone 
resorption factors such as prostaglandin E2 and a lower proliferation cell rate [191, 
194, 195]. 
 
It has been previously suggested that toxicity due to direct contact of particles with 
cells occurs with particles smaller than about 5 μm in diameter [196].  Later, Sun et 
al. [191] demonstrated that for HAp particles smaller than 53 μm, Osteoblast counts 
significantly decreased compared to those with larger-sized HAp particles (>177 μm).  
Fine particles of HAp are normally a very non toxic material; yet are shown to cause 
cell damage in vitro [196]. This toxicity depends on direct contact between cells and 
particles and it was associated with membrane damage. For an equal volume, lower 
granulometries offer a larger contact surface with the biological environment, 
inducing greater interactions between marrow cells, extracellular substances, and 
ceramic. In deed, smaller (~10 - 20 microns) particles may be directly phagocytosed 
by inflammatory cells, thereby leading to a faster reduction of cells growth ceramic in 
contact with HAp with lower granulometries. Evans [196] showed that the 
phagocytosis of 3.7μm HAp particles by cultured fibroblasts is consistent with lower 
cell development and a higher nuclear picnotic level. Moreover, Higashi et al. [197] 
performed pulpar fibroblast cultures showing a higher proliferation rate with 300μm 
than 40μm particles. Invocation of mechanism involving direct contact does not 
exclude other mechanisms such as leaching of toxic ions. The tested HAp may have a 
low level of toxicity which is not sufficient to kill cells but may inhibit normal cell 
function [198].   
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4.5.3 Influence Of HAp Crystallinity 
In addition to the difference of mean particles size, XRD analyses showed that the 
crystallinity of fine HAp particle size was significantly lower than that of larger ones 
in our prepared powders (see Table 4-27). Figure 4-56 shows that the cells counts 
increase with the increase of powder crystallinity. Indeed, osteoblast grows well on 
N16, N15, N10 and N9 powders having crystallinity in the range of  ~70 to ~95%  
than on the others.  
 
 
Figure 4-56: Rate of cell proliferation (by times) for MG-63 osteoblast-like cells in 
contact with controls and various HAp powders 
 
The same osteoblast behaviour has been already reported by Qu et al. [199] but only 
after 3 days incubation. They demonstrated that the cells cultured on higher 
crystallinity ceramics showed higher proliferation at initial time and reached the 
highest proliferation after 3 days. Then the proliferation decreased with cultured time. 
This discordance can be explained by the fact that the influence of particle size 
dominates that of crystallinity. Indeed, Evans et al. [200] showed that the mechanism 
of cell damage in vitro depends on a direct interaction between cells and particles and 
is largely independent of the chemical nature of the particles. Moreover, the 
osteoblasts tested in this work had different origin. Lang et al. already reported that 
the human osteoblast-like cells reacted slightly more sensitive to toxic substances of 
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the materials tested than rat osteoblast-like cells [201]. This comportment can be 
attributed to the alkaline pH of the surrounding environment. Indeed, it has been 
already indicated the rate of calcium phosphate ceramic dissolution correlated with 
the increase of Ca and P ion concentrations and pH value of surrounding environment. 
This dissolution in body fluids or in vitro is more important for lower crystallinity. 
This alkaline pH would lead to a cytotoxic effect inhibiting DNA and protein 
synthesis and cell proliferation in cell culture. This result agreed well with other 
literature.  
 
4.5.4 Influence Of HAp Particle Morphology 
SEM micrographs of the source powders (in their particulate form), studied in this 
investigation are shown in Figures 4-13 and 4-49 - 4-50.  The micrographs shown in 
Figures 4-57 to 4-59 represent the typical cell morphology at each culture period, 
since all osteoblast-like cells do not spread at the same rate. At 1 days, on the 
Thermanox surface, the MG-63 osteoblast-like cells without any contact with the 
HAp powders, spread extensively, and are totally flattened on the surface (Figure 
457(-)). After 7 days however, the cells appear to progress to a monolayer of cells 
with the classical fibroblast spindle shape (Figure 4-59(-)). These SEM micrographs 
shows that cells are densely colonised in N9, N10, N15, N16  wells after 1, 4 and 7 
days. However, they are still sparsely colonised in the wells with HAp1, HAp2, N3, 
N4, N5 and N6, even after 7 days of incubation. SEM analysis of the cultured cells 
show a good compatibility of the osteoblasts to all the powders tested. In particular, in 
contact with  N3, N10, N15 and N16 powders, the cells showed a diffuse spread-like 
morphology with several cytoplasmatic extensions contacting the powder (see Figure 
4-59), while in the case of N4, N5, N6 and N9, the cells were elongated with fewer 
extensions interacting with apatite granules. Control cultures (HAp1 and HAp5) 
showed a uniform layer of confluent cells with a frequent elongated shape and also 
overlapping growth (see Figures 4-57 to 4-59). 
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Figure 4-57: SEM micrograph showing the morphology of MG-63 osteoblast- like cells 
cultured on a thermanox surface (-) and in contact with control powder (HAp1) and 
various HAp (N3, N4, N6, N9, N10, N15, N16) at 1 day (micro scale bar length = 50µm at 
magnification x1500)  
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Figure 4-58: SEM micrograph showing the morphology of MG-63 osteoblast- like cells 
cultured on a thermanox surface (-) and in contact with control powders (HAp1 and 
HAp5) and various HAp (N3, N4, N6, N9, N10, N15, N16) at 4 days (micro scale bar 
length = 50µm at magnification x1500) 
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Figure 4-59: SEM micrograph showing the morphology of MG-63 osteoblast- like cells 
cultured on a thermanox surface (-) and in contact with control powders (HAp1 and 
HAp5) and various HAp (N3, N4, N6, N9, N10, N15, N16) at 7 days (micro scale bar 
length = 50µm at magnification x1500) 
 
4.5.5 Summary 
The formation of new bone is a multi-step cascade, initiated with chemotaxis and 
adhesion of osteogenic cells to the implant. The adhesive cells undergo a sequence of 
cell functions (such as, proliferation and synthesis of extracellular matrix proteins 
formation of mineral deposits). In order to enhance osteoblast proliferation, which 
promotes new bone formation, it is necessary to employ suitable Ca-P ceramics, 
which simulate the natural normal, healthy bone. This present study, therefore, 
provides evidence that the development of a new generation of bioactive ceramics, 
through the control of the crystallinity, particle size and morphology, to promote 
osseointegration, which is vital for the clinical success of orthopaedic implant.   
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4.6 OPTIMISATION OF CHEMICAL PRECIPITATION PROCESS 
PARAMETERS 
In this section, the experimental design used, the range of each chemical precipitation 
process parameter and experimental layout are presented. This section demonstrates 
the results for the optimisation of the chemical precipitation process parameters, in 
terms of the ANOVA analysis for each response investigated, and the validation of 
the models produced. The effects of the process parameters on each response are 
described and discussed. Furthermore, the results of the phase purity, crystallinity, 
crystallite size, lattice parameters and particle size are illustrated and discussed to 
distinguish the effects of the process parameters on the final HAp powder properties 
obtained, with a view to optimising the investigated parameters. The processing 
window for each factor was limited to the region over which existing literature 
indicated as optimum values and was also selected based on the results as obtained at 
the screening stages of the design of experiments. The lower levels selected in the 
screening investigation were shown to have little influence in obtaining the desired 
powder characteristics. Therefore the lower levels have been increased for the 
optimisation studies. Based on these observations, the key controllable process factors 
investigated in the optimisation model include the three most critical parameters (see 
Table 4-24(a) and (b)) as observed during the screening design: Factor A: 
Temperature (40 - 60°C), Factor B: Stirring Speed (900 – 1500rpm) and Factor C: 
Ripening Time (24 – 48h). 
 
A Box-Behnken experimental design, with three levels on the three most influential 
factors was used to allow the estimation of a full quadratic model, including 
interaction effects. Box-Behnken designs have two parts: (i) centerpoints, and (ii) 
points lying on one sphere, equally distant from the centerpoint. The latter points 
consist of small two-level full factorials where some factors are fixed at their center 
values. The number of centerpoints is chosen to establish rotatability. The levels 
selected for the optimisation experiments are shown in Table 4-28 (denoted as -1, 0 
and +1). The other parameters (Ca
2+
 conc. (2.0M), acid addition rate (0.01 mol/min) 
with atmospheric control) were kept constant in all cases. As only the main effects 
were considered in the building of the optimisation design, the optimisation models 
developed for each response will vary from those developed during the screening 
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stage, since the interaction between other factors (such as, acid addition rate and 
calcium concentration) is set (see Section 3.6.2). 
 
Table 4-28: Experimental factors and level of factors 
 Variable Level -1 Level 0 Level +1 
A  Reaction Temperature, To 40°C 50°C 60°C 
B  Stirring Speed, Vst 900rpm 1200rpm 1500rpm 
C  Ripening Time, tr 24h 36h 48h 
 
The experiments were carried out according to the design matrix shown in Table 4-29 
in a fully randomised order to avoid any systematic error. Conditions for N13 – 17 are 
replicated to assess the reproducibility at a given set of process conditions. For the 
optimisation, several mathematical models were developed successfully to predict the 
following responses: phase purity (Xp), crystallinity (Xc), crystallite size (Xs, L002 and 
L300), lattice parameters (a and c) and the powder particle size (Ps). The responses 
obtained were calculated according to the experimental design matrix, characterized 
as per experimental methods outlined in Chapter 3 and are discussed in the following 
sections. The averages for three measurements are presented in Table 4-30. 
Table 4-29: Box-Behnken experimental design, real values 
Exp. Number To(ºC) Vst (rpm) tr (h) 
N1 40 900 36 
N2 60 900 36 
N3 40 1500 36 
N4 60 1500 36 
N5 40 1200 24 
N6 60 1200 24 
N7 40 1200 48 
N8 60 1200 48 
N9 50 900 24 
N10 50 1500 24 
N11 50 900 48 
N12 50 1500 48 
N13 50 1200 36 
N14 50 1200 36 
N15 50 1200 36 
N16 50 1200 36 
N17 50 1200 36 
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Table 4-30: Phase purity (Xp), crystallinity (Xc), crystallite size (Xs, L002 and L300), lattice parameter ratio (a/c) and mean particle size (Ps) of the 
different HAp samples for various conditions of  temperature (To), stirring speed (Vst), and ripening time (tr) 
Sample  Purity,           
Xp, (%)  
Crystallinity, 
Xc, (%) 
Crystallite Size, Xs, L002 
(nm) 
Crystallite Size, Xs, L300 
(nm) 
Lattice 
Parameter, a (nm) 
Lattice  
Parameter,  c (nm) 
Mean Particle Size, Ps  
(µm) 
N1 72.24 75.12 57.42 58.29 9.4195 6.8934 28.04 
N2 49.62 76.47 51.34 47.29 9.4484 6.8858 24.63 
N3 84.56 76.4 56.53 81.38 9.4058 6.8650 28.20 
N4 57.79 82.36 53.52 61.78 9.4246 6.8867 26.71 
N5 61.04 77.95 48.99 62.37 9.4279 6.8650 26.45 
N6 23.53 82.52 80.01 72.55 9.4720 6.8498 40.95 
N7 60.26 78.94 53.68 72.55 9.4282 6.8780 26.62 
N8 18.71 80.98 69.41 65.10 9.4312 6.8565 34.22 
N9 50.50 72.81 66.00 56.00 9.4322 6.8558 37.07 
N10 71.16 79.18 59.19 69.65 9.4775 6.8525 27.99 
N11 55.27 73.87 51.44 48.84 9.4245 6.8859 25.55 
N12 84.73 77.36 57.78 48.84 9.4456 6.8887 32.28 
N13 48.62 72.10 51.16 72.59 9.4186 6.8681 24.36 
N14 49.79 73.00 51.66 72.59 9.4186 6.8681 26.39 
N15 47.98 71.78 51.26 73.00 9.4186 6.8681 27.37 
N16 47.65 72.05 51.68 72.56 9.4186 6.8681 28.17 
N17 48.55 72.55 51.17 72.67 9.4186 6.8681 27.99 
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4.6.1 Development Of Phase Purity Model 
As a result of analysing the measured responses using the Design Expert software, the fit 
summary selected the highest order polynomial where the additional terms are significant 
and the model is not aliased. Choosing the step-wise regression method led to the 
elimination of the insignificant model terms automatically. Table 4-31 presents the 
ANOVA results for the phase purity and shows the significant model terms. The same 
tables show also the other adequacy measures R
2
, Adjusted R
2
 and Predicted R
2
. These 
were shown to be high, thus the model is statistically significant and leaving out the 
calcium concentration did not significantly affect the results here as it did not have a 
major influence on the purity results in the screening study. A significant lack of fit can 
also be attributed to the elimination of the acid addition rate as a controlling factor. An 
Adequate Precision ratio of 21.046 indicates adequate model discrimination [160].  
 
The result of the Analysis of Variance for the phase purity model shows that the main 
effect of two of the chemical precipitation parameters and the quadratic effect of the 
stirring speed are significant model terms. However, the reaction synthesis temperature is 
the factor which possesses the most significant main effect on the phase purity, with the 
stirring speed containing a lesser effect. However, the quadratic effect of the stirring 
speed is found to have a more significant effect, in comparison to being considered solely 
as a main effect. This result correlates well with literature, which suggests that both the 
temperature and stirring speed is critical in controlling the final phase purity [89]. The 
order of significance for these effects follows the order: To > Vst
2
 > Vst. The final model 
in terms of coded factors is shown in Equation 4-20, while the final model in terms of 
coded factors is presented in Equation 4-21.  
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Table 4-31: ANOVA table for phase purity, Xp,  reduced quadratic model 
Source  Sum of 
squares 
d.f. Mean 
Square 
F value Prob >F  
Model  4484.04 3 1494.68 41.13 < 0.0001 significant 
To  2062.61 1 2062.61 56.75 < 0.0001  
Vst  623.25 1 623.25 17.15 0.0012  
Vst
2  1798.18 1 1798.18 49.48 < 0.0001  
Residual  472.47 13 36.34    
Lack of Fit  469.81 9 52.20 78.44 0.0004 significant 
Pure Error  2.66 4 0.67    
Corrected Total  4956.51 16     
R
2
 = 0.9047; predicted R
2
 = 0.8205; adjusted R
2
 = 0.8827; adequate precision = 21.046  
 
 
Phase Purity = +45.13 
Xp (%) -16.06    * To 
  +8.83    * Vst 
  +20.61    * Vst
2                                                                                   
Equation (4-20) 
 
 
Phase Purity, = +419.78901 
Xp (%) -1.60570   * Reaction Temp 
  -0.52005   * Stirring Speed 
  +2.28946E-004 * (Stirring Speed)
2 
                                Equation (4-21)
 
 
 
The above equation (4-20) indicates that the order of the level of significance of the 
positive effects of the chemical precipitation process parameters on the phase purity 
follows the order: (Vst
2
) > (Vst) while the order of the level of significance of the negative 
effects on the lattice parameter ratio is as follows: (To). Fig 4-60 shows the relationship 
between the actual and predicted values of the phase purity. This figure indicates that the 
developed model is adequate, since the residuals in the prediction of each response are 
small, with the residuals tending to be close to the diagonal line.  
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Figure 4-60: Scatter diagram for phase purity 
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4.6.2 Effect Of The Process Parameters On Phase Purity  
The 3-D surface and 2-D contour plots illustrated in Figure 4-61 examine the effects of 
the two significant factors (reaction temperature and stirring speed) on the phase purity 
response. The results indicate that both the reaction synthesis temperature and the stirring 
speed exert a significant effect on the response for phase purity. The positive response of 
the stirring speed indicates that higher levels of stirring speed are required, while the 
negative effect for the reaction synthesis temperature indicates that a lower temperature, 
in the range of about 40⁰C is optimum for increased responses of phase purity. This 
optimum temperature is in good agreement with Afshar [83] and Saeri [84]. 
 
(A) 
 
(B) 
 
Figure 4-61: 3D surface (A) and 2D contour plot (B) of phase purity at a ripening time of 48h 
 
The perturbation plot shown in Figure 4-62 helps to compare the effect of both the 
significant factors at a particular point in the design space. This plot shows a comparison 
between the effects of the reaction synthesis temperature and stirring speed on the 
maximum phase purity, Xp. It is evident from this illustration that in the case of the steep 
curvilinear effect representing the stirring speed, the response is highly sensitive to this 
factor, with a sharp increase in phase purity. While the steep slope in the case of the 
reaction synthesis temperature indicates that the response is relatively sensitive to this 
factor, with an increase of parameter resulting in a decrease of the phase purity 
obtainable.  
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Table 4-32 shows the effects of increasing the reaction temperature, stirring speed or 
ripening time on experimental results obtained during the optimisation (BBD) and on the 
original screening (FFD) study. 
 
Table 4-33 shows the top four most influencing main and interaction effects (if any), in 
chronological order, for both the screening (FFD) and optimisation (BBD) with respect to 
attaining high levels of phase purity. Firstly, interactions involving the acid addition rate 
and calcium concentration did not appear in the BBD, as it was excluded from this 
design. One main influencing factor that appeared in the screening but not in the 
optimisation is the ripening time. Clearly, this has no significant effect on the ranges 
studied for the optimisation (24 - 48h) as opposed to the broader range (0.5 – 48) 
investigated during the screening stage. 
 
 
Figure 4-62: Perturbation plot demonstrating the effect of the three parameters on phase 
purity 
 
The stirring speed has both a linear and quadratic effect on the Box-Behnken design and 
therefore is the most important factor along with the reaction temperature. The increase 
of the effect of the stirring speed on the ranges investigated for optimisation can also be 
attributed to the loss of significance on the ripening time for achieving high purity. 
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Table 4-32: Effect of increasing process factors on phase purity  
Experimental 
Design 
 Factors Response 
Sample To  
(°C) 
Vst 
 (rpm) 
tr  
(h) 
Xp 
(%) 
Increasing Temperature     
BBD N5 40 1200 24 61.0433 
BBD N6 60 1200 24 23.5338 
BBD N7 40 1200 48 60.2630 
BBD N8 60 1200 48 18.7108 
      
Increasing Stirring Speed     
BBD N9 50 900 24 50.4973 
BBD N10 50 1500 24 71.1554 
      
Increasing Ripening Time     
BBD N4 60 1500 36 57.79250 
FFD N16 60 1500 48 98.88860 
BBD = Box Behnken Design (Optimisation), FFD – Fractional Factorial Design (Screening) 
 
Table 4-33: Comparison of significant effects for screening (stage I) and optimisation (stage 
II) for phase purity, Xp 
Order of 
Significance 
Fractional Factorial Design 
(FFD) 
Box – Behnken Design 
(BBD) 
↑Purity, Xp (%) 
1 ↑Vac * Vst ↑ Vst
 2
 
2 ↑Vac * To * atm. ↓ To 
3 ↑tr ↑ Vst 
4 ↑To  
 
Both the reaction temperature and the stirring speed were discussed in terms of their 
influence on the phase purity during the screening stage. Therefore, it is assumed their 
effects also stand here.  
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4.6.3 Development Of Crystallinity Model 
As a result of analysing the measured responses using the same statistical software used 
at the screening stage of this study, the fit summary output indicated that for the response 
concerning crystallinity, the quadratic model is statistically recommended for further 
analysis as this has the maximum predicted and adjusted R
2
. The test for significance of 
the regression model, the test for significance on individual model coefficients and the 
lack of fit test were performed for this response. By selecting the step-wise regression 
method, the insignificant model terms were automatically eliminated. The resulting 
ANOVA tables (Table 4-34) for the reduced quadratic models outline the analysis of 
variance of each response and show the significant model terms. The same tables show 
also the other adequacy measures R
2
, Adjusted R
2
 and Predicted R
2
, with an Adequate 
Precision Ratio of 28.021, to indicate adequate model discrimination was achieved and 
shows that elimination of the acid addition rate and the calcium concentration did not 
have an influence on attaining a significant model . The order of significance for these 
effects follows the order: To
2
 > tr
2 
> Vst > To > To * Vst > Vst * tr > To * tr > Vst
2
 
 
Table 4-34: ANOVA table for crystallinity, Xc,  reduced quadratic model 
Source  Sum of 
squares 
d.f. Mean 
Square 
F value Prob >F  
Model  214.86 8 26.86 104.98 < 0.0001 significant 
To  23.99 1 23.99 93.76 < 0.0001  
Vst  36.52 1 36.52 142.73 < 0.0001  
To * Vst  5.13 1 5.13 20.05 0.0021  
To * tr  1.62 1 1.62 6.32 0.0362  
Vst * tr  2.08 1 2.08 8.12 0.0215  
To
2  97.11 1 97.11 379.55 < 0.0001  
Vst
2  1.09 1 1.09 4.28 0.0725  
tr
2  37.88 1 37.88 148.08 < 0.0001  
Residual  2.05 7 0.26    
Lack of Fit  1.12 4 0.28 1.21 0.4283 not significant 
Pure Error  0.93 4 0.23    
Corrected Total  216.91 16     
R
2
 = 0.9906; predicted R
2
 = 0.9381; adjusted R
2
 = 0.9811; adequate precision = 28.021  
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The final model in terms of coded factors is shown below in Equation 4-22, while the 
final model in terms of coded factors is presented in Equation 4-23. 
 
Crystallinity, = 72.29  
Xc, (%)  + 1.73  *To 
+ 2.14  *Vst 
+ 1.13  *To* Vst   
-  0.64  *To* tr 
-  0.72  *Vst * tr  
+ 4.80  *To
2
 
+0.51  *Vst
2
 
+3.00             *tr
2
         Equation (4-22) 
 
 
Crystallinity  =+189.50859 
Xc, (%)  -4.69975   * Reaction Temp 
  -0.013023   * Stirring Speed 
  +3.77508E-004 * Reaction Temp * Stirring Speed 
  -0.011957   * Reaction Temp * Ripening Time 
  -3.77806E-004  * Stirring Speed * Ripening Time 
  +0.048503   * Reaction Temp
2
 
  +6.19594-006   * Stirring Speed
2
 
  +0.014503   * Ripening Time
2                                                   
Equation (4-23) 
 
 
The above equation (4-22) indicates that the order of the level of significance of the 
positive effects of the chemical precipitation process parameters on the crystallinity 
follows the order:  (To
2
) > (tr
2
) > (Vst) > (To) > (To * Vst) > (Vst
2
) while the order of the 
level of significance of the negative effects on the lattice parameter ratio is as follows: 
(Vst* tr) > (To * tr).
 
CHAPTER 4: Results And Discussion 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-269- 
Figure 4-63 shows the relationship between the actual and predicted values of the 
crystallinity. This figure indicates that the developed model is adequate, since the 
residuals in the prediction of each response are small, with the residuals tending to be 
close to the diagonal line.  
 
 
Figure 4-63: Scatter diagram for crystallinity 
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4.6.4 Effect Of The Process Parameters On The Crystallinity 
One of the response surface methodology advantages over the one factor at a time 
experimental procedure is its ability to specify the interaction effect between any two 
factors. Figure 4-64(a) to (c) shows the 3-D surface and 2-D contour graphs, highlighting 
the significant interaction effect between the reaction temperatures and stirring speed at 
ripening times of between 24 to 48h. It is clear from this figure that an increase in both 
factors results in a marked increase in crystallinity, while the ripening time has little 
effect between 24 to 48h, demonstrating a difference in crystallinity of 2.7126%. The 
maximum crystallinity of 86.9629% occurs at a reaction synthesis temperature of 60ºC 
and a stirring speed of 1500rpm at a ripening time of 24h. 
 
The cube plot shown in Figure 4-65 displays the relationship between three significant 
factors and is especially useful in interpreting the interaction effects (such as, To* Vst, To* 
tr and  Vst * tr). This type of figure presents the predicted values of the responses from the 
model for the combinations of the -1 and +1 levels of the three factors. This figure 
presents the effect of the three factors on the crystallinity by using a cube plot to 
represent this effect. It is noted that the process input parameters can be selected where 
the crystallinity would be minimum or maximum. 
 
The perturbation plot aids in comparing the effect of all the factors at a particular point in 
the design space. Figure 4-66 shows a comparison between the effects of reaction 
temperature, stirring speed and ripening time on the maximum crystallinity. It is evident 
from this figure that the stirring speed has a slightly positive effect on the crystallinity.  In 
the case of the reaction temperature, the curvilinear effect demonstrates that increasing 
the temperature until it reaches its maximum value would result in enhanced crystallinity, 
with decreased levels obtained at approximately mid range (50⁰C). The non significance 
of the ripening time is also demonstrated whereby there is little or no effect in varying the 
ripening time between 24 to 48h, with the minimum crystallinity being obtained at 36h. 
Increasing the stirring speed will result in a direct increase of crystallinity.  
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(A) Ripening Time: 24h 
 
 
(B) Ripening Time: 36h 
 
 
(C) Ripening Time: 48h 
  
Figure 4-64: 3D surface and 2D contour plots of crystallinity at (A) a ripening time of 24h; 
(B) a ripening time of 36h and (C) a ripening time of 48h  
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Figure 4-65: Cube graph demonstrating the effect of the three parameters on crystallinity 
 
 
Figure 4-66: Perturbation plot demonstrating the effect of the three parameters on 
crystallinity 
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Table 4-35 shows the top four most influencing main and interaction effects (if any), in 
chronological order, for both the screening (FFD) and optimisation (BBD) with respect to 
attaining high levels of crystallinity. 
 
Table 4-35: Comparison of significant effects for screening (stage I) and optimisation (stage 
II) for crystallinity, Xc 
Order of 
Significance 
Fractional Factorial Design 
(FFD) 
Box – Behnken Design 
(BBD) 
↑Crystallinity, Xc (%) 
1 ↑tr ↑ To
2
 
2 ↑To * atm. ↑ tr
2
 
3 ↓atm. ↑ Vst 
4 ↑Vac * Ca
2+
 ↑To 
 
Since the acid addition rate, calcium concentration and atmospheric control (as factors) 
were eliminated from the optimisation study; their effects do not appear as being 
significant in the BBD model developed for crystallinity. The reaction temperature and 
the ripening time effects appear in both models. However, their quadratic effects included 
on the BBD model, shows that their level of significance has increased dramatically 
within the ranges investigated. These factors were discussed, at the screening stage, in 
relation to their effects on crystallinity. Hence, these observations will also apply here. 
However, the stirring speed is now introduced as a significant main effect in the top four 
most influencing factors effecting crystallinity during optimisation. Instead, the screening 
results show the stirring speed to have a less significant effect on the crystallinity 
(marked 6
th
, Figure 4-27). Therefore, it has increased in level of significance due to the 
elimination of other factors (such as, acid addition rate, calcium concentration and 
atmospheric control). It would be expected that the stirring speed would affect the 
crystallinity as high mixing intensity is required to attain high levels of crystallinity [86]. 
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4.6.5 Development Of Crystallite Size Models (L002 and L300) 
As a result of analysing the measured responses using the Design Expert software, the fit 
summary selected the highest order polynomial where the additional terms are significant 
and the model is not aliased. Choosing the step-wise regression method led to the 
elimination of insignificant model terms automatically. Tables 4-36 and 4-37 present the 
ANOVA results for crystallite size in the 002 and 300 plane, respectively. The same 
tables show also the other adequacy measures R
2
, Adjusted R
2
 and Predicted R
2
, with an 
Adequate Precision ratio of 6.1602 and 8.227, respectively, showing that adequate model 
discrimination has been achieved for both models [160]. The lack of fit in both cases is 
significant, with a transformation required in the case of the crystallite size in the 300 
plane to improve model adequacy. Again, this may be attributed to eliminating the factors 
(acid addition rate, calcium concentration and atmospheric control) included in the 
screening study, as it had either an interaction effect (Vac * tr, ranked 4
th
) or a main effect 
(ranked 3
rd
) and interaction effect (Vac * atm., ranked 4
th
) for the crystallite size, L002 and 
L300, respectively. Therefore, eliminating the acid addition rate and atmospheric control 
appears to affect the models produced here and produce a significant lack of fit. 
 
The result of the ANOVA for the crystallite size model, L002, shows that while the main 
effect of the reaction temperature has a significant effect on the crystallite size in this 
plane, the quadratic effect of ripening time has a greater level of significance. The order 
of significance for these effects follows the order: tr
2
 > To. The ANOVA for the crystallite 
size model, L300, shows instead, that the stirring speed (main and quadratic) is the most 
significant factor, while the quadratic effect of ripening time has a lesser significance on 
the final crystallite size for the 300 plane. The order of significance for these effects 
follows the order: Vst > Vst
2
 > tr
2
. 
 
The final mathematical models for the crystallite size response, L002 in terms of coded 
and actual factors as determined by the Design Expert software are shown in Equations 4-
24 to 4-25. While, the final mathematical models in terms of coded and actual factors for 
L300 are presented in Equations 4-26 to 4-27.  
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Table 4-36: ANOVA table for crystallite size, L002 reduced quadratic polynomial model 
Source  Sum of 
squares 
d.f. Mean 
Square 
F value Prob >F  
Model  445.49 2 222.74 4.94 0.0237 significant 
To  177.45 1 177.45 3.94 0.0671  
tr
2  268.04 1 268.04 5.95 0.0286  
Residual  630.65 14 45.04    
Lack of Fit  630.37 10 63.04 900.14 < 0.0001 significant 
Pure Error  0.28 4 0.070    
Corrected Total  1076.14 16     
R
2
 = 0.4140; predicted R
2
 = 0.0315; adjusted R
2
 = 0.3302; adequate precision = 6.162 
 
Table 4-37: ANOVA table for crystallite size, L300 reduced quadratic polynomial model 
Source  Sum of 
squares 
d.f. Mean 
Square 
F value Prob >F  
Model  976.19 3 325.40 11.11 0.0007 significant 
Vst  548.61 1 548.61 18.73 0.0008  
Vst
2  314.46 1 314.46 10.73 0.0060  
tr
2  92.82 1 92.82 3.17 0.0984  
Residual  380.81 13 29.29    
Lack of Fit  380.69 9 42.30 1372.37 < 0.0001 significant 
Pure Error  0.12 4 0.031    
Corrected Total  1357.00 16     
R
2
 = 0.7194; predicted R
2
 = 0.4415; adjusted R
2
 = 0.6546; adequate precision = 8.227  
 
Crystallite Size, = +52.86 
L002 (nm) +4.71 * To 
+7.96 * tr
2                                  
Equation (4-24) 
 
Crystallite Size, = +36.21562 
L002 (nm) +0.47097        * Reaction Temp 
  -2.31882E-003 * Ripening Time
2                                    
Equation (4-25)
 
 
 
The above equation (4-24) indicates that the two effects are positively affecting the 
crystallite size (L002) in the same order as shown previously:  tr
2
 > To. 
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Crystallite Size, = +71.86 
L300 (nm) +8.28   * To 
 -8.63   * To
2
 
 -4.69   * tr2                                                                                                         Equation (4-26) 
 
Crystallite Size, = -101.01519 
L300 (nm) +0.26403    * Stirring Speed 
  -9.85094E-005 * Stirring Speed
2
 
  -3.07859E-003 * Ripening Time
2                                    
Equation (4-27) 
 
 
The above equation (4-26) indicates that the only positive effects of the chemical 
precipitation process parameters on the crystallite size (L300) is (To) while the order of the 
level of significance of the negative effects on the lattice parameter ratio is as follows: 
(To
2
) > (tr
2
). 
 
Fig 4-67(a) and (b) shows the relationship between the actual and predicted values of the 
L002 and L300 crystallite sizes, respectively. The figures indicate that the developed 
models are relatively adequate, since the residuals in the prediction of each response are 
small, with the residuals tending to be close to the diagonal line.  
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(A) 
 
(B) 
 
Figure 4-67: Scatter diagram for (A) crystallite size, L002 and (B) crystallite size L300 
 
 
4.6.6 Effect Of The Process Parameters On The Crystallite Size 
The perturbation plot aids in comparing the effect of the significant factors at a particular 
point in the design space. Figure 4-68(a) shows a comparison between the significant 
effects of reaction temperature and ripening time on the crystallite size, L002, while Figure 
4-68(b) shows a comparison between the significant effects of stirring speed and ripening 
time on the crystallite size. In Figure 4-68(a), it is evident that the positive linear 
relationship of the reaction temperature indicates that an increase in this parameter will 
directly increase the crystallite size, while the curvilinear relationship of the ripening time 
shows that the L002 crystallite size is at its minimum mid-range (at 36h).  Figure 4-68(b) 
shows the comparison between the significant effects of both the stirring speed and 
ripening time, both of which exhibit curvilinear relationships with the crystallite size in 
the 300 plane. For this plane, an increase of stirring speed will result in an increase of the 
crystallite size, while the crystallite size is at its minimum at a ripening time of 36h and 
highest values at 24 and 48h ripening. 
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(A) 
 
 
(B) 
 
Figure 4-68: Perturbation plot showing the effect of all the parameters on the crystallite 
size, L002 (A) and L300 (B) 
 
 
Tables 4-38 and 4-39 shows the top four most influencing main and interaction effects (if 
any), in chronological order, for both the screening (FFD) and optimisation (BBD) with 
respect to attaining high levels of crystallite size in the 002 and 300 plane, respectively. 
 
Table 4-38: Comparison of significant effects for screening (stage I) and optimisation (stage 
II) for crystallite size, L002 
Order of 
Significance 
Fractional Factorial Design 
(FFD) 
Box – Behnken Design 
(BBD) 
↑Crystallite Size, L002 (nm) 
1 ↑atm. ↑ To 
2 ↑To * tr ↑ tr
2
 
3 ↓ Ca
2+
  
4 ↑Vac * tr  
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For L002, atmospheric control, calcium concentration and acid addition rate were 
eliminated in the Box-Behnken design. Therefore, the remaining factors (To and tr) that 
were originally found to affect this response have increased in their level of significance 
in attaining a high crystallite size. While for L300, the same approach applies. However, 
the significance of the stirring speed is now included during optimisation. This factor was 
previously ranked the 5
th
 most influencing factor for this response. Therefore, it may be 
assumed that the removal of the other factors has resulted in this increase of significance. 
Clearly, it is noted that it has an influence similar to that for crystallinity. However, the 
stirring speed and reaction temperature do not appear to significantly affect the crystallite 
size for the 002 and 300 plane, respectively. The difference for these models (screening 
and optimisation) may be attributed to the variance in the range of factors selected.  
 
Table 4-39: Comparison of significant effects for screening (stage I) and optimisation (stage 
II) for crystallite size, L300 
Order of 
Significance 
Fractional Factorial Design 
(FFD) 
Box – Behnken Design 
(BBD) 
↓Crystallite Size, L300 (nm) 
1 ↑tr ↑ Vst
 
 
2 ↑To * atm. ↑ Vst
 2
 
3 ↓atm. ↑tr
2
 
4 ↑Vac * Ca
2+
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4.6.7 Development Of Lattice Parameter Ratio Model 
As a result of analysing the measured responses using the Design Expert software, the fit 
summary selected the highest order polynomial where the additional terms are significant 
and the model is not aliased. Choosing the step-wise regression method led to the 
automatic elimination of the insignificant model terms. Table 4-39 presents the ANOVA 
results for the lattice parameter ratio and shows the significant model terms. The same 
tables show also the other adequacy measures R
2
, Adjusted R
2
 and Predicted R
2
. An 
Adequate Precision ratio of 17.249 indicates adequate model discrimination [160]. The 
predicted R
2
 in this mode is not as high as that obtained for the screening model, so 
therefore the elimination of the factors (acid addition rate, calcium concentration and 
atmospheric) has resulted in this decrease, since the interaction of the acid addition rate 
and calcium concentration was ranked as the fourth most significant effect in the 
screening model and moreover, either of the two factors were involved in interactions 
with other factors at ranks below this. 
 
The result of the ANOVA for the lattice parameter ratio model shows that the main effect 
of all three of the chemical precipitation parameters investigated have a significant effect 
on the lattice parameter ratio. An interaction effect between the reaction synthesis 
temperature and the stirring speed quadratic effect of the stirring speed are significant 
model terms, while the quadratic effects of both the stirring speed and ripening time are 
also shown to be influencing factors. The order of significance for these effects follows 
the order: tr > tr
2
 > To > Vst
2
 > To * Vst > Vst 
 
The final model in terms of coded factors is shown in Equation 4-28, while the final 
model in terms of coded factors is presented in Equation 4-29.  
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Table 4-40: ANOVA table for a/c ratio reduced quadratic polynomial model 
Source  Sum of 
squares 
d.f. Mean 
Square 
F value Prob >F  
Model  0.0003147 6 0.0003147 19.80 < 0.0001 significant 
To  0.0000265 1 0.0000265 10.02  0.0101  
Vst  0.0000120 1 0.0000120 4.51 0.0596  
tr  0.0001335 1 0.0001335 50.40 < 0.0001  
To * Vst  0.0000133 1 0.0000133 5.02 0.0490  
Vst
2  0.0000163 1 0.0000163 6.17 0.0323  
tr
2  0.0001175 1 0.0001175 44.35 < 0.0001  
Residual  0.0000265 10 0.0000265    
Lack of Fit  0.0000265 6 0.0000044    
Pure Error  0.000 4 0.000    
Corrected Total  0.0003412 16     
R
2
 = 0.9223; predicted R
2
 = 0.5867; adjusted R
2
 = 0.8757; adequate precision = 17.249  
 
 
a/c ratio  = +1.37 
 +1.821E-003   * To 
 +1.223E-003   * Vst 
 -4.086E-003   * tr 
 -1.823E-003   * To * Vst 
 -1.968E-003   * Vst
2
 
 +5.276E-003   * tr
2                                                                                                      
Equation (4-28) 
 
 
a/c ratio  = +1.34913 
 +9.11212E-004   * Reaction Temp 
 +8.69209E-005   * Stirring Speed 
 -2.97829E-003   * Ripening Time 
 -6.07562E-007   * Reaction Temp * Stirring Speed 
 -2.18615E-008   * Stirring Speed
2
 
 +3.66365E-005   * Ripening Time
2                                                   
Equation (4-29) 
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Equation 4-28 indicates that the order of the level of significance of the positive effects of 
the chemical precipitation process parameters on the lattice parameter ratio follows the 
order:  (tr
2
) > (To) > (Vst) while the order of the level of significance of the negative 
effects on the lattice parameter ratio is as follows: (tr) > (Vst
2
) > (To* Vst). 
 
Figure 4-69 shows the relationship between the actual and predicted values of the lattice 
parameter ratio. This figure indicates that the developed model is adequate, since the 
residuals in the prediction of each response are small, with the residuals tending to be 
close to the diagonal line.  
 
 
 
Figure 4-69: Scatter diagram for lattice parameter ratio 
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4.6.8 Effect Of The Process Parameters On The Lattice Parameter Ratio 
Figure 4-70(a) to (c) shows the 3-D surface and 2-D contour graphs, highlighting the 
significant interaction effect between the reaction temperatures and stirring speed at 
ripening times of between 24 to 48h. It is clear from this figure that an increase in the 
reaction temperature produces a marked increase in ratio, while a reduction in the 
ripening time appears to favour this response. A median value (1200rpm) of stirring 
speed also appears to favour an increase in lattice parameter ratio. 
 
The cube plot shown in Figure 4-71 displays the relationship between three significant 
factors and is especially useful in interpreting the interaction effects (such as, To* Vst,). 
This type of figure presents the predicted values of the responses from the model for the 
combinations of the -1 and +1 levels of the three factors. This figure presents the effect of 
the three factors on the a/c ratio by using a cube plot to represent this effect. It is noted 
that the process input parameters can be selected where the a/c ratio would be minimum 
or maximum. The perturbation plot shown in Figure 4-72 shows a comparison between 
the effects of reaction temperature, stirring speed and ripening time on the maximum a/c 
ratio. This confirms how a direct increase of the reaction temperature can increase the 
resulting a/c ratio, while a curvilinear  
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(A) Ripening Time: 24h 
 
 
 
(B) Ripening Time: 36h 
 
 
(C) Ripening Time: 48h 
  
Figure 4-70: 3D surface and 2D contour plots of lattice parameter ratio at (A) a ripening 
time of 24h; (B) a ripening time of 36h and (C) a ripening time of 48h (under an inert 
environment) 
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Figure 4-71: Cube graph demonstrating the effect of the three parameters on the lattice 
parameter ratio 
 
 
relationship for the ripening time represents a high sensitivity of this factor to the a/c 
ratio, with decreased ripening times dramatically increasing this response. A less 
pronounced curvilinear effect for the stirring speed demonstrates how the maximum 
lattice ratio between 1200 – 1500rpm. 
 
 
Figure 4-72: Perturbation plot showing the effect of all the parameters on the lattice 
parameter ratio 
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Table 4-41 shows the top four most influencing main and interaction effects (if any), in 
chronological order, for both the screening (FFD) and optimisation (BBD) with respect to 
attaining lattice parameters within a desired range. 
 
Table 4-41: Comparison of significant effects for screening (stage I) and optimisation (stage 
II) for the lattice parameter ratio, a/c 
Order of 
Significance 
Fractional Factorial Design 
(FFD) 
Box – Behnken Design 
(BBD) 
↓Lattice parameter ratio, a/c 
1 ↑tr ↓tr
2
 
2 ↑Vst  ↑tr 
3 ↑To ↑Vst
2
 
4 ↑Vac * Ca
2+
 ↑To * Vst 
 
With the exception of the calcium concentration, all the other factors (tr, Vst and To) were 
the same for both models, with the quadratic effects of certain factors included in the 
optimisation model. The reasons for their influencing the lattice parameter ratio are valid 
for both models, as discussed previously, in the screening results. 
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4.6.9 Development Of Particle Size Model 
As a result of analysing the measured responses using the Design Expert software, the fit 
summary selected the highest order polynomial where the additional terms are significant 
and the model is not aliased. Choosing the step-wise regression method led to the 
automatic elimination of the insignificant model terms. Table 4-42 presents the ANOVA 
results for the particle size shows the significant model terms. The same tables show also 
the other adequacy measures R
2
, Adjusted R
2
 and Predicted R
2
. An Adequate Precision 
ratio of 7.330 indicates adequate model discrimination [160]. However, factors (such as 
acid addition rate and calcium concentration) were found to be included as one of the top 
four most influencing factors having an effect on the particle size in the screening model 
are not accounted for in this model. 
 
The result of the ANOVA for the particle size model shows that the main effect of one 
(reaction synthesis temperature) of the chemical precipitation parameters investigated 
have a significant effect on the lattice parameter ratio. An interaction effect between the 
stirring speed and the ripening time and a quadratic effect of the ripening time are the 
significant model terms influencing final response for particle size. The order of 
significance for these effects follows the order: tr
2
 > Vst * tr > To.  
 
Table 4-42: ANOVA table for particle size reduced quadratic polynomial model 
Source  Sum of 
squares 
d.f. Mean 
Square 
F value Prob >F  
Model  247.13 3 82.38 7.22 0.0042 significant 
To  36.98 1 36.98 3.24 0.0950  
Vst * tr  62.49 1 62.49 5.48 0.0358  
tr
2  147.66 1 147.66 12.95 0.0032  
Residual  148.27 13 11.41    
Lack of Fit  148.27 9 16.47    
Pure Error  0.000 4 0.000    
Corrected Total  395.40 16     
R
2
 = 0.6250; predicted R
2
 = 0.3185; adjusted R
2
 = 0.5385; adequate precision = 7.330 
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The final model in terms of coded factors is shown in Equation 4-30, while the final 
model in terms of coded factors is presented in Equation 4-31. 
 
Particle Size,  =  +25.49 
Ps (μm) +2.15   * A 
  +3.95   * B * C 
  +5.90   * C2                                                                                                                                        Equation (4-30) 
 
Particle Size,  = +19.51609 
Ps (μm) +0.21500    * Reaction Temp 
  -6.24224E-006 * Stirring Speed * Ripening Time 
  -1.26938E-003 * Ripening Time
2                                    
Equation (4-31) 
 
 
The above equation (4-30) indicates that all of the significant effects are positively 
affecting the lattice parameter ratio in the same order as shown previously:  (tr
2
) > (Vst * tr) 
> (To). 
 
Figure 4-73 shows the relationship between the actual and predicted values of the particle 
size. This figure indicates that the developed model is adequate, since the residuals in the 
prediction of each response are small, with the residuals tending to be close to the 
diagonal line.  
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Figure 4-73: Scatter diagram for particle size 
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4.6.10 Effect Of The Process Parameters On The Particle Size 
Figure 4-74(a) to (c) shows the 3-D surface and 2-D contour graphs, highlighting the 
significant interaction effect between the reaction temperatures and stirring speed at 
ripening times of between 24 to 48h. It is clear from this figure that for an increase in 
ripening time, an increase in both the stirring speed and the ripening time is required for 
an increased particle size.  
 
The cube plot shown in Figure 4-75 displays the relationship between three significant 
factors and is especially useful in interpreting the interaction effects (such as, Vst * tr). 
This type of figure presents the predicted values of the responses from the model for the 
combinations of the -1 and +1 levels of the three factors. This figure presents the effect of 
the three factors on the particle size by using a cube plot to represent this effect. It is 
noted that the process input parameters can be selected where the particle size would be 
minimum or maximum. However, it must also be noted that all the experimental results 
for particle size showed that the experimental conditions used for each experiment 
yielded a particle size of less than the required 100µm. Therefore, it is not our aim in this 
study to maximise or minimise this response. 
 
The perturbation plot shown in Figure 4-76 shows a comparison between the effects of 
reaction temperature, stirring speed and ripening time on the maximum particle size. This 
confirms how an increase in both the reaction temperature and the ripening time can 
significantly increase the resulting particle size, while a linear response for the stirring 
speed is shown to have little effect on tailoring the desired particle size.  The curvilinear 
relationship of the ripening time demonstrates a high sensitivity of this factor to the final 
response with the minimum response for particle size found at 36h and its maximum 
found at the lower (24h) and upper (48h) limits. The linear response for the reaction 
temperature indicates a less significant response. However, the plot also demonstrates 
how a direct increase in the reaction temperature can also maximise the final particle size. 
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(A) Ripening Time: 24h 
 
 
(B) Ripening Time: 36h 
 
 
(C) Ripening Time: 48h 
 
 
Figure 4-74: 3D surface and 2D contour plots of particle size at (A) a ripening time of 24h; 
(B) a ripening time of 36h and (C) a ripening time of 48h (under an inert environment) 
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Figure 4-75: Cube graph demonstrating the effect of the three parameters on the lattice 
parameter ratio 
 
 
Figure 4-76: Perturbation plot showing the effect of all the parameters on the particle 
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Table 4-43 shows the top four most influencing main and interaction effects (if any), in 
chronological order, for both the screening (FFD) and optimisation (BBD) with respect to 
attaining particle sizes with the desired range. 
 
Table 4-43: Comparison of significant effects for screening (stage I) and optimisation (stage 
II) for the particle size, Ps 
Order of 
Significance 
Fractional Factorial Design 
(FFD) 
Box – Behnken Design 
(BBD) 
↓Particle size, Ps 
1 ↑To ↓tr
2
 
2 ↑Ca2+  ↓Vst * tr 
3 ↓Vac * To ↓To 
4 ↑Vac * Ca
2+
  
 
Comparing the top four most influencing effects in both models, it is obvious that the 
reaction temperature, as expected, has a major influence over the resulting particle size. 
However, the influence of this factor appears to have the opposite effect: requiring an 
increase in the screening model and a decrease in the optimisation model to effectively 
increase the particle size. This may be explained by the fact that the temperature range 
varies between the models developed (that is, 20 - 60ºC for screening and 40 - 60ºC for 
optimisation). As a result it may be interpreted that, while an increase in the reaction 
temperature is known to result in an increase in particle size, the optimum temperature 
for acquiring the largest particle size may in fact lie around 40 - 50ºC. The desirability 
approach (used at a later stage), however, also indicates that use of a high reaction 
temperature is required to increase the particle size.  
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As discussed previously, it is also noted that all the experimental results for particle size 
demonstrated how the experimental conditions used for each experiment yielded a 
particle size of less than the required 100µm. Therefore, it is not our aim in this study to 
either maximise or minimise this response, as it is already found to be within acceptable 
limits. Instead, understanding the effects of the parameters and their influence on the 
resulting response obtained for particle size is of interest. 
 
With the acid addition rate and calcium concentration factors eliminated in the 
optimisation, the stirring speed, as an interaction effect with ripening time is now 
included as one of the top four most influencing factors. This factor, however, was 
previously ranked the 6
th
 most influencing factor in the screening model and therefore, it 
may be assumed that the removal of the other factors has resulted in this increase of its 
level of significance.  
 
Table 4-40 outlines the average of three results recorded for mode, mean particle sizes 
and the percentage (10, 50 and 90%) of powder particles within a specific range. Figure 
4-77 graphically compares the mean particle sizes obtained for the micron sized HAp 
powders analysed in this study. The order of mean particle size from the largest is as 
follows:  
 
N6 → N9 → N8 → N12 → N3 →N16 → N1 → N17 = N10 → N15 →N4 →N7 → N5 
→ N14 → N11 → N2 → N13 
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Table 4-44: Particle size analysis results: percentage diameter under 10, 50 and 90% 
micrometer, mean particle size, mode particle size and specific surface area data of the 
different HAp samples for various conditions of Box-Behnken experimental design 
HAp 
Powder 
Median 
 
Diameter (μm) on: Mean 
 
Mode 
 
(μm) 10% 50% 90% (μm) (μm) 
N1 
 
5.210 2.520 21.750 63.410 28.040 41.430 
N2 
 
4.650 2.330 17.530 57.950 24.630 41.430 
N3 
 
4.500 2.720 22.130 63.240 28.200 48.266 
N4 
 
5.610 3.040 19.440 61.530 26.710 41.430 
N5 
 
5.180 2.300 19.840 60.970 26.450 48.265 
N6 
 
9.280 9.220 37.630 77.620 40.950 56.229 
N7 
 
4.890 2.120 20.310 61.160 26.620 48.265 
N8 
 
6.800 4.850 28.910 72.190 34.220 48.265 
N9 
 
7.760 6.020 32.130 76.080 37.070 56.229 
N10 
 
4.920 2.270 19.860 66.000 27.990 48.265 
N11 
 
5.460 2.800 19.540 57.620 25.550 41.430 
N12 
 
6.060 2.980 23.650 71.410 32.280 41.430 
N13 
 
5.050 2.780 19.340 53.730 24.360 35.562 
N14 
 
5.870 2.900 20.400 59.270 26.390 41.430 
N15 
 
5.990 3.020 21.140 61.300 27.370 41.430 
N16 
 
6.250 3.210 21.750 63.040 28.170 41.430 
N17 
 
6.150 3.050 21.230 63.300 27.990 41.430 
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Figure 4-77: Comparison of particle size distributions obtained for various HAp powders 
synthesised according to the Box-Behnken design 
 
The majority of the powders synthesised in this study, possess a narrow particle size 
distribution, as indicated in Figures 4-78 to 4-79. 
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Figure 4-78: Comparison of particle size distributions obtained for optimisation 
experimental conditions (N1 – N8) 
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Figure 4-79: Comparison of particle size distributions obtained for optimisation 
experimental conditions (N9 – N17) 
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4.6.11 Morphological Evaluation Of the HAp Powders 
The SEM micrographs of the HAp powders in Figures 4-80 to 4-82 reveal how the HAp 
powders can vary according to the process parameters implemented in the optimisation 
study. An increase of the synthesis temperature (N1 to N2) is found to lead to more 
regular spherical HAp particles. These findings agree well with those reported by Bouyer 
[94], showing
 
that a low synthesis temperature can lead to HAp crystals possessing 
needle-shape like morphology [94]. Pang and Bao [90] also confirmed that the particles 
synthesised at a low reaction temperature were a bit thinner and longer, with more 
irregularity and less clear contours. Also the particles in these comparisons also show a 
higher tendancy towards agglomeration. Moreover, it is also noticed that the change from 
irregular to regular particle morphology with the increase in synthesis temperature 
corresponds to the increase in the crystallinity of the HAp crystals, that is, more regular 
shape of the particles was observed when the powders possessing a higher crystallinity. 
Hence, it is clear that the influence of the chemical precipitation process parameters on 
the morphology of the HAp powders must be inviestigated. A qualitative examination of 
the positive effect of the interaction between the reaction temperature and the srirring 
speed (N9 to N5 and N6 to N10) demonstrates how the powder particle size increases in 
correspondence to a more idealised spherical morphology. Examining the effect of 
increasing the stirring speed (N9 to N10), in isolation of the other factors, however also 
demonstrates a favaourable effect on the resultant morphology. Another positive 
interaction effect between the stirring speed and the ripening time (N5 to N3), while a 
reduction in the stirring speed coupled with an increase in ripening time also 
demonstrates an enhanced spherical powder morphology. This would suggest that the 
stirring speed is the least significant factor affecting this resposne. 
 
No visible colour changes from white to light blue were evident post sintering for all 
powders synthesised in this study, which meets with requirements outlined by the FDA. 
According to Gross et al. [70], these undesired colour changes are due to the presence of 
transitional elements located in the crystal lattice structure. Although they may not have 
any significant effect on the biocompatibility of HAp, the FDA criterion requires 
powders of a white colour [137]. 
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N1 
 
N2 
 
N3 
 
N4 
 
N5 
 
N6 
 
N7 
 
N8 
 
Figure 4-80: Comparison of the powder morphology for HAp samples synthesised using 
experimental conditions in the Box-Behnken Design (N1 to N8) 
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N9 
 
N10 
 
N11 
 
N12 
 
N13 
 
N14 
 
N15 
 
N16 
 
Figure 4-81: Comparison of the powder morphology for HAp samples synthesised using 
experimental conditions in the Box-Behnken design (N9 to N16) 
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                                         N17 
 
Figure 4-82: Comparison of the powder morphology for HAp samples synthesised using 
experimental conditions (N17) 
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4.6.12 Optimisation Of Chemical Precipitation Factors 
The RSM study has aided in the development of six response models, relating the phase 
purity, crystallinity, crystallite sizes (L002 and L300), lattice parameter ratio and particle 
size to the three factors investigated. However, the design of experiments in this 
investigation excluded any experiment being conducted, which examined the effect of 
setting all three factors at the upper level, and for this reason the models developed in the 
fractional factorial design study (screening) are instead used to identify the most 
appropriate combination of factors in order to achieve the optimum response, with 
respect to the HAp powder characteristics studied. These models also incorporated the 
full list of chemical precipitation parameters (acid addition rate, reaction temperature, 
stirring speed, ripening time, initial calcium concentration, atmospheric control) of which 
have been shown in literature to determine the final powder characteristics. 
 
(A) HAp Powder Characteristics Optimisation 
The HAp powder characteristics were optimised again using the Design Expert software. 
The models developed for each response were used for the process optimisation. Design 
Expert enables both Numerical Optimisation and Graphical Optimisation. The Numerical 
Optimisation step was carried out first, since it is most efficient in the determination of 
optimal zones. This approach can be applied in Industry to save costs associated to the 
control of each factor (such as, an increase of reaction temperature, ripening time, stirring 
speed) to yield the desired response. Each response for optimisation was given a goal and 
a level of importance attached to it. 
 
The desired optimisation aims to produce a highly phase pure and crystalline (both 
>95%) HAp powder with a particle size not exceeding 100µm. This HAp powder will 
fully satisfy regulatory requirements for successful coating application onto orthopaedic 
implants via the thermal spraying technique. In order to achieve the desired powder 
characteristics, the phase purity, crystallinity and crystallite sizes (L002) were maximised 
in the optimisation. This is to ensure that levels of impurities are kept to a minimum to 
ensure that the final coatings do not dissolve at a quicker rate in vivo and that increased 
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levels of crystallinity can also provide stability in the final coating as opposed to 
amorphous ones which are found to dissolve quickly and lead to undesirable coatings. 
The crystallite size in the 300 plane however was minimised: since this crystallite size 
has previously been suggested to be smaller than that of the 002 plane in previous work 
carried out by Smiciklas et al. [85]. The lattice parameter ratio was also minimised, as 
this is related to the introduction of impurities incorporated into the final lattice. An 
increased ratio (+a and -c) has also been reported to decrease crystallinity and promote β-
TCP [64]. Since particles, exceeding 100µm are undesired, the response for particle size 
was kept within the range based on those obtained for each model.  
 
The importance level for each response within this desired optimisation analysis was 
selected. The phase purity and crystallinity were set to an importance level of 5. The 
lattice parameter ratio was set to an importance level of 3, while the particle size and 
crystallite sizes in the 002 and 300 plane were set to an importance level of 2. The goal 
and importance for each optimisation parameter used is shown in Table 4-45. 
 
Table 4-45 Design optimisation parameters 
 Goal Importance 
Phase purity (%) Maximise +++++ 
Crystallinity (%) Maximise +++++ 
Crystallite Size, L002 (nm) Maximise ++ 
Crystallite Size, L300 (nm) Minimise ++ 
Lattice parameter ratio, a/c Minimise +++ 
Particle size (µm) In Range ++ 
 
Design Expert has the capability in generating numerous possible solutions based on the 
optimisation criteria selected. The desirability (0 to 1) of each solution is indicated. The 
preferred settings can then be selected manually. The optimum solutions for the 
Fractional Factorial and Box-Behnken models are shown in Table 4-46 and compared 
against actual experimental results obtained at the same experimental conditions (that is, 
N16 from the fractional factorial (screening) model. The fractional factorial solution 
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shows that the model is predicting each response to be smaller in comparison to those 
obtained experimentally at the same conditions (N16). This can be attributed to the fact 
that the model is predicting the responses through incorporating the full set of models 
obtained, while the experimental conditions represent a true indication of the real values 
which can be obtained at the same conditions (factors). However, the model and the 
experimental conditions succeeded in verifying that the same set of factors were required 
in order to tailor the desired powder characteristics to meet with minimum regulatory 
requirements. The Box-Behnken design, however, provides a set of factors which do not 
match that of the N16 experimental set-up. Although it shows a high desirability of 0.695 
(in comparison to 0.447 for the Fractional Factorial design), the main regulatory 
requirements for minimum phase purity and crystallinity is not attained. Therefore, the 
effect of leaving out the acid addition rate, calcium concentration and atmospheric 
control is found to exert a major effect on producing a HAp powder satisfying the 
minimum regulatory requirements. Thus, researchers [71] cannot accurately optimise the 
desired HAp powder characteristics, while eliminating any of the influences for all of the 
precipitation process parameters as proved by Table 4-46. The other factors (acid 
addition rate, calcium concentration and atmospheric control) must also be included.  
 
A desirability bar graph for each response in both the Fractional Factorial and Box-
Behnken design is shown in Figure 4-83. The bar charts show that less important 
responses, (requiring control for regulatory purposes) received a high desirability rating 
than the more critical responses (such as, phase purity and crystallinity). However, in 
terms of actual, predicted and experimental results (N16), the overall realistic outcome 
benefits what is desired. 
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Table 4-46: HAp powder characteristics optimisation results 
 Optimised                    
Solutions  
Experimental FDA 
 Values Req. 
 BBD FFD N16  
Factor  
Acid addition rate (mol/min) 0.01 0.01 0.01  
Reaction temperature  (⁰C) 40 60 60  
Stirring speed  (rpm) 900 1500 1500  
Ripening time  (h) 48 48 48  
Calcium concentration (M) 2.0 2.0 2.0  
Atmospheric control (yes / no) yes no no  
     
Response  
Phase purity (%) 72.9638 97.5919 98.8886 >95 
Crystallinity (%) 79.2267 91.2467 95.1881 >95 
Crystallite Size, L002 (nm) 56.1037 102.0189 107.9240  
Crystallite Size, L300 (nm) 50.2599 85.6456 90.5307  
Lattice parameter ratio, a/c 1.3658 1.3692 1.3692  
Particle size (µm) 25.2888 19.2181 15.3800 <100 
Desirability 0.695 0.447   
     
 
Figure 4-83 further confirms that all of the process factors studied (3 or more) need to be 
set as high as possible in order to obtain the desired responses for a phase pure and highly 
crystalline HAp, of particle size not exceeding 100µm. 
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(A) 
 
(B) 
 
Figure 4-83: Desirability bar graph obtained for (A) the fractional factorial model and (B) 
the box-behnken model 
 
HAp possessing optimum powder characteristics for orthopaedic application via a 
thermal spray technique can therefore be prepared using the following chemical 
precipitation process parameters: Reaction Temperature 60ºC, Ripening Time 48h and 
Stirring Speed 1500rpm using high reagent concentrations. The presence of an inert 
environment is less critical at this temperature, as opposed to a lower temperature range 
of 20ºC. In the case of HAp synthesis at lower temperatures, the atmospheric control is 
desired in order to achieve high phase purity and crystallinity. 
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5 CONCLUSIONS AND 
RECOMMENDATIONS 
 
5.1 Conclusions 
In this study, the effect of the chemical precipitation process parameters were quantified, 
using mathematical models developed using the Design Expert software, in order to 
assess their main and interaction effects on the final HAp powder characteristics obtained 
under the experimental conditions based on the experimental design. This aided in an 
optimisation of the precipitation parameters to produce HAp powders which fully satisfy 
minimum regulatory requirements. The synthesis of such HAp, however, having attained 
these desired characteristics is heavily dependent on numerous precipitation process 
parameters. The conclusions resulting from the investigation are summarised into 
sections as follows: 
 
HAp Powder Characteristics 
The preliminary investigation of this study involved analysing the HAp powder 
characteristics of commercial powders (HAp3 - HAp5) and comparing these against the 
HAp powder properties currently being produced by industry in Ireland and America 
(HAp1 and HAp2 respectively). HAp was synthesised in-house (HAp6), under the same 
conditions as that disclosed by the HAp manufacturing company in Ireland: characterised 
and compared against that of the HAp1 and also against the commercial powders to gain 
an understanding of the most important synthesis parameters influencing the HAp 
powder characteristics. The main findings at this stage include: 
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(A) Phase composition and purity  
 Concerning the phase composition, XRD patterns shows that no foreign elements, 
such as sodium (Na
2+
), ammonium (NH 4 ), potassium (K+), chloride (Cl-) and 
nitrate (NO
3
) ions were involved in any of the reaction syntheses. The absence of 
these elements can be explained by the nature of the raw material (Ca(OH)2 and 
H3PO4) used as precursors. Moreover, for all the HAp studied, no CaO was 
observed. This indicated that there was small or indeed no carbonation of the HAp 
having occurred during the synthesis. For HAp1 and HAp6 produced without the 
aid of atmospheric condition, the absence of CaO indicated that this parameter 
had no significant influence on the final HAp purity.    
 
 Although no foreign elements were found for the six HAp: a significant amount 
of (β-TCP) phase was observed in the HAp6 powder. Minor traces of this phase 
were also observed for HAp3 and HAp5. Insignificant levels of α-TCP were also 
observed for HAp3 and HAp6.  This concludes that the conditions imposed in the 
synthesis of these three powders resulted in the formation of Ca-dHAp. The 
obtained patterns showed that the amount of this TCP varies with the HAp origin. 
The HAp6 powder contains the highest content of β-TCP while the HAp2 and 
HAp4 are the purest powders. The apparition of the β-TCP can be attributed to the 
high calcination temperature (1210ºC) or to the Ca-deficient nature of all HAp 
powders. The synthesis of such Ca-dHAp is attributed to the low reaction 
synthesis temperature (~20ºC), insufficient stirring speed (1000rpm), high acid 
addition rate (1.5 ml/min) and maturation time (24h). The calculated purity 
allowed the HAp classification as follows:   
HAp2 = HAp4 > HAp5 > HAp3 > HAp1 > HAp6. 
  
CHAPTER 5: Conclusions And Recommendations 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-310- 
(B) Crystallinity, lattice parameters and crystallite size 
 The crystallinity of the six HAp powders demonstrated that all powders, with the 
exception of HAp6, have crystallinity greater than the 95% minimum regulatory 
requirement. These results are attributed to the reaction conditions. The 
crystallinity depends on the temperature, ripening time and acid addition rate. The 
increase of the synthesis temperature and the ripening time and the decrease of the 
acid addition rate are found to improve the HAp crystallinity. The study of the 
influence of the heat treatment on crystallinity for HAp shows that sintering at 
1210ºC increases the HAp crystallinity from 71.06% to 92.60%. According to the 
crystallinity and purity results, HAp1 and HAp6 fail to meet regulatory (FDA) 
requirement. Therefore, a higher temperature, ripening time, stirring speed and 
lower acid addition rate appears to improve these essential HAp powder 
characteristics. The calculated crystallinity allowed the HAp classification as 
follows:   
HAp3 > HAp4 > HAp5 > HAp6 > HAp2 > HAp1 
 
 A relationship was found between the purity and the lattice parameters for the size 
HAp. With decreasing purity of HAp, the a/c ratio increased; that is, the lattice 
parameter of the a-axis slightly decreases, while that of the c-axis increased. This 
comportment can be due to a change in the Ca/P ratio and/or Ca/OH ratio in the 
HA. The highest lattice parameter in the a-axis of HAp6 compared to the pure 
HAp4 confirms the Ca-deficient nature of this powder. The calculated lattice 
parameter ratio allowed the HAp classification as follows:   
HAp1 > HAp6 > HAp5 ~ HAp3 > HAp4 > HAp2 
 
 Similar crystallite sizes were obtained for HAp1, HAp2 and HAp6, since all three 
HAp were prepared at ambient reaction temperature of the same synthesis route as 
opposed to the HAp3 and HAp4. HAp5 possessed the lowest level of crystallinity, 
which can be attributed to unknown processing parameters. Irish spray dried HAp 
with crystallite size of ~41nm was found to increase to ~122nm post sintering.   
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(C) Particle size, specific surface area, particle size distribution and density 
 For all six HAp studied, the particle size and specific surface area was 
determined. The order of mean particle size from the largest is as follows: HAp5 
> HAp4 > HAp2 > HAp1 > HAp3 > HAp6. All the HAp analysed have 90% of 
their particles <100μm; which is a requirement for the powder for successful 
thermal plasma spraying application onto orthopaedic implants. The fine particles 
of HAp1-3 and HAp6, compared to HAp4 and HAp5, can be due to low synthesis 
temperature, low reactant concentration, high acid addition rate and short 
maturation time. The influence of the ripening time appears clearly in the case of 
HAp6 matured during 24h compared to HAp1 and HAp2, of which were matured 
for longer ripening times.  
 
 The sintering temperature is also found to have an impact on the final HAp 
particle size obtained. Sintering carried out on the HAp6 at 1200ºC, increased the 
average particle size from 9.22μm to 13.39μm and HAp1 from 11 – 14μm up to 
21.94μm.  
 
 The particle size distributions for the six HAp were determined. The results show 
that HAp1, HAp2, HAp4 and HAp5 demonstrated a unimodal distribution, while 
HAp3 and HAp6 possessed a bimodal distribution. The bimodal distribution is 
due to the finer particle size of both these HAp. The study of the influence of the 
sintering on the particle size distribution demonstrated that HAp6 cyclone spray 
dried HAp (particle size= 9.76μm) presents a bimodal distribution pre and post 
sintering, while HAp6 chamber spray dried HAp (9.22μm) attains a bimodal 
distribution post sintering. The appearance of the bimodal distribution after 
sintering is probably due to the agglomeration of the finer particle size. 
 
 The density results indicated that all HAp met with the minimum requirement of 
FDA regulation. This means that the particle size of all the HAp were fine enough 
to reach desired density values. 
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(D) Morphology 
 HAp3 and HAp4 possessed the most spherical and regular shaped particles, 
indicative of enhanced rheological properties. This may also be attributed to the 
fact that the powders may have been synthesised at higher reaction temperatures, 
longer ripening times, lower concentration and idealised spray drying condition. 
Post heat-treatments (such as, flame spheroidisation) may also have been 
implemented to enhance its spherical nature. HAp5 appeared the most irregular in 
morphology. This may be explained by the hydrothermal route in which the 
powders were prepared.  
 
 HAp1, HAp2 and HAp6 possessed a similar morphology, with regular shaped 
agglomerated particles, with a lower surface smoothness than that of HAp3 and 
HAp4. An increased ripening time may be required here to increase the surface 
smoothness. 
 
(E) Rheology and density 
 In addition to the reaction conditions, the HAp powder quality can also be 
influenced by the spray drying conditions. During HAp spray drying, in addition 
to the process parameters, the HAp slurry rheology has an effect on the final dried 
powder properties.  In order to succeed this step the evolution of the suspension 
rheology properties during HAp synthesis was studied. Rheology measurements 
are also useful in following the course of a chemical reaction. The obtained results 
showed that the dynamic viscosity was found to increase from 15 – 17 mPa.s, 
during calcium hydroxide synthesis to 35 mPa.s after a 24h maturation phase. 
Time-dependent behaviour was exhibited for all HA slurry analyses during HAp 
production. During calcium hydroxide formation dilatent behaviour of the HAp 
slurry was most evident, while additions of orthophosphoric acid indicated 
thixotropic behaviour.  
 
CHAPTER 5: Conclusions And Recommendations 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-313- 
 The kinematic viscosities (ratio of dynamic viscosity to density) of the HAp1 and 
HAp6 are calculated and compared against the range of kinematic viscosities 
recommended by Luo et al. [108] to aid in producing non-porous controlled 
morphology (spherical) HAp powder particles in the desired micron range for 
plasma spray onto orthopaedic implants. The results indicate that both HAp1 and 
HAp6 slurries are within the range after the maturation phase of 24h. However, 
further mixing of the slurry prior to spray drying was found to significantly 
increase the kinematic viscosity of the HAp1 slurry.The HAp1 slurry density was 
also measured during the synthesis of HAp 1 and HAp6 (as shown in Section 4.3). 
The results indicate the increase of density during the HAp preparation. This 
behaviour is due to the increase of the powder particle size.  
 
 Rheological properties of the powders were found to linearly increase with 
increasing the particle size. 
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Screening of Chemical Precipitation Process Parameters 
The effects of the chemical precipitation process parameters (Vac, To, Vst, tr, Ca
2+
 and 
atm.) were investigated using a fractional factorial design on several responses (purity, 
crystallinity, crystallite size, lattice parameter ratio and particle size). The mathematical 
models developed to predict each response showed the order of factors to the level of 
significance relating to each response analysed, as follows: 
 
(A) Study of Effects 
 
 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on the phase purity follows the order:  (Vac* Vst) 
> (Vac* To* atm.) > (tr) > (To) > (Vac* tr) > (atm.) > (To* atm.) while the order of 
the level of significance of the negative effects on the phase purity is as follows:  
(To* tr) > (Vac* Ca
2+
) > (Ca
2+
). 
 
 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on crystallinity follows the order:  (tr) > (To* 
atm.) > (Vac* Ca
2+
) > (Vst) > (To* tr) > (Vac) while the order of the level of 
significance of of the negative effects on the phase purity is as follows: (atm.) > 
(Vac* Vst) .  
 
 The order of the level of significance of the positive effects on the L002 model, 
from the most significant,  follows the order:  (atm.) > (To* tr) > (Ca
2+
) > (Vac* tr) 
> (Vst)  > (To * atm.),  while the only negative effect to significantly affect the 
L002 model is the ripening time (tr). The order of the level of significance of the 
most significant positive effects on the L300 model follows the order: (Vst) > (Vac * 
To * atm.) > (To * tr) > (Vac * To), while the order of the level of most significant 
negative effects follows the order: (Vac* atm.) > (tr) > (Vac) > (Vac* atm.) for the 
L002 model. 
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 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on the a/c ratio follows the order:  (Ca
2+
) > (Vac* 
To) while the order of the level of significance of the negative effects on the 
lattice parameter ratio is as follows: (tr) > (Vst) > (To) > (Vac* Ca
2+
) > (Vac* Vst). 
 
 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on the actual particle size follows the order:  
(Vac* To) > (To * tr) > (atm.) while the order of the level of significance of the 
negative effects on the lattice parameter ratio is as follows: (To) > (Ca
2+
) > (Vac* 
Ca
2+
) > (Vac* atm.) > (Vst). 
 
 
(B) Morphology 
 An increase of the synthesis temperature (N1 to N4 and N14 to N16) is found to 
lead to more regular spherical HAp particles. 
 
 
(C) Powder flowability 
 The flowability of the powder studied in this investigation follow the same order 
as that of the mean particle size:  
 
N9 → N1 → N6 → N5 → N14 → N12 →N4 → N2 → N15 → N13 → N10 → 
N3 → N8 → N11 → N7 → N16 
 
 
In summary, both the ripening time and stirring speed significantly affect the majority of 
the responses (effecting five responses), with the reaction temperature also having a 
significant effect on the purity, a/c ratio and particle size. 
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Osteoblast Behaviour in Contact with HAp 
 
(A) Cell content and viability 
 The most favourable result during the cell viability test were for N16, where after 
a 7 day incubation period, it appears to suggest that powders possessing a higher 
crystallinity have the capacity to yield higher counts of cell viability.  
 
(B) Cell proliferation 
 The cells counts increase with the increase of powder crystallinity. Indeed, 
osteoblast grows well on N16, N15, N10 and N9 powders having crystallinity in 
the range of  ~70 to ~95%  than on the others.  
 
(C) Morphology 
 In contact with N3, N10, N15 and N16 powders, the cells showed a diffuse 
spread-like morphology with several cytoplasmatic extensions contacting the 
powder, while in the case of N4, N5, N6 and N9, the cells were elongated with 
fewer extensions interacting with apatite granules. Control cultures (HAp1 and 
HAp5) showed a uniform layer of confluent cells with a frequent elongated shape 
and also overlapping growth 
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Optimisation of Chemical Precipitation Process Parameters 
The effects of the chemical precipitation process parameters (To, Vst, tr,) were 
investigated using a box-behnken design on several responses (purity, crystallinity, 
crystallite size, lattice parameter ratio and particle size). The mathematical models 
developed to predict each response showed the order of factors to the level of 
significance relating to each response analysed, as follows: 
 
 
(A) Study of Effects 
 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on the phase purity follows the order: (Vst
2
) > 
(Vst) while the order of the level of significance of the negative effects on the 
lattice parameter ratio is as follows: (To). 
 
 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on the crystallinity follows the order:  (To
2
) > (tr
2
) 
> (Vst) > (To) > (To * Vst) > (Vst
2
) while the order of the level of significance of the 
negative effects on the lattice parameter ratio is as follows: (Vst* tr) > (To * tr).he 
order of significance for these effects follows the order: To
2
 > tr
2 
> Vst > To > To * 
Vst > Vst * tr > To * tr > Vst
2
 
 
 The two effects are positively affecting the crystallite size (L002) in the same order 
as shown previously:  tr
2
 > To. 
 
 The only positive effects of the chemical precipitation process parameters on the 
crystallite size (L300) is (To) while the order of the level of significance of the 
negative effects on the lattice parameter ratio is as follows: (To
2
) > (tr
2
). 
 
 The order of the level of significance of the positive effects of the chemical 
precipitation process parameters on the lattice parameter ratio follows the order:  
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(tr
2
) > (To) > (Vst) while the order of the level of significance of the negative 
effects on the lattice parameter ratio is as follows: (tr) > (Vst
2
) > (To* Vst). 
 
 All of the significant effects are positively affecting the lattice parameter ratio in 
the order as follows:  (tr
2
) > (Vst * tr) > (To). 
 
 The order of mean particle size from the largest is as follows:  
N6 → N9 → N8 → N12 → N3 →N16 → N1 → N17 = N10 → N15 →N4 →N7 
→ N5 → N14 → N11 → N2 → N13 
 
 
(B) Morphology 
 This experimental conditions of the box-behnken design confirm that an increase 
of the synthesis temperature (N1 to N2) is found to lead to more regular spherical 
HAp particles.   
 A qualitative examination of the positive effect of the interaction between the 
reaction temperature and the srirring speed (N9 to N5 and N6 to N10) 
demonstrates how the powder particle size increases in correspondence to a more 
idealised spherical morphology.  
 Examining the effect of increasing the stirring speed (N9 to N10), in isolation of 
the other factors, however also demonstrates a favaourable effect on the resultant 
morphology. Another positive interaction effect between the stirring speed and 
the ripening time (N5 to N3), while a reduction in the stirring speed coupled with 
an increase in ripening time also demonstrates an enhanced spherical powder 
morphology. This would suggest that the stirring speed is the least significant 
factor affecting this resposne. 
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HAp possessing optimum powder characteristics for orthopaedic application via a 
thermal spray technique can therefore be prepared using the following chemical 
precipitation process parameters: Reaction Temperature 60ºC, Ripening Time 48h and 
Stirring Speed 1500rpm using high reagent concentrations. The presence of an inert 
environment is less critical at this temperature, as opposed to a lower temperature range 
of 20ºC. In the case of HAp synthesis at lower temperatures, the atmospheric control is 
desired in order to achieve high phase purity and crystallinity. 
 
 
5.2 Recommendations For Future Work 
The results documented in this research are significant, however further 
recommendations are as follows: 
 
Chemical Analyses 
Chemical testing of the HAp during the course of precipitation could be conducted 
through either XRF (X-ray Flourescence) or simple chemical analyses, such as EDTA 
and photospectrophotometry in order to evaluate the calcium and phosphate content of 
the HAp, respectively. This could be used to determine the specific Ca/P ratio throughout 
the course of the precipitation reaction, and hence determine the minimum ripening time 
required to produce stoichiometric HAp for each set of conditions.  
 
Kinetics study 
To investigate the HAp precipitation mechanisms, the transformation process could be 
investigated under different conditions, including the optimal ones. The results obtained 
could be used for the determination of the kinetic equation of the transformation and in 
some cases for some applications to guide the choice of the appropriate ripening time in 
function of the desired crystallinty, phase composition, particle size, density, specific 
surface area and powder particle morphology. 
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Investigation of the precipitation mechanisms  
In literature, only Liu et al. [91] have studied the kinetic equation of transformation under 
determined conditions. They demonstrated that the reaction of the transformation from 
ACP to HAP was a particle surface reaction controlled process whose magnitude of 
activation energy was 22.7 kcal/mol energy greater than the activation energy of other 
reactions in solution (5 kcal/mol). However, no precision was given about the 
mechanisms that limit such precipitation reaction. Therefore, an investigation could be 
carried out to make it clear that, it was controlled either by the dissolution of the grains or 
by the entrance of calcium and phosphate ions into the vacancy of crystal lattice. The 
results could then be used as the theoretical foundation for solving the scale-up problem 
for HAp synthesis. 
 
Modelling 
Modelling using computational fluid dynamics (such as, MixSim) could be used to better 
understand the complicated phenomena of the precipitation process. The moment 
transformations of the population balances, taking into account the chemical and 
crystallisation kinetics to describe the generation and transportation of the crystal phase. 
The influence of hydrodynamics in the stirred tank, as characterised by the stirrer speed, 
impeller location and feed location on the distribution of supersaturation and subsequent 
crystal size distribution could also be investigated to examine the effect of the stirrer set-
up on the final homogeneity of the HAp powder. 
 
Further Experimental Design Investigation 
Further work could extend to building a Box-Behnken design, incorporating all six of the 
influencing factors (reaction temperature, acid addition rate, stirring speed, ripening time, 
initial calcium concentration and atmospheric control) and obtaining mathematical based 
models to accurately predict their effect on the HAp powder characteristics. 
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APPENDIX A 
 
Figure A1: Computer aided drawing (2D) of the chemical precipitation set-up  
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Figure A2: Computer aided drawing (2D) of the the base plate (part 1)  
 
Figure A3: Computer aided drawing (2D) of the base plate (part 2)  
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Figure A4: Computer aided drawing (2D) of the sliding plate  
 
Figure A5: Computer aided drawing (2D) of the stirrer arm-hold  
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Figure A6: Computer aided drawing (2D) of the top plate  
 
Figure A7: Computer aided drawing (2D) of the upright supports 
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APPENDIX B 
 
Design Expert software was also used to correlate between the process factors and the 
responses using the Multiple Linear Regression (MLR) method for both the screening 
(fractional factorial) experimental design and the optimisation (box-behnken) design. 
With MLR, the coefficients of the model are computed to minimise the sum of squares of 
the residuals, (that is, the sum of squared deviations between the observed and fitted 
values of each response). The least squares regression method yields small variances for 
the coefficients and small prediction errors. It is also important to note that MLR 
separately fits one response at a time and hence assumes them to be independent 
 
For both the screening and optimisation approach, an iterative model fitting process was 
used in this research. First, a full linear/quadratic model is assumed, and significance tests 
(t-tests) are performed on each model coefficient. Insignificant terms are removed and the 
fitting process is repeated again, using a linear/quadratic model. The significance tests are 
repeated and insignificant terms, if any, are removed. The process is repeated until there 
are no insignificant terms. At this point, if the model contains two-factor interaction or 
quadratic terms, it is checked for hierarchy. Hierarchical terms are linear terms that may 
be insignificant by themselves but are part of significant higher order terms. For example, 
x1 and x3 are hierarchical terms of x1x3, a two-factor interaction term. If x1x3 is a 
significant term in the model, x1 and x3 are usually included in the model to maintain 
hierarchy. A hierarchical model allows for conversion of models between different sets of 
units. The elimination of insignificant terms can be performed, either manually or 
automatically. The three automatic procedures of evaluating all possible regression 
equations (or selection of variables) are explained in the following sections [160]. 
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A. Forward Selection Procedure 
This procedure begins with only the constant term, and the first variable added is the one 
with the highest simple correlation with y. If the regression coefficient of this variable is 
significant it remains in the equation and a new search for the second variable with 
highest correlation with y is begin, after y has been adjusted for the effect of the first 
variable and the significance of the regression coefficient of the second variable is then 
tested. If the regression coefficient is significant, a search for a third variable is made in 
the same way. The procedure is completed when the last variable entered to the equation 
has insignificant regression coefficient or all variables are included. The test statistic for 
this selection procedure is the standard t or F-statistic (which equal to t
2
). 
 
B. Backward Elimination Procedure 
In this procedure, the full equation is fitted and sequentially eliminates one variable each 
time. The variable with the smallest contribution to the reduction of error is eliminated 
first, or the variable with the smallest t ratio (that is, the ratio of the regression coefficient 
to its standard error) and so on. In the case of more than one variable that have 
insignificant t ratio, the procedure operates by dropping the variable with the smallest 
insignificant t ratio and the equation with the remaining variable is then fitted and the 
ratios for the new regression coefficient are tested. The procedure stopped when all the t 
ratios are significant or all but one variable has been deleted. 
 
C. Stepwise Regression Method  
This method is basically a Forward selection. However, the possibility of eliminating a 
variable that might be added in earlier stage, as in backward procedure, is considered. 
The calculation made for inclusion and deletion of variables are the same as Forward and 
Backward procedures. This procedure has the advantage of assuming different or similar 
levels of significance for inclusion or deletion of variables from the regression equation. 
 
At this stage the final reduced model can be build up as determined by applying the 
above steps. This model contains only the significant terms and the terms, that necessary 
to maintain hierarchically. Also, a reduced quadratic ANOVA table can be produced.  
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Methods For Determining The Significance Of The Regression Coefficients 
(Experimental Factors) 
 
Once the model fitting is performed, the next step is residual analysis to validate the 
assumptions used in the ANOVA and assess the graphical representations (such as, 
Pareto charts and normalized plots). A description of each is discussed in this section. 
 
A. ANOVA 
The ANalysis Of VAriance (ANOVA) was used to test the adequacy of the models 
developed. The statistical significance of the models developed and each term in 
regression equation were examined using the sequential F-test, lack-of-fit test and other 
adequacy measures (such as, R
2
, Adj- R
2
, Pred. R
2
 and Adq. Precision ratio) using the 
same software to obtain the best fit.  The Prob.>F (sometimes, it is called the p-value) of 
the model and of each term in the model can be computed by means of ANOVA. If the 
Prob.> F of the model and of each term in the model does not exceed the level of 
significance ( = 0.05) then the model may be considered adequate within the confidence 
interval of (1- ). For the lack-of-fit test, the lack of fit could be considered insignificant 
if the Prob.>F of the lack of fit exceeds the level of significance. Table 3-11 below shows 
a summary of the ANOVA table (from this research). The equations by which the 
adequacy measures can be calculated are shown below using Equations. 3.4 to 3.8 [160, 
167].  
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Table C1: ANOVA table of full model in the box-behken design 
Source SS df MS Fcal.- Value 
p-value 
or Prob > F 
Model SSM p 
Each SS 
divided by its 
df 
Each MS divided by 
MSE 
From table or 
software library 
 
A-Synthesis 
Temperature 
SS1 1 
B-Stirring speed SS2 1 
C-Ripening 
Time 
SS3 1 
AB SS12 1 
AC SS13 1 
BC SS23 1 
A^2 SS11 1 
B^2 SS22 1 
C^2 SS33 1 
Residual SSR N-p-1 - 
Lack of Fit SSlof N – p – n0 From table 
Pure Error SSE n0 - 1 - 
Cor Total SST N - 1 - - - 
Where; P is the number of coefficients in the model, N is the total number of runs, n0 is the number of 
centre points, df is the degree of freedom, MS is the mean square and SS is the sum of squares 
 
R
2
 is a measure of the variation around the mean explained by the model, such that: 
                                      
                                              MR
R
SSSS
SS
R 12                                Equation (1)  
 
Where, SSR is the residual sum of squares and SSM is the mean sum of squares. Adj R
2
 is 
a measure of the variation around the mean explained by the model, adjusted for the 
number of terms in the model, such that: 
 
         
1
2 1
MR
MR
R
R
dfdf
SSSS
df
SS
AdjR                               Equation (2) 
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Where SSR is the residual sum of squares and SSM is the mean sum of squares, dfM is the 
model degrees of freedom and dfR is the residual degrees of freedom. Predicted R
2
 is a 
measure of the amount of variation in new data explained by the model, whereby: 
 
                                                MR
SSSS
PRESS
edR 1Pr 2                    Equation (3) 
 
Where PRESS is the predicted residual error sum of squares; a measure of how the model 
fits each point in the design. The PRESS is computed by first predicting where each point 
should be from a model that contains all other points except the one in question. The 
square residuals (difference between actual and predicted values) are then summed as 
follows: 
 
                                                  
2
,
1
)ˆ( ii
n
i
i yyPRESS                               Equation (4) 
 
The Adequate precision is a signal to noise ratio and compares the range of the predicted 
values at the design points to the average prediction error. Ratios greater than 4 indicate 
adequate model discrimination. 
                                
n
n
MSp
YMinYMax
precisionAdeq
R
2)ˆ()ˆ(
.                   Equation (5) 
 
Where; MSR is the root mean square, p is the number of model parameters (including 
intercept b0), n is the number of experiments, and δ
2
 is the residual mean square from the 
ANOVA table.  
 
  
Appendices 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-B6- 
B. Pareto Charts 
A graphical display of data, Pareto charts and main effect plots, which were obtained 
after performing MLR and ANOVA, were used to identify the relationship between the 
input variables (for example, reaction synthesis temperature) and the system responses 
(for example, crystallinity). The change in response, produced by the change in the level 
of a variable, is the effect of that variable. The Pareto chart analyses the magnitude and 
the importance of each process variable effect. The length of bars in the bar chart is 
proportional to the standardized effect (estimated effect divided by its standard error). 
From this chart, absolute values of effects can be compared. The mean for a given level 
of variable is the average of all responses obtained for that level. So, the response means 
for each process variable level are plotted connecting the points for each process variable. 
The main effect plot is useful to determine which process variables influence the 
response and also to compare the relative strengths of effects. The relative magnitudes of 
the process variable effects can be compared by comparing the slopes of the lines (the 
greater the degree of departure from horizontal, the stronger the effect). In contrast to the 
Pareto chart, which compares absolute values of effects, the main effect plot provides 
additional information on whether the change between two variable levels decreases or 
increases the response. Plots such as main/interaction effects, 3D graphs and contours 
were also examined to present the factor effects on the responses found.  
 
  
Appendices 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-B7- 
OPTIMISATION 
 
Desirability Approach 
The desirability method is recommended due to its simplicity, availability in the software 
and provides flexibility in weighting and giving importance for individual response. 
Solving such multiple response optimisation problems using this technique consists of 
using a technique for combining multiple responses into a dimension less measure 
performance called overall desirability function. The desirability approach consists of 
transforming of each estimated response, Yi, into a dimensionless utilities bounded by 0 < 
di < 1, where a higher di value indicates that the response value Yi is more desirable, if di 
= 0 this means a completely undesired response or vice versa when di = 1 [160]. In the 
current research the individual desirability for each response di was calculated using 
Equations 3-9 to 3-12. The shape of the desirability function can be changed for each 
goal by the weight field ‗wti‘. Weights are used to give added emphasis to the 
upper/lower bounds or to emphasize the target value. Weights could be ranged between 
0.1 and 10 where weight greater than one gives more emphasis to the goal, while weight 
less than one gives less emphasis to the goal. With weight value of one, this will make 
the di‘s vary from zero to one in a linear mode. In the desirability objective function (D), 
each response can be assigned an importance (r), relative to the other responses. 
Importance varies from the least important a value of 1(+), to the most important a value 
of 5(+++++). If the varying degrees of importance are assigned to the different responses, 
the overall objective function is shown below in Equation 3-13. Where n is the number of 
responses in the measure and Ti is the target value of i
th 
response [160]. 
 
For a goal of maximum response, the desirability would be defined by: 
ii
iii
wt
ii
ii
ii
i
HighY
HighYLow
LowHigh
LowY
LowY
d
i
,1
,
,0
      Equation (6) 
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For a goal of minimum, the desirability defined by: 
ii
iii
wt
ii
ii
ii
i
HighY
HighYLow
LowHigh
YHigh
LowY
d
i
,0
,
,1
                 Equation (7) 
 
For a goal as a target, the desirability defined by: 
Otherwise
HighYT
HighT
HighY
TYLow
LowT
LowY
d
iii
wt
ii
ii
iii
wt
ii
ii
i
i
i
,0
,
,
2
1
                             Equation (8) 
  
For a goal within range: 
Otherwise
HighYLow
d
iii
i
,0
,1
                    Equation (9) 
 
the desirability will be defined by: 
 
i
i
rn
i
r
idD
1
1
                   Equation (10) 
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Optimisation Approach In Design - Expert Software 
The optimisation part in Design-Expert software searches for a combination of factor 
levels that simultaneously satisfy the requirements placed (that is, optimisation criteria) 
on each one of the responses and process factors (multiple response optimisation). 
Numerical and graphical optimisation methods were used in this work by choosing the 
desired goals for each factor and response. As mentioned previously, the numerical 
optimisation process involves combining the goals into an overall desirability function 
(D). The numerical optimisation feature in the design expert software package finds a 
point or more in the factors domain that would maximise this objective function. In a 
graphical optimisation with multiple responses, the software defines regions where 
requirements simultaneously meet the proposed criteria. Superimposing or overlaying 
critical response contours on a contour plot. Then, a visual search for the best 
compromise becomes possible. In the case of dealing with many responses, it is 
recommended to do numerical optimisation first, otherwise it could be impossible to 
uncover a feasible region. The graphical optimisation displays the area of feasible 
response values in the factor space. The regions that do not fit the optimisation criteria 
are therefore shaded [160].  
Dynamic viscosity flow curves of the HAp slurry during HAp synthesis via the chemical 
precipitation technique, using calcium hydroxide and orthophosphoric acid as the reagents are 
presented in this Appendix.
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APPENDIX C 
 
 
 
Figure B1: Computer aided drawing (2D) of the upright supports  
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APPENDIX D 
 
Figure D1: Flow curves for HAp slurry during calcium hydroxide formation 
(a) 
 
(b) 
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Figure D2: Flow curves for HAp slurry during addition of orthosphosphoric acid 
(a) 
 
(b) 
 
(c) 
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(d) 
 
(e) 
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Figure D3: Flow curve for HAp slurry during HAp maturation 
(a) 
 
(b) 
 
(c) 
 
 
Pre-Spray Dry Mix (Maturation Stage) after 17.75h - 
Behaviour with Time
0.00
5.00
10.00
15.00
20.00
25.00
30.00
35.00
40.00
45.00
50.00
0 50 100 150 200 250 300
Time (sec)
V
is
c
o
s
it
y
 (
m
P
a
.s
)
Pre-Spray Dry Mix (Maturation Stage) after 19.25h - 
Behaviour with Time
57
58
59
60
61
62
63
64
65
66
67
0 50 100 150 200 250 300
Time (sec)
V
is
c
o
s
it
y
 (
m
P
a
.s
)
Pre-Spray Dry Mix (Maturation Stage) after 20.83h - 
Behaviour with Time
0
5
10
15
20
25
30
35
0 50 100 150 200 250 300
Time (sec)
V
is
c
o
s
it
y
 (
m
P
a
.s
)
Appendices 
 
Optimisation of Hydroxyapatite (HAp) for Orthopaedic Application via the Chemical Precipitation Technique 
S. Kehoe 
-E1- 
APPENDIX E 
Figure E1: Repeatability results (for FFD) for phase purity (A), crystallinity (B), crystallite 
size in the 002 and 300 plane (C and D) and lattice parameters a and c (E and F) 
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APPENDIX F 
 
Figure F1: XRD patterns for N1, N2, N7 and N8 
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Figure F2: XRD patterns for N11 – N14 
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Figure F3: XRD patterns for N3 – N6 
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Figure F4: XRD patterns for N9, N10, N15 and N16 
 
